Updated on 2024/10/18

写真a

 
MATSUKAWA Akihiro
 
Organization
Faculty of Medicine, Dentistry and Pharmaceutical Sciences Professor
Position
Professor
External link

Degree

  • Doctor of Philosophy (Medicine) ( Kumamoto University )

Research Interests

  • Cytokine/Chemokine

  • Signal Transduction

  • Innate Immunity

  • Inflammation and Cancer

  • Infllamtion

Research Areas

  • Life Science / Experimental pathology

  • Life Science / Immunology

Education

  • Kumamoto University    

    1989.4 - 1993.3

      More details

    Country: Japan

    researchmap

  • Kumamoto University    

    1981.4 - 1987.3

      More details

Research History

  • 岡山大学医学部学部長補佐

    2022.10

      More details

  • 岡山大学医学部長補佐

    2019.4 - 2021.3

      More details

  • 岡山大学医学部副学部長

    2017.4 - 2019.3

      More details

  • 岡山大学全学教育・学生支援機構副機構長

    2017.4 - 2018.3

      More details

  • Sub-leader, University reform project, Okayama University

    2017.4 - 2018.3

      More details

  • 岡山大学高等教育開発推進室副室長

    2016.4 - 2018.3

      More details

  • 岡山大学副理事(大学改革担当)

    2016.4 - 2017.3

      More details

  • Okayama University   Medical School, Faculty of Medicine

    2015.4 - 2017.3

      More details

  • 岡山大学高等教育開発推進機構副機構長

    2014.10 - 2016.3

      More details

  • President's Aide, Okayama University

    2014.4 - 2016.3

      More details

  • 岡山大学高等教育開発推進機構設置準備室室長

    2014.4 - 2014.9

      More details

  • 岡山大学医歯薬学総合研究科医学教育リノベーションセンター長

    2012.4 - 2018.3

      More details

  • Vice Dean,Faculty of Medicine,Medical School,Okayama University

    2011.4 - 2015.3

      More details

  • Chief, education affair

    2009.4 - 2015.3

      More details

  • 岡山大学動物実験委員会委員長

    2006.4 - 2024.3

      More details

  • 岡山大学自然生命科学研究支援センター動物資源部門長

    2006.4 - 2024.3

      More details

  • 岡山大学医歯薬学総合研究科 教授

    2005.10

      More details

  • 熊本大学大学院医学薬学研究科 助教授

    2004.1 - 2005.9

      More details

  • 熊本大学大学院医学薬学研究科 講師

    2003.1 - 2004.1

      More details

  • ミシガン大学医学部病理学研究員

    1998.7 - 1999.4

      More details

  • Chief research fellow

    1998.5 - 2001.2

      More details

  • 熊本大学医学部 助手(第一病理)

    1993.11 - 2002.12

      More details

  • 熊本大学医学部附属病院 医員(整形外科)

    1993.4 - 1993.10

      More details

  • 菊水町立病院研修医(整形外科)

    1988.7 - 1989.3

      More details

  • Kumamoto University   University Hospital

    1987.6 - 1988.6

      More details

▼display all

Professional Memberships

▼display all

Committee Memberships

  • 日本サイトカイン学会   運営委員  

    2023.7   

      More details

    Committee type:Academic society

    researchmap

  • 日本病理学会秋期大会   学会副会長  

    2021.11   

      More details

    Committee type:Academic society

    researchmap

  • 日本臨床細胞学会   学会副会長  

    2019.11   

      More details

    Committee type:Academic society

    researchmap

  • 岡山県臨床細胞学会   学会会長  

    2019.7   

      More details

    Committee type:Academic society

    researchmap

  • 日本学術振興会   科研費応募書類審査委員  

    2019.4 - 2023.3   

      More details

    Committee type:Other

    researchmap

  • 岡山県臨床細胞学会   学会長  

    2017.4   

      More details

    Committee type:Academic society

    researchmap

  • Nature Group   Scientific reports, associate editor  

    2015.4   

      More details

    Committee type:Other

  • 日本病理学会   Pathology International 常任刊行委員  

    2014.4   

      More details

    Committee type:Academic society

  • マクロファージ分子細胞生物学研究会   運営委員  

    2014.4 - 2023.6   

      More details

    Committee type:Academic society

    researchmap

  • 日本炎症再生学会   Editorial Board Member of Inflammation and Regeneration  

    2011.4   

      More details

    Committee type:Academic society

  • 日本臨床細胞学会岡山県支部   広報委員会  

    2011.4 - 2017.3   

      More details

    Committee type:Academic society

    researchmap

  • マクロファージ分子細胞生物学研究会   幹事  

    2011.4 - 2014.3   

      More details

    Committee type:Academic society

    researchmap

  • 日本病理学会   研修委員会委員  

    2008.4 - 2010.3   

      More details

    Committee type:Academic society

    researchmap

  • 日本病理学会中国四国支部   学術評議員  

    2007.4 - 2011.3   

      More details

    Committee type:Academic society

    researchmap

  • 日本病理学会   評議員  

    2004.4   

      More details

    Committee type:Academic society

    researchmap

  • 日本炎症・再生学会   評議員  

    2003.4   

      More details

    Committee type:Academic society

    researchmap

▼display all

 

Papers

  • Loss of Nr4a1 ameliorates endothelial cell injury and vascular leakage in lung transplantation from circulatory-death donor. International journal

    Shinichi Kawana, Mikio Okazaki, Tomohisa Sakaue, Kohei Hashimoto, Kentaro Nakata, Haruki Choshi, Shin Tanaka, Kentaroh Miyoshi, Shinji Ohtani, Toshiaki Ohara, Seiichiro Sugimoto, Akihiro Matsukawa, Shinichi Toyooka

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation   2024.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Ischemia-reperfusion injury (IRI) stands as a major trigger for primary graft dysfunction (PGD) in lung transplantation (LTx). Especially in LTx from donation after cardiac death (DCD), effective control of IRI following warm ischemia (WIRI) is crucial to prevent PGD. This study aimed to identify the key factors affecting WIRI in LTx from DCD. METHODS: Previously reported RNA-sequencing dataset of lung WIRI was reanalyzed to identify nuclear receptor subfamily 4 group A member 1 (NR4A1) as the immediate early gene for WIRI. Dynamics of NR4A1 expression were verified using a mouse hilar clamp model. To investigate the role of NR4A1 in WIRI, a mouse model of LTx from DCD was established using Nr4a1 knockout (Nr4a1-/-) mice. RESULTS: NR4A1 was located around vascular cells, and its protein levels in the lungs increased rapidly and transiently during WIRI. LTx from Nr4a1-/- donors significantly improved pulmonary graft function compared to wild-type donors (P < 0.001). Histological analysis showed decreased microvascular endothelial cell death (P = 0.007), neutrophil infiltration (P < 0.001), and albumin leakage (P < 0.001). Evans blue permeability assay demonstrated maintained pulmonary microvascular barrier integrity in grafts from Nr4a1-/- donors, correlating with diminished pulmonary edema (P < 0.001). However, NR4A1 did not significantly affect the inflammatory response during WIRI, and IRI was not suppressed when a wild-type donor lung was transplanted into the Nr4a1-/- recipient. CONCLUSIONS: Donor NR4A1 plays a specialized role in the positive regulation of endothelial cell injury and microvascular hyperpermeability. These findings demonstrate the potential of targeting NR4A1 interventions to alleviate PGD and improve outcomes in LTx from DCD.

    DOI: 10.1016/j.healun.2024.09.028

    PubMed

    researchmap

  • Exosomal delivery of miR-200b-3p suppresses the growth of hepatocellular carcinoma cells by targeting ERG- and VEGF-mediated angiogenesis. Reviewed International journal

    Yuze Wang, Aye Moh-Moh-Aung, Tianyi Wang, Masayoshi Fujisawa, Toshiaki Ohara, Ken-Ichi Yamamoto, Masakiyo Sakaguchi, Teizo Yoshimura, Akihiro Matsukawa

    Gene   148874 - 148874   2024.8

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Hepatocellular carcinoma (HCC) remains a lethal malignancy with limited treatment options. Recent discoveries have highlighted the pivotal role of miRNAs in HCC progression. We previously reported that the expression of miR-200b-3p was decreased in HCC cells and exosomal miR-200b-3p from hepatocytes inhibited angiogenesis by suppressing the expression of the endothelial transcription factor ERG (erythroblast transformation-specific (ETS)-related gene), leading to the hypothesis that the delivery of this miRNA may inhibit angiogenesis and suppress HCC growth in vivo. Here, we tested this hypothesis by using human HCC inoculation models. First, we transfected the human HepG2 HCC cells and established a stable cell line that overexpressed a high level of miR-200b-3p. When miR-200b-3p-overexpressing cells were injected into severe combined immunedeficiency (SCID)-beige mice, tumor growth was significantly reduced compared to tumors of control cells, with a reduction in the expression of ERG and vascular endothelial growth factor (VEGF) and subsequent angiogenesis. Intra-tumoral injection of exosomes containing high levels of miR-200b-3p also reduced the growth of parental HepG2 tumors with reduced ERG and VEGF expression and angiogenesis. These results validate the inhibitory role of miR-200b-3p in tumor angiogenesis, thereby suppressing HCC tumor growth, and provide a novel insight into its potential therapeutic application.

    DOI: 10.1016/j.gene.2024.148874

    PubMed

    researchmap

  • SPRED2 Is a Novel Regulator of Autophagy in Hepatocellular Carcinoma Cells and Normal Hepatocytes. Reviewed International journal

    Tianyi Wang, Tong Gao, Masayoshi Fujisawa, Toshiaki Ohara, Masakiyo Sakaguchi, Teizo Yoshimura, Akihiro Matsukawa

    International journal of molecular sciences   25 ( 11 )   2024.6

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Sprouty-related enabled/vasodilator-stimulated phosphoprotein homology 1 domain containing 2 (SPRED2) is an inhibitor of the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway and has been shown to promote autophagy in several cancers. Here, we aimed to determine whether SPRED2 plays a role in autophagy in hepatocellular carcinoma (HCC) cells. The Cancer Genome Atlas (TCGA) Liver Cancer Database showed a negative association between the level of SPRED2 and p62, a ubiquitin-binding scaffold protein that accumulates when autophagy is inhibited. Immunohistochemically, accumulation of p62 was detected in human HCC tissues with low SPRED2 expression. Overexpression of SPRED2 in HCC cells increased the number of autophagosomes and autophagic vacuoles containing damaged mitochondria, decreased p62 levels, and increased levels of light-chain-3 (LC3)-II, an autophagy marker. In contrast, SPRED2 deficiency increased p62 levels and decreased LC3-II levels. SPRED2 expression levels were negatively correlated with translocase of outer mitochondrial membrane 20 (TOM20) expression levels, suggesting its role in mitophagy. Mechanistically, SPRED2 overexpression reduced ERK activation followed by the mechanistic or mammalian target of rapamycin complex 1 (mTORC1)-mediated signaling pathway, and SPRED2 deficiency showed the opposite pattern. Finally, hepatic autophagy was impaired in the liver of SPRED2-deficient mice with hepatic lipid droplet accumulation in response to starvation. These results indicate that SPRED2 is a critical regulator of autophagy not only in HCC cells, but also in hepatocytes, and thus the manipulation of this process may provide new insights into liver pathology.

    DOI: 10.3390/ijms25116269

    PubMed

    researchmap

  • Innovative submucosal injection solution for endoscopic resection with phosphorylated pullulan: a preclinical study. Reviewed International journal

    Takuya Satomi, Yukari Ochi, Takumi Okihara, Hiroki Fujii, Yasuhiro Yoshida, Katsumi Mominoki, Haruko Hirayama, Junki Toyosawa, Yasushi Yamasaki, Seiji Kawano, Yoshiro Kawahara, Hiroyuki Okada, Motoyuki Otsuka, Akihiro Matsukawa

    Gastrointestinal endoscopy   99 ( 6 )   1039 - 1047   2024.6

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND AND AIMS: A submucosal injection solution is used to assist in endoscopic surgery. The high viscosity of current solutions makes them difficult to inject. In the present study, we developed an extremely low-viscosity, easy-to-use submucosal injection solution using phosphorylated pullulan (PPL). METHODS: The PPL solutions were prepared at different concentrations, and their viscosities were measured. The mucosal elevation capacity was evaluated using excised porcine stomachs. Controls included 0.4% sodium hyaluronate (SH), 0.6% sodium alginate (SA), and saline. To evaluate the practicality, the catheter injectability of 0.7% PPL was measured, and EMR and endoscopic submucosal dissection (ESD) were performed using the stomach and colorectum of live pigs. As controls, 0.4% SH and saline were used. RESULTS: The PPL solutions were of extremely low viscosity compared to the solutions of 0.4% SH and 0.6% SA. Nevertheless, the mucosal elevation capacity of PPL solutions for up to 0.7% concentration was similar to that of 0.4% SH, and 0.7% PPL was less resistant to catheter infusion than 0.4% SH and 0.6% SA. In live pig experiments with endoscopic mucosal resection and ESD, snaring after submucosal injection of 0.7% PPL was easier than with 0.4% SH, ESD with 0.7% PPL produced less bubble formation than with 0.4% SH, and the procedure time tended to be shorter with 0.7% PPL than with 0.4% SH because of the shorter injection time. CONCLUSIONS: The PPL solution is an innovative and easy-to-use submucosal injection solution.

    DOI: 10.1016/j.gie.2024.01.015

    PubMed

    researchmap

  • The specific shapes of capillaries are associated with worse prognosis in patients with invasive breast cancer. Reviewed International journal

    Hnin-Wint-Wint Swe, Masayoshi Fujisawa, Toshiaki Ohara, Yu Komatsubara, Teizo Yoshimura, Tadahiko Shien, Akihiro Matsukawa

    Pathology international   2024.5

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Angiogenesis is considered essential for tumor progression; however, whether histological counting of blood vessel numbers, expressed as microvessel density (MVD), can be a prognostic factor in breast cancer remains controversial. It has been suggested that the specific morphology of blood vessels such as glomeruloid microvascular proliferation (GMP) is associated with clinical parameters. Here, we aimed to clarify the significance of MVD with revised immunohistochemistry and to identify new blood vessel shapes that predict prognosis in breast cancer. Four hundred and eleven primary breast cancer specimens were collected, and the sections were immunohistochemically stained with CD31 (single staining) and CD31 and Collagen IV (double staining). The prognosis of patients was examined based on the MVD value, and the presence of GMP and other blood vessels with other specific shapes. As a result, high MVD value and the presence of GMP were not associated with worse prognosis. By contrast, patients with deep-curved capillaries surrounding tumor cell nests (C-shaped) or excessively branched capillaries near tumor cell nests showed a significantly poor prognosis. The presence of these capillaries was also correlated with clinicopathological parameters such as Ki-67 index. Thus, the morphology of capillaries rather than MVD can be a better indicator of tumor aggressiveness.

    DOI: 10.1111/pin.13442

    PubMed

    researchmap

  • An osteoinductive surface by adhesive bone morphogenetic protein-2 prepared using the bioorthogonal approach for tight binding of titanium with bone. Reviewed International journal

    Xueli Ren, Hironori Tsuji, Takahiko Uchino, Izumi Kono, Takashi Isoshima, Akimitsu Okamoto, Noriyuki Nagaoka, Toshifumi Ozaki, Akihiro Matsukawa, Hideyuki Miyatake, Yoshihiro Ito

    Journal of materials chemistry. B   12 ( 12 )   3006 - 3014   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Inorganic biomaterials are used in various orthopedic and dental implants. Nevertheless, they cause clinical issues such as loosening of implants and patient morbidity. Therefore, inspired by mussel adhesive proteins, we aimed to design an adhesive and dimer-forming highly active bone morphogenetic protein-2 (BMP-2) using bioorthogonal chemistry, in which recombinant DNA technology was combined with enzymatic modifications, to achieve long-term osseointegration with titanium. The prepared BMP-2 exhibited substantially higher binding activity than wild-type BMP-2, while the adhered BMP-2 was more active than soluble BMP-2. Therefore, the adhesive BMP-2 was immobilized onto titanium wires and screws and implanted into rat bones, and long-term osteogenesis was evaluated. Adhesive BMP-2 promoted the mechanical binding of titanium to bones, enabling efficient bone regeneration and effective stabilization of implants. Thus, such adhesive biosignaling proteins can be used in regenerative medicine.

    DOI: 10.1039/d3tb02838k

    PubMed

    researchmap

  • Role of Macrophages in Liver Fibrosis Invited Reviewed

    Sun C, Matsukawa A

    Acta Med Okayama   78 ( 1 )   1 - 8   2024.2

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18926/AMO/66664

    researchmap

  • Influence of the coronavirus disease 2019 pandemic on the post-graduate career paths of medical students: a cross-sectional study Reviewed

    Ayumu Nishimura, Tomoko Miyoshi, Fumio Otsuka, Akihiro Matsukawa

    BMC Medical Education   24 ( 1 )   55   2024.1

     More details

    Authorship:Last author   Publisher:Springer Science and Business Media LLC  

    Abstract

    Background

    The World Health Organization first declared the coronavirus disease 2019 (COVID-19) pandemic in March 2020 and announced the end of the emergency in May 2023. Additionally, the COVID-19 pandemic significantly impacted individuals globally, including medical students. Although the COVID-19 pandemic increased online education, it restricted clinical training, extracurricular activities, and interprovincial travel. Therefore, this study aimed to examine whether the COVID-19 pandemic influenced the choice of training hospitals and career paths among 3rd- to 6th-year medical students in Japan.

    Methods

    We developed a questionnaire comprising 21 multiple-choice and 1 open-ended questions, which was administered anonymously via online platforms. The survey targeted Japanese medical students to obtain insights into their preferences for training hospitals and career paths during the COVID-19 pandemic. Participants included 4th- to 6th-year medical students from 51 medical schools in Japan. The survey was conducted through student networks from 8 February 2022 to 20 March 2022.

    Results

    Overall, 507 medical students participated in the survey, with representation from various academic years as follows: 102 (20.1%), 134 (26.4%), 121 (23.9%), and 150 (29.6%) students from the 3rd, 4th, 5th, and 6th year, respectively. Of these, 338 (66.6%) students reported that the COVID-19 pandemic had influenced their choice of training hospitals. The degree of the influence varied based on the university region and the student year. However, most of the students (473, 93.3%) did not change their course for clinical, basic research, or administrative pathways due to the COVID-19 pandemic. Among the clinically oriented students, 391 (77.2%) did not change their preferred speciality.

    Conclusions

    The COVID-19 pandemic influenced medical students’ choice of training hospitals. Although many students believed that the pandemic would not change their career choices, our results indicate a potential subconscious trend to avoid internal medicine, which is the speciality most directly involved in treating patients with COVID-19.

    DOI: 10.1186/s12909-023-05021-6

    researchmap

    Other Link: https://link.springer.com/article/10.1186/s12909-023-05021-6/fulltext.html

  • 【COVID-19パンデミック後の医学・医療者教育】ジグソー法とピア評価を取り入れたポストコロナ時代の行動科学 社会の中でのコミュニケーション実践と振り返り能力育成プログラム

    三好 智子, 小崎 吉訓, 越智 可奈子, 松川 昭博

    医学教育   54 ( 6 )   613 - 615   2023.12

  • In vivo lung perfusion for prompt recovery from primary graft dysfunction after lung transplantation. Reviewed International journal

    Kei Matsubara, Kentaroh Miyoshi, Shinichi Kawana, Yujiro Kubo, Dai Shimizu, Yasuaki Tomioka, Toshio Shiotani, Haruchika Yamamoto, Shin Tanaka, Takeshi Kurosaki, Toshiaki Ohara, Mikio Okazaki, Seiichiro Sugimoto, Akihiro Matsukawa, Shinichi Toyooka

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation   2023.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: No proven treatment after the development of primary graft dysfunction (PGD) is currently available. Here we established a novel strategy of in vivo lung perfusion (IVLP) for the treatment of PGD. IVLP involves the application of an in vivo isolated perfusion circuit to an implanted lung. This study aimed to explore the effectiveness of IVLP versus conventional post-lung transplant (LTx) extracorporeal membrane oxygenation (ECMO) treatment using an experimental swine LTx PGD model. METHODS: After 1.5-h warm ischemia of the donor lungs, a left LTx was performed. Following the confirmation of PGD development, pigs were divided into three groups (n = 5 each): control (no intervention), ECMO, and IVLP. After 2 h of treatment, a 4-h functional assessment was conducted and samples obtained. RESULTS: Significantly better oxygenation were achieved in the IVLP group (p ≤ 0.001). Recovery was confirmed immediately and maintained during the following 4-h observation. The IVLP group also demonstrated better lung compliance than the control group (p = 0.045). A histological evaluation showed that the lung injury score and terminal deoxynucleotidyl transferase dUTP nick end labeling assay showed significantly fewer injuries and a better result in the wet-to-dry weight ratio in the IVLP group. CONCLUSIONS: A two-hour IVLP is technically feasible and allows for prompt recovery from PGD after LTx. The posttransplant short-duration IVLP strategy can complement or overcome the limitations of the current practice for donor assessment and PGD management.

    DOI: 10.1016/j.healun.2023.10.011

    PubMed

    researchmap

  • The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis. Invited Reviewed International journal

    Teizo Yoshimura, Chunning Li, Yuze Wang, Akihiro Matsukawa

    Cellular & molecular immunology   20 ( 7 )   714 - 738   2023.7

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Breast cancer is the most prevalent cancer worldwide, and metastasis is the leading cause of death in cancer patients. Human monocyte chemoattractant protein-1 (MCP-1/CCL2) was isolated from the culture supernatants of not only mitogen-activated peripheral blood mononuclear leukocytes but also malignant glioma cells based on its in vitro chemotactic activity toward human monocytes. MCP-1 was subsequently found to be identical to a previously described tumor cell-derived chemotactic factor thought to be responsible for the accumulation of tumor-associated macrophages (TAMs), and it became a candidate target of clinical intervention; however, the role of TAMs in cancer development was still controversial at the time of the discovery of MCP-1. The in vivo role of MCP-1 in cancer progression was first evaluated by examining human cancer tissues, including breast cancers. Positive correlations between the level of MCP-1 production in tumors and the degree of TAM infiltration and cancer progression were established. The contribution of MCP-1 to the growth of primary tumors and metastasis to the lung, bone, and brain was examined in mouse breast cancer models. The results of these studies strongly suggested that MCP-1 is a promoter of breast cancer metastasis to the lung and brain but not bone. Potential mechanisms of MCP-1 production in the breast cancer microenvironment have also been reported. In the present manuscript, we review studies in which the role of MCP-1 in breast cancer development and progression and the mechanisms of its production were examined and attempt to draw a consensus and discuss the potential use of MCP-1 as a biomarker for diagnosis.

    DOI: 10.1038/s41423-023-01013-0

    PubMed

    researchmap

  • SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells. Reviewed International journal

    Tong Gao, Xu Yang, Masayoshi Fujisawa, Toshiaki Ohara, Tianyi Wang, Nahoko Tomonobu, Masakiyo Sakaguchi, Teizo Yoshimura, Akihiro Matsukawa

    International journal of molecular sciences   24 ( 5 )   2023.3

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    The downregulation of SPRED2, a negative regulator of the ERK1/2 pathway, was previously detected in human cancers; however, the biological consequence remains unknown. Here, we investigated the effects of SPRED2 loss on hepatocellular carcinoma (HCC) cell function. Human HCC cell lines, expressing various levels of SPRED2 and SPRED2 knockdown, increased ERK1/2 activation. SPRED2-knockout (KO)-HepG2 cells displayed an elongated spindle shape with increased cell migration/invasion and cadherin switching, with features of epithelial-mesenchymal transition (EMT). SPRED2-KO cells demonstrated a higher ability to form spheres and colonies, expressed higher levels of stemness markers and were more resistant to cisplatin. Interestingly, SPRED2-KO cells also expressed higher levels of the stem cell surface markers CD44 and CD90. When CD44+CD90+ and CD44-CD90- populations from WT cells were analyzed, a lower level of SPRED2 and higher levels of stem cell markers were detected in CD44+CD90+ cells. Further, endogenous SPRED2 expression decreased when WT cells were cultured in 3D, but was restored in 2D culture. Finally, the levels of SPRED2 in clinical HCC tissues were significantly lower than those in adjacent non-HCC tissues and were negatively associated with progression-free survival. Thus, the downregulation of SPRED2 in HCC promotes EMT and stemness through the activation of the ERK1/2 pathway, and leads to more malignant phenotypes.

    DOI: 10.3390/ijms24054996

    PubMed

    researchmap

  • Acrylamide monomers in universal adhesives Reviewed

    M. H. Ahmed, K. Yoshihara, N. Nagaoka, C. Yao, A. Matsukawa, Y. Yoshida, B. Van Meerbeek

    Dental Materials   39 ( 3 )   246 - 259   2023.3

     More details

    Publishing type:Research paper (scientific journal)  

    Objectives: The mono-functional monomer 2-hydroxyethyl methacrylate (HEMA) is often added to universal adhesives (UAs) to improve surface wetting and prevent phase separation. Nevertheless, HEMA promotes water sorption and hydrolysis at adhesive interfaces, hereby affecting long-term bonding to dentin. This study investigated if two acrylamide monomers could replace HEMA in an UA formulation applied in etch-and-rinse (2E&R) and self-etch (1SE) bonding mode. Methods: Four experimental UAs were bonded to bur-cut dentin. In addition to 12 wt% 10-MDP, 25 wt% Bis-GMA and 10 wt% TEGDMA as common monomer composition, 20 %wt ethanol and 15 %wt water as solvent, and 3 wt% polymerization-related additives, the four formulations solely differed for either the acrylamide cross-linker monomer ‘FAM-201′ as TEGDMA alternative and HEMA replacement, the hydroxyethyl acrylamide monomer ‘HEAA’ as HEMA alternative, HEMA (‘HEMA+’), or extra TEGDMA in a HEMA-free control (‘HEMA-’), all added in a 15 wt% concentration. The split-tooth study design involved application in 2E&R mode on one tooth half versus 1SE mode on the corresponding half. Micro-tensile bond strength of half of the micro-specimens was measured upon 1-week distilled water storage (‘immediate’ 1w μTBS), with the other half measured after additional 6-month storage (‘aged’ 6 m μTBS). Statistics involved linear mixed-effects (LME) modelling (p < .05). Additionally, interfacial TEM characterization, thin-film (TF) XRD surface analysis, LogP determination, and a cytotoxicity assay were carried out. Results: FAM-201 revealed significantly higher μTBS than HEMA+ at 1w and 6 m when applied both in E&R and SE bonding modes. HEAA's μTBS was significantly lower than that of HEMA+ at 1w when applied in SE mode. TF-XRD and TEM revealed similar chemical and ultrastructural interfacial characterization, including stable 10-MDP_Ca salt nano-layering. FAM-201 was least cytotoxic and presented with an intermediary LogP, while HEAA presented with the highest LogP, indicating high hydrophilicity and water-sorption sensitivity. Significance: The acrylamide co-monomer FAM-201 could replace HEMA in an UA formulation, while HEAA not.

    DOI: 10.1016/j.dental.2023.01.003

    Scopus

    PubMed

    researchmap

  • Highly Metastatic Subpopulation of TNBC Cells Has Limited Iron Metabolism and Is a Target of Iron Chelators Reviewed

    Yuze Wang, Toshiaki Ohara, Yuehua Chen, Yusuke Hamada, Chunning Li, Masayoshi Fujisawa, Teizo Yoshimura, Akihiro Matsukawa

    Cancers   15 ( 2 )   468   2023.1

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/cancers15020468

    researchmap

  • Osteoblast Response of Additively Manufactured Zirconia and Alumina-Toughened Zirconia. Reviewed International journal

    Hiroto Nakai, Masanao Inokoshi, Kosuke Nozaki, Kumiko Yoshihara, Akihiro Matsukawa, Noriyuki Nagaoka, Watcharapong Tonprasong, Shunsuke Minakuchi

    Materials (Basel, Switzerland)   15 ( 23 )   2022.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Zirconia ceramics have been widely used in dentistry. Herein, we assess the surface morphology, surface texture, and osteoblast response of additively manufactured zirconia and alumina-toughened zirconia (ATZ) in comparison with titanium. The surface roughness, contact angle, and surface microstructure of titanium sandblasted with large-grit alumina and subsequently acid-etched using 18% HCl and 49% H2SO4 (SLA-titanium), uniaxially pressed zirconia (UP zirconia), additively manufactured zirconia (AM zirconia), and additively manufactured ATZ (AM ATZ) were investigated. Moreover, the cell viability, alkaline phosphatase (ALP) activity, and gene expression of type I collagen on these materials were evaluated. The data were statistically analyzed using one-way ANOVA with Tukey's post hoc test. SLA-titanium showed the highest surface roughness and contact angle. The other three materials showed comparable surface roughness and contact angles. Micro- and nanoroughness were observed on the surface of SLA-titanium. UP zirconia and AM zirconia had similar surface morphologies. The cell viability, ALP activity, and gene expression of type I collagen on AM zirconia were comparable to or better than those on SLA-titanium. Our results indicate that AM zirconia is a promising material for zirconia dental implants.

    DOI: 10.3390/ma15238685

    PubMed

    researchmap

  • Functional Blockage of S100A8/A9 Ameliorates Ischemia-Reperfusion Injury in the Lung. Reviewed International journal

    Kentaro Nakata, Mikio Okazaki, Tomohisa Sakaue, Rie Kinoshita, Yuhei Komoda, Dai Shimizu, Haruchika Yamamoto, Shin Tanaka, Ken Suzawa, Kazuhiko Shien, Kentaroh Miyoshi, Hiromasa Yamamoto, Toshiaki Ohara, Seiichiro Sugimoto, Masaomi Yamane, Akihiro Matsukawa, Masakiyo Sakaguchi, Shinichi Toyooka

    Bioengineering (Basel, Switzerland)   9 ( 11 )   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    (1) Background: Lung ischemia-reperfusion (IR) injury increases the mortality and morbidity of patients undergoing lung transplantation. The objective of this study was to identify the key initiator of lung IR injury and to evaluate pharmacological therapeutic approaches using a functional inhibitor against the identified molecule. (2) Methods: Using a mouse hilar clamp model, the combination of RNA sequencing and histological investigations revealed that neutrophil-derived S100A8/A9 plays a central role in inflammatory reactions during lung IR injury. Mice were assigned to sham and IR groups with or without the injection of anti-S100A8/A9 neutralizing monoclonal antibody (mAb). (3) Results: Anti-S100A8/A9 mAb treatment significantly attenuated plasma S100A8/A9 levels compared with control IgG. As evaluated by oxygenation capacity and neutrophil infiltration, the antibody treatment dramatically ameliorated the IR injury. The gene expression levels of cytokines and chemokines induced by IR injury were significantly reduced by the neutralizing antibody. Furthermore, the antibody treatment significantly reduced TUNEL-positive cells, indicating the presence of apoptotic cells. (4) Conclusions: We identified S100A8/A9 as a novel therapeutic target against lung IR injury.

    DOI: 10.3390/bioengineering9110673

    PubMed

    researchmap

  • Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer. Reviewed International journal

    Chunning Li, Teizo Yoshimura, Miao Tian, Yuze Wang, Takamasa Kondo, Ken-Ichi Yamamoto, Masayoshi Fujisawa, Toshiaki Ohara, Masakiyo Sakaguchi, Akihiro Matsukawa

    Breast cancer research : BCR   24 ( 1 )   60 - 60   2022.9

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Patients with triple-negative breast cancer (TNBC) often have poorer prognosis than those with other subtypes because of its aggressive behaviors. Cancer cells are heterogeneous, and only a few highly metastatic subclones metastasize. Although the majority of subclones may not metastasize, they could contribute by releasing factors that increase the capacity of highly metastatic cells and/or provide a favorable tumor microenvironment (TME). Here, we analyzed the interclonal communication in TNBC which leads to efficient cancer progression, particularly lung metastasis, using the polyclonal murine 4T1 BC model. METHODS: We isolated two 4T1 subclones, LM.4T1 and HM.4T1 cells with a low and a high metastatic potential, respectively, and examined the effects of LM.4T1 cells on the behaviors of HM.4T1 cells using the cell scratch assay, sphere-forming assay, sphere invasion assay, RT-qPCR, and western blotting in vitro. We also examined the contribution of LM.4T1 cells to the lung metastasis of HM.4T1 cells and TME in vivo. To identify a critical factor which may be responsible for the effects by LM.4T1 cells, we analyzed the data obtained from the GEO database. RESULTS: Co-injection of LM.4T1 cells significantly augmented lung metastases by HM.4T1 cells. LM.4T1-derived exosomes promoted the migration and invasion of HM.4T1 cells in vitro, and blocking the secretion of exosome abrogated their effects on HM.4T1 cells. Analyses of data obtained from the GEO database suggested that Wnt7a might be a critical factor responsible for the enhancing effects. In fact, a higher level of Wnt7a was detected in LM.4T1 cells, especially in exosomes, than in HM.4T1 cells, and deletion of Wnt7a in LM.4T1 cells significantly decreased the lung metastasis of HM.4T1 cells. Further, treatment with Wnt7a increased the spheroid formation by HM.4T1 cells via activation of the PI3K/Akt/mTOR signaling pathway. Finally, infiltration of αSMA-positive fibroblasts and angiogenesis was more prominent in tumors of LM.4T1 cells and deletion of Wnt7a in LM.4T1 cells markedly reduced angiogenesis. CONCLUSIONS: We demonstrated, for the first time, that a low metastatic subclone can enhance lung metastasis of highly metastatic subclone via exosomal Wnt7a and propose Wnt7a as a molecular target to treat TNBC patients.

    DOI: 10.1186/s13058-022-01557-5

    PubMed

    researchmap

  • Inhibiting S100A8/A9 attenuates airway obstruction in a mouse model of heterotopic tracheal transplantation. Reviewed International journal

    Dai Shimizu, Mikio Okazaki, Seiichiro Sugimoto, Rie Kinoshita, Kentaro Nakata, Shin Tanaka, Kohei Hashimoto, Kentaroh Miyoshi, Masaomi Yamane, Akihiro Matsukawa, Masakiyo Sakaguchi, Shinichi Toyooka

    Biochemical and biophysical research communications   629   86 - 94   2022.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Although bronchiolitis obliterans syndrome (BOS) is a major cause of death after lung transplantation, an effective drug therapy for BOS has not yet developed. Here, we assessed the effectiveness of a neutralizing anti-S100 calcium binding protein (S100) A8/A9 antibody against BOS. A murine model of heterotopic tracheal transplantation was used. Mice were intraperitoneally administered control IgG or the S100A8/A9 antibody on day 0 and twice per week until they were sacrificed. Tissue sections were used to evaluate the obstruction ratio, epithelium-preservation ratio, α-smooth muscle actin (SMA)-positive myofibroblast infiltration, and luminal cell death. Quantitative reverse transcriptase-polymerase chain reaction analysis was performed to analyze the mRNA-expression levels of collagen, inflammatory cytokines, and chemokines on days 7, 14, and 21. The anti-S100A8/A9 antibody significantly improved the obstruction ratio and epithelium-preservation ratio, with less α-SMA-positive myofibroblast infiltration compared to the control group. Antibody treatment reduced the type-III collagen: type-I collagen gene-expression ratio. The antibody also significantly suppressed the number of dead cells in the graft lumen. The expression levels of tumor growth factor β1 and C-C motif chemokine 2 on day 21, but not those of interleukin-1β, interleukin-6, and tumor necrosis factor α, were significantly suppressed by S100A8/A9 antibody treatment. These findings suggest that S100A8/A9 may be a potential therapeutic target for BOS after lung transplantation.

    DOI: 10.1016/j.bbrc.2022.08.087

    PubMed

    researchmap

  • 皮膚原発Paget病手術の6年後に判明した肛門管粘液癌の1例

    樫野 かおり, 上田 武滋, 松川 昭博

    日本皮膚科学会雑誌   132 ( 9 )   2147 - 2153   2022.8

     More details

    Authorship:Last author   Language:Japanese   Publisher:(公社)日本皮膚科学会  

    75歳、男性。肛門周囲の紅斑があり、病理組織でPaget細胞を認めた。肛門管に病変がなく皮膚原発のPaget病として手術したが肛門側の断端にPaget細胞あり。免疫染色でCK7(+)、CK20(+)、GCDFP15(-)、CDX2(+)であった。6年後に肛門管の粘液癌が判明し腹会陰式直腸切断術を施行した。肛門腺由来癌は肛門粘膜表面には癌組織がほとんど見られないという特徴や上記の免疫染色結果から当初より肛門腺由来の肛門管癌による二次性Paget病であったと考えた。Paget病変は早期の肛門管癌から生じうるため、免疫染色は肛囲Paget病が皮膚原発か、肛門管癌によるものかの鑑別手段になると考えた。(著者抄録)

    researchmap

    Other Link: https://search-tp.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2022&ichushi_jid=J01174&link_issn=&doc_id=20220826400006&doc_link_id=10.14924%2Fdermatol.132.2147&url=https%3A%2F%2Fdoi.org%2F10.14924%2Fdermatol.132.2147&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_2.gif

  • Author Correction: Thioredoxin interacting protein protects mice from fasting induced liver steatosis by activating ER stress and its downstream signaling pathways. Reviewed International journal

    Hiroyuki Miyahara, Kosei Hasegawa, Masato Yashiro, Toshiaki Ohara, Masayoshi Fujisawa, Teizo Yoshimura, Akihiro Matsukawa, Hirokazu Tsukahara

    Scientific reports   12 ( 1 )   8026 - 8026   2022.5

     More details

  • Thioredoxin interacting protein protects mice from fasting induced liver steatosis by activating ER stress and its downstream signaling pathways. Reviewed International journal

    Hiroyuki Miyahara, Kosei Hasegawa, Masato Yashiro, Toshiaki Ohara, Masayoshi Fujisawa, Teizo Yoshimura, Akihiro Matsukawa, Hirokazu Tsukahara

    Scientific reports   12 ( 1 )   4819   2022.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Under normal conditions, fasting results in decreased protein disulfide isomerase (PDI) activity and accumulation of unfolded proteins, leading to the subsequent activation of the unfolded protein response (UPR)/autophagy signaling pathway to eliminate damaged mitochondria. Fasting also induces upregulation of thioredoxin-interacting protein (TXNIP) expression and mice deficient of this protein (TXNIP-KO mice) was shown to develop severe hypoglycemia, hyperlipidemia and liver steatosis (LS). In the present study, we aimed to determine the role of TXNIP in fasting-induced LS by using male TXNIP-KO mice that developed LS without severe hypoglycemia. In TXNIP-KO mice, fasting induced severe microvesicular LS. Examinations by transmission electron microscopy revealed mitochondria with smaller size and deformities and the presence of few autophagosomes. The expression of β-oxidation-associated genes remained at the same level and the level of LC3-II was low. PDI activity level stayed at the original level and the levels of p-IRE1 and X-box binding protein 1 spliced form (sXBP1) were lower. Interestingly, treatment of TXNIP-KO mice with bacitracin, a PDI inhibitor, restored the level of LC3-II after fasting. These results suggest that TXNIP regulates PDI activity and subsequent activation of the UPR/autophagy pathway and plays a protective role in fasting-induced LS.

    DOI: 10.1038/s41598-022-08791-z

    PubMed

    researchmap

  • Diagnostic Utility of the PD-L1 Immunostaining in Biopsy Specimens of Patients with Biliary Tract Neoplasms. Reviewed International journal

    Kazuyuki Matsumoto, Toshiaki Ohara, Masayoshi Fujisawa, Akinobu Takaki, Masahiro Takahara, Hironari Kato, Ryuichi Yoshida, Yuzo Umeda, Takahito Yagi, Akihiro Matsukawa, Hiroyuki Okada

    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract   26 ( 6 )   1213 - 1223   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Anti-programmed death 1/programmed death ligand 1 (PD1/PD-L1) antibodies have been successfully used as treatment agents for several solid tumors; however, it is difficult to predict their effectiveness. We evaluated whether biopsy specimens could predict the positive status of PD-L1 in surgically resected tissue. METHODS: Among 91 patients who underwent tissue sampling with endoscopic or liver biopsy before surgery for biliary tract neoplasms in an academic center, 45 (49%) patients were selected for retrospective analysis because the quality and quantity of their biopsy specimens were adequate for histologic evaluation. We performed immunohistochemical staining to investigate the PD-L1 expression in both resected and biopsy specimens. The percentage of the positively stained cells was calculated for subsequent use in the correlation investigation. RESULTS: The biopsy methods were endoscopic retrograde cholangiopancreatography (ERCP) in 28 cases, percutaneous liver biopsy in 10 cases, and endoscopic ultrasound fine-needle aspiration in 7 cases. Among the 45 patients, when patients with > 10% positive tumor cells in surgically resected tissues were regarded as truly positive PD-L1, the positive and negative concordance rates between surgically resected tissues and biopsy samples were 56% (5/9) and 100% (36/36), respectively. With regard to the use of preoperative biopsy as a diagnostic tool, all (5/5) PD-L1-positive patients had a positive resected specimen. The accuracy of each biopsy method was as follows: ERCP, 89% (25/28); fine-needle aspiration, 86% (6/7); and liver biopsy, 100% (10/10). CONCLUSIONS: Biopsy samples could be a surrogate material for the assessment of the PD-L1 expression with substantial positive and high negative concordance rates.

    DOI: 10.1007/s11605-021-05197-6

    PubMed

    researchmap

  • A novel mechanical plant compression system for biomass fuel and acquisition of squeezed liquid with water-soluble lignin as anti-virus materials Reviewed

    Toshiaki Ohara, Ken Yuasa, Kentaro Kimura, Shiho Komaki, Yuta Nishina, Akihiro Matsukawa

    Journal of Material Cycles and Waste Management   25 ( 1 )   249 - 257   2022

     More details

    Authorship:Last author   Publishing type:Research paper (scientific journal)  

    Plant biomass could be a viable alternative renewable resource, but the moisture content must be reduced to use it as fuel. Mechanical compression alone is generally insufficient for dehydration, necessitating the addition of thermal drying. This study develops a unique mechanical rolling compression method with high dehydration ability. The squeezed liquid was analyzed using 1H nuclear magnetic resonance (1H NMR), UV–Vis, and FT-IR indicating much water-soluble lignin. Cedar board, woody biomass, compressed more effectively than cedar chips, implying that mechanical rolling compression along vessels such as straw was important. Alpinia zerumbet, herbaceous biomass, was compressed in the same way, and the squeezed liquid contained water-soluble lignin. Pellets made from plant residues were evaluated by combustion test. The squeezed liquid with water-soluble liquid revealed a basic antiviral effect for influenza and the porcine epidemic diarrhea virus. Our developed, novel, rolling plant compression method has the potential to alter fossil fuels.

    DOI: 10.1007/s10163-022-01531-5

    Scopus

    researchmap

  • 細胞診断における簡易セルブロックの有用性

    戸田 久美子, 竹井 絵梨, 木下 実穂, 森田 美智子, 松川 昭博, 開原 正展

    尾道市立市民病院医学雑誌   34 ( 1 )   13 - 18   2021.12

     More details

    Language:Japanese   Publisher:尾道市立市民病院  

    2016年12月より細胞診標本作製後の残検体を用いた遺伝子変異解析や発現タンパクの検出を目的とした簡易セルブロックの作製を開始した。同時に、細胞診とセルブロックとの併用による診断精度の向上にも取り組んだ。今回、2021年3月までにセルブロックを作製した68例について有用性を検討した。その結果、細胞診残検体によるセルブロックを用いて免疫染色を追加でき、良悪性の鑑別に加えて組織型の決定も可能となった症例があった。さらに組織検体を採取できない症例でもコンパニオン診断を実施できるようになり、セルブロックの有用性が認められた。(著者抄録)

    researchmap

  • Crosstalk between Cancer Cells and Fibroblasts for the Production of Monocyte Chemoattractant Protein-1 in the Murine 4T1 Breast Cancer. Reviewed International journal

    Mayu Imamura, Tiantian Li, Chunning Li, Masayoshi Fujisawa, Naofumi Mukaida, Akihiro Matsukawa, Teizo Yoshimura

    Current issues in molecular biology   43 ( 3 )   1726 - 1740   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2) is shown to promote the progression of breast cancer. We previously identified cancer cell-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) as a potential regulator of MCP-1 production in the murine 4T1 breast cancer, but it played a minimum role in overall MCP-1 production. Here, we evaluated the crosstalk between 4T1 cells and fibroblasts. When fibroblasts were co-cultured with 4T1 cells or stimulated with the culture supernatants of 4T1 cells (4T1-sup), MCP-1 production by fibroblasts markedly increased. 4T1 cells expressed mRNA for platelet-derived growth factor (PDGF)-a, b and c, and the PDGF receptor inhibitor crenolanib almost completely inhibited 4T1-sup-induced MCP-1 production by fibroblasts. However, PDGF receptor antagonists failed to reduce MCP-1 production in tumor-bearing mice. Histologically, 4T1 tumors contained a small number of αSMA-positive fibroblasts, and Mcp-1 mRNA was mainly associated with macrophages, especially those surrounding necrotic lesions on day 14, by in situ hybridization. Thus, although cancer cells have the capacity to crosstalk with fibroblasts via PDGFs, this crosstalk does not play a major role in MCP-1 production or cancer progression in this model. Unraveling complex crosstalk between cancer cells and stromal cells will help us identify new targets to help treat breast cancer patients.

    DOI: 10.3390/cimb43030122

    PubMed

    researchmap

  • Protective effects of anti-HMGB1 monoclonal antibody on lung ischemia reperfusion injury in mice. Reviewed International journal

    Kentaro Nakata, Mikio Okazaki, Dai Shimizu, Ken Suzawa, Kazuhiko Shien, Kentaroh Miyoshi, Shinji Otani, Hiromasa Yamamoto, Seiichiro Sugimoto, Masaomi Yamane, Daiki Ousaka, Toshiaki Ohara, Akihiro Matsukawa, Masahiro Nishibori, Shinichi Toyooka

    Biochemical and biophysical research communications   573   164 - 170   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    During ischemia reperfusion (IR) injury, high mobility group box 1 (HMGB1), a chromatin binding protein, is released from necrotic cells and triggers inflammatory responses. We assessed the therapeutic effect of a neutralizing anti-HMGB1 monoclonal antibody (mAb) on lung IR injury. A murine hilar clamp model of IR was used, where mice were divided into sham and IR groups with intravenous administration of anti-HMGB 1 mAb or control mAb. We analyzed the effect of anti-HMGB1 mAb against IR injury by assessing lung oxygenation, lung injury score, neutrophil infiltration, expression of proinflammatory cytokines and chemokines, levels of mitogen-activated protein kinase (MAPK) signaling, and measurement of apoptotic cells. Anti-HMGB1 mAb significantly decreased the plasma level of HMGB1 elevated by IR. The severity of IR injury represented by oxygenation capacity, lung injury score, and neutrophil infiltration was significantly improved by anti-HMGB1 mAb treatment. The expression of proinflammatory factors, including IL-1β, IL-6, IL-12, TNF-α, CXCL-1, and CXCL-2, and phosphorylation of p38 MAPK were both significantly reduced by anti-HMGB1 mAb treatment. Furthermore, anti-HMGB1 mAb treatment suppressed apoptosis, as determined through TUNEL assays. Overall, anti-HMGB1 mAb ameliorated lung IR injury by reducing inflammatory responses and apoptosis. Our findings indicate that anti-HMGB1 mAb has potential for use as a therapeutic to improve IR injury symptoms during lung transplantation.

    DOI: 10.1016/j.bbrc.2021.08.015

    PubMed

    researchmap

  • PolyI:C suppresses TGF-β1-induced Akt phosphorylation and reduces the motility of A549 lung carcinoma cells. Reviewed International journal

    Takahiro Yamaguchi, Teizo Yoshimura, Toshiaki Ohara, Masayoshi Fujisawa, Gao Tong, Akihiro Matsukawa

    Molecular biology reports   48 ( 9 )   6313 - 6321   2021.8

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUNDS: Epithelial mesenchymal transition (EMT) is a critical process involved in the invasion and metastasis of cancer, including lung cancer (LC). Transforming growth factor (TGF)-β is one of factors capable of inducing EMT. Polyinosinic-polycytidylic acid (polyI:C), a synthetic agonist for toll-like receptor (TLR) 3, can enhance immune responses and has been used as an adjuvant for cancer vaccines; however, it remains unclear whether it influences other process, such as EMT. In the present study, we examined the effects of polyI:C on TGF-β-treated A549 human LC cells. METHODS AND RESULTS: By in vitro cell proliferation assay, polyI:C showed no effect on the growth of A549 cells treated with TGF-β1 at the concentration range up to 10 μg/ml; however, it markedly suppressed the motility in a cell scratch and a cell invasion assay. By Western blotting, polyI:C dramatically decreased TGF-β1-induced Ak strain transforming (Akt) phosphorylation and increased phosphatase and tensin homologue (PTEN) expression without affecting the Son of mothers against decapentaplegic (Smad) 3 phosphorylation or the expression level of E-cadherin, N-cadherin or Snail, indicating that polyI:C suppressed cell motility independently of the 'cadherin switching'. The Akt inhibitor perifosine inhibited TGF-β1-induced cell invasion, and the PTEN-specific inhibitor VO-OHpic appeared to reverse the inhibitory effect of polyI:C. CONCLUSION: PolyI:C has a novel function to suppress the motility of LC cells undergoing EMT by targeting the phosphatidylinositol 3-kinase/Akt pathway partly via PTEN and may prevent or reduce the metastasis of LC cells.

    DOI: 10.1007/s11033-021-06625-1

    PubMed

    researchmap

  • In Silico and In Cell Hybrid Selection of Nonrapalog Ligands to Allosterically Inhibit the Kinase Activity of mTORC1. Reviewed International journal

    Raef Shams, Akihiro Matsukawa, Yukari Ochi, Yoshihiro Ito, Hideyuki Miyatake

    Journal of medicinal chemistry   65 ( 2 )   1329 - 1341   2021.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Cancer-specific metabolic alterations hyperactivate the kinase activity of the mammalian/mechanistic target of rapamycin (mTOR) for overcoming stressful environments. Rapalogs, which allosterically inhibit mTOR complex 1 (mTORC1), have been approved as anticancer agents. However, the immunosuppressive side effect of these compounds results in the promotion of tumor metastasis, thereby limiting their therapeutic efficacy. We first report a nonrapalog inhibitor, WRX606, identified by a hybrid strategy of in silico and in cell selections. Our studies showed that WRX606 formed a ternary complex with FK506-binding protein-12 (FKBP12) and FKBP-rapamycin-binding (FRB) domain of mTOR, resulting in the allosteric inhibition of mTORC1. WRX606 inhibited the phosphorylation of not only the ribosomal protein S6 kinase 1 (S6K1) but also eIF4E-binding protein-1 (4E-BP1). Hence, WRX606 efficiently suppressed tumor growth in mice without promotion of metastasis. These results suggest that WRX606 is a potent lead compound for developing anticancer drugs discovered by in silico and in cell methods.

    DOI: 10.1021/acs.jmedchem.1c00536

    PubMed

    researchmap

  • Spred2 controls the severity of Concanavalin A-induced liver damage by limiting interferon-gamma production by CD4+ and CD8+ T cells Reviewed

    Sun C, Fujisawa M, Ohara T, Liu Q, Cao C, Yang X, Yoshimura T, Kunkel SL, Matsukawa A

    Journal of Advanced Research   online   2021.4

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Nanog is a promising chemo-resistant stemness marker and therapeutic target by iron chelators for esophageal cancer. Reviewed International journal

    Toru Narusaka, Toshiaki Ohara, Kazuhiro Noma, Noriyuki Nishiwaki, Yuki Katsura, Takuya Kato, Hiroaki Sato, Yasuko Tomono, Satoru Kikuchi, Hiroshi Tazawa, Yasuhiro Shirakawa, Akihiro Matsukawa, Toshiyoshi Fujiwara

    International journal of cancer   149 ( 2 )   347 - 357   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Esophageal cancer is a disease showing poor prognosis. Although combination chemotherapy using cisplatin and 5-fluorouracil is standard for unresectable esophageal cancer, the response rate is 35%. Cancer stem cells (CSCs) and inflammation are reportedly responsible for the poor prognosis of esophageal cancer. However, comprehensive analyses have not been conducted and proposals for progress remain lacking. Iron is known to be a key factor in the stemness of CSCs. This study focused on the therapeutic potential of iron control using iron chelators for CSCs in esophageal cancer. Among 134 immunohistochemically analyzed cases, Nanog expression was high in 98 cases and low in 36 cases. High Nanog expression correlated with low overall and disease-free survivals. The iron chelators deferasirox (DFX) and SP10 suppressed the proliferation and expression of stemness markers in TE8 and OE33 cells. DFX and SP10 did not induce compensatory interleukin (IL)-6 secretion, although cisplatin did result in high induction. Moreover, BBI608 and SSZ, as other CSC-targeting drugs, could not suppress the expression of stemness markers. Together, Nanog expression appears related to poor prognosis in esophageal cancer patients, and inhibition of stemness and compensatory IL-6 secretion by iron chelators may offer a novel therapeutic strategy for esophageal cancer.

    DOI: 10.1002/ijc.33544

    PubMed

    researchmap

  • Utility of gastric biopsy in diagnosing IgG4-related gastrointestinal disease. Reviewed International journal

    Kaori Uchino, Kenji Notohara, Takeshi Uehara, Yasuhiro Kuraishi, Junya Itakura, Akihiro Matsukawa

    Pathology international   71 ( 2 )   124 - 134   2021.2

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    The utility of gastric biopsy for diagnosing immunoglobulin (Ig)G4-related gastrointestinal disease (IgG4-GID) remains unclear. Bottom-heavy plasmacytosis (BHP) is a distinct feature of IgG4-GID. To clarify the feasibility of using gastric biopsies to diagnose BHP in IgG4-GID, we analyzed the histological features and immunostaining of gastric biopsy specimens from 31 known IgG4-related disease (IgG4-RD) patients and we assessed the presence of BHP in 1696 consecutive routine gastric biopsies. Cases with both >10 IgG4-positive plasma cells per high-power field and an IgG4/IgG-positive ratio >40% were defined as IgG4-high. Ten of the 31 IgG4-RD patients were concluded to have IgG4-GID, in which IgG4-positive plasma cells were notably detected at the deeper part of the mucosa. Six cases displayed BHP whereas the remaining four cases showed transmural infiltration with concomitant Helicobacter pylori-associated gastritis. In addition to BHP, we identified two unique histologic features for IgG4-GID: plasmacytic aggregation in the muscularis mucosae and permeative plasmacytic infiltration between fundic glands in the non-atrophic mucosa. Six of the routine cases (0.35%) displayed BHP, including a case with IgG4-RD. IgG4-GID can be suspected by the presence of gastric biopsy specimens with characteristic histological features. Such cases are recommended to undergo further examinations to determine whether IgG4-RD is present.

    DOI: 10.1111/pin.13059

    PubMed

    researchmap

  • Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder. Reviewed International journal

    Shinsuke Oda, Masayoshi Fujisawa, Li Chunning, Toshihiro Ito, Takahiro Yamaguchi, Teizo Yoshimura, Akihiro Matsukawa

    PloS one   16 ( 11 )   e0254289   2021

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Aberrant activation of the Ras/Raf/ERK (extracellular-signal-regulated kinase)-MAPK (mitogen-activated protein kinase) pathway is involved in the progression of cancer, including urothelial carcinoma; but the negative regulation remains unclear. In the present study, we investigated pathological expression of Spred2 (Sprouty-related EVH1 domain-containing protein 2), a negative regulator of the Ras/Raf/ERK-MAPK pathway, and the relation to ERK activation and Ki67 index in various categories of 275 urothelial tumors obtained from clinical patients. In situ hybridization demonstrated that Spred2 mRNA was highly expressed in high-grade non-invasive papillary urothelial carcinoma (HGPUC), and the expression was decreased in carcinoma in situ (CIS) and infiltrating urothelial carcinoma (IUC). Immunohistochemically, membranous Spred2 expression, important to interact with Ras/Raf, was preferentially found in HGPUC. Interestingly, membranous Spred2 expression was decreased in CIS and IUC relative to HGPUC, while ERK activation and the expression of the cell proliferation marker Ki67 index were increased. HGPUC with membranous Spred2 expression correlated significantly with lower levels of ERK activation and Ki67 index as compared to those with negative Spred2 expression. Thus, our pathological findings suggest that Spred2 counters cancer progression in non-invasive papillary carcinoma possibly through inhibiting the Ras/Raf/ERK-MAPK pathway, but this regulatory mechanism is lost in cancers with high malignancy. Spred2 appears to be a key regulator in the progression of non-invasive bladder carcinoma.

    DOI: 10.1371/journal.pone.0254289

    PubMed

    researchmap

  • Spred2-deficiency enhances the proliferation of lung epithelial cells and alleviates pulmonary fibrosis induced by bleomycin. Reviewed International journal

    Akina Kawara, Ryo Mizuta, Masayoshi Fujisawa, Toshihiro Ito, Chunning Li, Kaoru Nakamura, Cuiming Sun, Masaki Kuwabara, Masahiro Kitabatake, Teizo Yoshimura, Akihiro Matsukawa

    Scientific reports   10 ( 1 )   16490   2020.10

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    The mitogen-activated protein kinase (MAPK) pathways are involved in many cellular processes, including the development of fibrosis. Here, we examined the role of Sprouty-related EVH-1-domain-containing protein (Spred) 2, a negative regulator of the MAPK-ERK pathway, in the development of bleomycin (BLM)-induced pulmonary fibrosis (PF). Compared to WT mice, Spred2-/- mice developed milder PF with increased proliferation of bronchial epithelial cells. Spred2-/- lung epithelial cells or MLE-12 cells treated with spred2 siRNA proliferated faster than control cells in vitro. Spred2-/- and WT macrophages produced similar levels of TNFα and MCP-1 in response to BLM or lipopolysaccharide and myeloid cell-specific deletion of Spred2 in mice had no effect. Spred2-/- fibroblasts proliferated faster and produced similar levels of MCP-1 compared to WT fibroblasts. Spred2 mRNA was almost exclusively detected in bronchial epithelial cells of naïve WT mice and it accumulated in approximately 50% of cells with a characteristic of Clara cells, 14 days after BLM treatment. These results suggest that Spred2 is involved in the regulation of tissue repair after BLM-induced lung injury and increased proliferation of lung bronchial cells in Spred2-/- mice may contribute to faster tissue repair. Thus, Spred2 may present a new therapeutic target for the treatment of PF.

    DOI: 10.1038/s41598-020-73752-3

    PubMed

    researchmap

  • 胎児期に一過性骨髄異常増殖症を発症し、胎盤にfetal vascular malperfusionを伴ったダウン症候群の1剖検例

    濱崎 友洋, 藤澤 真義, 宮原 宏幸, 伏見 聡一郎, 堀田 真智子, 和仁 洋治, 松川 昭博

    診断病理   37 ( 4 )   428 - 434   2020.10

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    胎児期に一過性骨髄異常増殖症(transient abnormal myelopoiesis:TAM)を発症し、生後4日で死亡したダウン症候群の新生児の1剖検例を経験した。母体は20代の経産婦で、妊娠31週5日に胎児機能不全を認め緊急帝王切開となった。患児は新生児仮死の状態であった。出生直後の末梢血は白血球数が異常高値で、塗抹標本で多数の巨核球系の芽球を認めた。染色体検査で21トリソミーと判明したため、TAMと診断した。組織学的に、胎盤では絨毛の血管が消失した領域が認められ、fetal vascular malperfusion(FVM)と考えた。腫瘍細胞が絨毛内の血管内腔に充満し、血栓形成を伴っている像を認め、TAMがFVMの一因であることが推測された。(著者抄録)

    researchmap

  • Elastin and collagen IV double staining: A refined method to detect blood vessel invasion in breast cancer. Reviewed International journal

    Masayoshi Fujisawa, Masako Omori, Hiroyoshi Doihara, Ye-Min Than, Hnin Wint Wint Swe, Teizo Yoshimura, Akihiro Matsukawa

    Pathology international   70 ( 9 )   612 - 623   2020.9

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Blood vessel invasion (BVI) is a prognostic indicator in various cancers. Elastic stain, which highlights blood vessel walls, is commonly used to detect BVI. In the breast, however, its diagnostic usefulness is limited because it also highlights some intraductal carcinoma components, which often mimic BVI. In this study, we aimed to improve BVI detection in breast cancer and developed a double staining: Victoria blue for elastin and immunohistochemistry for collagen IV. Collagen IV fibers were retained along the basement membranes of intraductal carcinoma components, whereas they were rearranged or lost in BVI. From these observations, we defined BVI as the presence of tumor cells inside an elastic ring with a rearrangement or loss of collagen IV fibers. Using these criteria, we found BVI in 148 cases (49%) among 304 cases of primary operable invasive breast carcinoma, and the presence of BVI correlated significantly with poor prognosis. By contrast, we detected BVI in 94 cases (31%) or 14 cases (5%) by elastic van Gieson or CD31 immunostaining among the same cases, respectively, with no statistically significant association with prognosis. Thus, elastin and collagen IV double staining facilitates the detection of BVI in breast cancer and is useful to predict prognosis.

    DOI: 10.1111/pin.12971

    PubMed

    researchmap

  • Decreased miR-200b-3p in cancer cells leads to angiogenesis in HCC by enhancing endothelial ERG expression. Reviewed International journal

    Aye Moh-Moh-Aung, Masayoshi Fujisawa, Sachio Ito, Hiroshi Katayama, Toshiaki Ohara, Yoko Ota, Teizo Yoshimura, Akihiro Matsukawa

    Scientific reports   10 ( 1 )   10418   2020.6

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Transcription factor ERG (erythroblast transformation-specific (ETS)-related gene) is essential in endothelial differentiation and angiogenesis, in which microRNA (miR)-200b-3p targeting site is expected by miRNA target prediction database. miR-200b is known decreased in hepatocellular carcinoma (HCC), however, the functional relation between ERG and miR-200b-3p, originating from pre-miR-200b, in HCC angiogenesis remains unclear. We investigated whether hepatocyte-derived miR-200b-3p governs angiogenesis in HCC by targeting endothelial ERG. Levels of miR-200b-3p in HCC tissues were significantly lower than those in adjacent non-HCC tissues. Poorly differentiated HCC cell line expressed lower level of miR-200b-3p compared to well-differentiated HCC cell lines. The numbers of ERG-positive endothelial cells were higher in HCC tissues than in adjacent non-HCC tissues. There was a negative correlation between the number of ERG-positive cells and miR-200b-3p expression in HCC tissues. Culture supernatants of HCC cell lines with miR-200b-3p-overexpression reduced cell migration, proliferation and tube forming capacity in endothelial cells relative to the control, while those with miR-200b-3p-inhibition augmented the responses. Exosomes isolated from HCC culture supernatants with miR-200b-3p overexpression suppressed endothelial ERG expression. These results suggest that exosomal miR-200b-3p from hepatocytes suppresses endothelial ERG expression, and decreased miR-200b-3p in cancer cells promotes angiogenesis in HCC tissues by enhancing endothelial ERG expression.

    DOI: 10.1038/s41598-020-67425-4

    PubMed

    researchmap

  • Development of self-adhesive pulp-capping agents containing a novel hydrophilic and highly polymerizable acrylamide monomer. Reviewed International journal

    Kumiko Yoshihara, Noriyuki Nagaoka, Takumi Okihara, Masao Irie, Akihiro Matsukawa, Mariano Simón Pedano, Yukinori Maruo, Yasuhiro Yoshida, Bart Van Meerbeek

    Journal of materials chemistry. B   8 ( 24 )   5320 - 5329   2020.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Several studies have shown the clinical success of hydraulic calcium-silicate cements (hCSCs) for direct and indirect pulp capping and root repair. However, hCSCs have various drawbacks, including long setting time, poor mechanical properties, low bond strength to dentin, and relatively poor handling characteristics. To overcome these limitations, a light-curable, resin-based hCSC (Theracal LC, Bisco) was commercially introduced; however, it did not exhibit much improvement in bond strength. We developed a light-curable self-adhesive pulp-capping material that contains the novel acrylamide monomer N,N'-{[(2-acrylamido-2-[(3-acrylamidopropoxy)methyl]propane-1,3-diyl)bis(oxy)]bis(propane-1,3-diyl)}diacrylamide (FAM-401) and the functional monomer 4-methacryloxyethyl trimellitate anhydride (4-MET). Two experimental resin-based hCSCs containing different calcium sources (portlandite: Exp_Pl; tricalcium silicate cement: Exp_TCS) were prepared, and the commercial hCSCs Theracal LC and resin-free hCSC Biodentine served as controls. The performance of each cement was evaluated based on parameters relevant for vital pulp therapy, such as curing degree on a wet surface, mechanical strength, as determined using a three-point bending test, shear bond strength to dentin, cytotoxicity, as determined using an MTT assay, and the amount of calcium released, as determined using inductively coupled plasma atomic emission spectrometry. Both experimental cements cured on wet surfaces and showed relatively low cytotoxicity. Furthermore, their flexural and shear bond strength to dentin were significantly higher than those of the commercial references. High calcium release was observed for both Exp_Pl and Biodentine. Thus, Exp_Pl as a new self-adhesive pulp-capping agent performed better than the commercial resin-based pulp-capping agent in terms of mechanical strength, bond strength, and calcium release.

    DOI: 10.1039/d0tb00079e

    PubMed

    researchmap

  • 【パンデミック下の医学教育-現在進行形の実践報告-】オンライン授業 COVID-19によるパンデミック下での医学科5年生に対するオンラインを用いたプロフェッショナリズム・行動科学教育

    三好 智子, 山根 正修, 小崎 吉訓, 片岡 仁美, 横田 雄也, 光田 栄子, 越智 可奈子, 小比賀 美香子, 伊野 英男, 松川 昭博, 大塚 愛二

    医学教育   51 ( 3 )   279 - 281   2020.6

  • Juvenile Granulosa Cell Tumor with an Unusual Clinical Course: A Late-onset and Late Recurrent Case. Reviewed

    Thar Htet San, Yoko Ota, Soichiro Fushimi, Masayoshi Fujisawa, Hiroyuki Yanai, Hiroko Toda, Tadayoshi Kunitomo, Keisuke Kodama, Akihiro Matsukawa

    Acta medica Okayama   74 ( 2 )   159 - 163   2020.4

     More details

    Authorship:Last author, Corresponding author   Language:English  

    Juvenile granulosa cell tumors (JGCTs) are rare ovarian tumors with overall good prognoses. They differ from adult granulosa cell tumors (AGCTs), which are well known for late recurrence. Most JGCTs (~97%) occur in individuals <30 years old. We report a recurrent JGCT in a 40-year-old woman 5 years after initial presentation. The histological appearance and lack of 402C>G missense point mutation of FOXL2 gene (characteristic of AGCT but absent in JGCT) allowed differentiation from AGCT. This is the first comprehensive report of JGCT with late recurrence. Although rare, late recurrence of JGCT can occur; long-term surveillance is suggested.

    DOI: 10.18926/AMO/58275

    PubMed

    researchmap

  • A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs. Reviewed

    Yuehua Chen, Toshiaki Ohara, Boyi Xing, Jiping Qi, Kazuhiro Noma, Akihiro Matsukawa

    Acta medica Okayama   74 ( 1 )   1 - 6   2020.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Iron is a trace but vital element in the human body and is necessary for a multitude of crucial processes in life. However, iron overload is known to induce carcinogenesis via oxidative stress. Cancer cells require large amounts of iron for their rapid division and cell growth. Iron was recently found to play a role in cancer stem cells (CSCs); it maintains stemness during development. Iron also plays an important role in stemness by moderating reactive oxygen species. Thus, iron metabolism in CSCs is a promising therapeutic target. In this review, we summarize the roles of iron in cancer cells and CSCs. We also summarize anti-cancer therapeutic studies with iron chelators and describe our expectation of a new therapeutic strategy for CSCs on the basis of our findings.

    DOI: 10.18926/AMO/57946

    PubMed

    researchmap

  • A Surgical Instructor Training Course for the Next Generation. Reviewed

    Masaomi Yamane, Yasuhiro Mandai, Hideo Ino, Akihiro Matsukawa, Shinichi Toyooka

    Acta medica Okayama   74 ( 1 )   73 - 76   2020.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    In 2016, Gunma University Hospital's Medical Accident Investigation Committee released a report reiterating the necessity of medical education and the need for surgeons to master non-technical skills. We designed a 17-h training course for surgical instructors, designed to teach participants how to sufficiently educate surgeon trainees and encourage their professional identity formation. A post-training survey showed that participants improved their awareness, and their behavioral changes led to favorable team performances. We then began offering a 3-h workshop focusing on the participants' experiences. We propose that the training course using participant narratives is required and effective to establish surgeons' self-reflection and professional identity as surgeons.

    DOI: 10.18926/AMO/57956

    PubMed

    researchmap

  • Cancer Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Is Dispensable for the Progression of 4T1 Murine Breast Cancer. Reviewed International journal

    Teizo Yoshimura, Kaoru Nakamura, Chunning Li, Masayoshi Fujisawa, Tsuyoshi Shiina, Mayu Imamura, Tiantian Li, Naofumi Mukaida, Akihiro Matsukawa

    International journal of molecular sciences   20 ( 24 )   2019.12

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    We previously reported that 4T1 murine breast cancer cells produce GM-CSF that up-regulates macrophage expression of several cancer promoting genes, including Mcp-1/Ccl2, Ccl17 and Rankl, suggesting a critical role of cancer cell-derived GM-CSF in cancer progression. Here, we attempted to define whether 4T1 cell-derived GM-CSF contributes to the expression of these genes by 4T1tumors, and their subsequent progression. Intraperitoneal injection of anti-GM-CSF neutralizing antibody did not decrease the expression of Mcp-1, Ccl17 or Rankl mRNA by 4T1 tumors. To further examine the role of cancer cell-derived GM-CSF, we generated GM-CSF-deficient 4T1 cells by using the Crisper-Cas9 system. As previously demonstrated, 4T1 cells are a mixture of cells and cloning of cells by itself significantly reduced tumor growth and lung metastasis. By contrast, GM-CSF-deficiency did not affect tumor growth, lung metastasis or the expression of these chemokine and cytokine genes in tumor tissues. By in-situ hybridization, the expression of Mcp-1 mRNA was detected in both F4/80-expressing and non-expressing cells in tumors of GM-CSF-deficient cells. These results indicate that cancer cell-derived GM-CSF is dispensable for the tuning of the 4T1 tumor microenvironment and the production of MCP-1, CCL17 or RANKL in the 4T1 tumor microenvironment is likely regulated by redundant mechanisms.

    DOI: 10.3390/ijms20246342

    PubMed

    researchmap

  • Multipotent Neurotrophic Effects of Hepatocyte Growth Factor in Spinal Cord Injury. Reviewed International journal

    Kentaro Yamane, Haruo Misawa, Tomoyuki Takigawa, Yoshihiro Ito, Toshifumi Ozaki, Akihiro Matsukawa

    International journal of molecular sciences   20 ( 23 )   2019.12

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Spinal cord injury (SCI) results in neural tissue loss and so far untreatable functional impairment. In addition, at the initial injury site, inflammation induces secondary damage, and glial scar formation occurs to limit inflammation-mediated tissue damage. Consequently, it obstructs neural regeneration. Many studies have been conducted in the field of SCI; however, no satisfactory treatment has been established to date. Hepatocyte growth factor (HGF) is one of the neurotrophic growth factors and has been listed as a candidate medicine for SCI treatment. The highlighted effects of HGF on neural regeneration are associated with its anti-inflammatory and anti-fibrotic activities. Moreover, HGF exerts positive effects on transplanted stem cell differentiation into neurons. This paper reviews the mechanisms underlying the therapeutic effects of HGF in SCI recovery, and introduces recent advances in the clinical applications of HGF therapy.

    DOI: 10.3390/ijms20236078

    PubMed

    researchmap

  • Negative impact of recipient SPRED2 deficiency on transplanted lung in a mouse model. Reviewed International journal

    Hashimoto K, Yamane M, Sugimoto S, Hirano Y, Kurosaki T, Otani S, Miyoshi K, Ohara T, Okazaki M, Yoshimura T, Oto T, Matsukawa A, Toyooka S

    Transplant immunology   57   101242 - 101242   2019.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Ischemia-reperfusion injury (IRI) after lung transplantation mainly contributes to the development of primary graft dysfunction. The Sprouty-related EVH1-domain-containing (SPRED) protein family inhibits the mitogen activated protein kinase/extracellular-signal-regulated kinase (MAPK/ERK) pathway. Our study was aimed at examining the role of SPRED2 in IRI in mice that received orthotopic lung transplantation. Syngeneic mouse lung transplantation was performed in wild-type C57BL/6 J (WT) mice and Spred2 knockout (Spred2-/-) mice on the C57BL/6 J background from the WT donor. Four hours after reperfusion, blood gas analysis was performed, and lung grafts were sacrificed and analyzed. By using arterial oxygen tension measurements and histological evaluation using Lung Injury Score, we revealed more severe IRI in the grafts transplanted to Spred2-/- recipients, which manifested as exacerbated airway epithelial cell damage, interstitial edema with hemorrhage and neutrophil infiltration. Intragraft ERK1/2 activation and expression levels of proinflammatory cytokines and chemokines in Spred2-/- recipients were higher than those in WT recipients. SPRED2 plays an important role in protecting the lungs from IRI in lung transplantation recipients. We suggest that focused treatments suppressing the activity of the MAPK/ERK pathway in transplantation recipients could be the potential therapeutic option for the prevention of lung IRI.

    DOI: 10.1016/j.trim.2019.101242

    PubMed

    researchmap

  • Rechargeable anti-microbial adhesive formulation containing cetylpyridinium chloride montmorillonite. Reviewed International journal

    Kenya Matsuo, Kumiko Yoshihara, Noriyuki Nagaoka, Yoji Makita, Hideki Obika, Takumi Okihara, Akihiro Matsukawa, Yasuhiro Yoshida, Bart Van Meerbeek

    Acta biomaterialia   100   388 - 397   2019.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Long-term anti-bacterial effect is a desired ability of any dental material in combating tooth caries as one of the most common and widespread persistent diseases today. Among several cationic quaternary ammonium compounds with antiseptic properties, cetylpyridinium chloride (CPC) is often used in mouthrinses and toothpastes. In this study, we incorporated CPC in a soft phyllosilicate mineral (clay), referred to as montmorillonite (Mont), to enable gradual CPC release with rechargeability. Besides measuring CPC release and recharge, we examined the anti-bacterial effect, cytotoxicity and bonding effectiveness of five experimental adhesive formulations, prepared by adding 1 and 3 wt% CPC_Mont, 3 wt% Mont (without CPC), and 1 and 3 wt% CPC (without Mont) to the commercial adhesive Clearfil S3 Bond ND Quick ('C-S3B'; Kuraray Noritake). Strong inhibition of Streptococcus mutans biofilm formation by CPC_Mont adhesives was confirmed by optical density and SEM. CPC release from CPC_Mont adhesives was higher and lasted longer than from CPC adhesives, while CPC_Mont adhesives could also be recharged with CPC upon immersion in 2 wt% CPC. In conclusion, CPC_Mont technology rendered adhesives anti-bacterial properties with recharge ability, this without reducing its bonding potential, neither increasing its cytotoxicity. STATEMENT OF SIGNIFICANCE: Dental caries is one of the most prevalent chronic diseases in the population worldwide and is the major cause of tooth loss. In this study, we developed cetylpyridinium chloride (CPC) loaded montmorillonite (CPC-Mont) with a long-term antibacterial efficacy to prevent caries. CPC is an antibacterial agent approved by FDA, used as an OTC drug and contained in oral hygiene aids. CPC-Mont was incorporated in a dental adhesive to gradually release CPC. CPC_Mont technology rendered adhesives anti-bacterial properties with rechargeability, this without reducing its bonding potential, neither increasing its cytotoxicity.

    DOI: 10.1016/j.actbio.2019.09.045

    PubMed

    researchmap

  • The relationship between the PD-L1 expression of surgically resected and fine-needle aspiration specimens for patients with pancreatic cancer. Reviewed

    Matsumoto K, Ohara T, Fujisawa M, Takaki A, Takahara M, Tanaka N, Kato H, Horiguchi S, Yoshida R, Umeda Y, Fushimi S, Yagi T, Matsukawa A, Okada H

    Journal of gastroenterology   54 ( 11 )   1019 - 1028   2019.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Recently, therapeutic antibodies against programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) have shown promising clinical results for several solid tumors, including pancreatic cancer. In this study, we evaluated the relationship between the PD-L1 expression of surgical resected and fine-needle aspiration (FNA) specimens for patients with pancreatic cancer. METHODS: Of 121 patients who underwent endoscopic ultrasound-guided (EUS)-FNA before surgery for pancreatic cancer in an academic center, the 94 (78%) with adequate FNA specimens for a histological evaluation were retrospectively analyzed. All the patients had undergone upfront surgery without any chemotherapy or radiotherapy. We performed immunohistochemistry (IHC) staining to investigate the PD-L1 expression in both resected and FNA specimens. The positive-stained cells were counted, and their percentage was used for the investigation. RESULTS: Of the 94 patients, 16 (17%) and 11 (10%) were defined as positive on resected cancer specimens using cutoff points of 5% and 10% positively stained cancer cell counts, respectively. The concordance rates for the positive frequency of PD-L1 expression between resected and FNA specimens were 44% (7/16) and 55% (6/11) when the positivity was set to ≥ 5% and ≥ 10%, respectively. The concordance rates for the negative frequency of PD-L1 expression between two specimens were 97% (76/78) and 99% (82/83) when the positivity was set to ≥ 5% and ≥ 10%, respectively. CONCLUSIONS: Approximately, half of the patients with PD-L1 expression positive and almost all the patients with PD-L1 expression negative could be diagnosed on FNA specimens.

    DOI: 10.1007/s00535-019-01586-6

    Web of Science

    PubMed

    researchmap

  • Prolonged warm ischemia exacerbated acute rejection after lung transplantation from donation after cardiac death in a mouse. Reviewed

    Hirano Y, Sugimoto S, Yamamoto S, Okada M, Otani S, Ohara T, Yamane M, Matsukawa A, Oto T, Toyooka S

    General thoracic and cardiovascular surgery   68 ( 1 )   57 - 62   2019.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: In lung transplantation (LTx) from donation after cardiac death (DCD), the donor lungs are inevitably exposed to warm ischemic time (WIT) between the cardiac arrest and the initiation of cold preservation. We conducted this study to examine the effect of prolonged WIT on lung allograft rejection in a murine model of LTx from DCD. METHODS: Allogeneic BALB/c → B6 LTx from DCD was performed with a WIT of 15 min (WIT15 group, n = 5) or 60 min (WIT60 group, n = 5). Recipients were immunosuppressed by perioperative costimulatory blockade. The lung allografts were analyzed by histology and flow cytometry on day 7 after the LTx. RESULTS: Histologically, the rejection grade in the WIT60 group was significantly higher than that in the WIT15 group (3.4 ± 0.4 vs. 2.2 ± 0.2, P = 0.0278). Moreover, the intragraft CD8+ to CD4+ T cell ratio in the WIT60 group was significantly higher than that in the WIT15 group (2.3 ± 0.12 vs. 1.2 ± 0.11, P < 0.0001). CONCLUSIONS: Prolonged WIT could exacerbate the severity of lung allograft rejection after LTx from DCD. Minimization of the WIT could improve the outcomes after LTx from DCD.

    DOI: 10.1007/s11748-019-01181-9

    PubMed

    researchmap

  • SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model. Reviewed

    Mesaki K, Yamane M, Sugimoto S, Fujisawa M, Yoshimura T, Kurosaki T, Otani S, Miyoshi S, Oto T, Matsukawa A, Toyooka S

    Surgery today   49 ( 5 )   443 - 450   2019.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: Suppressor of cytokine signaling-3 (SOCS3) is a negative feedback inhibitor of cytokine signaling with T-cell-mediated immunosuppressive effects on obliterative bronchiolitis (OB). In this study, we aimed to investigate the impact of T-cell-specific overexpression of SOCS3 using a murine heterotopic tracheal transplantation (HTT) model. METHODS: Tracheal allografts from BALB/c mice were subcutaneously transplanted into wild-type C57BL/6J (B6; WT) mice and SOCS3 transgenic B6 (SOCS3TG) mice. Tracheal allografts were analyzed by immunohistochemistry and quantitative polymerase chain reaction assays at days 7 and 21. RESULTS: At day 21, allografts in SOCS3TG mice showed significant amelioration of airway obstruction and epithelial loss compared with allografts in WT mice. The intragraft expression of IFN-γ and CXCL10 was suppressed, while that of IL-4 was enhanced in SOCS3TG mice at day 7. The T-bet levels were lower in SOCS3TG allografts than in WT allografts at day 7. CONCLUSION: We revealed that the overexpression of SOCS3 in T cells effectively ameliorates OB development in a murine HTT model by inhibiting the Th1 phenotype in the early phase. Our results suggest that the regulation of the T-cell response, through the modulation of SOCS expression, has potential as a new therapeutic strategy for chronic lung allograft dysfunction.

    DOI: 10.1007/s00595-018-1753-5

    PubMed

    researchmap

  • THE RELATIONSHIP BETWEEN THE PD-L1 EXPRESSION OF SURGICAL RESECTED AND FINE-NEEDLE ASPIRATION SPECIMENS FOR PATIENTS WITH PANCREATIC CANCER Reviewed

    Matsumoto Kazuyuki, Ohara Toshiaki, Fujisawa Masayoshi, Takaki Akinobu, Takahara Masahiro, Kato Hironari, Horiguchi Shigeru, Matsukawa Akihiro, Okada Hiroyuki

    GASTROENTEROLOGY   156 ( 6 )   S758   2019.5

  • Combined effect of anti-high-mobility group box-1 monoclonal antibody and peramivir against influenza A virus-induced pneumonia in mice. Reviewed International journal

    Kazuki Hatayama, Nobuyuki Nosaka, Mutsuko Yamada, Masato Yashiro, Yosuke Fujii, Hirokazu Tsukahara, Keyue Liu, Masahiro Nishibori, Akihiro Matsukawa, Tsuneo Morishima

    Journal of medical virology   91 ( 3 )   361 - 369   2019.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Human pandemic H1N1 2009 influenza virus causes significant morbidity and mortality with severe acute lung injury due to the excessive inflammatory reaction, even with neuraminidase inhibitor use. The anti-inflammatory effect of anti-high-mobility group box-1 (HMGB1) monoclonal antibody (mAb) against influenza pneumonia has been reported. In this study, we evaluated the combined effect of anti-HMGB1 mAb and peramivir against pneumonia induced by influenza A (H1N1) virus in mice. Nine-week-old male C57BL/6 mice were inoculated with H1N1 and treated with intramuscularly administered peramivir at 2 and 3 days post-infection (dpi). The anti-HMGB1 mAb or a control mAb was administered at 2, 3, and 4 dpi. Survival rates were assessed, and lung lavage and pathological analyses were conducted at 5 and 7 dpi. The combination of peramivir with the anti-HMGB1 mAb significantly improved survival rate whereas the anti-HMGB1 mAb alone did not affect virus proliferation in the lungs. This combination therapy also significantly ameliorated histopathological changes, neutrophil infiltration, and macrophage aggregation by inhibiting HMGB1, inflammatory cytokines, and oxidative stress. Fluorescence immunostaining showed that the anti-HMGB1 mAb inhibited HMGB1 translocation from type I alveolar epithelial cells. In summary, combining anti-HMGB1 with conventional anti-influenza therapy might be useful against severe influenza virus infection.

    DOI: 10.1002/jmv.25330

    PubMed

    researchmap

  • A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing Stemness. Reviewed International journal

    Yuki Katsura, Toshiaki Ohara, Kazuhiro Noma, Takayuki Ninomiya, Hajime Kashima, Takuya Kato, Hiroaki Sato, Satoshi Komoto, Toru Narusaka, Yasuko Tomono, Boyi Xing, Yuehua Chen, Hiroshi Tazawa, Shunsuke Kagawa, Yasuhiro Shirakawa, Tomonari Kasai, Masaharu Seno, Akihiro Matsukawa, Toshiyoshi Fujiwara

    Cancers   11 ( 2 )   2019.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Excess iron causes cancer and is thought to be related to carcinogenesis and cancer progression including stemness, but the details remain unclear. Here, we hypothesized that stemness in cancer is related to iron metabolism and that regulating iron metabolism in cancer stem cells (CSCs) may be a novel therapy. In this study, we used murine induced pluripotent stem cells that expressed specific stem cell genes such as Nanog, Oct3/4, Sox2, Klf4, and c-Myc, and two human cancer cell lines with similar stem cell gene expression. Deferasirox, an orally available iron chelator, suppressed expression of stemness markers and spherogenesis of cells with high stemness status in vitro. Combination therapy had a marked antitumor effect compared with deferasirox or cisplatin alone. Iron metabolism appears important for maintenance of stemness in CSCs. An iron chelator combined with chemotherapy may be a novel approach via suppressing stemness for CSC targeted therapy.

    DOI: 10.3390/cancers11020177

    PubMed

    researchmap

  • Abrogated Caveolin-1 expression via histone modification enzyme Setdb2 regulates brain edema in a mouse model of influenza-associated encephalopathy. Reviewed International journal

    Imakita N, Kitabatake M, Ouji-Sageshima N, Hara A, Morita-Takemura S, Kasahara K, Matsukawa A, Wanaka A, Mikasa K, Ito T

    Scientific reports   9 ( 1 )   284   2019.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Influenza-associated encephalopathy (IAE) is a serious complication that can follow influenza virus infection. Once a cytokine storm is induced during influenza virus infection, tight junction protein disruption occurs, which consequently leads to blood-brain barrier (BBB) breakdown. However, the details of IAE pathogenesis are not well understood. Here, we established a murine IAE model by administration of lipopolysaccharide following influenza virus infection. Brains from IAE model mice had significantly higher expression of type I interferons and inflammatory cytokines. In addition, the expression of Caveolin-1, one of the key proteins that correlate with protection of the BBB, was significantly lower in brains from the IAE group compared with the control group. We also found that, among 84 different histone modification enzymes, only SET domain bifurcated 2 (Setdb2), one of the histone methyltransferases that methylates the lysine 9 of histone H3, showed significantly higher expression in the IAE group compared with the control group. Furthermore, chromatin immunoprecipitation revealed that methylation of histone H3 lysine 9 was correlated with repression of the Caveolin-1 promoter region. These studies identify Caveolin-1 as a key regulator of BBB permeability in IAE and reveal that it acts through histone modification induced by Setdb2.

    DOI: 10.1038/s41598-018-36489-8

    PubMed

    researchmap

  • Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice. Reviewed International journal

    Takahiro Ohkura, Teizo Yoshimura, Masayoshi Fujisawa, Toshiaki Ohara, Rie Marutani, Kaya Usami, Akihiro Matsukawa

    Frontiers in immunology   10   17 - 17   2019

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Chronic low-grade inflammation in visceral adipose tissues triggers the development of obesity-related insulin resistance, leading to the metabolic syndrome, a serious health condition with higher risk of cardiovascular disease, diabetes, and stroke. In the present study, we investigated whether Sprouty-related EVH1-domain-containing protein 2 (Spred2), a negative regulator of the Ras/Raf/ERK/MAPK pathway, plays a role in the development of high fat diet (HFD)-induced obesity, adipose tissue inflammation, metabolic abnormalities, and insulin resistance. Spred2 knockout (KO) mice, fed with HFD, exhibited an augmented body weight gain, which was associated with enhanced adipocyte hypertrophy in mesenteric white adipose tissue (mWAT) and deteriorated dyslipidemia, compared with wild-type (WT) controls. The number of infiltrating macrophages with a M1 phenotype, and the crown-like structures, composed of macrophages surrounding dead or dying adipocytes, were more abundant in Spred2 KO-mWAT compared to in WT-mWAT. Exacerbated adipose tissue inflammation in Spred2 KO mice led to aggravated insulin resistance and fatty liver disease. To analyze the mechanism(s) that caused adipose tissue inflammation, cytokine response in mWAT was investigated. Stromal vascular fraction that contained macrophages from Spred2 KO-mWAT showed elevated levels of tumor necrosis factor α (TNFα) and monocyte chemoattractant protein-1 (MCP-1/CCL2) compared with those from WT-mWAT. Upon stimulation with palmitate acid (PA), bone marrow-derived macrophages (BMDMs) derived from Spred2 KO mice secreted higher levels of TNFα and MCP-1 than those from WT mice with enhanced ERK activation. U0126, a MEK inhibitor, reduced the PA-induced cytokine response. Taken together, these results suggested that Spred2, in macrophages, negatively regulates high fat diet-induced obesity, adipose tissue inflammation, metabolic abnormalities, and insulin resistance by inhibiting the ERK/MAPK pathway. Thus, Spred2 represents a potential therapeutic tool for the prevention of insulin resistance and resultant metabolic syndrome.

    DOI: 10.3389/fimmu.2019.00017

    PubMed

    researchmap

  • SPRED2 deficiency may lead to lung ischemia-reperfusion injury via ERK1/2 signaling pathway activation. Reviewed

    Okada M, Yamane M, Yamamoto S, Otani S, Miyoshi K, Sugimoto S, Matsukawa A, Toyooka S, Oto T, Miyoshi S

    Surgery today   48 ( 12 )   1089 - 1095   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: Inflammatory changes during lung ischemia-reperfusion injury (IRI) are related to the activation of the extracellular signal-regulated kinase (ERK)1/2 signaling pathway. Sprouty-related EVH1 (enabled/vasodilator-stimulated phosphoprotein homology 1)-domain-containing proteins (SPREDs) are known inhibitors of ERK1/2 signaling. The role of SPRED2 in lung IRI was examined in a left hilar clamp mouse model. METHODS: C57BL/6 wild-type (WT) and Spred2-/- mice were used in the left hilar clamp model. Experimental groups underwent 30 min of left hilar clamping followed by 1 h of reperfusion. U0126, an ERK1/2 inhibitor, was administered to Spred2-/- mice with reperfused lungs. RESULTS: The partial pressures of oxygen of the Spred2-/- mice after reperfusion were significantly worse than those of WT mice (p < 0.01). Spred2-/- mice displayed more severe injuries than WT mice with increased neutrophil infiltration observed by a histological evaluation and flow cytometry (p < 0.001). This severe inflammation was inhibited by U0126. In addition, the rate of ERK1 activation was significantly higher in the lungs of Spred2-/- mice after reperfusion than in WT mice according to a Western blot analysis (p < 0.05). CONCLUSION: The activation of the ERK1/2 signaling pathway influences the severity of lung IRI, causing inflammation with neutrophil infiltration. SPRED2 may be a promising target for the suppression of lung IRI.

    DOI: 10.1007/s00595-018-1696-x

    PubMed

    researchmap

  • A novel, nontoxic iron chelator, super-polyphenol, effectively induces apoptosis in human cancer cell lines. Reviewed International journal

    Toshiaki Ohara, Yasuko Tomono, Xing Boyi, Sun Yingfu, Kazuhiro Omori, Akihiro Matsukawa

    Oncotarget   9 ( 67 )   32751 - 32760   2018.8

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Iron chelation therapy is the main treatment for iron overload disease. Iron chelators were recently reported to be useful for cancer therapy; however, they cause side effects that make them difficult to use in some cancer patients. Thus, a novel oral iron chelator, super-polyphenol (SP), was developed for cancer therapy to decrease the side effects. SP is either water soluble or insoluble, and has different isoforms according to the number of side chains. Of these isoforms, water-soluble SP6 and SP10 appear to be the best candidates, as they have the strongest chelating abilities. In this study, we focused on the usefulness and safety of SP6 and SP10 as anti-cancer drugs, and examined their anti-cancer effects and toxicity. The results showed that SP6 and SP10 inhibited cancer cell proliferation by inducing apoptosis in HCT116, HSC-2, A549, and MCF-7 cancer cells. SP10 also inhibited tumor growth in an HCT116 xenograft model. SP6 and SP10 had no acute toxicities. An intravenous injection test revealed that SP6 and SP10 had better safety profiles than the iron chelator deferoxamine. In conclusion, SP is a novel oral iron chelator with anti-cancer effects and few adverse side effects. This is the first report of SP in the literature.

    DOI: 10.18632/oncotarget.25973

    PubMed

    researchmap

  • Overexpression of SOCS3 Attenuates Tracheal Allograft Rejection in the Early Phase After Murine Heterotopic Tracheal Transplantation by the Inhibition of Th1 Response Reviewed

    K. Mesaki, S. Sugimoto, H. Watanabe, M. Fujisawa, T. Yoshimura, T. Kurosaki, S. Otani, M. Yamane, S. Toyooka, A. Matsukawa, T. Oto

    The Journal of Heart and Lung Transplantation   37 ( 4 )   2018.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier {BV}  

    DOI: 10.1016/j.healun.2018.01.509

    researchmap

  • miRNA-133a-5p Inhibits the Expression of Osteoblast Differentiation-Associated Markers by Targeting the 3' UTR of RUNX2. Reviewed International journal

    Wei Zhang, Yonggang Wu, Yasuyuki Shiozaki, Yoshihisa Sugimoto, Tomoyuki Takigawa, Masato Tanaka, Akihiro Matsukawa, Toshifumi Ozaki

    DNA and cell biology   37 ( 3 )   199 - 209   2018.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Recent studies have recognized the involvement of microRNAs (miRNAs) in the development of osteoporosis, which regulate the balance between osteogenesis and osteoclasis. In this study, we investigated the regulation by miRNA-133a-5p on the osteoblast differentiation-associated markers in the mouse osteoblast-like MC3T3-E1 cells by RUNX2. First, we manipulated the miRNA-133a level in the MC3T3-E1 cells with 20 or 40 nM miR-133a-5p mimics, miR-133a-5p inhibitor, or scramble miRNA. Then, we quantified with real-time polymerase chain reaction (qRT-PCR) the expression of Collagen I, osteocalcin (OCN), and osteopontin (OPN) in the miR-133a-5p-manipulated MC3T3-E1 cells. And the confocal microscopy was also utilized to confirm the regulation by miR-133a-5p on the expression of the three molecules. We also investigated the extracellular matrix (ECM) mineralization and the alkaline phosphatase (ALP) activity in the miR-133a-5p-manipulated MC3T3-E1 cells. In addition, we explored the possible targeting by miR-133a-5p on RUNX2, which was a well-recognized promoter to osteoblast differentiation, with luciferase reporter, qRT-PCR, and Western blotting assay. Results demonstrated that the miRNA-133a-5p mimics markedly reduced, whereas the miRNA-133a-5p inhibitor significantly promoted the expression of Collagen I, OCN, and OPN, the ECM mineralization, and the ALP activity in MC3T3-E1 cells. The alignment analysis demonstrated a high homology between miRNA-133a-5p and the 3' UTR of RUNX2. Moreover, the luciferase reporter assay demonstrated that miRNA-133a-5p targeted the 3' UTR of RUNX2, and inhibited the expression of RUNX2 in both mRNA and protein levels. In conclusion, we identified the inhibition by miRNA-133a-5p to the expression of osteoblast differentiation markers, to the ECM mineralization, and to the ALP activity in MC3T3-E1 cells, by targeting the 3' UTR of RUNX2. Our study suggests that miRNA-133a-5p might be an important target to inhibit osteoblast differentiation in osteoporosis.

    DOI: 10.1089/dna.2017.3936

    PubMed

    researchmap

  • Spred2 Deficiency Exacerbates D-Galactosamine/Lipopolysaccharide -induced Acute Liver Injury in Mice via Increased Production of TNFα. Reviewed International journal

    Xu Yang, Masayoshi Fujisawa, Teizo Yoshimura, Toshiaki Ohara, Miwa Sato, Megumi Mino, Thar Htet San, Tong Gao, Steven L Kunkel, Akihiro Matsukawa

    Scientific reports   8 ( 1 )   188   2018.1

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Acute liver injury (ALI) is characterized by hepatocyte damage and inflammation. In the present study, we examined whether the absence of Sprouty-related EVH1-domain-containing protein 2 (Spred2), a negative regulator of the Ras/Raf/ERK/MAPK pathway, influences ALI induced by D-galactosamine (D-GalN) and lipopolysaccharide (LPS). Compared to wild-type mice, Spred2-/- mice developed exacerbated liver injury represented by enhanced hepatocyte damage and inflammation. Enhanced ERK activation was observed in Spred2-/--livers, and the MEK/ERK inhibitor U0126 ameliorated ALI. Hepatic tumour necrosis factor α (TNFα) and interleukin (IL)-1β levels were increased in Spred-2-/--livers, and the neutralization of TNFα dramatically ameliorated ALI, which was associated with decreased levels of endogenous TNFα and IL-1β. When mice were challenged with D-GalN and TNFα, much severer ALI was observed in Spred2-/- mice with significant increases in endogenous TNFα and IL-1β in the livers. Immunohistochemically, Kupffer cells were found to produce TNFα, and isolated Kupffer cells from Spred2-/- mice produced significantly higher levels of TNFα than those from wild-type mice after LPS stimulation, which was significantly decreased by U0126. These results suggest that Spred2 negatively regulates D-GalN/LPS-induced ALI under the control of TNFα in Kupffer cells. Spred2 may present a therapeutic target for the treatment of ALI.

    DOI: 10.1038/s41598-017-18380-0

    PubMed

    researchmap

  • Collagen-Binding Hepatocyte Growth Factor (HGF) alone or with a Gelatin- furfurylamine Hydrogel Enhances Functional Recovery in Mice after Spinal Cord Injury. Reviewed International journal

    Yamane K, Mazaki T, Shiozaki Y, Yoshida A, Shinohara K, Nakamura M, Yoshida Y, Zhou D, Kitajima T, Tanaka M, Ito Y, Ozaki T, Matsukawa A

    Scientific reports   8 ( 1 )   917   2018.1

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    The treatment of spinal cord injury (SCI) is currently a significant challenge. Hepatocyte growth factor (HGF) is a multipotent neurotrophic and neuroregenerative factor that can be beneficial for the treatment of SCI. However, immobilized HGF targeted to extracellular matrix may be more effective than diffusible, unmodified HGF. In this study, we evaluated the neurorestorative effects of an engineered HGF with a collagen biding domain (CBD-HGF). CBD-HGF remained in the spinal cord for 7 days after a single administration, while unmodified HGF was barely seen at 1 day. When a gelatin-furfurylamine (FA) hydrogel was applied on damaged spinal cord as a scaffold, CBD-HGF was retained in gelatin-FA hydrogel for 7 days, whereas HGF had faded by 1 day. A single administration of CBD-HGF enhanced recovery from spinal cord compression injury compared with HGF, as determined by motor recovery, and electrophysiological and immunohistochemical analyses. CBD-HGF alone failed to improve recovery from a complete transection injury, however CBD-HGF combined with gelatin-FA hydrogel promoted endogenous repair and recovery more effectively than HGF with hydrogel. These results suggest that engineered CBD-HGF has superior therapeutic effects than naïve HGF. CBD-HGF combined with hydrogel scaffold may be promising for the treatment of serious SCI.

    DOI: 10.1038/s41598-018-19316-y

    PubMed

    researchmap

  • Ovarian stromal cells as a source of cancer-associated fibroblasts in human epithelial ovarian cancer: A histopathological study. Reviewed International journal

    Masayoshi Fujisawa, Aye Moh-Moh-Aung, Zheng Zeng, Teizo Yoshimura, Yoji Wani, Akihiro Matsukawa

    PloS one   13 ( 10 )   e0205494   2018

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Fibroblasts are a major component of cancer tissue and known to contribute to cancer progression. However, it remains unknown whether they are derived from local fibroblasts or of other origin. This study was designed to identify the contribution of local stromal cells to cancer stroma in human epithelial ovarian cancer. Seventy-six cases of surgically resected primary ovarian carcinoma (48 cases confined to the ovaries and 28 cases with distant metastases) and 17 cases of secondary ovarian tumor (e.g. colon cancer metastasized to the ovary) were enrolled in this study. The tissues were immunostained for forkhead box protein L2 (FOXL2), a transcription factor crucial for ovarian development and function, and markers for cancer-associated fibroblasts (CAFs) and inflammatory cells. Under normal condition, FOXL2 expression was restricted to ovarian stromal cells and some other types of cells in female genital tracts and never found in other sites of the body. FOXL2-positive cells were found in all primary and secondary tumors in the ovary, and were the dominant stromal cells in most cases. In contrast, only a few FOXL2-positive cells were found in peritoneal seeding sites of four serous carcinoma cases, and all the other tumors at extraovarian sites had no FOXL2-positive cells. FOXL2-positive cells in the ovarian lesion variably expressed CAFs markers, such as alpha-smooth muscle actin and fibroblast activating protein, as determined by double immunostaining. Background inflammation, but not histological subtype or origin of the neoplasm seemed to correlate with the proportion of FOXL2-positive cells. These results suggest that ovarian stromal cells are the main source of cancer stroma in the ovary but do not seem to move to distant sites via circulation together with tumor cells. Our results also support the hypothesis that cancer-associated fibroblasts may originate locally, which was previously demonstrated using animal models.

    DOI: 10.1371/journal.pone.0205494

    PubMed

    researchmap

  • Iron depletion is a novel therapeutic strategy to target cancer stem cells. Reviewed International journal

    Takayuki Ninomiya, Toshiaki Ohara, Kazuhiro Noma, Yuki Katsura, Ryoichi Katsube, Hajime Kashima, Takuya Kato, Yasuko Tomono, Hiroshi Tazawa, Shunsuke Kagawa, Yasuhiro Shirakawa, Fumiaki Kimura, Ling Chen, Tomonari Kasai, Masaharu Seno, Akihiro Matsukawa, Toshiyoshi Fujiwara

    Oncotarget   8 ( 58 )   98405 - 98416   2017.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Adequate iron levels are essential for human health. However, iron overload can act as catalyst for the formation of free radicals, which may cause cancer. Cancer stem cells (CSCs), which maintain the hallmark stem cell characteristics of self-renewal and differentiation capacity, have been proposed as a driving force of tumorigenesis and metastases. In the present study, we investigated the role of iron in the proliferation and stemness of CSCs, using the miPS-LLCcm cell model. Although the anti-cancer agents fluorouracil and cisplatin suppressed the proliferation of miPS-LLCcm cells, these drugs did not alter the expression of stemness markers, including Nanog, SOX2, c-Myc, Oct3/4 and Klf4. In contrast, iron depletion by the iron chelators deferasirox and deferoxamine suppressed the proliferation of miPS-LLCcm cells and the expression of stemness markers. In an allograft model, deferasirox inhibited the growth of miPS-LLCcm implants, which was associated with decreased expression of Nanog and Sox2. Altogether, iron appears to be crucial for the proliferation and maintenance of stemness of CSCs, and iron depletion may be a novel therapeutic strategy to target CSCs.

    DOI: 10.18632/oncotarget.21846

    PubMed

    researchmap

  • Corrigendum: Induction of monocyte chemoattractant proteins in macrophages via the production of Granulocyte/Macrophage Colony-Stimulating Factor By Breast Cancer Cells [Front Immunol, 7, (2016) (2)] DOI:10.3389/fimmu.2016.00002 Reviewed

    Teizo Yoshimura, Tomozumi Imamichi, Jonathan M. Weiss, Miwa Sato, Liangzhu Li, Akihiro Matsukawa, Ji Ming Wang

    Frontiers in Immunology   8   2017.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media S.A.  

    DOI: 10.3389/fimmu.2017.01524

    Scopus

    researchmap

  • Spred2-deficiecy Protects Mice from Polymicrobial Septic Peritonitis by Enhancing Inflammation and Bacterial Clearance Reviewed International journal

    Junya Itakura, Miwa Sato, Toshihiro Ito, Megumi Mino, Soichiro Fushimi, Sakuma Takahashi, Teizo Yoshimura, Akihiro Matsukawa

    SCIENTIFIC REPORTS   7 ( 1 )   12833   2017.10

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Sepsis is an infection-induced systemic inflammatory syndrome and a major cause of death for critically ill patients. Here, we examined whether the absence of Sprouty-related EVH1-domain-containing protein 2 (Spred2), a negative regulator of the Ras/Raf/ERK/MAPK pathway, influences host defense against polymicrobial sepsis (PMS) induced by cecal ligation and puncture (CLP). Compared to wildtype mice, Spred2(-)/(-) mice exhibited higher survival rates with increased level of leukocyte infiltration and local chemokine production and reduced plasma and peritoneal bacterial loads after CLP. The MEK inhibitor U0126 significantly reduced LPS-induced chemokine production by Spred2(-)/(-) resident macrophages in vitro, and decreased CLP-induced leukocyte infiltration in vivo. Spred2(-)/(-)resident macrophages, but not neutrophils or elicited macrophages, exhibited increased phagocytic activity. Interestingly, surface expression of complement receptor 1/2 (CR1/2) was increased in Spred2(-)/(-) resident macrophages in response to lipopolysaccharide in a manner dependent on the ERK/MAPK pathway, and blocking CR1/2 in vivo resulted in reduced leukocyte infiltration and increased bacterial loads after CLP. Taken together, our results indicate that Spred2-deficiency protects mice from PMS via increased activation of the ERK/MAPK pathway and subsequent increase in innate immune responses. Thus, inhibiting Spred2 may present a novel means to prevent the development of PMS.

    DOI: 10.1038/s41598-017-13204-7

    Web of Science

    PubMed

    researchmap

  • The STAT4/MLL1 Epigenetic Axis Regulates the Antimicrobial Functions of Murine Macrophages Reviewed International journal

    William F. Carson, Karen A. Cavassani, Elyara M. Soares, Soichiro Hirai, Nicolai A. Kittan, Matthew A. Schaller, Melissa M. Scola, Amrita Joshi, Akihiro Matsukawa, David M. Aronoff, Craig N. Johnson, Yali Dou, Katherine A. Gallagher, Steven L. Kunkel

    JOURNAL OF IMMUNOLOGY   199 ( 5 )   1865 - 1874   2017.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ASSOC IMMUNOLOGISTS  

    Macrophages are critical immune cells for the clearance of microbial pathogens and cellular debris from peripheral tissues. Macrophage inflammatory responses are governed by gene expression patterns, and these patterns are often subject to epigenetic control. Chromatin modifications, such as histone methylation, regulate gene accessibility in macrophages, and macrophage polarization is governed in part by the expression and function of chromatin-modifying enzymes. The histone methyltransferase mixed-lineage leukemia 1 (MLL1) preferentially modifies lysine residue 4 on the unstructured protein tail of histone H3. MLL1 expression and function have been shown to be governed by signal transduction pathways that are activated by inflammatory stimuli, such as NF-kappa B. Therefore, we sought to investigate the role of MLL1 in mediating macrophage inflammatory responses. Bone marrow-derived macrophages from mice with a targeted MLL1 gene knockout (Lys2-Cre(+/-) MLL1(fx/fx)) exhibited decreased proinflammatory gene expression with concurrent decreases in activating histone methylation. However, MLL1-deficient macrophages also exhibited increased phagocytic and bacterial killing activity in vitro. RNA profiling of MLL1-knockout macrophages identified numerous genes involved with inflammatory responses whose expression was altered in response to TLR ligands or proinflammatory cytokines, including STAT4. STAT4-dependent cytokines, such as type I IFNs were able to drive MLL1 expression in macrophages, and MLL1-knockout macrophages exhibited decreased activating histone methylation in the STAT4 promoter. These results implicate an important role for MLL1-dependent epigenetic regulation of macrophage antimicrobial functions.

    DOI: 10.4049/jimmunol.1601272

    Web of Science

    PubMed

    researchmap

  • Molecular Subtypes of Breast Cancers from Myanmar Women: A Study of 91 Cases at Two Pathology Centers Reviewed International journal

    Thar Htet San, Masayoshi Fujisawa, Soichiro Fushimi, Lamin Soe, Ngu Wah Min, Teizo Yoshimura, Toshiaki Ohara, Myint Myint Yee, Shinsuke Oda, Akihiro Matsukawa

    Asian Pacific journal of cancer prevention : APJCP   18 ( 6 )   1617 - 1621   2017.6

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Background: Breast cancer is the most common cancer in Myanmar women. Revealing the hormonal receptor
    status, human epidermal growth factor receptor 2 (HER2) and Ki-67 expression is useful for estimating patient
    prognosis as well as determination of treatment strategy. However, immunohistochemical features and classification of
    molecular subtypes in breast cancers from Myanmar remain unknown. Methods: The clinicopathological features of
    91 breast cancers from Myanmar women were examined. Immunohistochemistry was performed on tissue specimens
    with antibodies to estrogen receptor (ER), progesterone receptor (PgR), HER2, Ki-67, cytokeratin (CK)5/6 and CK14.
    Immunohistochemistry-based molecular subtyping was conducted. Results: Breast cancers in Myanmar women were
    relatively large, high grade with frequent metastatic lymph nodes. Of the 91 patients, tumors with ER positive, PgR
    positive, and HER2 positive were 57.1%, 37.4%, and 28.6%, respectively. The most prevalent subtype was luminal B
    (HER2-) (39.6%), followed by HER2 (22.0%), triple negative (TN)-basal-like (12.1%), luminal A (11.0%), TN-null
    (8.8%) and luminal B (HER2+) (6.6%). The mean Ki-67 expression of 91 cases was 33.9% (33.9% ± 19.2%) and the
    median was 28% (range; 4%-90%). The mean Ki-67 expression of luminal A, luminal B, HER2 and TN-basal-like/
    null was 7%, 30%, 40%, and 57%/43%, respectively. A higher Ki-67 expression significantly correlated with a higher
    grade, larger size and higher stage of malignancy. Conclusions: We, for the first time, investigated the histopathological
    features of breast cancers from Myanmar women. Myanmar breast cancers appeared to be aggressive in nature, as
    evidenced by high frequency of poor-prognosis subtypes with high level of Ki-67 expression.

    DOI: 10.22034/APJCP.2017.18.6.1617

    PubMed

    researchmap

  • Low prevalence of human mammary tumor virus (HMTV) in breast cancer patients from Myanmar Reviewed International journal

    Thar Htet San, Masayoshi Fujisawa, Soichiro Fushimi, Teizo Yoshimura, Toshiaki Ohara, Lamin Soe, Ngu Wah Min, Ohnmar Kyaw, Xu Yang, Akihiro Matsukawa

    INFECTIOUS AGENTS AND CANCER   12 ( 1 )   60 - 66   2017.4

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIOMED CENTRAL LTD  

    Background: Human mammary tumor virus (HMTV) is 90-95% homologous to mouse mammary tumor virus (MMTV), one of the causal agents of murine mammary tumors. HMTV (MMTV-like) sequences were reported to be present in human breast cancers from several populations with a prevalence range of 0-78%; however, the prevalence of HMTV in breast cancers from Myanmar remains unknown.
    Methods: Fifty-eight breast cancer samples from Myanmar women were examined in this study. DNA was isolated from formalin-fixed paraffin-embedded specimens, and HMTV envelope sequences were detected by semi-nested PCR. The sequence of the PCR products was also confirmed.
    Results: Only 1.7% (1 of 58) of the breast cancers were positive for HMTV, and the sequence of PCR products was 98.9% identical to the reference HMTV sequence (GenBank accession No. AF243039). The tumor with HMTV was grade III invasive ductal carcinoma, 7.0 cm in size with lymph node metastasis (T3, N1, M0).
    Conclusions: We, for the first time, investigated the presence of HMTV in Myanmar breast cancer patients. In accordance with other Asian studies, the prevalence of HMTV in Myanmar was quite low, supporting the hypothesis that Asian breast cancers have different etiologies than in Western countries, where HMTV is more prevalent.

    DOI: 10.1186/s13027-017-0130-0

    Web of Science

    PubMed

    researchmap

  • 緑内障手術のサイエンス - 濾過手術とサイトカインを中心に

    井上俊洋, 谷原秀信, 布田龍佑, 福島美紀子, 伊藤康裕, 川路隆博, 岩尾圭一郎, 高橋枝里, 藤本智和, 井上みゆき, 岩尾美奈子, 笠岡奈々子, 原竜平, 正林耕平, 榮木大輔, 大平さおり, 後藤章子, 小島祥, 芳賀彰, 黒田詩子, 中島圭一, 平川沙織, 福島亜矢子, 松村理世, 徳永瞳, 川畑和幸, 北村文香, 西澤麻保, 二口亜希子, 松本桃佳, 吉村長久, 亀田隆範, 吉田晃敏, 川井基史, 川井尚子, 木下茂, 上田真由美, 古賀彩加, 稲谷大, 瀧原祐史, 本庄恵, 石井優, 菊田順一, 古家雅之, 松川昭博, 猿渡淳二, 田賀哲也, 鹿川哲史

    日本眼科学会雑誌   121 ( 3 )   314 - 335   2017

     More details

    Language:Japanese   Publisher:(公財)日本眼科学会  

    緑内障に対する手術治療は流出路再建術,濾過手術,毛様体破壊/凝固術に大別される.理想的な効果と安全性を兼ね備えた術式はないが,その中で眼圧下降効果は濾過手術が優るといえる.濾過手術の一種である線維柱帯切除術は最も標準的な緑内障手術の一つであり,優れた眼圧下降効果を有する一方で,術後に過剰な創傷治癒に伴って眼圧コントロール不良となる症例が一定数存在し,重篤な術中・術後合併症もまれではない.したがって,緑内障手術成績のさらなる改善は緑内障診療において重要な命題であり,本総説では,この命題に取り組むべく,我々が多面的に行ってきた臨床研究および基礎研究について紹介し,その成果と新しい試みについて論じた.まず,臨床成績の解析から,白内障手術の既往および施行が線維柱帯切除術の手術成績に一定の影響を与えることが明らかとなった.また硝子体手術既往眼,緑内障手術既往眼は手術既往なしと比較して,ぶどう膜炎に伴う緑内障,血管新生緑内障,家族性アミロイドポリニューロパチーに伴う緑内障は一般的に原発開放隅角緑内障と比較して線維柱帯切除術の成績が不良であった.これらの危険因子は眼内環境に変化を及ぼし,その結果,線維柱帯切除術の創傷治癒に影響が及び,最終的に眼圧コントロールが不良となったと考えられる.次に,背景因子が眼内環境に及ぼした変化に焦点を当て,房水サイトカインに着目して解析を行った.白内障手術既往眼では術後1年以上経過してもinterleukin(IL)-6,IL-8,monocyte chemoattractant protein(MCP)-1などの炎症性サイトカインの濃度が高値であった.これらのサイトカイン濃度は互いに正の相関があるとともに,ぶどう膜炎に伴う緑内障や血管新生緑内障でさらに高値であり,複合的に創傷治癒に影響を与えていることが示唆された.このうち房水内MCP-1は線維柱帯切除術術後成績に影響を与える因子と確認された.さらに,眼内の環境変化が濾過胞に与える影響を詳細に観察するために,我々は三次元光干渉断層計を用いた定量的な濾過胞解析を行った.三次元的な解析によって線維柱帯切除術術後の強膜弁縁における開口部を同定し,術中所見からこれが濾過胞への房水流出路となっていることを確認した.前向き研究によって,この開口部の幅は時間経過とともに狭くなり将来的な眼圧コントロールに関係することが示唆されるとともに,房水内MCP-1濃度と相関していることが明らかとなった.最後に,線維柱帯切除術術後の創傷治癒機転を細胞レベルで理解するために,マクロファージと結膜線維芽細胞を用いた細胞生物学的な実験を行った.創傷治癒機転において,マクロファージなどの関与によって線維芽細胞が筋線維芽細胞化することが重要であることが分かっている.この変化をROCK阻害薬やエピジェネティック薬が抑制することを見出した.また,2光子顕微鏡を用いた生体イメージングにより,手術によって結膜下の炎症細胞の動態は大きく影響を受けることが確認された.眼内環境の病的シフトをリスクの低い状態に近づけることを目的とした抗MCP-1治療やレセプターであるCCR2の阻害薬は,緑内障手術成績改善の試みの新たな糸口となる可能性を秘めていると考えられた.(著者抄録)

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2017&ichushi_jid=J01049&link_issn=&doc_id=20170316410005&doc_link_id=%2Fdz1nigan%2F2017%2F012103%2F005%2F0314-0335%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fdz1nigan%2F2017%2F012103%2F005%2F0314-0335%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • Tumor-Associated Macrophages in the Development of 4-Nitroquinoline-1-Oxide-Induced Tongue Squamous Cell Carcinoma in a Mouse Model Reviewed International journal

    Kentaro Miki, Yorihisa Orita, Yuka Gion, Soshi Takao, Kyotaro Ohno, Mai Takeuchi, Toshihiro Ito, Akira Minoura, Tomoyasu Tachibana, Hidenori Marunaka, Takuma Makino, Akihiro Matsukawa, Kazunori Nishizaki, Tadashi Yoshino, Yasuharu Sato

    ONCOLOGY   93 ( 3 )   204 - 212   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:KARGER  

    Objective: We aimed to determine the distribution of tumor-associated macrophages (TAMs) in the development of tongue squamous cell carcinoma (SCC) and to elucidate the role of TAMs in the progression of tongue SCC. Methods: The expression of the macrophage markers nitric oxide synthase, Retnla, and mannose receptor 1 in the development of tongue SCC was longitudinally observed using real-time quantitative polymerase chain reaction. Additionally, an immunohistochemical study using an anti-mannose receptor (MR) antibody was performed. Results: The numbers of both of M1 and M2 macrophages in the tongues of mice treated with 4-nitroquinoline-1-oxide (4NQO) were significantly lower compared with those of normal tongues. The cyclo-oxygenase-2 (COX-2) inhibitor did not prevent cancer progression and did not affect the total number of macrophages in the tongues of 4NQO-treated mice. In the immunohistochemical studies, MR staining was observed in lymphangio-endothelium in the subepithelial area of the tongues. The staining intensity of the MR was significantly stronger in the 4NQO-treated mice compared with that in control mice and 4NQO-treated mice treated with the COX-2 inhibitor. Conclusion: TAMs may not contribute to the development of 4NQO-induced tongue SCC. MR expression is associated with the progression of 4NQO-induced tongue SCC. (C) 2017 S. Karger AG, Basel

    DOI: 10.1159/000477301

    Web of Science

    PubMed

    researchmap

  • 多忙生嚢胞性変化を呈した輪状細管を伴う性策腫瘍(SCAT)の一例

    太田陽子, 伏見聡一郎, 堀田真智子, タテサン, 内野かおり, 藤澤真義, 和仁洋治, 松川昭博

    診断病理   34 ( 3 )   231 - 235   2017

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    多房化した肉眼形態を示し、術前診断が困難であったsex cord tumor with annular tubules(SCTAT)の1例を経験したので報告する。症例は月経不順でホルモン治療中の20代女性。増大傾向の右卵巣腫瘍を指摘され、臨床的には境界悪性ないし悪性の粘液性腫瘍が疑われ手術が行われた。腫瘍は多房性嚢胞性、肥厚した壁の部分には腫瘍細胞の輪状細管を含む胞巣を認めた。免疫染色ではinhibin-αとFOXL2が陽性、遺伝子解析ではFOXL2(C134W)変異はなく、SCTATと診断した。(著者抄録)

    researchmap

  • 前頭葉に発生し,てんかん原性を示した髄膜腫合併髄膜血管腫症の1例

    河原明奈, 伏見聡一郎, 板倉淳哉, 藤澤真義, 小林勝弘, 林裕美子, 伊達勲, 上利崇, 柳井広之, 松川昭博

    診断病理   34 ( 1 )   46 - 50   2017

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    17歳、男性。てんかん発作を幼少期より繰り返していた。3歳時の頭部CTでは病変を指摘されなかったが、13歳時に左中前頭回の脳表に石灰化を伴う病変を認めた。発作頻度が増したため、17歳時に病変とその直下のてんかん焦点を含む左前頭葉部分切除術が施行された。脳表側では砂粒体と渦巻き状に紡錘形細胞が認められ、移行性髄膜腫であった。大脳側では血管が網目状に増生し、血管周囲には髄膜皮細胞が取り巻く髄膜血管腫症であった。症状や画像の経過より髄膜血管腫症が先行し、その後髄膜腫が合併したと考えられた。(著者抄録)

    researchmap

  • Internationalization of medical education

    Matsukawa Akihiro

    Okayama Igakkai Zasshi (Journal of Okayama Medical Association)   129 ( 3 )   195 - 197   2017

     More details

  • 超音波内視鏡下穿刺吸引術(EUS-FNA)で得られたgangliocytic paragangliomaの細胞像の検討

    河合 穂高, 伏見 聡一郎, 板倉 淳哉, 井上 博文, 藤井 昌江, 武部 祐一郎, 松川 昭博

    日本臨床細胞学会雑誌   55 ( 6 )   376 - 381   2016.11

     More details

    Language:Japanese   Publisher:(公社)日本臨床細胞学会  

    背景:Gangliocytic paraganglioma(GP)は、十二指腸乳頭部に好発するまれな腫瘍で、主として粘膜下に存在するため、生検による確定診断は困難なことが多い。EUS-FNAは術前診断の有効な方法として期待されるが、その報告は少ない。症例:60歳代、男性。タール便を主訴に上部消化管内視鏡が施行された。生検では十二指腸粘膜のみしか得られなかった。EUS-FNA検体では、細顆粒状クロマチンを有する短紡錘形〜類円形の核をもつ紡錘形細胞に加え、少数ながら核小体の目立つ大型細胞も認められた。多彩な細胞像を呈し、核所見などから神経内分泌系の腫瘍が疑われた。膵十二指腸切除検体では十二指腸乳頭部の近傍に粘膜下腫瘍が認められた。組織学的に腫瘍は、Zellballen配列をとる上皮様細胞、明瞭な核小体をもつ神経節細胞様細胞、束状の紡錘形細胞(支持細胞)の3成分から構成されていた。最終的にGPと病理診断された。結論:EUS-FNA検体では必ずしも3成分の細胞が採取されない可能性がある。しかし、3成分の細胞が正しく採取され、さらにセルブロックの免疫組織化学的検討を加えれば、診断は可能と思われた。(著者抄録)

    DOI: 10.5795/jjscc.55.376

    researchmap

    Other Link: https://search-tp.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2016&ichushi_jid=J01209&link_issn=&doc_id=20170214130003&doc_link_id=10.5795%2Fjjscc.55.376&url=https%3A%2F%2Fdoi.org%2F10.5795%2Fjjscc.55.376&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_2.gif

  • A Novel Role of Spred2 in the Colonic Epithelial Cell Homeostasis and Inflammation Reviewed International journal

    Sakuma Takahashi, Teizo Yoshimura, Takahiro Ohkura, Masayoshi Fujisawa, Soichiro Fushimi, Toshihiro Ito, Junya Itakura, Sakiko Hiraoka, Hiroyuki Okada, Kazuhide Yamamoto, Akihiro Matsukawa

    SCIENTIFIC REPORTS   6   37531   2016.11

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Rapid and adequate mucosal healing is important for a remission of ulcerative colitis (UC) patients. Here, we examined whether Spred2, a member of the Sprouty-related EVH1-domain-containing proteins that inhibit the Ras/Raf/ERK pathway, plays a role in colonic mucosal homeostasis and inflammation by using Spred2 knockout (KO) mice. We first detected increased epithelial cell proliferation and cadherin 1 expression in the colon of naive Spred2 KO mice compared to wild-type mice. Interestingly, Spred2 KO mice were resistant to dextran sulfate sodium (DSS)-induced acute colitis as indicated by lower levels of body weight loss and disease activity index. Histologically, epithelial cell injury and inflammation were milder in the colonic mucosa of Spred2 KO mice on day 3 and almost undetectable by day 8. Experiments with bone chimeric mice indicated that Spred2 deficiency in non-hematopoietic cells was responsible for the reduced sensitivity to DSS. Finally, Spred2 KO mice developed significantly fewer tumors in response to azoxymethane plus DSS. Taken together, our results demonstrate, for the first time, that Spred2 plays an important role in the regulation of colonic epithelial cell proliferation and inflammation by potentially down-regulating the activation of ERK. Thus, Spred2 may be a new therapeutic target for the treatment of UC.

    DOI: 10.1038/srep37531

    Web of Science

    PubMed

    researchmap

  • Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinoma Reviewed International journal

    Kentaro Miki, Yorihisa Orita, Yuka Gion, Soshi Takao, Kyotaro Ohno, Mai Takeuchi, Toshihiro Ito, Hiroyuki Hanakawa, Tomoyasu Tachibana, Hidenori Marunaka, Takuma Makino, Akira Minoura, Akihiro Matsukawa, Kazunori Nishizaki, Tadashi Yoshino, Yasuharu Sato

    CANCER IMMUNOLOGY IMMUNOTHERAPY   65 ( 11 )   1401 - 1410   2016.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER  

    The objective of this study was to observe the distribution of regulatory T cells (Tregs) in the development of tongue squamous cell carcinoma (SCC) and to determine the role of Tregs in the progression of tongue SCC. A mouse model of 4-nitroquinoline-1-oxide (4NQO)-induced-tongue SCC was established. The expression of Forkhead box P3 (Foxp3), interleukin 10, transforming growth factor-beta, chemokine CC motif ligands 17, 20, and CC chemokine receptor 4 was determined using real-time quantitative polymerase chain reaction. Foxp3 expression was also analyzed using immunohistochemistry. The results were compared with those of control mice and of 4NQO-treated mice treated with a cyclooxygenase-2 (COX-2) inhibitor. Well to moderately differentiated tongue SCC was induced in all of the experimental mice. The amount of Tregs of the experimental mice was over 10 times as much as control mice at the early stage of tumor progression. COX-2 inhibitor did not prevent the progression of tongue SCC and did not reduce the total amount of Tregs. Tregs function at the early stage of the development of tongue SCC, and it may be effective to suppress Tregs at the early stage of tumor progression for the treatment and/or prevention of tongue SCC.

    DOI: 10.1007/s00262-016-1902-x

    Web of Science

    PubMed

    researchmap

  • Sprouty-Related Ena/Vasodilator-Stimulated Phosphoprotein Homology 1-Domain-Containing Protein-2 Critically Regulates Influenza A Virus-Induced Pneumonia Reviewed International journal

    Toshihiro Ito, Junya Itakura, Sakuma Takahashi, Miwa Sato, Megumi Mino, Soichiro Fushimi, Masao Yamada, Tuneo Morishima, Steven L. Kunkel, Akihiro Matsukawa

    CRITICAL CARE MEDICINE   44 ( 7 )   E530 - E543   2016.7

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Objectives: Influenza A virus causes acute respiratory infections that induce annual epidemics and occasional pandemics. Although a number of studies indicated that the virus-induced intracellular signaling events are important in combating influenza virus infection, the mechanism how specific molecule plays a critical role among various intracellular signaling events remains unknown. Raf/MEK/extracellular signal-regulated kinase cascade is one of the key signaling pathways during influenza virus infection, and the Sprouty-related Ena/vasodilator-stimulated phos-phoprotein homology 1-domain-containing protein has recently been identified as a negative regulator of Raf-dependent extracellular signal-regulated kinase activation. Here, we examined the role of Raf/MEK/extracellular signal-regulated kinase cascade through sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein in influenza A viral infection because the expression of sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein was significantly enhanced in human influenza viral-induced pneumonia autopsy samples.
    Design: Prospective animal trial.
    Setting: Research laboratory.
    Subjects: Wild-type and sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein-2 knockout mice inoculated with influenza A.
    Interventions: Wild-type or sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein-2 knockout mice were infected by intranasal inoculation of influenza A (A/PR/8). An equal volume of phosphate-buffered saline was inoculated intranasally into mock-infected mice.
    Measurements and Main Results: Influenza A infection of sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein-2 knockout mice led to higher mortality with greater viral load, excessive inflammation, and enhanced cytokine production than wild-type mice. Administration of MEK inhibitor, U0126, improved mortality and reduced both viral load and cytokine levels. Furthermore, bone marrow chimeras indicated that influenza A-induced lung pathology was most severe when sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein-2 expression was lacking in nonimmune cell populations. Furthermore, microarray analysis revealed knockdown of sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein-2 led to enhanced phosphatidylinositol 3-kinase signaling pathway, resulting that viral clearance was regulated by sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein-2 expression through the phosphatidylinositol 3-kinase signaling pathway in murine lung epithelial cells.
    Conclusions: These data support an important function of sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein-2 in controlling influenza virus-induced pneumonia and viral replication. Sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein-2 may be a novel therapeutic target for controlling the immune response against influenza influenza A virus infection.

    DOI: 10.1097/CCM.0000000000001562

    Web of Science

    PubMed

    researchmap

  • Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage ColonyStimulating Factor by Breast Cancer Cells Reviewed International journal

    Teizo Yoshimura, Tomozumi Imamichi, Jonathan M. Weiss, Miwa Sato, Liangzhu Li, Akihiro Matsukawa, Ji Ming Wang

    FRONTIERS IN IMMUNOLOGY   7 ( JAN )   1524 - 1524   2016.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:FRONTIERS MEDIA SA  

    Monocyte chemoattractant protein-1 (MCP-1)/CCL2 plays an important role in the initiation and progression of cancer. We previously reported that in 4T1 murine breast cancer, non-tumor stromal cells, including macrophages, were the major source of MCP-1. In the present study, we analyzed the potential mechanisms by which MCP-1 is upregulated in macrophages infiltrating 4T1 tumors. We found that cell free culture supernatants of 4T1 cells (4T1-sup) markedly upregulated MCP-1 production by peritoneal inflammatory macrophages. 4T1-sup also upregulated other MCPs, such as MCP-3/CCL7 and MCP-5/CCL12, but modestly upregulated neutrophil chemotactic chemokines, such as KC/CXCL1 or MIP-2/CXCL2. Physicochemical analysis indicated that an approximately 2-3 kDa 4T1 cell product was responsible for the capacity of 4T1-sup to upregulate MCP-1 expression by macrophages. A neutralizing antibody against granulocyte/macrophage colony stimulating factor (GM-CSF), but not macrophage CSF, almost completely abrogated MCP-1-inducing activity of 4T1-sup, and recombinant GM-CSF potently upregulated MCP-1 production by macrophages. The expression levels of GM-CSF in 4T1 tumors in vivo were higher than other tumors, such as Lewis lung carcinoma. Treatment of mice with anti-GM-CSF antibody significantly reduced the growth of 4T1 tumors at the injection sites but did not reduce MCP-1 production or lung metastasis in tumor-bearing mice. These results indicate that 4T1 cells have the capacity to directly upregulate MCP-1 production by macrophages by releasing GM-CSF; however, other mechanisms are also involved in increased MCP-1 levels in the 4T1 tumor microenvironment.

    DOI: 10.3389/fimmu.2016.00002

    Web of Science

    PubMed

    researchmap

  • Iron depletion enhances the effect of sorafenib in hepatocarcinoma Reviewed International journal

    Shinichi Urano, Toshiaki Ohara, Kazuhiro Noma, Ryoichi Katsube, Takayuki Ninomiya, Yasuko Tomono, Hiroshi Tazawa, Shunsuke Kagawa, Yasuhiro Shirakawa, Fumiaki Kimura, Kazuhiro Nouso, Akihiro Matsukawa, Kazuhide Yamamoto, Toshiyoshi Fujiwara

    CANCER BIOLOGY & THERAPY   17 ( 6 )   648 - 656   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:TAYLOR & FRANCIS INC  

    Human hepatocellular carcinoma (HCC) is known to have a poor prognosis. Sorafenib, a molecular targeted drug, is most commonly used for HCC treatment. However, its effect on HCC is limited in clinical use and therefore new strategies regarding sorafenib treatment are required. Iron overload is known to be associated with progression of chronic hepatitis and increased risk of HCC. We previously reported that iron depletion inhibited cancer cell proliferation and conversely induced angiogenesis. Indeed iron depletion therapy including iron chelator needs to be combined with anti-angiogenic drug for its anti-cancer effect. Since sorafenib has an anti-angiogenic effect by its inhibitory targeting VEGFR, we hypothesized that sorafenib could complement the anti-cancer effect of iron depletion. We retrospectively analyzed the relationship between the efficacy of sorafenib and serum iron-related markers in clinical HCC patients. In clinical cases, overall survival was prolonged in total iron binding capacity (TIBC) high- and ferritin low-patients. This result suggested that the low iron-pooled patients, who could have a potential of more angiogenic properties in/around HCC tumors, could be adequate for sorafenib treatment. We determined the effect of sorafenib (Nexavar (R)) and/or deferasirox (EXJADE (R)) on cancer cell viability, and on cell signaling of human hepatocarcinoma HepG2 and HLE cells. Both iron depletion by deferasirox and sorafenib revealed insufficient cytotoxic effect by each monotherapy, however, on the basis of increased angiogenesis by iron depletion, the addition of deferasirox enhanced anti-proliferative effect of sorafenib. Deferasirox was confirmed to increase vascular endothelial growth factor (VEGF) secretion into cellular supernatants by ELISA analysis. In in vivo study sorafenib combined with deferasirox also enhanced sorafenib-induced apoptosis. These results suggested that sorafenib combined with deferasirox could be a novel combination chemotherapy for HCC.

    DOI: 10.1080/15384047.2016.1177677

    Web of Science

    PubMed

    researchmap

  • Bone engineering by phosphorylated-pullulan and beta-TCP composite Reviewed International journal

    Tomohiro Takahata, Takumi Okihara, Yasuhiro Yoshida, Kumiko Yoshihara, Yasuyuki Shiozaki, Aki Yoshida, Kentaro Yamane, Noriyuki Watanabe, Masahide Yoshimura, Mariko Nakamura, Masao Irie, Bart Van Meerbeek, Masato Tanaka, Toshifumi Ozaki, Akihiro Matsukawa

    BIOMEDICAL MATERIALS   10 ( 6 )   065009 - 065009   2015.12

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:IOP PUBLISHING LTD  

    A multifunctional biomaterial with the capacity bond to hard tissues, such as bones and teeth, is a real need for medical and dental applications in tissue engineering and regenerative medicine. Recently, we created phosphorylated-pullulan (PPL), capable of binding to hydroxyapatite in bones and teeth. In the present study, we employed PPL as a novel biocompatible material for bone engineering. First, an in vitro evaluation of the mechanical properties of PPL demonstrated both PPL and PPL/beta-TCP composites have higher shear bond strength than materials in current clinical use, including polymethylmethacrylate (PMMA) cement and a-tricalcium phosphate (TCP) cement, Biopex-R. Further, the compressive strength of PPL/beta-TCP composite was significantly higher than Biopex-R. Next, in vivo osteoconductivity of PPL/beta-TCP composite was investigated in a murine intramedular injection model. Bone formation was observed 5 weeks after injection of PPL/beta-TCP composite, which was even more evident at 8 weeks; whereas, no bone formation was detected after injection of PPL alone. We then applied PPL/beta-TCP composite to a rabbit ulnar bone defect model and observed bone formation comparable to that induced by Biopex-R. Implantation of PPL/beta-TCP composite induced new bone formation at 4 weeks, which was remarkably evident at 8 weeks. In contrast, Biopex-R remained isolated from the surrounding bone at 8 weeks. In a pig vertebral bone defect model, defects treated with PPL/beta-TCP composite were almost completely replaced by new bone; whereas, PPL alone failed to induce bone formation. Collectively, our results suggest PPL/beta-TCP composite may be useful for bone engineering.

    DOI: 10.1088/1748-6041/10/6/065009

    Web of Science

    PubMed

    researchmap

  • Early Growth Response-1 Plays an Important Role in Ischemia-Reperfusion Injury in Lung Transplants by Regulating Polymorphonuclear Neutrophil Infiltration. Reviewed International journal

    Yamamoto S, Yamane M, Yoshida O, Waki N, Okazaki M, Matsukawa A, Oto T, Miyoshi S

    Transplantation   99 ( 11 )   2285 - 2293   2015.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Early growth response-1 (Egr-1) has been shown to be a trigger-switch transcription factor that is involved in lung ischemia-reperfusion injury (IRI). METHODS: Mouse lung transplants were performed in wild-type (WT) C57BL/6 and Egr1-knockout (KO) mice in the following donor → recipient combinations: WT → WT, KO → WT, WT → KO, and KO → KO to determine whether the presence of Egr-1 in the donor or recipient is the most critical factor for IRI. Pulmonary grafts were retrieved after 18 hours of ischemia after 4 hours of reperfusion. We analyzed graft function by analyzing arterial blood gas and histology in each combination and assessed the effects of Egr1 depletion on inflammatory cytokines that are regulated by Egr-1 as well on polymorphonuclear neutrophil (PMN) infiltration. RESULTS: Deletion of Egr1 improved pulmonary graft function in the following order of donor → recipient combinations: WT → WT < WT → KO < KO → WT < KO → KO. Polymerase chain reaction assays for Il1B, Il6, Mcp1, Mip2, Icam1, and Cox2 showed significantly lower expression levels in the KO → KO group than in the other groups. Immunohistochemistry demonstrated clear Egr-1 expression in the nuclei of pulmonary artery endothelial cells and PMN cytoplasm in the WT grafts. Flow cytometry analysis showed that Egr1 deletion reduced PMN infiltration and that the extent of reduction correlated with graft function. CONCLUSIONS: Both graft and recipient Egr-1 played a role in lung IRI, but the graft side contributed more to this phenomenon through regulation of PMN infiltration. Donor Egr-1 expression in pulmonary artery endothelial cells may play an important role in PMN infiltration, which results in IRI after lung transplantation.

    DOI: 10.1097/TP.0000000000000783

    PubMed

    researchmap

  • Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice Reviewed International journal

    Nobuyuki Nosaka, Masato Yashiro, Mutsuko Yamada, Yosuke Fujii, Hirokazu Tsukahara, Keyue Liu, Masahiro Nishibori, Akihiro Matsukawa, Tsuneo Morishima

    CRITICAL CARE   19 ( 249 )   s13054-0 - 249   2015.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIOMED CENTRAL LTD  

    Introduction: Provision for the emergence of an influenza pandemic is an urgent issue. The discovery of a novel anti-influenza therapeutic approach would increase the effectiveness of traditional virus-based strategies. This study was undertaken to evaluate the therapeutic effects of anti-high mobility group box-1 (HMGB1) monoclonal antibody (mAb) treatment on influenza A virus (H1N1)-induced pneumonia in mice.
    Methods: Nine-week-old male C57BL/6 mice were inoculated with H1N1, then anti HMGB1 mAb or control mAb were administered intravenously at 1, 24 and 48 hours after H1N1 inoculation and the survival rate was analyzed. Lung lavage and histopathological analysis were performed on days 3, 5, 7 and 10 after inoculation.
    Results: Anti-HMGB1 mAb significantly improved the survival rate of H1N1-inoculated mice (1 out of 15 versus 8 out of 15 deaths in the anti-HMGB1 mAb-treated group versus the control mAb-treated group, p &lt; 0.01), although the treatment did not affect virus propagation in the lungs. The treatment also significantly attenuated histological changes and neutrophil infiltration in the lungs of H1N1-inoculated mice. This was associated with inhibition of HMGB1 and suppression of inflammatory cytokine/chemokine expression and oxidative stress enhancement, which were observed in H1N1-inoculated mice. The expression of receptor for advanced glycation end products and nuclear factor kappa B was attenuated by the treatment.
    Conclusions: Anti-HMGB1 mAb may provide a novel and effective pharmacological strategy for severe influenza virus infection in humans by reducing the inflammatory responses induced by HMGB1.

    DOI: 10.1186/s13054-015-0983-9

    Web of Science

    PubMed

    researchmap

  • The anabolic effect of plasma-mediated ablation on the intervertebral disc: stimulation of proteoglycan and interleukin-8 production. Reviewed International journal

    Fabrice A Kuelling, Kevin T Foley, Jane J Liu, Ellen Liebenberg, Anthony H Sin, Akihiro Matsukawa, Jeffrey C Lotz

    The spine journal : official journal of the North American Spine Society   14 ( 10 )   2479 - 87   2014.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND CONTEXT: Plasma-mediated radiofrequency-based ablation (coblation) is an electrosurgical technique currently used for tissue removal in a wide range of surgical applications, including lumbar microdiscectomy. In vitro and in vivo studies have shown the technique to alter the expression of inflammatory cytokines in the disc, increasing the levels of interleukin-8 (IL-8), which may promote maturation and remodeling of the disc matrix. PURPOSE: To better understand the effect of coblation treatment, this study characterizes the temporal and spatial pattern of healing after stab injury to the rabbit intervertebral disc, with and without plasma-mediated radiofrequency treatment. PATIENT SAMPLE: A total of 23 New Zealand white rabbits. STUDY DESIGN: Annular and nuclear stab injuries. OUTCOME MEASURES: Sandwich enzyme-linked immunosorbent assay evaluated the concentrations of cytokines tumor necrosis factor-α, IL-1β, and IL-8. Histopathologic evaluations were performed on whole discs and end plates. Tissue sections were stained with Safranin-O to evaluate nucleus pulposus and annulus fibrosus proteoglycan content and with Alcian blue for extracellular proteoglycan content. Intradiscal leakage pressure was evaluated by injecting methylene blue dye into the nucleus. METHODS: Animals underwent annular and nuclear stab injuries on three consecutive lumbar discs (L2-L3 to L4-L5). The three levels were randomly assigned into one of the three groups for treatment with a plasma-mediated radiofrequency ablation device (TOPAZ; ArthroCare Corp., Austin, TX, USA): active treatment of the nucleus only (SN); active treatment of both nucleus and annulus (SNA); sham treatment. Unstabbed/untreated discs from L5-L6 (n=5) served as normal controls. Animals were euthanized at 4, 8, and 28 days postsurgery. RESULTS: Tumor necrosis factor-α was detected in sham discs at 4 and 8 days, but not in coblation groups (SN or SNA); IL-1β was below detection in all three treatment groups. Interleukin-8 levels increased in all treatment groups at 4 and 8 days compared with normal control, peaking at 4th day for sham and SN groups and 8th day (p>.3) for the SNA group (a 2.5-fold increase). Pressure measurements revealed higher leakage in the SN group, but no statistically significant differences. Histopathology showed higher proteoglycan production by 28 days in the SNA and SN groups compared with sham. All three treatment groups showed ruptured annular fibers from the stab injury, but maintained the overall architecture. Remnants of notochordal tissue within the nucleus were evident in all treatment groups at 4 and 8 days, but were only found in sham group by 28 days. At this time, unlike the normal or sham controls, the nucleus of SN and SNA discs had fibrocartilaginous tissue with chondrocyte-like cells. Significant differences in the disc architecture grade were only noted when comparing normal controls with other groups by 28 days (p<.001). CONCLUSIONS: Plasma-mediated radiofrequency ablation appears to have an anabolic effect on disc cells, stimulating proteoglycan and IL-8 production and maintaining annulus architecture. Coblation treatment appears to reduce cellular response to proinflammatory stimuli and restore overall disc architecture that may prove beneficial in a number of degenerative disc paradigms. Further studies are encouraged to investigate the therapeutic effect of the technique.

    DOI: 10.1016/j.spinee.2014.04.010

    PubMed

    researchmap

  • Metastasis of 4T1 murine breast cancer cells to the lung is dependent on the chemokine CCL2/MCP-1 produced by stromal cells in the primary tumor Reviewed

    Teizo Yoshimura, O. M. Zack Howard, Toshihiro Ito, Masaki Kuwabara, Akihiro Matsukawa, Keqiang Chen, Ying Liu, Mingyong Liu, Ji Ming Wang

    CANCER RESEARCH   74 ( 19 )   2014.10

     More details

    Language:English   Publisher:AMER ASSOC CANCER RESEARCH  

    DOI: 10.1158/1538-7445.AM2014-3585

    Web of Science

    researchmap

  • Spred-2 Deficiency Exacerbates Lipopolysaccharide-Induced Acute Lung Inflammation in Mice Reviewed International journal

    Yang Xu, Toshihiro Ito, Soichiro Fushimi, Sakuma Takahashi, Junya Itakura, Ryojiro Kimura, Miwa Sato, Megumi Mino, Akihiko Yoshimura, Akihiro Matsukawa

    PLOS ONE   9 ( 10 )   e108914   2014.10

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    Background: Acute respiratory distress syndrome (ARDS) is a severe and life-threatening acute lung injury (ALI) that is caused by noxious stimuli and pathogens. ALI is characterized by marked acute inflammation with elevated alveolar cytokine levels. Mitogen-activated protein kinase (MAPK) pathways are involved in cytokine production, but the mechanisms that regulate these pathways remain poorly characterized. Here, we focused on the role of Sprouty-related EVH1-domain-containing protein (Spred)-2, a negative regulator of the Ras-Raf-extracellular signal-regulated kinase (ERK)-MAPK pathway, in lipopolysaccharide (LPS)-induced acute lung inflammation.
    Methods: Wild-type (WT) mice and Spred-2(-/-) mice were exposed to intratracheal LPS (50 mu g in 50 mu L PBS) to induce pulmonary inflammation. After LPS-injection, the lungs were harvested to assess leukocyte infiltration, cytokine and chemokine production, ERK-MAPK activation and immunopathology. For ex vivo experiments, alveolar macrophages were harvested from untreated WT and Spred-2(-/-) mice and stimulated with LPS. In in vitro experiments, specific knock down of Spred-2 by siRNA or overexpression of Spred-2 by transfection with a plasmid encoding the Spred-2 sense sequence was introduced into murine RAW264.7 macrophage cells or MLE-12 lung epithelial cells.
    Results: LPS- induced acute lung inflammation was significantly exacerbated in Spred-2(-/-) mice compared with WT mice, as indicated by the numbers of infiltrating leukocytes, levels of alveolar TNF-alpha, CXCL2 and CCL2 in a later phase, and lung pathology. U0126, a selective MEK/ERK inhibitor, reduced the augmented LPS-induced inflammation in Spred-2(-/-) mice. Specific knock down of Spred-2 augmented LPS-induced cytokine and chemokine responses in RAW264.7 cells and MLE-12 cells, whereas Spred-2 overexpression decreased this response in RAW264.7 cells.
    Conclusions: The ERK-MAPK pathway is involved in LPS-induced acute lung inflammation. Spred-2 controls the development of LPS-induced lung inflammation by negatively regulating the ERK-MAPK pathway. Thus, Spred-2 may represent a therapeutic target for the treatment of ALI.

    DOI: 10.1371/journal.pone.0108914

    Web of Science

    PubMed

    researchmap

  • CPC解説(第59回) シュウ酸カルシウム結晶沈着を伴ったAspergillus nigerによる侵襲性肺アスペルギルス症の1例

    板倉 淳哉, 伏見 聡一郎, 荻野 哲也, 伊藤 利洋, 小田 晋輔, 河原 明奈, 萩谷 英大, 桑原 宏子, 松川 昭博

    病理と臨床   32 ( 6 )   669 - 675   2014.6

     More details

    Language:Japanese   Publisher:(株)文光堂  

    researchmap

  • Chemokine Receptor CCR8 Is Required for Lipopolysaccharide-Triggered Cytokine Production in Mouse Peritoneal Macrophages Reviewed International journal

    Tomoyuki Oshio, Rei Kawashima, Yuki I. Kawamura, Teruki Hagiwara, Noriko Mizutani, Toshihiko Okada, Takeshi Otsubo, Kyoko Inagaki-Ohara, Akihiro Matsukawa, Tatsuya Haga, Shigeru Kakuta, Yoichiro Iwakura, Seijiro Hosokawa, Taeko Dohi

    PLOS ONE   9 ( 4 )   e94445   2014.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    Chemokine (C-C motif) receptor 8 (CCR8), the chemokine receptor for chemokine (C-C motif) ligand 1 (CCL1), is expressed in T-helper type-2 lymphocytes and peritoneal macrophages (PM phi) and is involved in various pathological conditions, including peritoneal adhesions. However, the role of CCR8 in inflammatory responses is not fully elucidated. To investigate the function of CCR8 in macrophages, we compared cytokine secretion from mouse PM phi or bone marrow-derived macrophages (BMM phi) stimulated with various Toll-like receptor (TLR) ligands in CCR8 deficient (CCR8(-/-)) and wild-type (WT) mice. We found that CCR8(-/-) PM phi demonstrated attenuated secretion of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and IL-10 when stimulated with lipopolysaccharide (LPS). In particular, LPS-induced IL-10 production absolutely required CCR8. CCR8-dependent cytokine secretion was characteristic of PM phi but not BMM phi. To further investigate this result, we selected the small molecule compound R243 from a library of compounds with CCR8-antagonistic effects on CCL1-induced Ca2+ flux and CCL1-driven PM phi aggregation. Similar to CCR8(-/-) PM phi, R243 attenuated secretion of TNF-alpha, IL-6, and most strikingly IL-10 from WT PM phi, but not BMM phi. CCR8(-/-)PM phi and R243-treated WT PM phi both showed suppressed c-jun N-terminal kinase activity and nuclear factor-kappa B signaling after LPS treatment when compared with WT PM phi. A c-Jun signaling pathway inhibitor also produced an inhibitory effect on LPS-induced cytokine secretion that was similar to that of CCR8 deficiency or R243 treatment. As seen in CCR8(-/-) mice, administration of R243 attenuated peritoneal adhesions in vivo. R243 also prevented hapten-induced colitis. These results are indicative of cross talk between signaling pathways downstream of CCR8 and TLR-4 that induces cytokine production by PMQ. Through use of CCR8(-/-) mice and the new CCR8 inhibitor, R243, we identified a novel macrophage innate immune response pathway that involves a chemokine receptor.

    DOI: 10.1371/journal.pone.0094445

    Web of Science

    PubMed

    researchmap

  • A novel, visible light-induced, rapidly cross-linkable gelatin scaffold for osteochondral tissue engineering Reviewed International journal

    Tetsuro Mazaki, Yasuyuki Shiozaki, Kentaro Yamane, Aki Yoshida, Mariko Nakamura, Yasuhiro Yoshida, Di Zhou, Takashi Kitajima, Masato Tanaka, Yoshihiro Ito, Toshifumi Ozaki, Akihiro Matsukawa

    SCIENTIFIC REPORTS   4   4457 - 302   2014.3

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Osteochondral injuries remain difficult to repair. We developed a novel photo-cross-linkable furfurylamine-conjugated gelatin (gelatin-FA). Gelatin-FA was rapidly cross-linked by visible light with Rose Bengal, a light sensitizer, and was kept gelled for 3 weeks submerged in saline at 37 degrees C. When bone marrow-derived stromal cells (BMSCs) were suspended in gelatin-FA with 0.05% Rose Bengal, approximately 87% of the cells were viable in the hydrogel at 24 h after photo-cross-linking, and the chondrogenic differentiation of BMSCs was maintained for up to 3 weeks. BMP4 fusion protein with a collagen binding domain (CBD) was retained in the hydrogels at higher levels than unmodified BMP4. Gelatin-FA was subsequently employed as a scaffold for BMSCs and CBD-BMP4 in a rabbit osteochondral defect model. In both cases, the defect was repaired with articular cartilage-like tissue and regenerated subchondral bone. This novel, photo-cross-linkable gelatin appears to be a promising scaffold for the treatment of osteochondral injury.

    DOI: 10.1038/srep04457

    Web of Science

    PubMed

    researchmap

  • Erythroid and megakaryocytic differentiation of K562 erythroleukemic cells by monochloramine Reviewed

    T. Ogino, H. Kobuchi, H. Fujita, A. Matsukawa, K. Utsumi

    FREE RADICAL RESEARCH   48 ( 3 )   292 - 302   2014.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:INFORMA HEALTHCARE  

    The induction of leukemic cell differentiation is a hopeful therapeutic modality. We studied the effects of monochloramine (NH2Cl) on erythroleukemic K562 cell differentiation, and compared the effects observed with those of U0126 and staurosporine, which are known inducers of erythroid and megakaryocytic differentiation, respectively. CD235 (glycophorin) expression, a marker of erythroid differentiation, was significantly increased by NH2Cl and U0126, along with an increase in c mRNA levels. Other erythroid markers such as. gamma-globin and CD71 (transferrin receptor) were also increased by NH2Cl and U0126. In contrast, CD61 (integrin beta 3) and CD42b (GP1b alpha) expression, markers of megakaryocytic differentiation, was increased by staurosporine, but did not change significantly by NH 2 Cl and U0126. NH2Cl retarded cell proliferation without a marked loss of viability. When ERK phosphorylation (T202/ Y204) and CD235 expression were compared using various chemicals, a strong negative correlation was observed (r =-0.76). Paradoxically, NH2Cl and staurosporine, but not U0126, induced large cells with multiple or lobulated nuclei, which was characteristic to megakaryocytes. NH 2 Cl increased the mRNA levels of gata1 and scl, decreased that of gata2, and did not change those of pu.1 and klf1. The changes observed in mRNA expression were different from those of U0126 or staurosporine. These results suggest that NH2Cl induces the bidirectional differentiation of K562. Oxidative stress may be effective in inducing leukemic cell differentiation.

    DOI: 10.3109/10715762.2013.865840

    Web of Science

    PubMed

    researchmap

  • In vitro and in vivo enhanced osteogenesis by kaempferol found by a high-throughput assay using human mesenchymal stromal cells Reviewed

    Tetsuro Mazaki, Takashi Kitajima, Yasuyuki Shiozaki, Miwa Sato, Megumi Mino, Aki Yoshida, Mariko Nakamura, Yasuhiro Yoshida, Masato Tanaka, Toshifumi Ozaki, Akihiro Matsukawa, Yoshihiro Ito

    JOURNAL OF FUNCTIONAL FOODS   6   241 - 247   2014.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    High-throughput screening was performed as a phenotypic screening on clinically relevant human mesenchymal stem cells to identify small molecules that affect stem cell fate. From a library of pharmacologically active small molecules, we identified kaempferol, which is a natural flavonol, with a high osteogenic activity. Kaempferol achieved the highest levels of bone-specific markers among the chemicals tested in vitro. The osteogenic activity of kaempferol was the same as that of ipriflavone, which is a synthetic isoflavone, in ovariectomized mouse experiments. Considering that kaempferol is present in various foods such as vegetables and fruits, it will be useful as a new preventive medicine for osteoporosis. (C) 2013 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.jff.2013.10.013

    Web of Science

    researchmap

  • Galectin-9 prolongs the survival of septic mice by expanding tim-3-expressing natural killer T cells and PDCA-1+ CD11c+ macrophages Reviewed International journal

    Takashi Kadowaki, Asahiro Morishita, Toshiro Niki, Junko Hara, Miwa Sato, Joji Tani, Hisaaki Miyoshi, Hirohito Yoneyama, Tsutomu Masaki, Toshio Hattori, Akihiro Matsukawa, Mitsuomi Hirashima

    Critical Care   17 ( 6 )   R284   2013.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Introduction: Galectin-9 ameliorates various inflammatory conditions including autoimmune diseases by regulating T cell and macrophage/dendritic cell (DC) functions. However, the effect of galectin-9 on polymicrobial sepsis has not been assessed.Methods: We induced polymicrobial sepsis by cecal ligation and puncture (CLP) in mice. The survival rate was compared between galectin-9- and PBS-treated CLP mice. An ELISA was used to compare the levels of various cytokines in the plasma and culture supernatants. Fluorescence-activated cell sorting analysis was further performed to compare the frequencies of subpopulations of spleen cells.Results: Galectin-9 exhibited a protective effect in polymicrobial sepsis as demonstrated in galetin-9 transgenic mice and therapeutic galectin-9 administration. In contrast, such effect was not observed in nude mice, indicating the involvement of T cells in galectin-9-mediated survival prolongation. Galectin-9 decreased TNFα, IL-6, IL-10 and, high mobility group box 1 (HMGB1) and increased IL-15 and IL-17 plasma and spleen levels. Galectin-9 increased the frequencies of natural killer T (NKT) cells and PDCA-1+ CD11c+ macrophages (pDC-like macrophages) but did not change the frequency of CD4 or CD8 T cells, γδT cells or conventional DC. As expected, galectin-9 decreased the frequency of Tim-3+ CD4 T cells, most likely Th1 and Th17 cells. Intriguingly, many spleen NK1.1+ NKT cells and pDC-like macrophages expressed Tim-3. Galectin-9 increased the frequency of Tim-3-expressing NK1.1+ NKT cells and pDC-like macrophages. Galectin-9 further increased IL-17+ NK1.1+ NKT cells.Conclusion: These data suggest that galectin-9 exerts therapeutic effects on polymicrobial sepsis, possibly by expanding NKT cells and pDC-like macrophages and by modulating the production of early and late proinflammatory cytokines. © 2013 Kadowaki et al.; licensee BioMed Central Ltd.

    DOI: 10.1186/cc13147

    Scopus

    PubMed

    researchmap

  • Oxaliplatin-induced liver injury mimicking metastatic tumor on images: a case report. Reviewed International journal

    Kaori Uchino, Masayoshi Fujisawa, Takanori Watanabe, Yoshikatsu Endo, Tetsuji Nobuhisa, Yusuke Matsumoto, Kyohei Kai, Shiso Sato, Kenji Notohara, Akihiro Matsukawa

    Japanese journal of clinical oncology   43 ( 10 )   1034 - 8   2013.10

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Oxaliplatin-based chemotherapy is widely used for advanced colorectal cancer treatment, but it occasionally induces liver injury that is characterized histologically by sinusoidal dilatation, hepatic plate atrophy and/or venular obstruction. Most of the patients do not reveal apparent radiological abnormalities, however. Here, we report the case of a 47-year-old man with a radiologically detectable mass-forming oxaliplatin-induced sinusoidal injury that mimicked multiple liver tumors. These mass lesions were found on computed tomography images after the administration of six cycles of folinic acid, fluorouracil and oxaliplatin therapy as adjuvant chemotherapy for Stage III rectal cancer. The patient had to undergo liver resection because imaging studies could not exclude metastases. The histological examination revealed that a resected mass lesion was composed of severe sinusoidal dilatation. Milder dilatation was also seen in the surrounding parenchyma. We diagnosed the patient as having an oxaliplatin-induced sinusoidal injury with severe deviation. As oxaliplatin is a standard agent in colorectal cancer therapy today, all clinicians and pathologists should be aware of such non-neoplastic lesions as one of the rare differential diagnoses of metastatic liver tumor, to prevent overtreatment.

    DOI: 10.1093/jjco/hyt113

    PubMed

    researchmap

  • 小腸腸間膜嚢胞腺癌の1例

    宇田 征史, 吉岡 貴裕, 伏見 卓郎, 佐々木 洸太, 松本 朝子, 村田 年弘, 松川 昭博

    日本臨床外科学会雑誌   74 ( 4 )   968 - 972   2013.4

     More details

    Language:Japanese   Publisher:日本臨床外科学会  

    症例は80歳,男性.直腸S状部癌の精査目的CT検査,MRI検査にて回腸腸間膜に長径12cmの一部に石灰化を伴い造影効果のある充実性成分を伴う嚢胞性腫瘤を認めた.小腸腸間膜嚢胞腺癌,重複腸管,変性したGIST等を鑑別診断とし手術を行った.腫瘤は回腸末端から40から50cmの腸間膜に位置し浸潤傾向はなく腸管切除することなく核出術にて完全切除を行えた.摘出した腫瘤は13×6×5cm,256gで病理検査にて充実性腫瘤部に癌細胞を認め他部位の嚢胞壁には正常の円柱上皮,高円柱状異型細胞への移行像を認め嚢胞腺癌と診断された.腸間膜嚢胞に発生する腸間膜嚢胞腺癌は極めてまれな疾患であるが,今回われわれは直腸S状部癌の術前精査にて偶然発見された小腸腸間膜嚢胞腺癌の1例を経験したので若干の文献的考察を加え報告する.(著者抄録)

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2013&ichushi_jid=J03156&link_issn=&doc_id=20130507160021&doc_link_id=10.3919%2Fjjsa.74.968&url=https%3A%2F%2Fdoi.org%2F10.3919%2Fjjsa.74.968&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • In reply. Reviewed International journal

    Yoshimasa Takeda, Hiroshi Hashimoto, Koji Fumoto, Tetsuya Danura, Hiromichi Naito, Naoki Morimoto, Hiroshi Katayama, Soichiro Fushimi, Akihiro Matsukawa, Aiji Ohtsuka, Kiyoshi Morita

    Anesthesiology   118 ( 2 )   469 - 70   2013.2

     More details

  • Pharyngeal Cooling, Brain Temperature Reduction and a Neglect of History Reply Reviewed

    Yoshimasa Takeda, Hiroshi Hashimoto, Koji Fumoto, Tetsuya Danura, Hiromichi Naito, Naoki Morimoto, Hiroshi Katayama, Soichiro Fushimi, Akihiro Matsukawa, Aiji Ohtsuka, Kiyoshi Morita

    ANESTHESIOLOGY   118 ( 2 )   469 - 470   2013.2

     More details

    Language:English   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    DOI: 10.1097/ALN.0b013e31827e3c53

    Web of Science

    researchmap

  • Redox-active protein Thioredoxin-1 administration ameliorates influenza a virus (H1N1)-induced acute lung injury in mice Reviewed International journal

    Masato Yashiro, Hirokazu Tsukahara, Akihiro Matsukawa, Mutsuko Yamada, Yosuke Fujii, Yoshiharu Nagaoka, Mitsuru Tsuge, Nobuko Yamashita, Toshihiro Ito, Masao Yamada, Hiroshi Masutani, Junji Yodoi, Tsuneo Morishima

    Critical Care Medicine   41 ( 1 )   171 - 181   2013.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES:: Influenza virus infections can cause severe acute lung injury leading to significant morbidity and mortality. Thioredoxin-1 is a redox-active defensive protein induced in response to stress conditions. Animal experiments have revealed that thioredoxin-1 has protective effects against various severe disorders. This study was undertaken to evaluate the protective effects of recombinant human thioredoxin-1 administration on influenza A virus (H1N1)-induced acute lung injury in mice. DESIGN:: Prospective animal trial. SETTING:: Research laboratory. SUBJECTS:: Nine-week-old male C57BL/6 mice inoculated with H1N1. INTERVENTION:: The mice were divided into a vehicle-treated group and recombinant human thioredoxin-1-treated group. For survival rate analysis, the vehicle or recombinant human thioredoxin-1 was administered intraperitoneally every second day from day-1 to day 13. For lung lavage and pathological analyses, vehicle or recombinant human thioredoxin-1 was administered intraperitoneally on days-1, 1, and 3. MEASUREMENTS AND MAIN RESULTS:: Lung lavage and pathological analyses were performed at 24, 72, and 120 hrs after inoculation. The recombinant human thioredoxin-1 treatment significantly improved the survival rate of H1N1-inoculated mice, although the treatment did not affect virus propagation in the lung. The treatment significantly attenuated the histological changes and neutrophil infiltration in the lung of H1N1-inoculated mice. The treatment significantly attenuated the production of tumor necrosis factor-α and chemokine (C-X-C motif) ligand 1 in the lung and oxidative stress enhancement, which were observed in H1N1-inoculated mice. H1N1 induced expressions of tumor necrosis factor-α and chemokine (C-X-C motif) ligand 1 in murine lung epithelial cells MLE-12, which were inhibited by the addition of recombinant human thioredoxin-1. The recombinant human thioredoxin-1 treatment started 30 mins after H1N1 inoculation also significantly improved the survival of the mice. CONCLUSIONS:: Exogenous administration of recombinant human thioredoxin-1 significantly improved the survival rate and attenuated lung histological changes in the murine model of influenza pneumonia. The protective mechanism of thioredoxin-1 might be explained by its potent antioxidative and anti-inflammatory actions. Consequently, recombinant human thioredoxin-1 might be a possible pharmacological strategy for severe influenza virus infection in humans. © 2013 by the Society of Critical Care Medicine and Lippincott Williams &amp
    Wilkins.

    DOI: 10.1097/CCM.0b013e3182676352

    Scopus

    PubMed

    researchmap

  • 妊娠中に発症し高度のネフローゼを呈した急性糸球体腎炎の生検例

    伏見 聡一郎, 桑本 聡史, 野坂 加苗, 徳安 祐輔, 中本 周, 上浦 望, 尾田 高志, 城 謙輔, 松川 昭博

    診断病理   30 ( 1 )   66 - 70   2013.1

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    症例は妊娠中の20代女性。高度のネフローゼ症候群を呈し、腎生検が行われた。組織学的に糸球体の腫大と管内への炎症細胞浸潤を認めた。免疫染色では有意な所見は得られなかったが、組織化学的に糸球体でplasmin活性が認められ、溶連菌感染後急性糸球体腎炎と考えられた。本例の鑑別診断においてplasmin活性の酵素組織化学的所見が意義あると考えられた。文献的考察も加えて報告する。(著者抄録)

    researchmap

  • Therapeutic effects of redox-active protein thioredoxin(TRX)-1 in influenza-virus-induced pneumonia in mice

    YASHIRO MASATO, TSUKAHARA HIROKAZU, MATSUKAWA AKIHIRO, YAMADA MUTSUKO, FUJII YOSUKE, NAGAOKA YOSHIHARU, TSUGE MITSURU, YAMASHITA NOBUKO, ITO TOSHIHIRO, YAMADA MASAO, MASUTANI HIROSHI, YODOI JUNJI, MORISHIMA TSUNEO

    岡山医学会雑誌   125 ( 2 )   109-112 (J-STAGE) - 112   2013

  • Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. Reviewed International journal

    Yoshimura T, Howard OM, Ito T, Kuwabara M, Matsukawa A, Chen K, Liu Y, Liu M, Oppenheim JJ, Wang JM

    PloS one   8 ( 3 )   e58791   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    MCP-1/CCL2 plays an important role in the initiation and progression of cancer. Since tumor cells produce MCP-1, they are considered to be the main source of this chemokine. Here, we examined whether MCP-1 produced by non-tumor cells affects the growth and lung metastasis of 4T1 breast cancer cells by transplanting them into the mammary pad of WT or MCP-1(-/-) mice. Primary tumors at the injected site grew similarly in both mice; however, lung metastases were markedly reduced in MCP-1(-/-) mice, with significantly longer mouse survival. High levels of MCP-1 mRNA were detected in tumors growing in WT, but not MCP-1(-/-) mice. Serum MCP-1 levels were increased in tumor-bearing WT, but not MCP-1(-/-) mice. Transplantation of MCP-1(-/-) bone marrow cells into WT mice did not alter the incidence of lung metastasis, whereas transplantation of WT bone marrow cells into MCP-1(-/-) mice increased lung metastasis. The primary tumors of MCP-1(-/-) mice consistently developed necrosis earlier than those of WT mice and showed decreased infiltration by macrophages and reduced angiogenesis. Interestingly, 4T1 cells that metastasized to the lung constitutively expressed elevated levels of MCP-1, and intravenous injection of 4T1 cells producing a high level of MCP-1 resulted in increased tumor foci in the lung of WT and MCP-1(-/-) mice. Thus, stromal cell-derived MCP-1 in the primary tumors promotes lung metastasis of 4T1 cells, but tumor cell-derived MCP-1 can also contribute once tumor cells enter the circulation. A greater understanding of the source and role of this chemokine may lead to novel strategies for cancer treatment.

    DOI: 10.1371/journal.pone.0058791

    PubMed

    researchmap

  • The linkage of innate and adaptive immune response during granulomatous development. Reviewed International journal

    Ito T, Connett JM, Kunkel SL, Matsukawa A

    Frontiers in immunology   4   10 - 10   2013

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Granulomas represent a spectrum of inflammatory sequestration responses that may be initiated by a variety of agents, including non-infectious environmental factors and infectious microbial pathogens. Although this reaction is designed to be protective, the associated tissue injury is often responsible for a profound degree of pathology. While many of the mechanisms that sustain the development of the granuloma are enigmatic, it is accepted that the maintenance of this inflammatory process is dependent upon dynamic interactions between an inciting agent, inflammatory mediators, various immune and inflammatory cells, and structural cells of the involved tissue. The best studied of the host-dependent processes during granuloma development is the innate and adaptive immune response. The innate immune response by antigen-presenting cells [APCs; dendritic cells (DCs) and macrophages] is initiated quickly to protect from overwhelming pathogens, but with time, can also activate the adaptive immune response. APCs, essential regulators of the innate immune response, can respond to microbial ligands through Toll-like receptors (TLRs), which function in the recognition of microbial components and play an important role to link the innate and adaptive immune responses. CD4(+) T helper (Th) cells are essential regulators of adaptive immune responses and inflammatory diseases. Recently, the Notch system has been shown to be an important bridge between APCs and T cell communication circuits. In the present review, we discuss recent findings that explore the mechanisms in the linkage of innate and adaptive immunity, including granulomatous formation though TLRs and Notch activation.

    DOI: 10.3389/fimmu.2013.00010

    PubMed

    researchmap

  • Enhanced in vivo osteogenesis by nanocarrier-fused bone morphogenetic protein-4. Reviewed International journal

    Yasuyuki Shiozaki, Takashi Kitajima, Tetsuro Mazaki, Aki Yoshida, Masato Tanaka, Akihiro Umezawa, Mariko Nakamura, Yasuhiro Yoshida, Yoshihiro Ito, Toshifumi Ozaki, Akihiro Matsukawa

    International journal of nanomedicine   8   1349 - 60   2013

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: Bone defects and nonunions are major clinical skeletal problems. Growth factors are commonly used to promote bone regeneration; however, the clinical impact is limited because the factors do not last long at a given site. The introduction of tissue engineering aimed to deter the diffusion of these factors is a promising therapeutic strategy. The purpose of the present study was to evaluate the in vivo osteogenic capability of an engineered bone morphogenetic protein-4 (BMP4) fusion protein. METHODS: BMP4 was fused with a nanosized carrier, collagen-binding domain (CBD), derived from fibronectin. The stability of the CBD-BMP4 fusion protein was examined in vitro and in vivo. Osteogenic effects of CBD-BMP4 were evaluated by computer tomography after intramedullary injection without a collagen-sponge scaffold. Recombinant BMP-4, CBD, or vehicle were used as controls. Expressions of bone-related genes and growth factors were compared among the groups. Osteogenesis induced by CBD-BMP4, BMP4, and CBD was also assessed in a bone-defect model. RESULTS: In vitro, CBD-BMP4 was retained in a collagen gel for at least 7 days while BMP4 alone was released within 3 hours. In vivo, CBD-BMP4 remained at the given site for at least 2 weeks, both with or without a collagen-sponge scaffold, while BMP4 disappeared from the site within 3 days after injection. CBD-BMP4 induced better bone formation than BMP4 did alone, CBD alone, and vehicle after the intramedullary injection into the mouse femur. Bone-related genes and growth factors were expressed at higher levels in CBD-BMP4-treated mice than in all other groups, including BMP4-treated mice. Finally, CBD-BMP4 potentiated more bone formation than did controls, including BMP4 alone, when applied to cranial bone defects without a collagen scaffold. CONCLUSION: Altogether, nanocarrier-CBD enhanced the retention of BMP4 in the bone, thereby promoting augmented osteogenic responses in the absence of a scaffold. These results suggest that CBD-BMP4 may be clinically useful in facilitating bone formation.

    DOI: 10.2147/IJN.S44124

    PubMed

    researchmap

  • Occult Compression Fracture of Metacarpal Head without Evidence of Avascular Necrosis. Reviewed

    Keiichiro Nishida, Hiroyuki Hashizume, Akihiro Matsukawa, Kenzo Hashizume, Yasunori Shimamura, Yasuyuki Torigoe, Toshifumi Ozaki

    Acta medica Okayama   67 ( 5 )   311 - 7   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We report a case of 4th metacarpal head collapse of a 19-year-old healthy man. MRI revealed T1 low and T2 high regions in the collapsed 4th metacarpal head, as well as in the right 3rd and left 4th metacarpal head. Our initial diagnosis was occult compression fracture due to avascular necrosis, known as Dieterich's disease. However, pathological findings of surgically resected right 4th metacarpal head were compatible with transient osteoporosis and metacarpal head fracture followed by active tissue repair. The autologous osteochondral transplants from costchondral junction survived and maintained their size and shape even at 10-year follow-up.

    PubMed

    researchmap

  • Elevated Levels of Monocyte Chemoattractant Protein-1 in the Aqueous Humor after Phacoemulsification Reviewed International journal

    Motofumi Kawai, Toshihiro Inoue, Masaru Inatani, Naoko Tsuboi, Kohei Shobayashi, Akihiro Matsukawa, Akitoshi Yoshida, Hidenobu Tanihara

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE   53 ( 13 )   7951 - 7960   2012.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ASSOC RESEARCH VISION OPHTHALMOLOGY INC  

    PURPOSE. To elucidate the impact of phacoemulsification on aqueous monocyte chemoattractant protein-1 (MCP-1) levels, and identify its cell origin.
    METHODS. For clinical study, aqueous humor samples were collected before and after surgery (17.0 +/- 4.0 months postoperatively) from 21 cataract cases that underwent phacoemulsification and intraocular lens (IOL) implantation. Aqueous MCP-1 levels were determined using a multiplex immunoassay. For animal experiments, rabbits underwent phacoemulsification (+/- IOL). Aqueous humor samples were collected from nonoperated eyes and operated eyes, and immunoassays were performed. Eyes were analyzed by reverse transcription-polymerase chain reaction and immunohistochemical studies.
    RESULTS. In the clinical study, mean (+/- SD) aqueous MCP-1 levels were higher postoperatively (1773.5 +/- 321.2 pg/mL) than preoperatively (796.9 +/- 211.3 pg/mL; P &lt; 0.0001). In animal experiments, mean aqueous MCP-1 levels (pg/mL) were higher in postoperative eyes on day 30 (207.1 +/- 62.9) than in nonoperated eyes (31.2 +/- 12.5; P = 0.018). IOL implantation did not affect the changes in MCP-1 levels. After phacoemulsification, MCP-1 mRNA expression was increased in the cornea, iris, ciliary body, and capsular bag. Expression of MCP-1 mRNA in the capsular bag, but not the other tissues, increased from day 30 to 90. Immunohistochemical studies showed positive immunoreactivity for MCP-1 in cells of the posterior capsule after phacoemulsification.
    CONCLUSIONS. Aqueous MCP-1 levels were elevated in both human and animal eyes after phacoemulsification. Proliferated lens epithelial cells on the capsule might be the major cell origin for prolonged MCP-1 production after phacoemulsification. (http://www.umin.ac.jp/number, UMIN000005788.) (Invest Ophthalmol Vis Sci. 2012;53:7951-7960) DOI: 10.1167/iovs.12-10231

    DOI: 10.1167/iovs.12-10231

    Web of Science

    PubMed

    researchmap

  • 炎症の発現・制御におけるサイトカインシグナル伝達

    松川 昭博

    小児感染免疫   24 ( 3 )   303 - 307   2012.10

     More details

    Language:Japanese   Publisher:日本小児感染症学会  

    researchmap

  • Spred-2 deficiency exacerbates acetaminophen-induced hepatotoxicity in mice Reviewed International journal

    Hiroshi Wakabayashi, Toshihiro Ito, Soichiro Fushimi, Yuki Nakashima, Jyunya Itakura, Liu Qiuying, Min Min Win, Sun Cuiming, Cao Chen, Miwa Sato, Megumi Mino, Tetsuya Ogino, Hirofumi Makino, Akihiko Yoshimura, Akihiro Matsukawa

    CLINICAL IMMUNOLOGY   144 ( 3 )   272 - 282   2012.9

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    MAPKs are involved in acetaminophen (APAP)-hepatotoxicity, but the regulatory mechanism remains unknown. Here, we explored the role of Spred-2 that negatively regulates Ras/ERK pathway in APAP-hepatotoxicity. Spred-2 knockout (KO) mice demonstrated exacerbated liver injury, an event that was associated with increased numbers of CD4(+) T, CD8(+) T and NK cells in the liver compared to the control. Levels of CXCL9/CXCL10 that attract and activate these cells were increased in Spred-2 KO-liver. Kupffer cells isolated from Spred-2 KO mice after APAP challenge expressed higher levels of CXCL9/CXCL10 than those from the control. Upon stimulation with APAP or IFN gamma, naive Kupffer cells from Spred-2 KO mice expressed higher levels of CXCL9/CXCL10. NK cell-depletion attenuated APAP-hepatotoxicity with lowered hepatic IFN gamma and decreased numbers of not only NK cells but also CD4(+) T and CD8(+) T cells in the liver. These results suggest that Spred-2 negatively regulates APAP-hepatotoxicity under the control of Kupffer cells and NK cells. (C) 2012 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.clim.2012.07.002

    Web of Science

    PubMed

    researchmap

  • Notch system in the linkage of innate and adaptive immunity. Reviewed International journal

    Ito T, Connett JM, Kunkel SL, Matsukawa A

    Journal of leukocyte biology   92 ( 1 )   59 - 65   2012.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The lung is one of the most immunologically challenged organs and can be affected by a number of pathogens, including bacteria, virus, fungi, and parasites. The development and chronicity of pulmonary infection are determined by the early innate response to the pathogenic stimuli and are regulated at multiple levels. Initial studies have indicated that the interaction of Notch and Notch ligands plays a critical role during development, and further, the Notch system is an important bridge between APCs and T cell communication circuits. APCs are essential regulators of the innate immune response. They can respond to PAMPs through PRRs, which function in the recognition of pathogenic components and play an important role in the innate and adaptive immune response. T cells are essential regulators of adaptive immune responses and infectious diseases. However, the role of the Notch system in the cross-talk between APC and T cells during pulmonary infection is still poorly understood. In the present review, we discuss recent findings that explore the mechanisms underlying the role of Notch signaling in the linkage of innate and adaptive immunity, including pulmonary infection though PPRs and Notch activation.

    DOI: 10.1189/jlb.1011529

    PubMed

    researchmap

  • Effects of Pharyngeal Cooling on Brain Temperature in Primates and Humans A Study for Proof of Principle Reviewed International journal

    Yoshimasa Takeda, Hiroshi Hashimoto, Koji Fumoto, Tetsuya Danura, Hiromichi Naito, Naoki Morimoto, Hiroshi Katayama, Soichiro Fushimi, Akihiro Matsukawa, Aiji Ohtsuka, Kiyoshi Morita

    ANESTHESIOLOGY   117 ( 1 )   117 - 125   2012.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Background: Pharyngeal cooling decreases brain temperature by cooling carotid arteries. This study was designed to evaluate the principle of pharyngeal cooling in monkeys and humans.
    Methods: Monkeys (n = 10) were resuscitated following 12 min of cardiac arrest. Pharyngeal cooling (n = 5), in which cold saline (5 degrees C) was perfused into the cuff at the rate of 500 ml/min, was initiated simultaneously with the onset of resuscitation for 30 min. Patients (n = 3) who were in an intensive care unit were subjected to 30 min of pharyngeal cooling under propofol anesthesia.
    Results: In the animal study, core brain temperature was significantly decreased compared with that in the control group by 1.9 degrees C (SD = 0.8, P &lt; 0.001) and 3.1 degrees C (SD = 1.0, P &lt; 0.001) at 10 ruin and 30 min after the onset of cooling, respectively. The cooling effect was more evident in an animal with low postresuscitation blood pressure. Total dose of epinephrine, number of direct current shocks, and recovery of blood pressure were not different between the two groups. The pharyngeal epithelium was microscopically intact on day 5. In the clinical study, insertion of the cuff and start of perfusion did not affect heart rate or blood pressure. Tympanic temperature was decreased by 0.6 +/- 0.1 degrees C/30 min without affecting bladder temperature. The pharynx was macroscopically intact for 3 days.
    Conclusions: Pharyngeal cooling rapidly and selectively decreased brain temperature in primates and tympanic temperature in humans and did not have adverse effects on return of spontaneous circulation, even when initiated during cardiac arrest in primates.

    DOI: 10.1097/ALN.0b013e3182580536

    Web of Science

    PubMed

    researchmap

  • Spred-2 negatively regulates influenza A virus (H1N1)-induced pneumonia Reviewed

    Toshihiro Ito, Akihiko Yoshimura, Akihiro Matsukawa

    JOURNAL OF IMMUNOLOGY   188   2012.5

     More details

    Authorship:Last author, Corresponding author   Language:English   Publisher:AMER ASSOC IMMUNOLOGISTS  

    Web of Science

    researchmap

  • Egr1: a novel target for ameliorating acute allograft rejection in an experimental lung transplant model Reviewed International journal

    Naohisa Waki, Masaomi Yamane, Sumiharu Yamamoto, Mikio Okazaki, Seiichiro Sugimoto, Akihiro Matsukawa, Takahiro Oto, Shinichiro Miyoshi

    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY   41 ( 3 )   669 - 675   2012.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS INC  

    Acute allograft rejection is one of the significant complications occurring in lung transplant recipients. Early growth response-1 (Egr-1), zinc-finger-type transcription factor, is known as a master switch regulator of diverse chemical mediators. We used an orthotopic mouse model of left lung transplant to elucidate the function of Egr-1 in acute pulmonary rejection.
    Left lung grafts retrieved from C57BL/6 wild mice or C57BL/6 Egr-1-null mice were orthotopically transplanted into BALB/c mice; the lungs were harvested at day 1, 3, 5 or 7 after lung transplantation. The grade of acute rejection was histopathologically evaluated. The intragraft gene expression levels of Egr-1 and downstream target mediators were quantitatively measured by real-time polymerase chain reaction. Immunohistochemical analysis was used to determine the location and distribution of the Egr-1 protein in the pulmonary graft.
    Severe acute rejection was observed in allografts from wild-type mice at 5 days after transplantation. Only minimal rejection was seen in the lung graft from Egr-1-null donor mice at 5 days after transplantation. Strong upregulation of Egr-1 mRNA transcripts was observed at day 1, which then decreased during the next 5 days. The mRNA of Egr-1 target mediators [interleukin-1-beta (IL-1 beta), monocyte chemotactic protein-1 (MCP-1) and plasminogen activator inhibitor-1] reached maximal levels at day 5. Egr-1-null allografts exhibited significantly lower expressions of IL-1 beta and MCP-1 mRNA (P &lt; 0.05).
    Our study showed that deletion of Egr-1 in lung allografts ameliorates severe acute rejection with the reduction of expression levels of chemical mediators, implying a new possible strategy for treating acute pulmonary allograft rejection.

    DOI: 10.1093/ejcts/ezr030

    Web of Science

    PubMed

    researchmap

  • Prostatic stromal tumor of uncertain malignant potential (STUMP) with unrecognized growth pattern Reviewed International journal

    Soichiro Fushimi, Tetsuya Ogino, Ken Aoki, Junya Itakura, Toshihiro Ito, Tadashi Oeda, Hiroyuki Yanai, Akihiro Matsukawa

    PATHOLOGY INTERNATIONAL   62 ( 1 )   69 - 71   2012.1

     More details

    Authorship:Last author, Corresponding author   Language:English   Publisher:WILEY-BLACKWELL  

    DOI: 10.1111/j.1440-1827.2011.02741.x

    Web of Science

    PubMed

    researchmap

  • Local effects of intra-articular injection of anti-rabbit tumor necrosis factor alpha monoclonal antibody in antigen-induced arthritis of the rabbit temporomandibular joint Reviewed International journal

    Taishi Ohtani, Manabu Habu, Amit Khanal, Izumi Yoshioka, Akihiro Matsukawa, Kazuhiro Tominaga

    JOURNAL OF ORAL PATHOLOGY & MEDICINE   41 ( 1 )   96 - 105   2012.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    BACKGROUND: Local effects of intra-articular (IA) injection of anti-rabbit tumor necrosis factor alpha monoclonal antibody (anti-TNF alpha mAb) for antigen-induced mono-arthritis (AIA) of the rabbit temporomandibular joint (TMJ) and its systemic influences were evaluated.
    METHODS: Biochemical analysis of synovial fluid (SF), clinical and histopathological analyses of TMJ, and serum analysis were performed after inducing AIA in bilateral TMJs of 40 New Zealand White rabbits. IA injection of anti-TNF alpha mAb in unilateral TMJ (TNF blockade side; n = 12) and IgG (n = 12) was performed while saline injected on the contralateral side. TNF alpha and IL-1 beta in SF was analyzed at Days 1, 3, 7, and 21. Joint swelling and head withdrawal reflex threshold (WRT) over TMJs were evaluated in TNF blockade side (n = 12) with histopathological analysis at Days 3, 7, and 21. In remaining four animals with TNF blockade, TNF alpha and anti- TNF alpha mAb in serum were analyzed.
    RESULTS: Tumor necrosis factor alpha in SF was significantly lower in TNF blockade side on all days but IL-1 beta was lower only on Day 3. WRT was significantly higher at all times in the blockade side. Less inflammatory reactions and degenerative changes of cartilage were observed on Days 7 and 21 in the blockade side. TNF alpha and anti- TNF alpha mAb were under detection level in serum at all times.
    CONCLUSIONS: Intra-articular injection of anti- rabbit TNF alpha mAb in mono-arthritis model was effective to control local inflammation and degenerative joint changes. Further, low-dose IA injection of antibody may not have systemic side effects. J Oral Pathol Med (2012) 41: 96105

    DOI: 10.1111/j.1600-0714.2011.01056.x

    Web of Science

    PubMed

    researchmap

  • Correlation of neutrophil and monocyte derived interleukin-1 receptor antagonist and interleukin-8 with colitis severity in the rabbit Reviewed International journal

    Kenta Kaneda, Fumio Saitoh, Hirom Shibusawa, Hidetaka Maegawa, Abbi R. Saniabadi, Nobuhito Kashiwagi, Akihiro Matsukawa

    CYTOKINE   56 ( 2 )   508 - 514   2011.11

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    Activated neutrophils and monocytes produce interleukin (IL)-8, a pro-inflammatory chemokine, but also IL-1 receptor antagonist (IL-1ra), which is an anti-inflammatory cytokine. We were interested to see the profiles of IL-8 and IL-1ra in the colonic tissue and in the peripheral blood leukocytes (PBL) during the development of immune complex induced colitis in rabbits. IL-1ra and IL-8 in PBL were measured in 26 rabbits at time 0 h, 24 h, and 48 h after induction of colitis. The colons were removed at 48 h for measuring myeloperoxidase (MPO), ulcer area, IL-1ra and IL-8. Epithelial damage, crypt abscess formation and leukocyte infiltration of the colonic tissue were major features of this colitis model. During the development of colitis, there was an increase in circulating neutrophils and monocytes (P &lt; 0.0001), but not lymphocytes. Likewise, elevated amounts of IL-Ira (P = 0.0001) and IL-8 (P = 0.0219) production by PBL were observed following induction of colitis. Flow cytometry revealed major source of IL-1ra was monocytes, while the main sources of IL-8 were neutrophils and monocytes. There was correlation between MPO and ulcer area (R(s) = 0.6327, P &lt; 0.0001). At 24 h, PBL from MPO(High) group (n = 11) showed increased IL-1ra (P = 0.027) and IL-8 (P = 0.0128) levels vs MPO(Low) group (n = 15). IL-8 production by PBL showed correlation with tissue MPO (R(s) = 0.4273, P = 0.0295). The colitis in this model was associated with an increase in circulating monocytes and neutrophils, which released increased amounts of IL-8 and IL-1ra. Further, IL-8 and IL-1ra showed correlation with the severity of colitis. These observations should significantly further understandings on the role of neutrophils and monocytes in the immunopathogenesis of ulcerative colitis. (C) 2011 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.cyto.2011.07.008

    Web of Science

    PubMed

    researchmap

  • The Critical Role of Notch Ligand Delta-like 1 in the Pathogenesis of Influenza A Virus (H1N1) Infection Reviewed International journal

    Toshihiro Ito, Ronald M. Allen, William F. Carson, Matthew Schaller, Karen A. Cavassani, Cory M. Hogaboam, Nicholas W. Lukacs, Akihiro Matsukawa, Steven L. Kunkel

    PLOS PATHOGENS   7 ( 11 )   e1002341   2011.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    Influenza A viral infections have been identified as the etiologic agents for historic pandemics, and contribute to the annual mortality associated with acute viral pneumonia. While both innate and acquired immunity are important in combating influenza virus infection, the mechanism connecting these arms of the immune system remains unknown. Recent data have indicated that the Notch system is an important bridge between antigen-presenting cells (APCs) and T cell communication circuits and plays a central role in driving the immune system to overcome disease. In the present study, we examine the role of Notch signaling during influenza H1N1 virus infection, focusing on APCs. We demonstrate here that macrophages, but not dendritic cells (DCs), increased Notch ligand Delta-like 1 (Dll1) expression following influenza virus challenge. Dll1 expression on macrophages was dependent on retinoic acid-inducible gene-I (RIG-I) induced type-I IFN pathway, and not on the TLR3-TRIF pathway. We also found that IFN alpha-Receptor knockout mice failed to induce Dll1 expression on lung macrophages and had enhanced mortality during influenza virus infection. Our results further showed that specific neutralization of Dll1 during influenza virus challenge induced higher mortality, impaired viral clearance, and decreased levels of IFN-gamma. In addition, we blocked Notch signaling by using gamma-secretase inhibitor (GSI), a Notch signaling inhibitor. Intranasal administration of GSI during influenza infection also led to higher mortality, and higher virus load with excessive inflammation and an impaired production of IFN-gamma in lungs. Moreover, Dll1 expression on macrophages specifically regulates IFN-gamma levels from CD4(+) and CD8(+) T cells, which are important for anti-viral immunity. Together, the results of this study show that Dll1 positively influences the development of anti-viral immunity, and may provide mechanistic approaches for modifying and controlling the immune response against influenza H1N1 virus infection.

    DOI: 10.1371/journal.ppat.1002341

    Web of Science

    PubMed

    researchmap

  • 黒色真菌Exophiala. jeanselmeiによる左手背皮下膿瘍を呈したフェオヒフォミコーシスの1例

    森三郎, 平谷恵子, 井上さおり, 川上直明, 藤野寿幸, 松川昭博

    尾道市立病院医学雑誌   27 ( 1 )   55 - 58   2011

     More details

    Language:Japanese   Publisher:尾道市立市民病院  

    84歳女性。左手指示中手指関節背側の腫脹および発赤、圧痛、左手背部の軽度熱感を主訴に近医を受診後、著者らの施設へ紹介受診となった。左手指示中手指関節背側に対し皮化膿瘍部の穿刺吸引、排膿、ならびに患部切開排膿が施行された。その結果、、微生物的検査では糸状菌が、また培養検査では黒色真菌が検出された。更に加えて生育温度テストではExophiala jeanselmeiが同定された。尚、施行後は抗真菌薬の服用により左手背腫脹は軽減し、疼痛も消失した。

    researchmap

  • Oxidative stress enhances granulocytic differentiation in HL 60 cells, an acute promyelocytic leukemia cell line. Reviewed International journal

    Tetsuya Ogino, Michitaka Ozaki, Akihiro Matsukawa

    Free radical research   44 ( 11 )   1328 - 1337   2010

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    This paper studied the effects of physiologically available oxidants on HL 60 differentiation induced by all-trans retinoic acid (ATRA) or dimethyl sulfoxide (DMSO). Hydrogen peroxide (15 μM) and taurine chloramine (200 μM) induced HL 60 differentiation, which was detected by CD11b expression and superoxide production. Cd11b and p67phox mRNA expression was also augmented by these oxidants. In contrast, reducing chemicals, such as dithiothreitol, 2,3-dimercapto-1-propanol and N-acetylcysteine inhibited CD11b expression. Notably, DMSO inhibited methionine sulfoxide reductase activity, induced heme oxygenase-1 (ho-1) mRNA and enhanced oxidant-induced cell death, which indicated that DMSO intensified oxidative stress. After the addition of oxidants, ho-1 expression preceded the cd11b expression. Vicinal dithiol-reactive phenylarsine oxide (50 nM) also increased CD11b expression induced by DMSO or ATRA. These observations suggested that oxidative stress enhanced granulocytic differentiation of HL 60 cells and that leukaemic cell differentiation was affected by cellular redox status.

    DOI: 10.3109/10715762.2010.503757

    PubMed

    researchmap

  • Perioperative three-dimensional ultrasonographic assessment of carotid artery stenting : a case report

    FUJII Motoharu, MATSUKAWA Hidetoshi, YAMAMOTO Daisuke, MURAKATA Atsushi, SHINODA Masaki, ISHIKAWA Ryoichi, UEMURA Akihiro

    Neurosonology   23 ( 1 )   13 - 16   2010

     More details

    Language:Japanese   Publisher:The Japan Academy of Neurosonology  

    We report an 84-year-old woman who underwent carotid artery stenting because of asymptomatic carotid artery stenosis. Perioperative monitoring by three-dimensional ultrasonography (US) revealed more than 80% stenosis in the right carotid artery. The patient initially had transient ischemic attacks manifested by dizziness and vertigo, and was diagnosed by carotid artery US at the brain dock. As intravascular treatment, carotid artery stenting was performed using the Angioguard XP filter protection device and Precise stent. Three-dimensiona] us and three-dimensional reconstruction of color Doppler sonography (CDS) enabled examination of carotid artery blood flow prior to surgery, as well as blood flow in the stent, and conditions of the grafted stent after surgery. Intravascular images, such as plaque shift or subacute thrombosis, were visualized in three spatial dimensions by a combination of three-dimensional US and standard two-dimensional US, indicating their benefit for the evaluation of intra-stent blood flow. On the other hand, two-dimensional US showed better performance in terms of plaque diagnosis, specifically for evaluation of the morphology and properties of plaques, than three-dimensional US. Further improvements in three-dimensional US including CDS systems are anticipated.

    DOI: 10.2301/neurosonology.23.13

    CiNii Article

    CiNii Books

    researchmap

  • Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages Reviewed International journal

    Tomohiro Arikawa, Kota Watanabe, Masako Seki, Akihiro Matsukawa, Souichi Oomizu, Ken-mei Sakata, Atsuko Sakata, Masaki Ueno, Naoki Saita, Toshiro Niki, Akira Yamauchi, Mitsuomi Hirashima

    CLINICAL IMMUNOLOGY   133 ( 3 )   382 - 392   2009.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Galectin-9 up-regulated Fc gamma RIIb expression of mouse peritoneal macrophages in vitro but down-regulated Fc gamma RIII expression. Galectin-9-treated macrophages stimulated with immune complexes (IC) produced less TNF alpha and IL-1 beta but more IL-10 than PBS-treated macrophages. Macrophage enhancing effects on IC-induced C5a and neutrophil chemotactic activity were also diminished for galectin-9-treated macrophages. In galectin-9-treated mice, the severity of IC-induced arthritis was reduced, as were pro-inflammatory cytokine levels in inflamed joints and serum C5a. Fc gamma RIIb expression of macrophages from galectin-9-treated mice was up-regutated, whereas Fc gamma RIII expression was down-regulated. Macrophages from galectin-9-treated mice produced less TNF alpha and IL-1 beta but more IL-10 than PBS-treated mice. Disease severity of galectin-9-transgenic mice was milder than wild-type mice, whereas that of galectin-9-deficient mice was exaggerated. Furthermore, macrophage Fc gamma RIIb expression in galectin-9-deficient mice was down-regutated, while Fc gamma RIII expression was up-regutated. These results suggest that galectin-9 suppresses IC-induced inflammation partly by regulating Fc gamma R expression on macrophages. (C) 2009 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.clim.2009.09.004

    Web of Science

    PubMed

    researchmap

  • Forced expression of suppressor of cytokine signaling 3 in T cells protects the development of concanavalin A-induced hepatitis in mice Reviewed International journal

    Soichiro Fushimi, Tetsuya Ogino, Junko Hara, Tomohiro Takahata, Hiroshi Wakabayashi, Haruyuki Watanabe, Yasuharu Arashima, Masato Kubo, Akihiro Matsukawa

    CLINICAL IMMUNOLOGY   133 ( 3 )   437 - 446   2009.12

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    T cells play central rotes in liver diseases, but the regulatory mechanism by cytokine signaling is not well understood. In the present study, we explored the role of SOCS3 in T cells in concanavalin A (ConA)-induced hepatitis. Mice with T-cell-specific overexpression of SOCS3 (SOCS3-cTg) showed reduced hepatic damage and improved mice survival relative to the control, an event that was associated with decreased apoptotic signals Fas and pStat1. Expression of Th1-cytokines/chemokines was decreased in SCCS3-cTg liver with reduced expression of T-bet, a Th1-transcription factor. Flow cytometric analysis of the liver lymphocytes demonstrated that activated CD4(+) T cells, cytotoxic T cells and. natural killer T cells were significantly decreased in SOCS3-cTg liver with decreased expression of perforin and granzyme 8, injurious molecules for hepatocyte damage. These results suggest that forced expression of SOCS3 in T cells prevents ConA-induced liver injury by inhibiting several phases of Th1 responses. (C) 2009 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.clim.2009.08.015

    Web of Science

    PubMed

    researchmap

  • Increased CCL2 Expression and Macrophage/Monocyte Migration During Microbicide-Induced Vaginal Irritation Reviewed International journal

    Carsten Alt, Travis Harrison, Linda Dousman, Nahoko Fujita, Ken Shew, Thanh-Thuy Tran, Sara Shayesteh, Akihiro Matsukawa, Jon Mirsalis, Annalisa D&apos, Andrea

    CURRENT HIV RESEARCH   7 ( 6 )   639 - 649   2009.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BENTHAM SCIENCE PUBL LTD  

    Despite availability of successful prevention strategies, HIV continues to spread at alarming rates, especially among women in developing countries. Vaginal microbicides offer a promising approach for blocking transmission of HIV when condom use cannot be negotiated with male partners. A major problem in the development of vaginal microbicides is chemically induced vaginal irritation, which can enhance the risk of HIV transmission. Evaluation of vaginal irritation prior to clinical trials typically uses an expensive and animal-intensive rabbit vaginal irritation model, which could be supplemented by measuring additional inflammatory biomarkers. We studied several immunological parameters as potential biomarkers of vaginal irritation, using the spermicides nonoxynol-9 and benzalkonium chloride as test microbicides. We measured amounts of cytokines, as well as inflammatory cells, in vaginal tissue lysates and on the vaginal surface. We observed that treatment with the selected microbicides increases quantities of the inflammatory cytokines interleukin-1, CXCL8, and CCL2 in the vaginal tissue parenchyma, and of CCL2 on the vaginal surface. This observation was correlated with increases in macrophages in the vaginal parenchyma. We suggest that measurements of CCL2 and macrophages can serve as new inflammatory biomarkers to evaluate the safety of promising novel microbicides for prevention of HIV.

    DOI: 10.2174/157016209789973682

    Web of Science

    PubMed

    researchmap

  • Successful steroid pulse therapy for brain lesion caused by Shiga toxin 2 in rabbits (vol 46, pg 179, 2009) Reviewed

    Jun Fujii, Yoshimasa Kinoshita, Akihiro Matsukawa, Sharon Y. A. M. Villanueva, Takashi Yutsudo, Shin-ichi Yoshida

    MICROBIAL PATHOGENESIS   46 ( 6 )   345 - 345   2009.6

     More details

    Language:English   Publisher:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    DOI: 10.1016/j.micpath.2009.04.001

    Web of Science

    researchmap

  • Galectin-9 accelerates transforming growth factor beta 3-induced differentiation of human mesenchymal stem cells to chondrocytes Reviewed International journal

    Tomohiro Arikawa, Akihiro Matsukawa, Kota Watanabe, Ken-mei Sakata, Masako Seki, Megumi Nagayama, Keisuke Takeshita, Kanako Ito, Toshiro Niki, Souichi Oomizu, Rika Shinonaga, Naoki Saita, Mitsuomi Hirashima

    BONE   44 ( 5 )   849 - 857   2009.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE INC  

    Galectin-9 (Gal-9), a beta-galactoside binding lectin, plays a crucial role in innate and adaptive immunity. in the rat collagen-induced arthritis model, administration of Gal-9 induced repair of existing cartilage injury even when joints were already swollen with cartilage destruction. We thus attempted to explore the role of Gal-9 in chondrocyte differentiation utilizing human mesenchymal stem cell (MSC) pellet Cultures. During chondrogenesis induced by transforming growth factor beta 3 (TGF beta 3), MSCs strongly expressed endogenous Gal-9. Expression of Gal-9 peaked on day 14 and the neutralization of endogenous Gal-9 resulted in the reduced chondrogenesis, indicating possible involvement of Gal-9 in TGF beta-mediated chondrogenesis. In pellets, addition of Gal-9 significantly enhanced TGF beta 3-induced chondrogenesis. as evidenced by increasing proteoglycan content, but not cell proliferation. In the absence of Gal-9, collagen expression by MSCs switched from type I to type II on 28 days after stimulation with TGR beta 3. When MSCs were co-stimulated with Gal-9, the class switch occurred on day 21. In addition, Gal-9 synergistically enhanced TGF beta 3-induced phosphorylation of Smad2, though Gal-9 did not itself induce detectable Smad2 phosphorylation. These results Suggest that Gal-9 has a beneficial effect on cartilage repair in injured joints by induction of differentiation of MSCs into chondrocytes. (C) 2009 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bone.2009.01.365

    Web of Science

    PubMed

    researchmap

  • Successful steroid pulse therapy for brain lesion caused by Shiga toxin 2 in rabbits Reviewed International journal

    Jun Fujii, Yoshirnasa Kinoshita, Akihiro Matsukawa, Sharon Y. A. M. Villanueva, Takashi Yutsudo, Shin-ichi Yoshida

    MICROBIAL PATHOGENESIS   46 ( 4 )   179 - 184   2009.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    Betamethasone sodium phosphate (BSP) is usually used as a steroid therapy for human brain edema. High doses of BSP (36 mg/kg) twice a day for two days statistically reduced the mortality rate and improved the survival period of Stx2 (1.4 mu g/kg: 1.6LD(50))-toxemic rabbits. We made evaluations on three kinds of magnetic resonance images (MRI) including T1-weighted, T2-weighted, and enhanced MRI using gadopentetate dimeglumine (Gd-DTPA) to detect brain lesion induced by an intravenous injection of Stx2 in rabbits. Enhanced T1-weighted MRI was the most sensitive tool to find leakage of Gd-DTPA suggesting impairment of the blood brain barrier caused by Stx2. Enhanced MRI revealed that BSP treatment inhibited the leakage of Gd-DTPA, as directly evidenced by the protective effect of BSP against brain edema induced by intravenous injection of Stx2. Interleukin 1 beta was not induced after Stx2 treatment in brain primary mixed cell culture. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.micpath.2009.01.005

    Web of Science

    PubMed

    researchmap

  • Activation of c-Jun N-terminal kinase is essential for oxidative stress-induced Jurkat cell apoptosis by monochloramine Reviewed International journal

    Tetsuya Ogino, Michitaka Ozaki, Mutsumi Hosako, Masako Omori, Shigeru Okada, Akihiro Matsukawa

    LEUKEMIA RESEARCH   33 ( 1 )   151 - 158   2009.1

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    Leukemic cell apoptosis may be enhanced by appropriate oxidative stress. We report here the mechanism of Jurkat cell apoptosis by monochloramine (NH(2)Cl), a neutrophil-derived oxidant. NH(2)Cl induced caspase-dependent apoptosis, which was preceded by cytochrome c and Smac/Diablo release from mitochondfia. Within 10 min of NH(2)Cl treatment, c-Jun N-terminal kinase (JNK) activation and elevation of cytosolic Ca(2+) were observed. JNK inhibitors (SP600125 or JNK inhibitor VIII) significantly suppressed the apoptosis as well as caspase cleavage and cytochrome c release. In contrast, Ca(2+) chelation by EGTA + acetoxymethyl-EGTA had no effects on apoptosis. Our results indicated that JNK activation contributed most importantly to the NH(2)Cl-induced apoptosis. (C) 2008 Elsevier Ltd. All fights reserved.

    DOI: 10.1016/j.leukres.2008.07.009

    Web of Science

    PubMed

    researchmap

  • Pathophysiology of sepsis and recent patents on the diagnosis, treatment and prophylaxis for sepsis Invited Reviewed International journal

    Yasumasa Okazaki, Akihiro Matsukawa

    Recent Patents on Inflammation and Allergy Drug Discovery   3 ( 1 )   26 - 32   2009

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Despite advances in the development of powerful antibiotics and intensive care unit, sepsis is still life threatening and the mortality rate remains unchanged for the past three decades. Recent prospective trials with biological response modifiers have shown a modest clinical benefit. The pathological basis of sepsis is initially an excessive inflammatory response against invading pathogens, leading to systemic inflammatory response syndrome (SIRS). Evidence reveals that a variety of inflammatory mediators orchestrate the intense inflammation through complicated cellular interactions. More recent data indicate that most septic patients survive this stage and then subjected to an immunoparalysis phase, termed compensatory anti-inflammatory response syndrome (CARS), which is more fatal than the initial phase. Sepsis is a complicated clinical syndrome with multiple physiologic and immunologic abnormalities. In this review, we summarize the recent understandings of the pathophysiology of sepsis, and introduce recent patents on diagnosis, treatment and prophylaxis for sepsis. © 2009 Bentham Science Publishers Ltd.

    DOI: 10.2174/187221309787158416

    Scopus

    PubMed

    researchmap

  • Invasion of atheromatous plaques into tunica media causes coronary outward remodeling in WHHLMI rabbits Reviewed International journal

    Masashi Shiomi, Satoshi Yamada, Akihiro Matsukawa, Hiroyuki Itabe, Takashi Ito

    ATHEROSCLEROSIS   198 ( 2 )   287 - 293   2008.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER IRELAND LTD  

    To clarify the mechanism of coronary outward remodeling, we examined atherosclerotic coronary arteries morphologically using WHHLMI rabbits that develop coronary atherosclerosis spontaneously. Perfusion-fixed coronary segments of WHHLMI rabbits were prepared at 500 mu m intervals. After immunohistochemical staining and histopathological staining, the areas and lengths of the arterial wall and the lesions were measured. Obvious outward remodeling was observed in coronary sections with greater than 40% cross-sectional narrowing. In coronary sections with greater than 40% cross-sectional narrowing, the tunica media was thick at the shoulder of atheromatous plaque and was thin beneath the atheromatous plaques. Macrophages infiltrated those attenuated tunica media expressed matrix metalloproteinases and oxidized LDL was accumulated in those areas. In those areas, collagen fibers and the internal elastic lamina had disappeared partly and apoptotic smooth muscle cells were observed. Proliferation of smooth muscle cells was observed at the attenuated tunica media and adjacent adventitia. The present results suggest that invasion of atheromatous plaques into the tunica media causes coronary outward remodeling. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.atherosclerosis.2008.02.010

    Web of Science

    PubMed

    researchmap

  • Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis Reviewed International journal

    Masako Seki, Souichi Oomizu, Ken-mei Sakata, Atsuko Sakata, Tomohiro Arikawa, Kota Watanabe, Kanako Ito, Keisuke Takeshita, Toshiro Niki, Naoki Saita, Nozomu Nishi, Akira Yamauchi, Shigeki Katoh, Akihiro Matsukawa, Vijay Kuchroo, Mitsuomi Hirashima

    CLINICAL IMMUNOLOGY   127 ( 1 )   78 - 88   2008.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    The effects of galectin-9 on a mouse collagen-induced arthritis (CIA) model were assessed to clarify whether galectin-9 suppresses CIA by regulating T cell. immune responses. Galectin-9 suppressed CIA in a dose-dependent manner, and such suppression was observed even when treatment was started on 7 days after the booster, indicating its preventive and therapeutic effects. Galectin-9 induced the decreased levels of pro-inflammatory cytokines, IL-17, IL-12, and IFN gamma in the joint. Gatectin-9 induced the decreased number of CD4(+) TIM-3(+) T cells in peripheral blood. Galectin-9-deficient mice became susceptible to CIA may be by increased number of CD4(+) TIM-3(+) T cells and decreased number of Treg cells. We further found that galectin-9 induces differentiation of naive T cells to Treg cells, and it suppresses differentiation to Th17 cells in vitro. The present results suggested that galectin-9 ameliorates CIA by suppressing the generation of Th17, promoting the induction of regulatory T cells. (C) 2008 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.clim.2008.01.006

    Web of Science

    PubMed

    researchmap

  • 悪性中皮腫の1剖検例

    尾関孝二, 三輪栄子, 筑田絵理, 原田美由紀, 松川昭博

    日本臨床細胞学会岡山支部会誌   26   37 - 38   2008

     More details

  • 乳腺血管肉腫の1例.

    松岡博美, 井上博文, 今井みどり, 藤田勝, 森下由美子, 大森昌子, 市村浩一, 柳井広之, 大原信哉, 松川昭博

    日本臨床細胞学会岡山支部会誌   27   34 - 35   2008

     More details

    Language:Japanese   Publisher:岡山県臨床細胞学会  

    32歳女。主訴は左乳房のしこりであった。腫瘤は20cm大で、針生検にて血管系腫瘍が疑われた。右乳房にも超音波・MRIで左腫瘍と類似した腫瘤影があり、左皮下乳腺全摘+右乳腺部分切除術を施行した。摘出材料は出血を伴った充実性腫瘤で、HE標本ではクロマチン増量と核異型を有する短紡錘形細胞が毛細血管類似の管腔を形成し、浸潤性増殖していた。捺印細胞標本では赤血球を背景に単在〜集塊状に類円形細胞と紡錘形細胞が混在する腫瘍細胞を認め、いずれも切れ込みを有する核や核の抱きこみ像を多数認めた。細胞質内にはhaloを伴う赤血球様物質を容れた腫瘍細胞やベルリン青陽性ヘモジデリン顆粒を貪食した細胞を認め、免疫染色ではCD31・CD34が類円形細胞・紡錘形細胞ともに陽性で、MIB1陽性率は40%であり、血管肉腫と診断した。

    researchmap

  • 悪性転化を示したnuclear palisadingを伴う隆起性皮膚線維肉腫の一例.

    大森昌子, 柳井広之, 荻野哲也, 松川昭博, 吉野正

    診断病理   25 ( 2 )   72 - 76   2008

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    症例は59歳女性。左膝窩部の皮膚から皮下組織におよぶ8×6cm大の腫瘍が存在し、腫瘍切除術が施行された。組織学的には、通常型の隆起性皮膚線維肉腫(dermatofibrosarcoma protuberans;DFSP)の領域から移行して明瞭なnuclear palisadingを示す部分が散在性に認められた。いずれの領域もCD34はびまん性に強陽性を示した。また線維肉腫に相当する高悪性度肉腫の領域が存在し、その部分ではCD34が減弱〜陰性化していた。Nuclear palisadingを示すDFSPから発生した稀なfibrosarcomaの1例を報告する。(著者抄録)

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2008&ichushi_jid=J03623&link_issn=&doc_id=20080515230004&doc_link_id=%2Fcd9jjodp%2F2008%2F002502%2F004%2F0072-0076%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fcd9jjodp%2F2008%2F002502%2F004%2F0072-0076%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • A case of nonbacterial thrombotic endocarditis with difficult antemortem diagnosis

    Tachibana Motomi, Kubo Motoki, Takamura Toshiyuki, Kobayashi Hiroo, Matsumoto Yoshinori, Matsukawa Akihiro

    Shinzo   40 ( 10 )   875 - 880   2008

     More details

    Language:Japanese   Publisher:Japan Heart Foundation  

    DOI: 10.11281/shinzo1969.40.10_875

    CiNii Article

    researchmap

  • 第34回医学教育者のためのワークショップ (富士研ワークショップ) の記録

    齋藤 宣彦, 伴 信太郎, 堀内 三郎, 平出 敦, 木下 牧子, 中島 宏昭, 吉岡 俊正, 船橋 俊一, 小林 直人, 日野原 重明, 竹内 弘高, 水流 聡子, 本田 麻由美, 三浦 公嗣, 栗山 雅秀, 菅野 典子, 海老根 潤, 久保田 久里, 伊藤 達朗, 今中 啓之, 川前 金幸, 酒井 賢一郎, 清水 俊明, 冨田 泰彦, 松本 哲哉, 和佐 勝史, 青木 昭子, 和泉 俊一郎, 犬塚 裕樹, 及川 公生, 大槻 眞嗣, 大野 浩司, 栂 博久, 奈良 正之, 伊坪 真理子, 井廻 道夫, 内ヶ崎 西作, 岡見 豊一, 高水間 亮治, 錦見 尚道, 濱田 久之, 稲葉 宗通, 入江 徹美, 内田 伸恵, 首藤 太一, 永山 和宜, 廣川 慎一郎, 増田 友之, 吉村 明修, 樫田 光夫, 金子 一成, 田中 克之, 谷 憲治, 福沢 嘉孝, 俣木 志朗, 松川 昭博, 守屋 利佳

    医学教育   39 ( 3 )   205 - 220   2008

     More details

    Language:Japanese   Publisher:日本医学教育学会  

    記事種別: 特集 ; 会議・学会報告・シンポジウム

    DOI: 10.11307/mededjapan1970.39.205

    CiNii Article

    CiNii Books

    researchmap

  • 腹水中に腫瘍細胞を認めた乳腺小葉癌の1例.

    藤田勝, 松岡博美, 井上博文, 今井みどり, 森下由美子, 大森昌子, 市村浩一, 柳井広之, 大原信哉, 松川昭博

    日本臨床細胞学会岡山支部会誌   27   36 - 37   2008

     More details

    Language:Japanese   Publisher:岡山県臨床細胞学会  

    70歳女。5年前に右乳癌にて乳房切除を施行され化学療法を続けてきたが、CEAの上昇とともに結腸の多発通過障害が出現したため開腹手術を行った。腹膜・大網に播種結節を認め、貯留腹水の細胞診では核異型が軽度で散在性ないし小集塊状の腫瘍細胞が散見された。一部の腫瘍細胞では細胞質の突出像や相互封入像を認め、PAS反応は細胞質にびまん性陽性を認めた。大網生検組織でも均一な小型の異型細胞が疎な結合を示して浸潤性に増殖し、原発巣に類似する組織所見を認めた。PAS反応では腫瘍細胞の胞体にびまん性陽性を認め、免疫染色ではエストロゲン受容体陽性、プロゲステロン受容体・HER2・Eカドヘリン陰性であり、乳癌invasive lobular carcinoma転移と診断した。

    researchmap

  • STAT proteins in innate immunity during sepsis: Lessons from gene knockout mice Invited Reviewed

    Akihiro Matsukawa

    ACTA MEDICA OKAYAMA   61 ( 5 )   239 - 245   2007.10

     More details

    Authorship:Lead author, Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:OKAYAMA UNIV MED SCHOOL  

    The innate immune system provides immediate defense against infection and serves as the first line of host defense during infection. In innate immunity, leukocytes such as neutrophils; and macrophages recognize and respond to pathogens in a non-specific manner. Therefore, the recruitment and activation of leukocytes are essential in innate immunity, and are governed by a variety of chemical mediators including cytokines. Cytokines are generally divided into 2 types, termed type-1 and type-2 cytokines. Type-1 cytokines are important in local host defense, while type-2 cytokines play a protective role when inflammatory response spreads to the body. These cytokines exert their biological functions through the janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway. STAT1/3/4/6 are transcription factors that mediate IFN gamma/IL-10/IL-12/IL-13 cytokine signaling, respectively. Evidence indicates that STAT proteins have a significant impact on innate immunity during sepsis. This review focuses on recent understandings in the regulation of innate immunity by STAT proteins during sepsis and septic shock. The suppressor of cytokine signaling (SOCS) proteins are a family of SH2 domain-containing cytoplasmic proteins that complete a negative feedback loop to attenuate signal transduction from cytokines that act through the JAK/STAT pathway. The participation of SOCS proteins in sepsis is also discussed.

    DOI: 10.18926/AMO/32897

    Web of Science

    PubMed

    researchmap

  • CCL2/monocyte-chemoattractant protein-1 as a novel biomarker for the safety evaluation of microbicide-induced vaginal irritation Reviewed

    Carsten Alt, Travis Harrison, Nahoko Fujita, Kenneth Shew, Thuy Tran, Akihiro Matsukawa, Charles Litterst, Jon Mirsalis, Annalisa D'Andrea

    CYTOKINE   39 ( 1 )   1 - 2   2007.7

     More details

    Language:English   Publisher:ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD  

    DOI: 10.1016/j.cyto.2007.07.009

    Web of Science

    researchmap

  • Inhibition of CCL1-CCR8 interaction prevents aggregation of macrophages and development of peritoneal adhesions Reviewed International journal

    Akiyoshi Hoshino, Yuki I. Kawamura, Masato Yasuhara, Noriko Toyama-Sorimachi, Kenji Yamamoto, Akihiro Matsukawa, Sergio A. Lira, Taeko Dohi

    JOURNAL OF IMMUNOLOGY   178 ( 8 )   5296 - 5304   2007.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ASSOC IMMUNOLOGISTS  

    Peritoneal adhesions are a significant complication of surgery and visceral inflammation; however, the mechanism has not been fully elucidated. The aim of this study was to clarify the mechanism of peritoneal adhesions by focusing on the cell trafficking and immune system in the peritoneal cavity. We investigated the specific recruitment of peritoneal macrophages (PM phi) and their expression of chemokine receptors in murine models of postoperative and postinflammatory peritoneal adhesions. PM phi aggregated at the site of injured peritoneum in these murine models of peritoneal adhesions. The chemokine receptor CCR8 was up-regulated in the aggregating PN phi when compared with naive PM phi. The up-regulation of CCR8 was also observed in PM phi, but not in bone marrow-derived M phi, treated with inflammatory stimulants including bacterial components and cytokines. Importantly, CCL1, the ligand for CCR8, a product of both PM phi and peritoneal mesothelial cells (PMCs) following inflammatory stimulation, was a potent enhancer of CCR8 expression. Cell aggregation involving PM phi and PMCs was induced in vitro in the presence of CCL1. CCL1 also up-regulated mRNA levels of plasminogen activator inhibitor-1 in both PM phi and PMCs. CCR8 gene-deficient mice or mice treated with anti-CCL1-neutralizing Ab exhibited significantly reduced postoperational peritoneal-adhesion. Our study now establishes a unique autocrine activation system in PM phi and the mechanism for recruitment of PM phi together with PMCs via CCL1/CCR8, as immune responses of peritoneal cavity, which triggers peritoneal adhesions.

    Web of Science

    PubMed

    researchmap

  • Sudden death of a young woman due to aortic dissection caused by Turner's syndrome Reviewed International journal

    Sohtaro Mimasaka, Yuki Ohtsu, Shigeyuki Tsunenari, Akihiro Matsukawa, Masaki Hashiyada, Shirushi Takahashi, Masato Funayama

    PATHOLOGY INTERNATIONAL   57 ( 4 )   219 - 223   2007.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BLACKWELL PUBLISHING  

    A 24-year-old woman was found dead in her bed. There had been an episode of fainting with cervicodynia 1 day before death but no significant past medical history, except for menstrual irregularities. Post-mortem examination revealed that death was due to hemopericardium caused by rupture of the ascending aorta by thoracic aortic dissection (Stanford type A). Microscopically, weakness of the aorta was due to cystic medial necrosis. On external examination, short stature, a short neck and multiple pigmented nevi were observed, while internal examination revealed coarctation of the aorta and funicular ovaries. Examination of the X chromatin showed a decrease in numbers of Barr bodies in the tissues, and a 45,X/46,XX mosaicism was suspected. It is concluded that the cause of death was aortic dissection due to Turner's syndrome.

    DOI: 10.1111/j.1440-1827.2007.02084.x

    Web of Science

    PubMed

    researchmap

  • Overexpression of suppressor of cytokine signaling-3 in T cells exacerbates acetaminophen-induced hepatotoxicity Reviewed International journal

    Kosuke Numata, Masato Kubo, Hiroyuki Watanabe, Katsumasa Takagi, Hiroshi Mizuta, Seiji Okada, Steven L. Kunkel, Takaaki Ito, Akihiro Matsukawa

    JOURNAL OF IMMUNOLOGY   178 ( 6 )   3777 - 3785   2007.3

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ASSOC IMMUNOLOGISTS  

    Cytokines have been implicated in the progression of acetaminophen (APAP)-induced acute liver injury. Suppressors of cytokine signaling (SOCS) proteins are negative regulators of cytokine signaling by inhibiting the JAK-STAT pathway, but their role in APAP hepatotoxicity is unknown. In this present study, we attempted to explore the role of SOCS3 in T cells in APAP-induced liver injury. Mice with a cell-specific overexpression of SOCS3 in T cells (SOCS3Tg, in which Tg is transgenic) exhibited exaggerated hepatic injury after APAP challenge, as evidenced by increased serum alanine aminotransferase levels, augmented hepatic necrosis, and decreased survival relative to the wild-type mice. Adaptive transfer of SOCS3Tg-CD4(+) T cells into T and B cell-deficient RAG-2(-/-) mice resulted in an exacerbated liver injury relative to the control. In SOCS3Tg mice, hepatocyte apoptosis was enhanced with decreased expression of antiapoptotic protein bcl-2, whereas hepatocyte proliferation was reduced with altered cell cycle-regulatory proteins. Levels of IFN-gamma and TNF-alpha in the circulation were augmented in SOCS3Tg mice relative to the control. Studies using neutralizing Abs indicated that elevated IFN-gamma and TNF-alpha were responsible for the exacerbated hepatotoxicity in SOCS3Tg mice. Activation of STATl that is harmful in liver injury was augmented in SOCS3Tg hepatocytes. Alternatively, hepatoprotective STAT3 activation was decreased in SOCS3Tg hepatocytes, an event that was associated with augmented SOCS3 expression in the hepatocytes. Altogether, these results suggest that forced expression of SOCS3 in T cells is deleterious in APAP hepatotoxicity by increasing STAT1 activation while decreasing STAT3 activation in hepatocytes, possibly through elevated IFN-gamma and TNF-alpha.

    Web of Science

    PubMed

    researchmap

  • 非定型奇形腫様/ラブドイド腫瘍 atypical teratoid/rhabdoid tumor (AT/RT)の1例

    大森昌子, 柳井広之, 荻野哲也, 井上智, 市川智継, 松川昭博, 吉野正

    診断病理   24;115-120 ( 1 )   115 - 120   2007

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    非定型奇形腫様/ラブドイド腫瘍(atypical teratoid/rhabdoid tumor(AT/RT))はrhabdoid cellの出現を特徴とした中枢神経に発生する胎児性腫瘍で予後はきわめて不良である。症例は生後6ヵ月、女児。頭囲の拡大、発達遅延を認め、近医にて水頭症を指摘された。腫瘍は松果体部、中脳被蓋部、第四脳室にかけて存在し、脊髄に播種性病変が存在した。組織学的に腫瘍はprimitive neuroectodermal tumor(PNET)様の小型未熟細胞の充実性増殖が主体をなし、小範囲にrhabdoid cellや索状配列を示す領域が存在した。AT/RTと診断し、腫瘍摘出後化学療法が施行されたが、5ヵ月後水頭症が悪化し死亡した。(著者抄録)

    researchmap

  • Overexpression of suppressor of cytokine signaling-5 in T cells augments innate immunity during septic peritonitis Reviewed International journal

    Hiroyuki Watanabe, Masato Kubo, Kosuke Numata, Katsumasa Takagi, Hiroshi Mizuta, Seiji Okada, Takaaki Ito, Akihiro Matsukawa

    JOURNAL OF IMMUNOLOGY   177 ( 12 )   8650 - 8657   2006.12

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ASSOC IMMUNOLOGISTS  

    Suppressors of cytokine signaling (SOCS) proteins are negative regulators of cytokine signaling by inhibiting the JAK-STAT signal transduction pathway, but their role in innate immunity remains to be investigated. In the present study, we demonstrate that overexpression of SOCS5 in T cells augments innate immunity during septic peritonitis induced by cecal ligation and puncture (CLP). Mice with a cell-specific overexpression of SOCS5 in T cells (SOCS5 transgenic (Tg)) were resistant to the lethality relative to the wild-type (WT) mice. This was most likely due to the enhanced innate immunity in SOCS5Tg mice, as bacterial burden in SOCS5Tg mice was significantly lower than WT mice. Accumulation of neutrophils and macrophages was augmented in SOCS5Tg mice, an event that was accompanied by increased peritoneal levels of IL-12, IFN-gamma, and TNF-alpha. In vitro bactericidal activities of macrophages and neutrophils were enhanced in SOCS5Tg mice. Both neutrophils and macrophages from WT mice adopted enhanced bacterial killing activity when cocultured with CD4(+) T cells from SOCS5Tg mice, relative to CD4(+) T cells from WT mice. Adoptive transfer of SOCS5Tg-CD4(+) T cells into T- and B cell-deficient RAG-2(-/-) mice resulted in augmented leukocyte infiltration and increased peritoneal levels of IL-12, IFN-gamma, and TNF-alpha after CLP, as compared with the controls. Furthermore, CLP-induced bacterial burden in RAG2(-/-) mice harboring SOCS5Tg-CD4(+) T cells was significantly reduced relative to the controls. These findings provide evidence that intervention of SOCS5 expression in T cells affects innate immunity, which highlight a novel role of T cells during sepsis.

    Web of Science

    PubMed

    researchmap

  • The neuropeptide neuromedin U promotes IL-6 production from macrophages and endotoxin shock Reviewed International journal

    M Moriyama, A Matsukawa, S Kudoh, T Takahashi, T Sato, T Kano, A Yoshimura, M Kojima

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   341 ( 4 )   1149 - 1154   2006.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Neuromedin U (NMU) is a neuropeptide involved in appetite, circadian rhythm, and pronociception. However, the NMU receptor NMU-R1 has been shown to be expressed in immune cells and NMU promotes mast cell-dependent inflammation. In this study, we demonstrated that NMU plays an important role in IL-6 production in macrophages. NMU-deficient mice were resistant against cecal ligation puncture- as well as LPS-induced septic shock. IL-6 but not TNF-alpha levels were markedly reduced in LPS-treated NMU-deficient mice compared with wild type mice. Both NMU and NMU-R1 were expressed in wild type peritoneal macrophages, and treatment with LPS resulted in up-regulation of NMU but down-regulation of NMU-RI expression, however, no down-regulation of NMU-RI was observed in NMU-deficient macrophages where LPS-induced IL-6 production was severely reduced. These data suggest that LPS-induced IL-6 expression is partly dependent on autocrine/paracrine activation of the NMU-NMU-R1 signals in macrophages. (c) 2006 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2006.01.075

    Web of Science

    PubMed

    researchmap

  • Relationship between TNF-alpha and TUNEL-positive chondrocytes in antigen-induced arthritis of the rabbit temporomandibular joint Reviewed International journal

    Y Hirota, M Habu, K Tominaga, M Sukedai, A Matsukawa, T Nishihara, J Fukuda

    JOURNAL OF ORAL PATHOLOGY & MEDICINE   35 ( 2 )   91 - 98   2006.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BLACKWELL PUBLISHING  

    BACKGROUND: Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate biotin nick end-labeling (TUNEL) staining is a widely accepted method for the detection of DNA fragmentation in nuclei of apoptotic cells. Tumor necrosis factor (TNF)-alpha is closely associated with changes in condylar cartilage and modulates apoptosis in various tissues including cartilage. The aim of this study was to investigate the relationship between apoptotic chondrocytes and TNF-alpha in a rabbit model of arthritis.
    METHOD: Unilateral temporomandibular joint (TMJ) arthritis was induced in 20 adult New Zealand White rabbits. From 1 day to 6 weeks after the induction of arthritis, immunohistochemical analysis for TNF-alpha and TUNEL was performed.
    RESULTS: In condylar cartilage, TNF-alpha-positive cells and TUNEL-positive cells were localized together. TNF-alpha-positive chondrocytes seemed to precede TUNEL-positive cells.
    CONCLUSIONS: The results of the present study suggest that TNF-alpha may be involved in apoptosis and/or apoptotic necrosis of chondrocytes as TMJ arthritis progresses from the acute to chronic stage.

    DOI: 10.1111/j.1600-0714.2006.00367.x

    Web of Science

    PubMed

    researchmap

  • Absence of CC chemokine receptor 8 enhances innate immunity during septic peritonitis Reviewed International journal

    Akihiro Matsukawa, Shinji Kudoh, Gen-ichiro Sano, Takako Maeda, Takaaki Ito, Nicholas W. Lukacs, Cory M. Hogaboam, Steven L. Kunkel, Sergio A. Lira

    FASEB JOURNAL   20 ( 2 )   302 - 304   2006.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:FEDERATION AMER SOC EXP BIOL  

    An effective clearance of microbes is crucial in host defense during infection. In the present study, we demonstrate that CC chemokine receptor 8 (CCR8) skews innate immune response during septic peritonitis induced by cecal ligation and puncture (CLP). CCR8 was expressed in resident peritoneal macrophages and elicited leukocytes during CLP in the wild-type CCR8+/+ mice. CCR8-/- mice were resistant to CLP-induced lethality relative to CCR8+/+ mice, and this resistance was associated with an augmented bacterial clearance in CCR8-/- mice. In vitro, peritoneal macrophages from CCR8-/- mice, but not neutrophils, exhibited enhanced bactericidal activities relative to those from CCR8+/+ mice. Upon stimulation with the bacterial component LPS, elevated levels of superoxide generation, lysosomal enzyme release, and nitric oxide generation, effector molecules for bacterial killing were detected in CCR8-/- macrophages relative to CCR8+/+ macrophages. In addition, CCR8-/- macrophages produced significantly higher levels than CCR8+/+ macrophages of several cytokines and chemokines known to augment bactericidal activities of leukocytes that include TNF-alpha, IL-12, macrophage-derived chemokine (MDC/CCL22), macrophage inflammatory protein (MIP)-2, and KC. Altogether, these results indicate that CCR8 may have a negative impact on host defense during septic peritonitis, providing a new paradigm for the role of CCR8 in innate immunity.

    DOI: 10.1096/fj.04-1728fje

    Web of Science

    PubMed

    researchmap

  • Inhibitory effects of dimethylacetyl-beta-cyclodextrin on lipopolysaccharide-induced macrophage activation and endotoxin shock in mice Reviewed International journal

    H Arima, K Motoyama, A Matsukawa, Y Nishimoto, F Hirayama, K Uekama

    BIOCHEMICAL PHARMACOLOGY   70 ( 10 )   1506 - 1517   2005.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    The potential use of hydrophilic cycloclextrins (CyDs) as an inhibitor for lipopolysaccharide (LPS) was examined. Of the five CyDs used in this study, dimethylacetyl-beta-cyclodextrin (DMA7-beta-CyD) had greater inhibitory activity than other CyDs against the production of nitric oxide (NO) and various proinflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha) in murine macrophages stimulated with two serotypes of LPS and lipid A. The inhibitory effect of DMA7-beta-CyD on NO production was also observed in macrophages stimulated with lipoteichoic acid (LTA), but not peptidoglycan (PGN), polyinosinic-polycytidylic acid (poly I:C) or CpG oligonucleotide (CpG-ODN). Several studies have suggested that the inhibitory effects of DMA7-beta-CyD could be ascribed to the interaction with LPS. Simultaneous administration of DMA7-beta-CyD not only intraperitoneally but also intravenously and intraperitoneal injection of aqueous solution containing LPS and D-galactosamine in murine endotoxin shock model suppressed fatality. Also, DMA7-beta-CyD decreased blood level of TNF-alpha as well as serum levels of aspartate transaminase (AST) and alanine transaminase (ALT) in mice. In conclusion, DMA7-beta-CyD may have promise as a new therapeutic agent for endotoxin shock induced by LPS. (c) 2005 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bcp.2005.08.021

    Web of Science

    PubMed

    researchmap

  • Effects of denervation on neuromuscular junctions in the thyroarytenoid muscle Reviewed International journal

    Y Kumai, T Ito, A Matsukawa, E Yumoto

    LARYNGOSCOPE   115 ( 10 )   1869 - 1872   2005.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    Objectives/Hypothesis. To evaluate the effects of denervation on muscle fibers and neuromuscular junctions (NMJ) of the rat thyroarytenoid (TA) muscle with a histochemical method to monitor the status of degenerative NMJ. Study Design: Quantitative assessment to monitor the status of degenerative muscle fibers and NMJ in the TA muscle. Methods: Wistar rats were killed at 6, 12, 18, and 24 hours and at 2, 4, and 10 weeks after left recurrent laryngeal nerve (RLN) transection. Hematoxylin-eosin stain was used to evaluate the atrophic changes of the TA muscle. The pre- and postsynaptic structures of the NMJ were detected histochemically. These changes were evaluated by comparing the results between the treated (T) and untreated (U) sides (T/U ratio) in the same section. Results. The atrophic changes in the TA muscle progressed gradually, and at 10 weeks, the T/U ratios of the entire muscle area and of the muscle fiber size decreased to 53.2 +/- 10.7% and 55.5 +/- 6.8%, respectively (P &lt; .01). The number of nerve terminals decreased significantly at 18 hours (P &lt; .01), and they disappeared completely by 24 hours. In contrast, at 10 weeks, 70.5 +/- 12.4% (P &lt; .01) of acetylcholine receptors (AchRs) were preserved. Conclusions: In the rat TA muscle, denervation. influences the presynaptic nerve terminals more than the postsynaptic AchRs and the muscle fibers. The results could be a basis for understanding the mechanism of laryngeal denervation and reinnervation processes in animal models.

    DOI: 10.1097/01.mlg.0000177076.33294.89

    Web of Science

    PubMed

    researchmap

  • Stat3 in resident macrophages inflammatory response Reviewed International journal

    A Matsukawa, S Kudo, T Maeda, K Numata, H Watanabe, K Takeda, S Akira, T Ito

    JOURNAL OF IMMUNOLOGY   175 ( 5 )   3354 - 3359   2005.9

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ASSOC IMMUNOLOGISTS  

    Inflammation is counterbalanced by anti-inflammatory cytokines such as IL-10, in which Stat3 mediates the signaling pathway. In this study, we demonstrate that resident macrophages, but not other cell types, are important targets of IL-10 in a murine model of acute peritonitis. Injection of thioglycollate i.p. induced a considerable number of neutrophils and macrophages in the peritoneum, which was significantly augmented in mice with a cell-type specific disruption of the Stat3 gene in macrophages and neutrophils (LysMcre/Stat3flox(/-) mice). The augmented leukocyte infiltration was accompanied by increased peritoneal levels of TNF-alpha, MIP-2, KC chemokine (KC), and MCP-1/CCL2. Stat3 was tyrosine phosphorylated in peritoneal resident macrophages as well as infiltrating leukocytes in the littermate controls, suggesting that Stat3 in either or both of these cells might play a regulatory role in inflammation. The peritoneal levels of TNF-alpha, MIP-2, KC, and MCP-1 were similarly elevated in LysMcre/Stat3(flox/)-mice rendered leukopenic by cyclophosphamide treatment as compared with the controls. Adoptive transfer of resident macrophages from LysMcre/Stat3(flox/-) mice into the control littermates resulted in increases in the peritoneal level of TNF-alpha, MIP-2, KC, and MCP-1 after i.p. injection of thioglycollate. Under these conditions, control littermates harboring LysMcre/Stat3(flox/-) macrophages exhibited an augmented leukocyte infiltration relative to those received control macrophages. Taken together, these data provide evidence that resident macrophages, but not other cell types, play a regulatory role in inflammation through a Stat3 signaling pathway. Stat3 in resident macrophages appears to function as a repressor protein in this model of acute inflammation.

    Web of Science

    PubMed

    researchmap

  • 悪性腱鞘巨細胞腫と鑑別を要した手に発生した平滑筋肉腫の一例

    川添 泰弘, 薬師寺 俊剛, 岩本 克也, 佐藤 広生, 前川 剛士, 林田 実, 松川 昭博

    整形外科と災害外科   54 ( 3 )   595 - 599   2005.9

     More details

    Language:Japanese   Publisher:西日本整形・災害外科学会  

    58歳男.近医にて1年前に右手掌軟部腫瘤に対して摘出術が施行され,4ヵ月前に局所再発に対して再度摘出術が施行され,平滑筋肉腫である腱鞘巨細胞腫と診断された.今回,再び局所に腫瘤が出現したため紹介来院となった.臨床経過・局所所見・MRI所見などより腱鞘巨細胞腫と診断し摘出術を施行した.摘出標本の病理組織学的所見と平滑筋肉腫との鑑別目的の免疫染色結果から悪性腱鞘巨細胞腫と診断された.CTによる全身検索にて肺野に多発性結節性病変を認め,肺転移と診断し化学療法を開始した.悪性腱鞘巨細胞腫と平滑筋肉腫の鑑別には免疫組織化学的検索が有用であった.手に悪性腫瘍が発生することは比較的稀であるが,術前の良性・悪性の鑑別は慎重に行うべきであるものと考えられた

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2005&ichushi_jid=J00766&link_issn=&doc_id=20050927120047&doc_link_id=10.5035%2Fnishiseisai.54.595&url=https%3A%2F%2Fdoi.org%2F10.5035%2Fnishiseisai.54.595&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • Intervertebral disc cells produce tumor necrosis factor alpha, interleukin-1 beta, and monocyte chemoattractant protein-1 immediately after herniation: An experimental study using a new hernia model Reviewed International journal

    M Yoshida, T Nakamura, A Sei, T Kikuchi, K Takagi, A Matsukawa

    SPINE   30 ( 1 )   55 - 61   2005.1

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Study Design. A new hernia model that simulates human disc herniations was developed in rabbits. The herniated discs were examined by gross appearance and histology and production of tumor necrosis factor alpha, interleukin-1beta, and monocyte chemoattractant protein-1 was investigated.
    Objectives. To clarify the early mechanism of spontaneous herniated disc resorption.
    Summary of Background Data. Macrophage infiltration in herniated discs is essential for disc resorption. However, surgically removed human herniated disc tissues and existing animal hernia models are not suitable for analyzing the mechanism of macrophage infiltration. Recently, we have demonstrated that intervertebral disc cells are capable of producing monocyte chemoattractant protein-1, a potent macrophage chemoattractant, after stimulation with tumor necrosis factor alpha and interleukin-1beta.
    Methods. Intervertebral disc herniations were surgically developed in rabbits using a new technique. The herniated discs were excised at appropriate time intervals after the surgery, and the size and histologic findings were examined. Expressions of tumor necrosis factor alpha, interleukin-1beta, and monocyte chemoattractant protein-1 in herniated discs were investigated immunohistochemically.
    Results. A new rabbit model of disc herniation was established. The herniated discs spontaneously reduced in size by 12 weeks postsurgery. Infiltrating cells, mainly composed of macrophages, were observed from day 3. Immunohistochemically, intervertebral disc cells in the herniated discs produced tumor necrosis factor alpha and interleukin-1beta on day 1, followed by monocyte chemoattractant protein-1 on day 3.
    Conclusions. The new hernia model appears to be very useful for studying herniated disc resorption. Intervertebral disc cells may produce inflammatory cytokines/chemokine immediately after the onset of disc herniation, possibly triggering subsequent macrophage infiltration that leads to disc resorption.

    Web of Science

    PubMed

    researchmap

  • Chief cell hyperplasia with structural and nuclear atypia: a variant of fundic gland polyp Reviewed International journal

    A Matsukawa, R Kurano, T Takemoto, M Kagayama, T Ito

    PATHOLOGY RESEARCH AND PRACTICE   200 ( 11-12 )   817 - 821   2005

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:URBAN & FISCHER VERLAG  

    A case of an unusual variant of fundic gland polyp (FGP) composed of chief cell hyperplasia with structural and nuclear atypia in an 87-year-old woman is presented. Gastrointestinal endoscopy revealed a sessile polyp in the cardia/corpus transition zone and a polypoid lesion in the fundus. Histologically, the polyp in the cardia/corpus showed a typical appearance of FGP, while that in fundus demonstrated a tumorous lesion composed of irregular branched tubules with nuclear stratification. Despite the structural distortion and nuclear atypia, mitotic figures were absent and MIB-1 positive cells were less than 3%. Immunohistochemically, the cytoplasms of the tubules were negative for gastric mucin and Muc-5AC glycoprotein, but mostly positive for pepsinogen-I, indicating that the proliferated glands consisted mainly of chief cells, not mucous cells. Parietal cells were occasionally found in the glands. At the periphery of the lesion, microcysts composed of parietal cells, chief cells, and mucous cells had developed. Altogether, the polyp in the fundus was diagnosed as an unusual variant of FGP with chief cell hyperplasia. This FGP should be differentiated from tubular adenocarcinoma. Proliferation of chief cells with occasional parietal cells is critical for the differential diagnosis. (c) 2004 Elsevier GmbH. All rights reserved.

    DOI: 10.1016/j.prp.2004.10.005

    Web of Science

    PubMed

    researchmap

  • Innate immune response in Th1- and Th2-dominant mouse strains Reviewed International journal

    H Watanabe, K Numata, T Ito, K Takagi, A Matsukawa

    SHOCK   22 ( 5 )   460 - 466   2004.11

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    C57BL/6 and BALB/c mice are prototypical Th1- and Th2-type mouse strains, respectively. In the present study, we attempted to characterize the innate immune response of macrophages from these mouse strains. Macrophages from C57BL/6 mice produced higher levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-12 than those from BALB/c mice after stimulation with macrophage-activating lipopeptide-2 (MALP-2, a synthetic TLR-2 ligand) or lipopolysaccharide (LPS, a TLR-4 ligand). The augmented IL-12 production by C57BL/6 macrophages increased interferon-gamma and, in contrast, decreased IL-13 production by CD4+ T cells. On stimulation with MALP-2 or LIPS, C57BL/6 macrophages produced lysosomal enzyme and nitric oxide, effector molecules for bacterial killing, whereas BALB/c macrophages did not. Bactericidal activity of BALB/c macrophages was impaired relative to C57BL/6 macrophages when cells were infected with live bacteria in vitro. In a murine model of septic peritonitis induced by cecal ligation and puncture (CLP), BALB/c mice failed to facilitate bacterial clearance relative to C57BL/6 mice despite an augmented peritoneal leukocyte infiltration that was associated with increased peritoneal levels of cytokines/chemokines. BALB/c mice exhibited increased plasma and hepatic levels of cytokines/chemokines, resulting in an exaggerated systemic inflammation as determined by acute-phase proteins. Finally, BALB/c mice were vulnerable to CILP-induced lethality relative to C57BL/6 mice. Altogether, innate immune response of macrophages is different between these mouse strains, which may affect the development of Th1 and Th2 adaptive immunity in these strains. Reduced systemic inflammatory response in C57BL/6 mice that may result from an eminent local response appears to be beneficial during sepsis.

    DOI: 10.1097/01.shk.0000142249.08135.e9

    Web of Science

    PubMed

    researchmap

  • Role of CC chemokine CCL6/C10 as a monocyte chemoattractant in a murine acute peritonitis Reviewed International journal

    AM LaFleur, NW Lukacs, SL Kunkel, A Matsukawa

    MEDIATORS OF INFLAMMATION   13 ( 5-6 )   349 - 355   2004.10

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:CARFAX PUBLISHING  

    THE aim of this study was to determine the role of CC chemokine CCL6/C10 in acute inflammation. Intraperitoneal injection of thioglycollate increased peritoneal CCL6, which peaked at 4 h and remained elevated at 48 h. Neutralization of CCL6 significantly inhibited the macrophage infiltration (34-48% reduction), but not other cell types, without decreasing the other CC chemokines known to attract monocytes/macrophages. CCL6 was expressed in peripheral eosinophils and elicited macrophages, but not in elicited neutrophils. Peritoneal CCL6 level was not decreased in granulocyte-depleted mice where eosinophil influx was significantly impaired. Thus, CCL6 appears to contribute to the macrophage infiltration that is independent of other CC chemokines. Eosinophils pre-store CCL6, but do not release CCL6 in the peritoneum in this model of inflammation.

    DOI: 10.1080/09629350400014172

    Web of Science

    PubMed

    researchmap

  • Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice Reviewed International journal

    C Jakubzick, HT Wen, A Matsukawa, M Keller, SL Kunkel, CM Hogaboam

    AMERICAN JOURNAL OF PATHOLOGY   165 ( 4 )   1211 - 1221   2004.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC INVESTIGATIVE PATHOLOGY, INC  

    Controversy persists pertaining to the role of CCR4 ligands, namely CCL17 (or thymus and activation regulated chemokine; TARC) and CCL22 (or macrophage-derived chemokine; MDC), in Th2-type cytokine-dominated responses in the lung. Accordingly, the present study addressed the relative role of each of these CC chemokines during an evolving pulmonary granulomatous response elicited by the intrapulmonary embolization of live Schistosoma mansoni eggs into S. mansoni-sensitized mice. CCL22 protein expression peaked at day 4, but CCL17 levels were not increased significantly at any time after egg challenge. CCR4 transcript and protein expression were highest at day 8 after egg embolization and CCR4 protein was prominently expressed in macrophages surrounding S. mansoni eggs. Systemic immunoneutralization of CCL22 from the time of egg injection into S. mansoni-sensitized mice for 8 days significantly decreased CCR4 protein expression, the eosinophil content, the overall size of the egg granuloma, and its hydroxyproline content. Whole lung levels of interferon-gamma were also significantly increased at day 8 in anti-CCL22-treated mice. The systemic immunoneutralization of CCL17 had a lesser effect on all of the granuloma parameters listed above, but this antibody treatment significantly decreased granuloma hydroxyproline content to a greater extent than the anti-CCL22 antibody treatment. In addition, the immunoneutralization of CCL17 significantly increased whole lung levels of interleukin (IL)-4, IL-5, IL-13, transforming growth factor-beta, ILL-12, and tumor necrosis factor-a at day 8 after egg infusion. Thus, these studies demonstrate a major role for CCL22 and a lesser role for CCL17 during an evolving S. mansoni egg granuloma in the lung.

    Web of Science

    PubMed

    researchmap

  • Wall shear modulation of cytokines in early vein grafts Reviewed International journal

    ZH Jiang, SA Berceli, CL Pfahnl, LZ Wu, D Goldman, M Tao, M Kagayama, A Matsukawa, CK Ozaki

    JOURNAL OF VASCULAR SURGERY   40 ( 2 )   345 - 350   2004.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MOSBY, INC  

    Objective: Pro-inflammatory cytokine-driven mechanisms have been implicated in vein graft failure, though little is known about the effect of hemodynamic factors and anti-inflammatory counter-regulatory mechanisms. We hypothesized that early temporal expression of the pro-inflammatory cytokine interleukin (IL)-1beta and the anti-inflammatory cytokine IL-10 proceeds by way of wall shear stress-dependent pathways in the arterializing vein graft.
    Methods. Rabbits (n = 27) underwent bilateral jugular vein carotid interposition grafts, and simultaneous unilateral distal carotid branch ligation, to produce both low-flow and high-flow grafts in the same animal. Vein grafts were harvested at 1, 3, 7, 14, and 28 days and were assessed for architecture, wall shear stress, and cytokine messenger RNA levels (quantitative real-time two-step reverse transcription polymerase chain reaction).
    Results. The model resulted in an immediate 90% flow reduction (P &lt; .001, paired t test) in the vein graft on the ligated side, and a 36% increase (P = .01) in contralateral graft flow. This persisted as similar to15-fold flow differential throughout the 28-day period. The construction yielded a 15-fold differential in wall shear stress between low-flow and high-flow vein grafts (P &lt; .001, two-way repeated measures analysis of variance). Intimal hyperplasia began by day 3, and was 6-fold more in low wall shear grafts by 28 days (230.6 +/- 35.4 mum intimal thickness vs 36.1 +/- 17.6 mum for low shear versus high shear grafts; P = .001). For both cytokines time independently affected mRNA expression (P &lt; .001, global analysis of variance). Exposure of vein grafts to the arterial circulation markedly up-regulated IL-10 at 1 day, with significantly more induction in the low shear setting (P =.002). IL-1beta protein localized to the developing neointima at days 1 and 3. Conversely, IL-10 slowly increased until day 14, with significantly more expression in the high shear grafts (P &lt; .001).
    Conclusions. Vein graft adaptation induces early pro-inflammatory cytokine IL-1beta expression and delayed protective IL-10 expression (most notable under high shear conditions), both of which are modulated by wall shear. These differential temporal windows offer strategies for appropriately timed pro-inflammatory or anti-inflammatory therapies to interrupt pathologic vein graft adaptations. (J Vasc Surg 2004;40:345-50.)
    Clinical Relevance: Neointimal hyperplasia continues to limit the durability of vein bypass grafts. Emerging evidence suggests that inflammatory mechanisms drive the neointimal hyperplasic response. This study demonstrates that specific hemodynamic forces (altered wall shear stress) differentially affect early pro-inflammatory interleukin (IL)-1beta and delayed anti-inflammatory IL-10 signaling. These distinct temporal windows for IL-1beta and IL-10 cytokine expression offer strategies for appropriately timed pro-inflammatory and anti-inflammatory therapies to interrupt pathologic vein graft adaptations.

    DOI: 10.1016/j.jvs.2004.03.048

    Web of Science

    PubMed

    researchmap

  • Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis. Reviewed International journal

    Carole L Galligan, Wataru Matsuyama, Akihiro Matsukawa, Hiroshi Mizuta, David R Hodge, O M Zack Howard, Teizo Yoshimura

    Arthritis and rheumatism   50 ( 6 )   1806 - 14   2004.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: Rheumatoid arthritis (RA) is a chronic inflammatory condition characterized by a cellular influx and destruction of the joint architecture. Chemokines characteristically regulate leukocyte recruitment and activation. Chemokine (CC motif) receptor-like 2 (CCRL2) is an orphan receptor with homology to other CC chemokine receptors. We undertook this study to examine CCRL2 expression in RA, cytokine regulation of expression, and the source of a putative ligand in an attempt to determine the role of this receptor during inflammation. METHODS: Expression of CCRL2 on joint-infiltrating leukocytes was examined by immunocytochemistry. In vitro studies evaluated CCRL2 expression in primary neutrophils using Northern and Western blotting and reverse transcriptase-polymerase chain reaction. HEK 293 cells expressing two splice variants of CCRL2 (HEK/CCRL2A or HEK/CCRL2B) were generated with a retroviral expression system, and their migration in response to fractions of synovial fluid (SF) from RA patients was examined using a 48-well chamber. RESULTS: CCRL2 expression was observed on all infiltrating neutrophils and on some macrophages obtained from the SF of 5 RA patients. In vitro studies of primary neutrophils revealed that CCRL2 messenger RNA (mRNA) was rapidly up-regulated following stimulation with lipopolysaccharide (1 microg/ml) or tumor necrosis factor (5 ng/ml). The mRNA for both CCRL2A and CCRL2B were expressed in cytokine-stimulated neutrophils. Cells expressing either of these splice variants migrated in response to a fraction of RA SF. CONCLUSION: CCRL2 expression is up-regulated on synovial neutrophils of RA patients. Inflammatory products present in the SF activate this receptor, indicating that CCRL2 is a functional receptor that may be involved in the pathogenesis of RA.

    PubMed

    researchmap

  • Upregulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis Reviewed

    C Galligan, W Matsuyama, A Matsukawa, H Mizuta, DR Hodge, OMZ Howard, T Yoshimura

    FASEB JOURNAL   18 ( 4 )   A469 - A469   2004.3

     More details

    Language:English   Publisher:FEDERATION AMER SOC EXP BIOL  

    DOI: 10.1002/art.20275

    Web of Science

    researchmap

  • Involvement of tumor necrosis factor-alpha and interleukin-8 in antigen-induced arthritis of the rabbit temporomandibular joint Reviewed International journal

    M Sukedai, K Tominaga, M Habu, A Matsukawa, T Nishihara, J Fukuda

    JOURNAL OF ORAL PATHOLOGY & MEDICINE   33 ( 2 )   102 - 110   2004.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BLACKWELL MUNKSGAARD  

    BACKGROUND: In temporomandibular joint (TMJ) arthritis, knowledge is limited about the source of the inflammatory mediators. The aim of this study was to investigate the immunohistochemical role of tumor necrosis factor-alpha (TNF-alpha) and interleukin-8 (IL-8) in the development of the antigen-induced arthritis of the rabbit TMJ.
    METHODS: Unilateral TMJ arthritis was induced in 28 adult rabbits. From 6 h to 6 weeks after induction of arthritis, the topology of TNF-alpha and IL-8 was observed.
    RESULTS: Positive reaction for TNF-alpha of synovial cells was observed within 3 days after induction and at 3 weeks after induction. TNF-alpha positive vascular endothelial cells and chondrocytes were identified throughout the observation period. IL-8 was detected only during the acute stage.
    CONCLUSIONS: The cytokines TNF-alpha and IL-8 were observed in specific cells depending on the stage. TNF-alpha was particularly related with angiogenesis and cartilage destruction and IL-8 was involved in the acute stage of inflammation.

    DOI: 10.1111/j.1600-0714.2004.00008.x

    Web of Science

    PubMed

    researchmap

  • Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils Reviewed International journal

    A Matsukawa, K Takeda, S Kudo, T Maeda, M Kagayama, S Akira

    JOURNAL OF IMMUNOLOGY   171 ( 11 )   6198 - 6205   2003.12

     More details

    Authorship:Lead author, Last author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ASSOC IMMUNOLOGISTS  

    Stat3 is a transcription factor mediating anti-inflammatory properties of IL-10. In the present study, we demonstrate a pivotal role of Stat3 expressed in innate immune cells during septic peritonitis induced by cecal ligation and puncture (CLP). Mice with targeted disruption of Stat3 in macrophages and neutrophils were succumbed to septic peritonitis induced by CLP. The mice displayed an excessive local and systemic inflammation relative to the control mice, an event that was accompanied by substantial increases in the level of multiple cytokines. Hepatic and renal injury was significantly exacerbated in mice with Stat3 deficiency. Despite enhanced inflammatory responses, the mice failed to facilitate bacterial clearance as compared with the control mice. In addition, the mice exhibited an increased lethality after i.p. inoculation of live bacteria recovered from CLP-mice. In vitro, resident peritoneal macrophages from mice with Stat3 deficiency impaired bactericidal activity relative to the control whereas productions of inflammatory cytokines were significantly augmented when cells were stimulated with a synthetic lipopeptide, macrophage-activating lipopeptide-2 and LPS. Elicited macrophages and neutrophils with Stat3 deficiency also impaired bactericidal activity as compared with those with Stat3. Lysosomal enzyme release, an effector molecule for bacterial clearance, was significantly decreased in elicited leukocytes with Stat3 deficiency while increasing the production of inflammatory cytokines. Altogether, these results suggest that macrophage/neutrophil-specific STAT3 is crucial in not only modulating multiple organ failure associated with systemic inflammation but also intensifying the bactericidal activity, which highlight the significance of cell-specific Stat3 in the protective immunity during sepsis.

    Web of Science

    PubMed

    researchmap

  • Detection of neutrophils and possible involvement of interleukin-8 in diffuse lamellar keratitis after laser in situ keratomileusis Reviewed International journal

    N Asano-Kato, Toda, I, S Shimmura, T Noda-Tsuruya, K Fukagawa, M Yoshinaga, A Matsukawa, K Tsubota

    JOURNAL OF CATARACT AND REFRACTIVE SURGERY   29 ( 10 )   1996 - 2000   2003.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE INC  

    Purpose: To investigate the cell populations in diffuse lamellar keratitis (DLK) infiltration after laser in situ keratomileusis and the possible mechanism underlying the infiltration.
    Setting: Department of Ophthalmology, Tokyo Dental College, Chiba, Japan.
    Methods: To develop DLK in rabbit eyes, 25 muL of lipopolysaccharide (LPS) solution at a concentration of 50 mug/mL was applied to the stromal bed beneath corneal flaps. For control rabbits, phosphate-buffered saline was applied. Postoperative examination by slitlamp microscopy was performed for 3 days after surgery. Rabbit eyes were excised and examined for histopathology with hematoxylin and eosin staining. Immunohistochemical analysis for interleukin (IL)-8 was performed.
    Results: Diffuse lamellar keratitis-like inflammation composed mainly of neutrophils was reproduced by LIDS instillation in rabbit eyes. In eyes with severe inflammation, IL-8 immunoreactivity was found in the stromal keratocytes and infiltrating neutrophils.
    Conclusions: The major cell type in the DLK infiltration induced by LPS instillation in rabbit eyes was the neutrophil. Interleukin-8, a prototype of CXC chemokine produced by keratocytes and neutrophils, may contribute to the development of DLK. (C) 2003 ASCRS and ESCRS

    DOI: 10.1016/S0886-3350(03)00496-6

    Web of Science

    PubMed

    researchmap

  • Tumor necrosis factor-a inhibition reduces CXCL-8 levels but fails to prevent fibrin generation and does not improve outcome in a rabbit model of endotoxic shock Reviewed International journal

    P Rodriguez-Wilhelmi, R Montes, A Matsukawa, H Nariuchi, Hurtado, V, M Montes, J Hermida, E Rocha

    JOURNAL OF LABORATORY AND CLINICAL MEDICINE   141 ( 4 )   257 - 264   2003.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MOSBY, INC  

    The effects of a monoclonal antibody (mAb) to tumor necrosis factor-alpha (TNF-alpha) were examined in a rabbit model of endotoxic shock. Intravenous administration of lipopolysaccharide (100 mug/kg/hr) for 6 hours (n = 11) increased TNF-alpha levels. Fibrinogen was partially consumed, and fibrin deposits were seen in kidney and lungs at 24 hours. Mortality at 24 hours was 64%. Levels of interleukin-8 (aka CXCL-8) were notably increased. Mean arterial pressure (MAP) and leukocyte counts decreased, whereas creatinine levels were enhanced. The anti-TNF-alpha mAb (20 mg/kg i.v. bolus + 5 mg/kg/h Lv. for the first 90 minutes) (n = 10) efficiently inhibited the TNF-activity. Rabbits exhibited lower CXCL-8 levels; MAP improved, the decrease in leukocyte counts was partially prevented and creatinine levels were lower, but fibrinogen, fibrin deposits in kidneys and lungs and mortality, 55%, were similar to the LPS group. Rabbits that did not survive exhibited lower fibrinogen levels, more fibrin in kidneys and lungs and higher CXCL-8 and creatinine levels than survivors, while there were no differences in TNF-alpha, MAP and leukocytes. Thus, the inhibition of TNF-alpha, although beneficial through lowering CXCL-8 levels, is not enough to improve the outcome, which could be partly due to the inability to prevent the fibrin deposits formation in kidneys and lungs.

    DOI: 10.1067/mlc.2003.32

    Web of Science

    PubMed

    researchmap

  • Chemokines in granulomatous lung inflammation

    Stephen W. Chensue, Akihiro Matsukawa, Cory M. Hogaboam, Steven L. Kunkel

    Chemokines in the Lung   221 - 237   2003.1

     More details

    Language:English   Publishing type:Part of collection (book)   Publisher:CRC Press  

    The clinical manifestations of pulmonary granulomatous diseases are usually the consequence of long-term leukocyte elicitation and activation, resulting in chronic tissue inflammation and lung injury (1). Most interstitial granulomatous diseases in the lung are difficult to treat, requiring therapies that may seriously compromise the immunologic and physiologic integrity of the patient. Historically, the therapeutic approach to the treatment of infectious granulomatous disease has been to target the known infectious agent, while treatment of idiopathic granulomatous diseases has usually targeted immune/inflammatory cell function. Once the pulmonary disease is diagnosed, antimicrobial agents are used to treat the former, while immunosuppressive agents are usually used to treat the latter disease states (2,3). Unfortunately, the clinical management of these diseases does not necessarily ablate the subsequent pathology, which is observed in certain patients. This is especially true in difficult clinical cases, such as drug-resistant mycobacterial diseases or progressive sarcoidosis refractory to corticosteroids (2). Thus, the limited therapeutic options, which are available to effectively manage patients with granulomatous lung disease, may reflect the limited understanding of the mechanisms underlying these chronic diseases.

    Scopus

    researchmap

  • Regulation of innate immune response by Stat proteins during septic peritonitis ; in The biological response to planned and unplanned injuries : Cellular, molecular and genetic aspects Invited Reviewed

    MATSUKAWA A

    Excerpta Medica International Congress Series   1255   7 - 14   2003

     More details

    Authorship:Lead author, Last author, Corresponding author  

    DOI: 10.1016/S0531-5131(03)00236-X

    CiNii Article

    researchmap

  • Interleukin (IL)-8 and growth related oncogene-alpha in severe endotoxemia and the effects of a tumor necrosis factor-alpha/IL-1 beta inhibitor on these chemokines Reviewed International journal

    P Rodriguez-Wilhelmi, R Montes, A Matsukawa, Hurtado, V, M Montes, J Hermida, E Rocha

    EXPERIMENTAL AND MOLECULAR PATHOLOGY   73 ( 3 )   220 - 229   2002.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    FR167653 inhibits the production of tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta, powerful inducers of CXC chemokines IL-8 and growth related oncogene (GRO)-alpha. The production of IL-8 and GRO-alpha was investigated and the effects of FR167653 were examined in a rabbit model of endotoxin shock. Male New Zealand rabbits were given endotoxin at a dose sufficient to induce DIC. Three groups of rabbits received FR167653 at different doses. TNF-alpha, IL-1beta, IL-8, and GRO-alpha levels were measured, several pathologic features were evaluated, and the results were compared with those obtained in control rabbits, which received only endotoxin. Endotoxin increased serum levels of IL-8 and GRO-alpha. which were associated with hypotension, renal dysfunction, and mortality, peaking at 4 It. FR167653 improved mortality, an event that was associated with decreased levels of not only TNF-alpha and IL-1beta but also IL-8 and GRO-alpha. TNF-alpha peaked at 2 h, at a time point before IL-8 and GRO-alpha reached their peak, and the TNF-alpha level was tightly correlated with that of IL-8 and GRO-alpha. Altogether, these data suggest the possible involvement of IL-8 and GRO-a in endotoxin shock, and FR167653 may foster a beneficial outcome in part by modulating the chemokines level by inhibiting TNF-alpha and IL-1beta. (C) 2002 Elsevier Science (USA).

    DOI: 10.1006/exmp.2002.2467

    Web of Science

    PubMed

    researchmap

  • Expression of monocyte chemoattractant protein-1 in primary cultures of rabbit intervertebral disc cells Reviewed International journal

    M Yoshida, T Nakamura, T Kikuchi, K Takagi, A Matsukawa

    JOURNAL OF ORTHOPAEDIC RESEARCH   20 ( 6 )   1298 - 1304   2002.11

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCI LTD  

    Macrophages are considered essential for herniated disc resorption, and chemokines may play a role in their recruitment. Here we demonstrate that intervertebral disc cells are capable of producing monocyte chemoattractant protem-1 (MCP-1), a CC chemokine that is chemotactic for macrophages. Nucleus pulposus cells and anulus fibrosus cells were harvested from intervertebral discs of healthy rabbits, and the cells were stimulated with either interleukin (IL)-1beta or tumor necrosis factor (TNF)alpha. Reverse transcriptase polymerase chain reaction demonstrated that IL-1beta and TNFalpha induced mRNA expression for MCP-1 in nucleus pulposus and anulus fibrosus cells. Protein concentrations of MCP-1 in the culture supernatants were quantitated by fluoroimmunoassay, which showed that nucleus pulposus and anulus fibrosus cells dose- and time-dependently produced MCP-1 after IL-1beta- and TNFalpha-stimulation, an event that was completely abrogated by IL-1 receptor antagonist and anti-TNFalpha monoclonal antibody, respectively. Nucleus pulposus cells produced significantly higher levels of MCP-1 than did anulus fibrosus cells. Immunohistochemically, the intensity of MCP-1 positive cells in nucleus pulposus cells was stronger than that in anulus fibrosus cells. Altogether, our data clearly demonstrated the production of MCP-1 in intervertebral disc cells, suggesting the possible involvement of disc cells in an early stage of macrophage infiltration. (C) 2002 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.

    DOI: 10.1016/S0736-0266(02)00060-8

    Web of Science

    PubMed

    researchmap

  • The endotoxin-induced plasminogen activator inhibitor-1 increase in rabbits is not tumor necrosis factor-alpha dependent and can occur in the absence of interleukin-1 beta Reviewed International journal

    R Montes, P Rodriguez-Whilhelmi, Hurtado, V, A Matsukawa, M Montes, J Hermida, E Rocha

    THROMBOSIS AND HAEMOSTASIS   88 ( 4 )   639 - 643   2002.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN  

    The plasminogen activator inhibitor-1 (PAI-1)-dependent fibrinolytic inhibition occurring in endotoxemia contributes to disseminated intravascular coagulation (DIC). Previous findings suggest that tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) are responsible for the increase in the level of PAI-1. These observations usually arose from mild endotoxemia models. We analyzed the effect of FR167653, an inhibitor of the TNF-alpha/IL-1beta production, on the PAI-1 levels in rabbits given endotoxin at a dose sufficient to induce DIC: the steep plasma PAI-1 increase was not attenuated by FR167653, in spite of achieving efficient inhibition of the TNF-alpha production. No IL-1beta was detected during endotoxemia. These results suggest that PAI-1 increase might be independent of TNF-alpha and IL-1beta. If these findings applied to humans, therapeutic intervention directing these cytokines would not be useful for the treatment of fibrinolysis in patients with severe sepsis.

    Web of Science

    PubMed

    researchmap

  • Involvement of CXC chemokine growth-related oncogene-alpha in monosodium urate crystal-induced arthritis in rabbits Reviewed International journal

    K Fujiwara, S Ohkawara, K Takagi, M Yoshinaga, A Matsukawa

    LABORATORY INVESTIGATION   82 ( 10 )   1297 - 1304   2002.10

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Accumulation of neutrophils is a prominent feature of gouty arthritis in which CXC chemokines may play a role. Recently, we have shown that IL-8 (CXCL8) contributes to neutrophil influx in a rabbit model of gouty arthritis. Here, we demonstrate that growth-related oncogene-a (GROalpha) (CXCL1), a prototype of CXC chemokine, is also involved in this process. GROalpha level in the joints peaked at 2 hours after intra-articular injection of monosodium urate crystals, at a time before the neutrophil influx reached the maximal level (9 hours). Once decreased, the level increased and reached the second peak at 9 hours. The kinetics was comparable to that of IL-8. Administration of anti-GROalpha mAb attenuated the neutrophil influx at the same level as did the anti-IL-8 IgG, and combination of these antibodies enhanced the inhibition, resulting in a 33% reduction. Interaction of GROalpha with TNFalpha, IL-1beta, and IL-8 was next investigated by injecting antibodies or receptor antagonist with monosodium urate crystals. Administration of anti-TNFalpha mAb did not alter GROalpha level at 2 hours, but inhibited the levels 9 hours after the injection. Treatment with either IL-1 receptor antagonist or anti-IL-8 IgG resulted in decreased levels of GROalpha at 2 and 9 hours. Neutralization of GROalpha with anti-GROalpha mAb did not alter TNFalpha, IL-1beta, and IL-8 levels at their peak (2 hours), but decreased the second peak of IL-1beta (9 hours) and IL-8 (12 hours). These results provide evidence that GROalpha as well as IL-8 are involved ad eundem in the neutrophil infiltration in this model. IL-1 and IL-8, but not TNFalpha, are responsible in part for the initial phase of GROalpha, whereas these cytokines induce GROalpha in a late phase. GROalpha does not seem to initiate TNFalpha, IL-1beta, and IL-8, in an early phase, but induces IL-1beta and IL-8 in a late phase.

    DOI: 10.1097/01.LAB.0000029206.27080.D2

    Web of Science

    PubMed

    researchmap

  • Mice genetically lacking endothelial selectins are resistant to the lethality in septic peritonitis Reviewed International journal

    A Matsukawa, NW Lukacs, CM Hogaboam, RN Knibbs, DC Bullard, SL Kunkel, LM Stoolman

    EXPERIMENTAL AND MOLECULAR PATHOLOGY   72 ( 1 )   68 - 76   2002.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Leukocyte interactions with vascular endothelium are an initial step for leukocyte entry into infectious foci where endothelial selectins may play a key role. Infiltrating leukocyte is essential for bacterial clearance, suggesting that endothelial selectins would be important in host defense against microorganisms. To address this, E-, P-, and E/P-selectiti-deficient mice (E-/-, P-/-, E/P-/-) and wild-type (WT) mice underwent cecal ligation and puncture (CLP). Neither leukocyte infiltration nor bacterial load in the peritoneum was altered in E-/-, P-/- and E/P-/- mice compared to WT mice. However, E-/-, P-/- and E/P-/- mice were resistant to the lethality induced by CLP. At the mechanistic level, E-/-, P-/-, and E/P-/- mice did not develop renal dysfunction, a possible cause of death during sepsis. The serum level of interleukin-13 in E`, P-/-, and E/P-/- mice that had undergone CLP was higher than that in WT mice, whereas levels of macrophage inflammatory protein-2, KC in serum, and KC in kidney were lower than those in WT mice. These experiments demonstrate that endothelial selectin-mediated leukocyte rolling is not required for leukocyte entry in septic peritonitis and that endothelial selectins may affect mice survival during sepsis by influencing the cytokine profiles. (C) 2002 Elsevier Science.

    DOI: 10.1006/exmp.2001.2416

    Web of Science

    PubMed

    researchmap

  • Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion - Synergism with hypercholesterolemia Reviewed International journal

    M Namiki, S Kawashima, T Yamashita, M Ozaki, T Hirase, T Ishida, N Inoue, K Hirata, A Matsukawa, R Morishita, Y Kaneda, M Yokoyama

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY   22 ( 1 )   115 - 120   2002.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Monocyte/macrophage infiltration to the arterial wall is an initial step in atherosclerosis, and monocyte chemoattractant protein-1 (MCP-1) is thought to play a central role in the recruitment of these cells. In the present study, we examined the role of local expression of MCP-1 at the vessel wall in the initiation and development of atherosclerosis. We transfected the cDNA encoding rat MCP-1 into the vessel wall of the rabbit carotid artery with the use of the hemagglutinating virus of Japan (HVJ)-liposome method. The rabbits were divided into the following groups: (1) those fed normal chow and transfected with MCP-1-HVJ, (2) those fed a high cholesterol diet (1% cholesterol) and transfected with MCP-1-HVJ, and (3) those fed a high cholesterol diet and transfected with control-HVJ. Prescribed diets were started 2 weeks before transfection and were continued for another 2 weeks. In group I, vascular lesion formation was not found, and anti-rabbit monocyte/macrophage antibody (RAM-11) staining for monocytes/macrophages was negative, although anti-rat MCP-1 antibody (R-17) staining for rat MCP-1 was positive mainly in endothelial cells. Cholesterol feeding increased plasma cholesterol levels to 1801+/-444 mg/dL in group 2. In group 2, all rabbits displayed neointimal formation with infiltration of RAM-11-positive cells, and a part of the lesion was also positive for Sudan III lipid staining. In group 3, hypercholesterolemia did not induce the infiltration of monocytes/ macrophages and subsequent lesion formation in the vessel wall despite definite upregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 on the endothelium. To initiate atherosclerotic changes, local MCP-1 overexpression at the vessel is not sufficient, and activation of other factors induced by hypercholesterolemia is required.

    DOI: 10.1161/hq0102.102278

    Web of Science

    PubMed

    researchmap

  • Functional distinction between CXC chemokines, interleukin-8 (IL-8), and growth related oncogene (GRO)alpha in neutrophil infiltration Reviewed International journal

    K Fujiwara, A Matsukawa, S Ohkawara, K Takagi, M Yoshinaga

    LABORATORY INVESTIGATION   82 ( 1 )   15 - 23   2002.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Interleukin-8 (IL-8: CXCL8) and growth related oncogene alpha (GROalpha: CXCL1) are members of the CXC chemokines. In the present study, we explored the functional distinction between these CXC chemokines in the regulation of neutrophil infiltration. Injection of either rabbit IL-8 or GROalpha (10 mug each) into rabbit knee joints resulted in a massive neutrophil infiltration in the joints. At their peak time point (6 hours), the number of neutrophils induced by IL-8 was more than that induced by GROalpha. Each chemokine induced the other chemokine in the joints. TNFalpha activity was induced in the joints after administration of GROalpha, but not IL-8. Treatment with anti-GROalpha mAb and/or anti-TNFalpha mAb failed to inhibit IL-8-induced neutrophil infiltration. In contrast, either anti-IL-8 IgG or anti-TNFalpha mAb decreased GROalpha-induced response, and the inhibition was further enhanced by coadministration of these antibodies. Thus, it appears that IL-8 acts directly, whereas GROalpha acts indirectly, in part, on neutrophil infiltration. The distinct difference in TNFalpha production between IL-8 and GROalpha was further investigated. In vitro, GROa induced TNFalpha activity in cultured synovial cells, the cells producing TNFalpha in the joints after GROalpha-injection. However, IL-8 failed to produce TNFalpha activity from the cells, although equivalent levels of the mRNA expression were induced by IL-8 as compared with GROalpha. When recombinant rabbit TNFalpha was incubated with synovial fluids obtained at 2 hours after IL-8 injection, the resultant TNFalpha activity was significantly decreased, an event that was completely restored by a serine protease inhibitor, phenylmethylsulphonyl fluoride (PMSF). Furthermore, TNFalpha activity was unveiled in the joints when IL-8 was intra-articularly injected with PMSF. These data suggest that TNFalpha is degraded by serine protease(s) in the case of IL-8. Taken together, the data clearly demonstrate the functional distinction between IL-8 and GROalpha, which may influence the inflammatory responses.

    Web of Science

    PubMed

    researchmap

  • Effect of methylprednisolone on phospholipase A(2) activity and lung surfactant degradation in acute lung injury in rabbits Reviewed

    K Kuwabara, S Furue, Y Tomita, M Ueno, T Ono, A Matsukawa, M Yoshinaga, K Mikawa, K Nishina, M Shiga, H Obara, Y Hori

    EUROPEAN JOURNAL OF PHARMACOLOGY   433 ( 2-3 )   209 - 216   2001.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    Glucocorticoids are the most potent and widely used anti-inflammatory agents, but they are not particularly effective against early phase of acute respiratory distress syndrome. We investigated whether methylprednisolone, a synthetic glucocorticoid, could inhibit increase of phospholipase A(2) activity in the lung and lead to protection against a model of acute respiratory distress syndrome in rabbits. Infusion of oleic acid (0.1 ml/kg/h, i.v. for 2 h) provoked pulmonary hemorrhage and edema, protein leakage and massive neutrophil infiltration, resulted in severe hypoxemia and impaired lung compliance, accompanying the increase of phospholipase A(2) activity and interleukin-8, and degradation of surfactant in the bronchoalveolar lavage fluid. Infusion of methylprednisolone (60 mg/kg/h, i.v. for 30 min before the oleic acid and then 0.5 mg/kg/h, i.v, for 6 h) did not improve the above described lung injury induced by oleic acid, nor did it suppress phospholipase A(2) activity and degradation of surfactant in bronchoalveolar lavage fluid, while it strongly reduced interleukin-8 levels in both plasma and bronchoalveolar lavage fluid. We conclude that methylprednisolone did not attenuate oleic acid-induced acute lung injury and this can be explained partly by its failure to reduce the increase of phospholipase A(2) activity and the surfactant degradation in the lung, which might also account for its clinical ineffectiveness against early acute respiratory distress syndrome. (C) 2001 Elsevier Science B.V All rights reserved.

    DOI: 10.1016/S0014-2999(01)01507-2

    Web of Science

    researchmap

  • Interleukin-1 beta in antigen-induced arthritis of the rabbit temporomandibular joint Reviewed

    K Tominaga, P Alstergren, H Kurita, A Matsukawa, J Fukuda, S Kopp

    ARCHIVES OF ORAL BIOLOGY   46 ( 6 )   539 - 544   2001.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    The aim was to investigate joint perfusate levels of interleukin-1 beta (IL-I beta) in antigen-induced monoarthritis of the rabbit temporomandibular (TMJ) and knee joints. Twenty-four adult male New Zealand White rabbits were divided into three groups: a control group as well as TMJ arthritis and knee joint arthritis groups. After sensitization, unilateral arthritis was induced by intra-articular injection with ovalbumin and the contralateral joint was injected with saline 3 weeks after induction of arthritis. Joints were then perfused continuously with saline and samples were collected at 10-min intervals over a 50-min period. The IL-1 beta concentrations in the samples were then analyzed. After killing the animals, the joints were examined histologically. The IL-1 beta concentrations in the samples from the arthritic TMJs and knee joints were significantly higher than in the saline-injected and the control joints. Histological signs of chronic arthritis of similar severity were;found in both joints. The IL-1 beta levels in the samples from the arthritic TM and knee joints correlated with the histological severity of the arthritis, including pannus formation. In conclusion, this study shows that IL-1 beta is released in the synovium of rabbit TMJs and knee joints during antigen-induced arthritis, and that high IL-1 beta levels in synovial fluid are associated with histological signs of inflammation including, pannus tissue formation. (C) 2001 Elsevier Science Ltd. All rights reserved.

    DOI: 10.1016/S0003-9969(01)00009-7

    Web of Science

    researchmap

  • III. Chemokines and other mediators, 8. Chemokines and their receptors in cell-mediated immune responses in the lung Invited Reviewed

    A Matsukawa, NW Lukacs, CM Hogaboam, SW Chensue, SL Kunkel

    MICROSCOPY RESEARCH AND TECHNIQUE   53 ( 4 )   298 - 306   2001.5

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-LISS  

    Chemokines constitute a large family of chemotactic cytokines that belong to a super-gene family of 8-10 kDa proteins. The chemokines are considered to be primarily beneficial in host defense against invading pathogens. However, the reactions induced by chemokines can be occasionally excessive, resulting in a harmful response to the host. Recent studies in chemokine biology have elucidated that chemokines are involved in the initiation, development, and maintenance of numbers of diseases including lung diseases. In addition to its chemotactic activity, evidence suggests that chemokines can modify the outcome of the cell-mediated immune responses by altering the Th1/Th2 cytokine profile. Chemokines are also capable of dictating the direction of specific immune responses. Chemokine action is mediated by a large super-family of G-protein coupled receptors, and the receptors are preferentially expressed on Th1/Th2 cells. Certain chemokine receptors are constitutively expressed in immune surveying cells such as dendritic cells and naive T cells. The corresponding chemokines are present in normal lymphoid tissues, suggesting a role of chemokines/receptors in cell homing and cell-cell communication in lymphoid tissue that can be an initial step for immune recognition. Thus, comprehension of the chemokine biology in immune responses appears to be fundamental for understanding the pathogenesis of T cell-mediated immune responses. The following review will highlight the current insight into the role of chemokines and their receptors in the cell-mediated immune response, with a special focus on lung diseases. (C) 2001 Wiley-Liss, Inc.

    DOI: 10.1002/jemt.1096

    Web of Science

    researchmap

  • Therapeutic time-window of a group IIA phospholipase A(2) inhibitor in rabbit acute lung injury: Correlation with lung surfactant protection Reviewed

    S Furue, K Mikawa, K Nishina, M Shiga, M Ueno, Y Tomita, K Kuwabara, Teshirogi, I, T Ono, Y Hori, A Matsukawa, M Yoshinaga, H Obara

    CRITICAL CARE MEDICINE   29 ( 4 )   719 - 727   2001.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Objective: We attempted to determine whether group IIA secretory phospholipase A(2) (sPLA(2)-IIA) blockade after the onset of lung injury exerted therapeutic efficacy in the treatment of oleic acid (OA)-induced acute lung injury by using S-5920/LY315920Na, a novel specific inhibitor of sPLA(2)-IIA, with special interest in the changes of lung surfactant.
    Design:Prospective animal study.
    Setting: University laboratory.
    Subjects: Forty Japanese white rabbits.
    Interventions: The rabbits, under anesthesia, were endotracheally intubated and mechanically ventilated and then were divided into the following groups: OA + vehicle groups, intravenous infusion of OA for the first 2 hrs (0.1 mL . kg(-1). hr(-1)) with the addition of vehicle (1 or 2 hrs after OA administration, each n = 9, total 18 rabbits); OA + S-59201/Y315920Na groups, treated identically to the OA control with the addition of S-5920/LY315920Na (1 mg/kg bolus followed by infusion at 0.5 mg . kg(-1). hr(-1)) after OA (1 or 2 hrs after OA administration, each n = 9, total 18 rabbits); saline control groups, treated with saline instead of OA with the addition of vehicle (1 hr after OA administration, 4 rabbits). Arterial blood gas, lung mechanics, lung inflammation, lung surfactant phospholipids, and production of inflammatory mediators in the lung were measured.
    Measurements and Main Results:Treatment with S-5920/ LY315920Na 1 hr after OA infusion, but not 2 hrs after infusion, significantly attenuated the lung injury, as estimated by hypoxemia, decreased lung compliance, pulmonary edema, and vascular permeability. The therapeutic efficacy was similar to that found in our previous pretreatment study. The treatment after 1 hr dramatically inhibited OA-induced surfactant degradation in the bronchoalveolar lavage fluid (BALF), without affecting the concentrations of thromboxane A(2), leukotriene B-4, and interleukin-8 in BALF. The degree of surfactant degradation in BALF paralleled well with the severity of the lung injury. Furthermore, recombinant human sPLA(2)-IIA reproduced the similar hydrolysis pattern of isolated surfactant in vitro, which was inhibited by S-5920/ LY315920Na.
    Conclusions:Our results indicate that therapeutic blockade of sPLA(2)-IIA ameliorated lung dysfunction via protection of surfactant degradation in an animal model of acute lung injury, and they suggest a new strategy in treating clinical acute lung injury.

    Web of Science

    researchmap

  • Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis Reviewed

    A Matsukawa, MH Kaplan, CM Hogaboam, NW Lukacs, SL Kunkel

    JOURNAL OF EXPERIMENTAL MEDICINE   193 ( 6 )   679 - 688   2001.3

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ROCKEFELLER UNIV PRESS  

    Signal transducer and activator of transcription (Stat)4 and Stat6 are transcription factors that provide type 1 and type 2 response, respectively. Here, we explored the role of Stat4 and Stat6 in innate immunity during septic peritonitis. Stat4(-/-) and Stat6(-/-) mice were resistant to the lethality compared with wild-type (WT) mice. At the mechanistic level, bacterial levels in Stat6(-/-) mice were much lower than in WT mice, which was associated with increased peritoneal levels of interleukin (IL)-12, tumor necrosis factor (TNF)-alpha, macrophage-derived chemokine (MDC), and C10, known to enhance bacterial clearance, In Stat4-/- mice, hepatic inflammation and injury during sepsis were significantly ameliorated without affecting local responses. This event was associated with increased hepatic levels of IL-10 and IL-13, while decreasing those of macrophage inflammatory protein (MIP)-2 and KC. Sepsis-induced renal injury was also abrogated in Stat4(-/-) mice, which was accompanied by decreased renal levels of MIP-2 and KC without altering IL-10 and IL-13 levels. Thus, Stat6(-/-) and Stat(4-/-) mice appeared to be resistant to septic peritonitis by enhancing local bacterial clearance and modulating systemic organ damage, respectively, via balancing cytokine responses. These results clearly highlight an important role of local type 1 and systemic type 2 cytokine response ill protective immunity during sepsis, which can be regulated by Stat proteins.

    DOI: 10.1084/jem.193.6.679

    Web of Science

    researchmap

  • Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia Reviewed

    K Tateda, TA Moore, JC Deng, MW Newstead, XY Zeng, A Matsukawa, MS Swanson, K Yamaguchi, TJ Standiford

    JOURNAL OF IMMUNOLOGY   166 ( 5 )   3355 - 3361   2001.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ASSOC IMMUNOLOGISTS  

    The contribution of neutrophils to lethal sensitivity and cytokine balance governing T1 and T2 host responses was assessed in a murine model of Legionella pneumophila pneumonia, Neutrophil depletion by administration of granulocyte-specific mAb RB6-8C5 at 1 day before infection rendered mice - 100-fold more susceptible to lethal pneumonia induced by L, pneumophila. However, this treatment did not alter early bacterial clearance, despite a substantial decrease in neutrophil influx at this time point. Cytokine profiles in the lungs of control mice demonstrated strong T1 responses, characterized by an increase of IFN-gamma and IL-12, In contrast, neutrophil-depleted mice exhibited significantly lower levels of IFN-gamma and IL-12, and elevation of T2 cytokines, IL-4 and IL-10, Immunohistochemistry of bronchoalveolar lavage cells demonstrated the presence of IL-12 in neutrophils, but not alveolar macrophages, Moreover, IL-12 was detected in lavage cell lysates by ELISA, which was paralleled to neutrophil number. However, intratracheal administration of recombinant murine IL-12 did not restore resistance, whereas reconstitution of IFN-gamma drastically improved bacterial clearance and survival in neutrophil-depleted mice. Taken together, these data demonstrated that neutrophils play crucial roles in primary L, pneumophila infection, not via direct killing but more immunomodulatory effects. Our results suggest that the early recruitment of neutrophils may contribute to T1 polarization in a murine model of L. pneumophila pneumonia.

    Web of Science

    researchmap

  • Erythromycin attenuates an experimental model of chronic bronchiolitis via augmenting monocyte chemoattractant protein-1 Reviewed

    T Takahashi, M Suga, A Matsukawa, K Sato, T Okamoto, H Ichiyasu, S Ohkawara, M Yoshinaga, M Ando

    EUROPEAN RESPIRATORY JOURNAL   17 ( 3 )   360 - 367   2001.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:EUROPEAN RESPIRATORY SOC JOURNALS LTD  

    The mechanisms underlying the therapeutic efficacy of erythromycin (EM) in diffuse panbronchiolitis (DPB) was investigated. For this purpose, an experimental rabbit model of DPB induced by Pseudomonas aeruginosa inoculation was employed. Daily administration of EM (3 mg(.)kg(.)day(-1)) led to an increase in the number of macrophages in bronchoalveolar lavage fluid (BALF) at an early phase, while reducing the size of granulomatous lesions at the late phase without affecting the number of viable bacteria recovered from the infected lung.
    Reverse transcriptase polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA) and immunohistochemical studies showed that monocyte chemoattractant protein (MCP)-1 was produced in both BALF and infected lung. EM treatment resulted in a significant increase in the level of MCP-1 in BALF, while reducing that of tumour necrosis factor (TNF)-alpha, interleukin (IL)-beta and IL-beta. EM also increased MCP-1 messenger ribonucleic acid (mRNA) and protein expression in the infected lung. MCP-1 blockade abolished the protective effect of EM, as neutralization of MCP-I with anti-MCP-l antibodies reduced the E;CZ-induced increase in the number of macrophages in BALF, and augmented size of the granulomatous lesions, as compared to control.
    The results of the present study suggest that erythromycin attenuates the pulmonary granuloma formation, at least in part, by increasing the production of monocyte chemoattractant protein-1.

    DOI: 10.1183/09031936.01.17303600

    Web of Science

    researchmap

  • 緑膿菌誘発家兎びまん性汎細気管支炎におけるエリスロマイシンの効果-MCP-1産生増加による肉芽腫様病変の改善

    高橋利弘, 菅守隆, 佐藤圭創, 岡本龍哉, 一安秀範, 松川昭博, 大河原進, 吉永秀, 安藤正幸

    Jpn. J. Antibiot   54 ( 増刊A )   125 - 129   2001

     More details

    Language:Japanese   Publisher:(公財)日本感染症医薬品協会  

    び漫性汎細気管支炎実験モデルにおけるマクロファージの浸潤と単球化学誘導蛋白(MCP)-1の産生に対するエリスロマイシン(EM)の効果について検討した.EM治療群では1日目の気管支肺胞洗浄(BAL)液中および肺組織中のMCP-1と3日目のBAL液中のマクロファージ数が有意に増加し,肉芽腫様病変1個あたりの面積が有意に減少した.又,EM治療群において抗MCP-1抗血清による中和試験を行った結果,3日目のBAL液中のマクロファージ数は有意に減少し,肉芽腫様病変の面積は有意に拡大した.これらの結果から,EMはMCP-1の産生を調節して病変を改善させていることが示唆された

    researchmap

  • Neutrophil infiltration as a crucial step for monocyte chemoattractant protein (MCP)-1 to attract monocytes in lipopolysaccharide-induced arthritis in rabbits Reviewed

    S Miyazaki, A Matsukawa, S Ohkawara, K Takagi, M Yoshinaga

    INFLAMMATION RESEARCH   49 ( 12 )   673 - 678   2000.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIRKHAUSER VERLAG AG  

    Objective and Design: To evaluate the mechanism whereby monocyte chemoattractant protein (MCP)-1 attracts monocytes in vivo.
    Subjects: New Zealand white rabbits (175 rabbits) were used.
    Treatment: LPS, MCP-1 or IL-8 was injected into knee joints. Antibodies against various cytokines or IL-1 receptor antagonist were injected to neutralize cytokine activities.
    Methods: The numbers of leukocyte populations, levels of cytokines in joints were estimated.
    Results: Partial inhibition of neutrophil influx with anti-IL-8 IgG (10 mug) suppressed LPS-induced macrophage influx by 43 +/- 8.5% (p&lt;0.05) without affecting the MCP-I level. Intraarticular injection of MCP-1 (1-30 &lt;mu&gt;g) induced macrophage influx. The event was accompanied by a small number of neutrophils in an early phase. Go-injection of IL-8 (1.0 mug) enhanced the MCP-1-induced macrophage infiltration (p&lt;0.01). In neutrophil-depleted rabbits, LPS failed to induce macrophage influx even though the MCP-1 level was maintained, and macrophage influx following exogenously administered MCP-1 was also dramatically inhibited.
    Conclusions: Early events associated with neutrophil infiltration appear to be important for MCP-1 to induce a later macrophage influx in LPS-arthritis.

    DOI: 10.1007/s000110050645

    Web of Science

    researchmap

  • Chemokine C10 promotes disease resolution and survival in an experimental model of bacterial sepsis Reviewed

    ML Steinhauser, CM Hogaboam, A Matsukawa, NW Lukacs, RM Strieter, SL Kunkel

    INFECTION AND IMMUNITY   68 ( 11 )   6108 - 6114   2000.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC MICROBIOLOGY  

    Previous studies have suggested that the C-C chemokine C10 is involved in the chronic stages of host defense reactions. The present study addressed the role of C10 in a murine model of septic peritonitis, induced by cecal ligation and puncture (CLP). Unlike other C-C chemokines, C10 levels in the peritoneal wash were increased approximately 30-fold above baseline levels at 48 h after CLP surgery. Immunoneutralization of peritoneal C10 Levels with polyclonal anti-C10 antiserum during CLP-induced peritonitis negatively impacted mouse survival over 4 days. In contrast,,when 500 ng of recombinant murine C10 was administered immediately after CLP surgery, the ii-day survival rate increased from 20% to over 60%. The C10 therapy appeared to facilitate a rapid and significant enhancement of the Levels of tumor necrosis factor alpha (TNF-alpha) and monocyte chemoattractant protein-1 (MCP-I) and a later increase in interleukin-13 (IL-13) levels in the peritoneal cavity. In vitro studies showed that the combination of IL-1 beta and C10 markedly augmented TNF-alpha synthesis by peritoneal macrophages and that C10 synthesis was induced in these cells following their exposure to IL-13, At 24 h after CLP surgery, only 25% of C10-treated mice were bacteremic versus 85% of the control group that exhibited dissemination of bacteria into the circulation, The Lack of bacteremia in C10-treated mice appeared to be related, in part, to in vitro evidence that C10 significantly enhanced the bacterial phagocytic activity of peritoneal macrophages. In addition, in vivo evidence suggested that C10 therapy significantly reduced the amount of material that leaked from the damaged gut. Taken together, the results of this study demonstrate that the C10 chemokine rapidly promotes disease resolution in the CLP model through its direct effects on the cellular events critically involved in host defense during septic peritonitis.

    DOI: 10.1128/IAI.68.11.6108-6114.2000

    Web of Science

    researchmap

  • Acute effects of smoke exposure on the cellular and cytokine profile in isolated perfused lungs Reviewed

    M Kyi, Y Miyazaki, T Inoue, S Miyake, A Matsukawa, Y Yoshizawa

    RESPIRATION PHYSIOLOGY   123 ( 1-2 )   143 - 151   2000.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    The aim of this study was to assess the acute effects of cigarette smoke exposure on cellular and cytokine profile in BAL fluids in an isolated perfused rabbit assay. The experimental animals were categorized into four groups: (1) unexposed controls and (2) cigarette smoke-exposed animals perfused with autologous whole blood; (3) unexposed controls and cigarette smoke-exposed; (4) cigarette smoke-exposed animals perfused with Krebs' Ringer solution containing 5% bovine serum albumin and glucose. Cigarette smoke induced an increase in total cell numbers (mainly alveolar macrophages in BAL fluids) and an increase in the permeability index of BAL. Levels of interleukin 8 were also significantly decreased in BAL fluids due to acute effects of cigarette smoke exposure. The most likely explanation for cigarette smoke-induced increase of inflammatory cells in BAL in lungs is because of the release of pre-existing cells from reservoirs within the lungs. The acute effects of cigarette smoke-induced increase of pulmonary epithelial permeability may also play an important role in the cellular recruitment into airspaces from the lung reservoirs. (C) 2000 Elsevier Science B.V. All rights reserved.

    DOI: 10.1016/S0034-5687(00)00147-X

    Web of Science

    researchmap

  • Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response Reviewed

    A Matsukawa, CM Hogaboam, NW Lukacs, PM Lincoln, HL Evanoff, SL Kunkel

    JOURNAL OF IMMUNOLOGY   164 ( 10 )   5362 - 5368   2000.5

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ASSOC IMMUNOLOGISTS  

    Macrophage-derived chemokine (MDC), a recently identified CC chemokine, has been regarded to be involved in chronic inflammation and dendritic cell and lymphocyte homing, In this study, we demonstrate a pivotal role for MDC during experimental sepsis induced by cecal ligation and puncture (CLP), Intraperitoneal administration of MDC (1 mu g/mouse) protected mice from CLP-induced lethality. The survival was accompanied by increased number of peritoneal macrophages and decreased recovery of viable bacteria from the peritoneum and peripheral blood. In addition, mice treated with an i.p. injection of MDC cleared bacteria more effectively than those in the control when 3 x 10(8) CFU live Escherichia coli was i.p. inoculated. Endogenous MDC was detected in the peritoneum after CLP, and neutralization of the MDC with anti-MDC Abs decreased CLP-induced recruitment of peritoneal macrophages and increased the recovery of viable bacteria from the peritoneum and peripheral blood. MDC blockade was deleterious in the survival of mice after CLP. In vitro, MDC enhanced the phagocytic and killing activities of peritoneal macrophages to E, coli and induced both a respiratory burst and the release of lysozomal enzyme from macrophages, Furthermore, MDC dramatically ameliorated CLP-induced systemic tissue inflammation as well as tissue dysfunction, which were associated in part with decreased levels of TNF-alpha, macrophage inflammatory proteins-1 alpha and -2, and KC in specific tissues. Collectively, these results indicate novel regulatory activities of MDC in innate immunity during sepsis and suggest that MDC may aid in an adjunct therapy in sepsis.

    Web of Science

    researchmap

  • Therapeutic use of chemokines Reviewed

    CM Hogaboam, C Bone-Larson, A Matsukawa, ML Steinhauser, K Blease, NW Lukacs, SL Kunkel

    CURRENT PHARMACEUTICAL DESIGN   6 ( 6 )   651 - 663   2000.4

     More details

    Language:English   Publisher:BENTHAM SCIENCE PUBL BV  

    Chemokines are involved in a number of pathological processes, and therefore represent important targets. However, it has also become apparent that chemokines have exciting therapeutic applications in inflammatory, infectious and cancer-related diseases. The following review will highlight the application of novel therapies including viral-encoded, recombinant, and genetically engineered chemokines to a number of diseases or disorders. Advances in the application of novel chemokine delivery procedures both at the research bench and the clinical bedside will also be discussed. Overall, the utilization of chemokines to prevent and treat disease has tremendous potential.

    Web of Science

    researchmap

  • Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2 Reviewed

    CM Hogaboam, CL Bone-Larson, ML Steinhauser, A Matsukawa, J Gosling, L Boring, IF Charo, KJ Simpson, NW Lukacs, SL Kunkel

    AMERICAN JOURNAL OF PATHOLOGY   156 ( 4 )   1245 - 1252   2000.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC INVESTIGATIVE PATHOLOGY, INC  

    Monocyte chemoattractant protein-1 is one of the major C-C chemokines that has been implicated in liver injury. The C-C chemokine receptor, CCR2, has been identified as the primary receptor that mediates monocyte chemoattractant protein-1 (MCP-1) responses in the mouse. Accordingly, the present study addressed the role of CCR2 in mice acutely challenged with acetaminophen (APAP). Mice genetically deficient in CCR2 (CCR2(-/-)) and their wild-type counterparts (CCR2(+/+)) were fasted for 10 hours before receiving an intraperitoneal injection of APAP (300 mg/kg), Liver and serum samples were removed from both groups of mice before and at 24 and 48 hours post APAP, Significantly elevated levels of MCP-1 were detected in liver samples from CCR2(+/+) and CCR2(-/-) mice at 24 hours post-APAP. Although CCR2(+/+) mice exhibited no liver injury at any time after receiving APAP, CCR2(-/-) mice exhibited marked evidence of necrotic and TUNEL-positive cells in the liver, particularly at 24 hours post-APAP, Enzyme-linked immunosorbent assay analysis of liver homogenates from both groups of mice at the 24 hours time point revealed that liver tissue from CCR2(-/-) mice contained significantly greater amounts of immunoreactive IFN-gamma and TNF-alpha. The in vivo immunoneutralization of IFN-gamma or TNF-alpha significantly attenuated APAP-induced liver injury in CCR2(-/-) mice and increased hepatic IL-13 levels. Taken together, these findings demonstrate that CCR2 expression in the liver provides a hepatoprotective effect through its regulation of cytokine generation during APAP challenge.

    Web of Science

    researchmap

  • Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis Reviewed

    A Matsukawa, CM Hogaboam, NW Lukacs, PM Lincoln, RM Strieter, SL Kunkel

    EXPERIMENTAL AND MOLECULAR PATHOLOGY   68 ( 2 )   77 - 84   2000.4

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC  

    Sepsis and septic syndrome represent an intense systemic response with multiple physiologic and immunologic abnormalities, leading to multiple organ failure. Recent investigations suggest that the critical conditions are balanced by endogenous cytokines. In the present study, we examined the involvement of endogenous monocyte chemoattractant protein (MCP)-1 in the regulation of cytokine production in tissue/organs in a murine model of acute septic peritonitis induced by cecal ligation and puncture (CLP). Initial studies showed that CLP induced elevated levels of MCP-1 in tissues, such as liver, lung, and kidney. To neutralize endogenous MCP-1, either anti-MCP-1 antibodies or control antibodies were intraperitoneally administered 2 h prior to CLP. Administration of anti-MCP-1 antibodies resulted in a decrease in the level of interleukin (IL)-13 in tissues, while increasing the level of tumor necrosis factor-alpha, compared to control. In addition, anti-MCP-1 treatment decreased the level of IL-12 and, in contrast, increased the level of IL-10 in specific tissues. These findings suggest that endogenous MCP-1 influences the cytokine balance in tissues in favor of antiinflammatory and immune-enhancing cytokines, probably protecting the host from tissue/organ damage during sepsis. (C) 2000 Academic Press.

    DOI: 10.1006/exmp.1999.2296

    Web of Science

    researchmap

  • Lazaroid reduces production of IL-8 and IL-1 receptor antagonist in ischemic spinal cord injury Reviewed

    T Kunihara, S Sasaki, N Shiiya, H Ishikura, Y Kawarada, A Matsukawa, K Yasuda

    ANNALS OF THORACIC SURGERY   69 ( 3 )   792 - 798   2000.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE INC  

    Background. 21-aminosteroids (lazaroids) have demonstrated the protective effect against cerebral ischemic injury through the inhibition of lipid peroxidation. We examined whether lazaroids affected the production of proinflammatory and antiinflammatory cytokines in ischemic spinal cord injury model.
    Materials. Anesthetized New Zealand white rabbits underwent a 20-minute infrarenal aortic cross-clamping (AXC) with pretreatment of either an intravenous 3 mg/kg lazaroid U74389G (group L; n = 10) or the same volume saline (group P; n = 10), Sham operation group (group S; n = 6) underwent only exposure of the aorta. Plasma concentrations of interleukin (IL)-8, -1 beta, -1 receptor antagonist (IL-1ra) and tumor necrosis factor (TNF)-alpha were measured at four time points. Functional assessment with Tarlov score at 24 and 48 hours after pretreatment, pathologic assessment of the spinal cord, and measurements of cytokine levels in the spinal cord were performed.
    Results, The maximum elevation of plasma IL-8 and -1ra levels occurred at 1 hour after declamping in four measurement points, Plasma IL-8 and -1ra levels in group L were significantly lower than those in group P (*p &lt; 0.05), Plasma TNF alpha peaked at 5 minutes after declamping, but decreased afterwards. Plasma TNF alpha levels were not different among three groups, Spinal IL-8 levels in group L (0.98 +/- 0.34 ng/g tissue) were lower than those in group P (7.26 +/- 2.26 ng/g tissue) (*p &lt; 0.05), Spinal IL-1ra and TNF alpha were not significantly different Tarlov scare and pathologic assessment were better in group L,
    Conclusions. Lazaroid U-74389G reduced the production of systemic IL-8 and -1ra and spinal IL-8 when AXC. caused spinal cord injury. These results indicate that lazaroids may attenuate ischemic endothelial cell injury or activation of leukocytes,
    (C) 2000 by The Society of Thoracic Surgeons.

    DOI: 10.1016/S0003-4975(99)01413-7

    Web of Science

    researchmap

  • Expression and contribution of endogenous IL-13 in an experimental model of sepsis Reviewed

    A Matsukawa, CM Hogaboam, NW Lukacs, PM Lincoln, HL Evanoff, RM Strieter, SL Kunkel

    JOURNAL OF IMMUNOLOGY   164 ( 5 )   2738 - 2744   2000.3

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ASSOC IMMUNOLOGISTS  

    IL-13 has been shown to exert potent anti-inflammatory properties. In this study, we elucidated the functional role of endogenous IL-13 in a murine model of septic peritonitis induced by cecal ligation and puncture (CLP). Initial studies demonstrated that the level of IL-13 increased in tissues including liver, lung, and kidney, whereas no considerable increase was found int either peritoneal fluid or serum after CLP, Immunohistochemically, IL-13-positive cells were Kupffer cells in liver, alveolar macrophages in lung, and epithelial cells of urinary tubules in kidney. IL-13 blockade with anti-IL-13 Abs significantly decreased the survival rate of mice after CLP from 53% to 14% on day 7 compared with control, To determine the potential mechanisms whereby IL-13 exerted a protective role in this model, the effects of anti-IL-13 Abs on both local and systemic inflammation were investigated, Administration of anti-IL-13 Abs did not alter the leukocyte infiltration and bacterial load in the peritoneum after CLP hut dramatically increased the neutrophil influx in tissues after CLP, an effect that was accompanied by significant increases in the serum levels of aspartate transaminase, alanine transaminase, blood urea nitrogen, and creatinine, Tissue injury caused by IL-13 blockade was associated with increases in mRNA and the protein levels of CXC chemokines macrophage inflammatory protein-2 and KC as web as the CC chemokine macrophage inflammatory protein-1 alpha and the proinflammatory cytokine TNF-alpha. Collectively, these results suggest that endogenous IL-13 protected mice from CLP-induced lethality by modulating inflammatory responses via suppression of overzealous production of inflammatory cytokines/chemokines in tissues.

    Web of Science

    researchmap

  • CXC chemokine GRO is essential for neutrophil infiltration in LPS-induced uveitis in rabbits Reviewed

    JS Mo, A Matsukawa, S Ohkawara, M Yoshinaga

    EXPERIMENTAL EYE RESEARCH   70 ( 2 )   221 - 226   2000.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS LTD  

    The purpose of this study was to investigate the role and regulation of the CXC chemokine GRO and the interaction between GRO and IL-8 in LPS-induced uveitis in rabbits. Uveitis was induced by intravitreal injection of 100 ng of LPS in rabbits. After the LPS injection, GRO was produced in aqueous humor and peaked at 24 hr. Immunohistochemistry showed that ciliary epithelial cells were responsible for production of GRO. Blocking the activity of GRO by anti-GRO serum reduced LPS-induced aqueous neutrophil counts by 80%, but did not reduce the mononuclear cell counts or protein levels or IL-8 levels. Regulation of GRO production by TNF alpha, IL-1 and IL-8 was studied. Anti-TNF alpha mAb alone did not inhibit the 24 hr LPS induced GRO levels, whereas rrIL-1Ra inhibited the GRO production by 58%. The combination of anti-TNF alpha mAb and rrIL-1Ra inhibited 93 % of GRO production. Although treatment with anti-IL-8 IgG inhibited the neutrophil infiltration by 66%, treatment with this antibody did not inhibit GRO production.
    Taken together, our results suggest that GRO is an essential mediator for neutrophil infiltration in LPS-induced uveitis in rabbits. Most of GRO production is mediated by TNF alpha and IL-1. GRO and IL-8 act in concert to mediate neutrophil infiltration. (C) 2000 Academic Press.

    DOI: 10.1006/exer.1999.0778

    Web of Science

    researchmap

  • Adenoviral-mediated overexpression of monocyte chemoattractant protein-1 differentially alters the development of Th1 and Th2 type responses in vivo Reviewed

    A Matsukawa, NW Lukacs, TJ Standiford, SW Chensue, SL Kunkel

    JOURNAL OF IMMUNOLOGY   164 ( 4 )   1699 - 1704   2000.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ASSOC IMMUNOLOGISTS  

    The expression of chemokines during an immune response may participate in determining the intensity and type of the developing immune response. In the present study, we have examined the effect of overexpressing monocyte chemoattractant protein (MCP)-1 at the site of immunization during different stages of Th1- and Th2-type granulomatous responses. The overexpression of MCP-1 by MCP-1 adenovirus during the sensitization phase of the purified protein derivative Th1-type model significantly reduced the elicitation of the granulomatous response. In contrast, the overexpression of MCP-1 during the sensitization phase of the schistosome egg Ag Th2 response led to an enhanced granulomatous reaction. When cytokines were examined upon restimulation of splenocytes ex vivo, an altered cytokine profile was observed, as compared with control mice. IFN-gamma and IL-12 were significantly reduced in the purified protein derivative Th1-type response, whereas IL-10 and IL-13 were up-regulated in the schistosome egg Ag Th2-type response. The regulation of the immune response was further examined by using the MCP-1 adenovirus at later time points during the elicitation phase. When MCP-1 was overexpressed during the elicitation phase of the responses, neither the Th1-type nor the Th2-type granuloma was altered. Likewise, the cytokine profiles after restimulation of splenocytes ex vivo were unchanged, Thus, the function of MCP-1 may depend on the stage and type of immune response.

    Web of Science

    researchmap

  • Chemokines and innate immunity Invited Reviewed

    Matsukawa A, Hogaboam CM, Lukacs NW, Kunkel SL

    Rev. Immunogenetics   2: 339-358   2000

     More details

    Authorship:Lead author  

    researchmap

  • 緑膿菌誘発家兎慢性細気管支炎モデルにおけるエリスロマイシンの効果-アポトーシスに対する作用

    高橋利弘, 菅守隆, 佐藤圭創, 岡本龍哉, 一安秀範, 松川昭博, 大河原進, 吉永秀, 安藤正幸

    Jpn. J. Antibiot   2000

     More details

  • 若年性多発性硝子化線維腫症の1症例

    本田由美, 大河原 進, 猪山賢一, 松川昭博, 吉永 秀

    診断病理   17 ( 2 )   190 - 192   2000

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    10歳女児.2歳時より繰り返し腫瘤切除を受けていた若年性多発性硝子化線維腫症(Juvenile hyaline fibromatosis)例で,本疾患は臨床像や病理組織像が極めて特徴的であるが,本邦での現在迄の報告は自験例を含めて13例と極めて稀である

    researchmap

  • 大腿骨後顆に高度なosteolysisをきたしたTKAの1例

    桑原 公倫, 白石 稔, 水田 博志, 中村 英一, 高木 克公, 吉田 正一, 松川 昭博

    整形外科と災害外科   48 ( 2 )   383 - 390   1999.3

     More details

    Language:Japanese   Publisher:西日本整形・災害外科学会  

    66歳女,変形性膝関節症にてMg-II,セメントレス人工膝関節置換術を施行し,4年後より膝関節腫脹と疼痛を来し,X線像で大腿骨後顆にosteolysisを認めた.再置換術を施行した際,大腿骨内側顆後方と外側顆後方に各30×20×15mm,15×15×10mm大の骨欠損と,滑膜増生,metallosis,膝蓋骨面のHDP及びtibia surfaceの磨耗を認めた

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=1999&ichushi_jid=J00766&link_issn=&doc_id=19990330030010&doc_link_id=%2Fdl8ortra%2F1999%2F004802%2F010%2F0383-0390%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fdl8ortra%2F1999%2F004802%2F010%2F0383-0390%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation. Reviewed International journal

    Tomohiro Arikawa, Naoki Saita, Souichi Oomizu, Masaki Ueno, Akihiro Matsukawa, Shigeki Katoh, Keisuke Kojima, Keiko Nagahara, Minoru Miyake, Akira Yamauchi, Hirotsugu Kohrogi, Mitsuomi Hirashima

    European journal of immunology   40 ( 2 )   548 - 558   1999

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Galectin-9 (Gal-9) plays pivotal roles in the modulation of innate and adaptive immunity to suppress T-cell-mediated autoimmune models. However, it remains unclear if Gal-9 plays a suppressive role for T-cell function in non-autoimmune disease models. We assessed the effects of Gal-9 on experimental hypersensitivity pneumonitis induced by Trichosporon asahii. When Gal-9 was given subcutaneously to C57BL/6 mice at the time of challenge with T. asahii, it significantly suppressed T. asahii-induced lung inflammation, as the levels of IL-1, IL-6, IFN-gamma, and IL-17 were significantly reduced in the BALF of Gal-9-treated mice. Moreover, co-culture of anti-CD3-stimulated CD4 T cells with BALF cells harvested from Gal-9-treated mice on day 1 resulted in diminished CD4 T-cell proliferation and decreased levels of IFN-gamma and IL-17. CD11b(+)Ly-6C(high)F4/80(+) BALF Mphi expanded by Gal-9 were responsible for the suppression. We further found in vitro that Gal-9, only in the presence of T. asahii, expands CD11b(+)Ly-6C(high)F4/80(+) cells from BM cells, and the cells suppress T-cell proliferation and IFN-gamma and IL-17 production. The present results indicate that Gal-9 expands immunosuppressive CD11b(+)Ly-6C(high) Mphi to ameliorate Th1/Th17 cell-mediated hypersensitivity pneumonitis.

    DOI: 10.1002/eji.200939886

    PubMed

    researchmap

  • Functional roles of MCP-1 in Propionibacterium acnes-induced, T cell-mediated pulmonary granulomatosis in rabbits Reviewed

    ICHIYASU H

    J Leukoc Biol   65 ( 4 )   482 - 91   1999

  • Crucial role of group IIA phospholipase A2 in oleic acid-induced acute lung injury in rabbits. Reviewed

    Furue S, Kuwabara K, Mikawa K, Nishina K, Shiga M, Maekawa N, Ueno M, Chikazawa Y, Ono T, Hori Y, Matsukawa A, Yoshinaga M, Obara H

    Am. J. Respir. Crit. Care Med   160   1292 - 1302   1999

  • Role and regulation of IL-8 and MCP-1 in LPS-induced uveitis in rabbits. Reviewed

    Mo JS, Matsukawa A, Ohkawara S, Yoshinaga M

    Exp. Eye Res.   68   333 - 340   1999

     More details

  • Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. Reviewed

    Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM, Kunkel SL

    J. Immunol.   163   6148 - 6154   1999

     More details

    Authorship:Lead author  

    CiNii Article

    researchmap

  • Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental shigellosis Reviewed

    Arondel J, Singer M, Matsukawa A, Zychlinsky A, Sansonetti PJ

    Infect. Immun.   67   6056 - 6066   1999

     More details

  • Involvement of growth-related protein in lipopolysaccharide-induced rabbit arthritis: cooperation between growth-related protein and IL-8, and interrelated regulation among TNFa, IL-1, IL-1 receptor antagonist, IL-8, and growth-related protein. Reviewed

    Matsukawa A, Yoshimura T, Fujiwara K, Maeda T, Ohkawara S, Yoshinaga M

    Lab. Invest.   79   591 - 600   1999

     More details

    Authorship:Lead author  

    researchmap

  • 緑膿菌誘発家兎び漫性汎細気管支炎におけるエリスロマイシンの効果 -MCP-1産生増加による肉芽腫様病変の改善-

    高橋 利弘, 菅 守隆, 岡本 竜哉, 松川 昭博, 大河原 進 [他]

    長崎大学熱帯医学研究所共同研究報告集   11   64 - 65   1999

     More details

    Language:Japanese   Publisher:長崎大学  

    CiNii Article

    CiNii Books

    researchmap

  • Interleukin-8 as an essential factor in the human chorionic gonadotropin-induced rabbit ovulatory process: interleukin-8 induces neutrophil accumulation and activation in ovulation. Reviewed

    Ujioka T, Matsukawa A, Tanaka N, Matsuura K, Yoshinaga M, Okamura H

    Biol. Reprod   58   526 - 530   1998

     More details

  • Analysis of the cytokine network among tumor necrosis factor a, interleukin-1b, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis. Reviewed

    Matsukawa A, Yoshimura T, Maeda T, Takahashi T, Ohkawara S, Yoshinaga M

    Lab. Invest.   78   559 - 569   1998

     More details

    Authorship:Lead author  

    researchmap

  • Analysis of the cytokine interaction among interleukin-1b, interleukin-8, and interleukin-1 receptor antagonist in the rabbit ovulatory process. Reviewed

    Ujioka T, Matsukawa A, Tanaka N, Matsuura K, Yoshinaga M, Okamura H

    Fertil. Steril   70   759 - 765   1998

     More details

  • Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide- or monosodium urate crystal-induced arthritis in rabbits: roles of tumor necrosis factor a, interleukin-1, and interleukin-8. Reviewed

    Matsukawa A, Miyazaki S, Maeda T, Tanase S, Feng L, Ohkawara S, Yoshinaga M, Yoshimura T

    Lab. Invest.   78   973 - 985   1998

     More details

    Authorship:Lead author  

    researchmap

  • Involvement of TNFa, IL-1b and IL-1 receptor antagonist in LPS-induced rabbit uveitis. Reviewed

    Mo JS, Matsukawa A, Ohkawara S, Yoshinaga M

    Exp. Eye Res   66   547 - 557   1998

     More details

  • IL-8 is an essential mediator of the increased delayed-phase vascular permeability in LPS-induced rabbit pleurisy. Reviewed

    Fukumoto T, Matsukawa A, Yoshimura T, Edamitsu S, Ohkawara S, Takagi K, Yoshinaga M

    J. Leukoc. Biol.   63   584 - 590   1998

     More details

  • Sequential generation of cytokines during the initiative phase of inflammation, with reference to neutrophils Invited Reviewed

    A. Matsukawa, M. Yoshinaga

    Inflammation Research   47 ( 3 )   S137 - S144   1998

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (international conference proceedings)   Publisher:Birkhauser Verlag Basel  

    Studies have suggested the role of cytokines in inflammation, as determined by results obtained in vitro, or with assessments of clinical samples. However, extrapolation of in vitro results to an in vivo situation must be made with caution, and findings obtained from clinical samples tend to lack a causal relation between cytokines and inflammatory responses. Animal models of inflammation can be useful in understanding roles of cytokines at sites of inflammation. We examined the production kinetics and cellular sources of tumor necrosis factor alpha (TNFα), interleukin (IL)-1β, IL-8, and IL-1 receptor antagonist (IL-1Ra), and obtained evidence for the involvement of these cytokines in a rabbit model of arthritis induced by lipopolysaccharide (LPS). We also attempted to analyze the inflammatory cytokine network among TNFα, IL-1β, IL-8, and IL-1Ra. Understanding the role of cytokines in animal models paves the way to a better understanding of disease in humans.

    DOI: 10.1007/s000110050304

    Scopus

    PubMed

    researchmap

  • Propionibacterium acnesによる実験的肺肉芽腫形成について

    一安 秀範, 菅 守隆, 溝部 孝則, 彌永 和宏, 山中 徹, 山本 太郎, 高橋 利弘, 松川 昭博, 吉永 秀, 安藤 正幸

    日本サルコイドーシス学会雑誌   16   21 - 22   1997.3

     More details

    Language:Japanese   Publisher:日本サルコイドーシス  

    DOI: 10.14830/jssog1987.16.21

    CiNii Article

    researchmap

  • Blocking of TNFa and IL-1 inhibits leukocyte infiltration at early, but not at late stage of S. aureus-induced arthritis and the concomitant cartilage destruction in rabbits. Reviewed

    Kimura M, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M

    Clin. Immunol. Immunopathol   82   18 - 25   1997

     More details

  • Detection and characterization of IL-1 receptor antagonist in tissues from healthy rabbits: IL-1 receptor antagonist is probably involved in health. Reviewed

    Matsukawa A, Fukumoto T, Maeda T, Ohkawara S, Yoshinaga M

    Cytokine   9   307 - 315   1997

     More details

    Authorship:Lead author  

    researchmap

  • IL-8 is involved in homologous TNFa-, but not in IL-1b-induced neutrophil infiltration in rabbits. Reviewed

    Miyamoto K, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M

    Inflamm. Res.   46   472 - 477   1997

     More details

  • Involvement of tumor necrosis factor-a, interleukin-1b, interleukin-8, and interleukin-1 receptor antagonist in acute lung injury caused by local shwartzman reaction. Reviewed

    Imamura S, Matsukawa A, Ohkawara S, Kagayama M, Yoshinaga M

    Pathol. Int.   47 ( 1 )   16 - 24   1997

  • Analysis of the inflammatory cytokine network among TNFa, IL-1b, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis. Reviewed

    Matsukawa A, Yoshimura T, Miyamoto K, Ohkawara S, Yoshinaga M

    Lab. Invest.   76   629 - 638   1997

     More details

    Authorship:Lead author  

    researchmap

  • 実験関節炎におけるIL-1raの動態と役割

    松川 昭博, 福本 巧, 吉永 秀

    日本整形外科学会雑誌   70 ( 11 )   751 - 758   1996.11

  • Interleukin-1 receptor antagonist: characterisation of its gene expression in rabbit tissues and large-scale expression in eucaryotic cells using a baculovirus expression system Reviewed

    Apostolopoulos J, Ross S, Davenport P, Matsukawa A, Yoshinaga M, Tipping PG

    J. Immunol. Methods   199   27 - 35   1996

     More details

  • Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits Reviewed

    Fukumoto T, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M

    Inflamm. Res   45   479 - 485   1996

     More details

  • Cytokine generation in rabbits during extracorporeal lung assist with a mini hollow fiber lung Reviewed

    Yanagi F, Terasaki H, Matsukawa A, Ohkawara S, Morioka T, Yoshinaga M

    Artif. Organs   20   209 - 217   1996

     More details

  • 19.胸部単純撮影で検出し得なかった肺高分化型腺癌の2例(第35回日本肺癌学会九州支部会)

    吉良 光子, 冨口 静二, 辻 明徳, 松川 哲也, 荒川 昭彦, 吉良 朋広, 中島 留美, 大山 洋一, 古嶋 昭博, 高橋 陸正

    肺癌   35 ( 6 )   818   1995.10

     More details

    Language:Japanese   Publisher:日本肺癌学会  

    CiNii Article

    CiNii Books

    researchmap

  • Suppressive effect of a neutrophil elastase inhibitor on the development of collagen-induced arthritis. Reviewed

    Kakimoto K, Matsukawa A, Yoshinaga M, and Nakamura H

    165   269 - 32   1995

     More details

  • Neutrophil accumulation and activation by homologous IL-8 in rabbits. IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo Reviewed

    Matsukawa A, Yoshimura T, Maeda T, Ohkawara S, Takagi K, Yoshinaga M

    J. Immunol   154   5418 - 5425   1995

     More details

  • Role of TNFa, IL-1, and IL-1ra in the mediation of leukocyte infiltration and increased vascular permeability in rabbits with LPS-induced pleurisy Reviewed

    Edamitsu S, Matsukawa A, Ohkawara S, Takagi K, Nariuchi H, Yoshinaga M

    Clin. Immunol. Immunopathol.   75   68 - 74   1995

     More details

  • 透水層埋設による海浜安定化効果の定量的評価

    塩見 雅樹, 戸引 勲, 松川 文彦, 津川 昭博, 長谷川 巌

    海岸工学論文集   42   721 - 725   1995

     More details

    Language:Japanese   Publisher:公益社団法人 土木学会  

    DOI: 10.2208/proce1989.42.721

    CiNii Article

    researchmap

  • Development of a neutralizing monoclonal antibody against rabbit IL-1 receptor antagonist and utilization for ELISA and measurement of masked IL-1 activity in biological materials. Reviewed

    Matsukawa A, Furukawa S, Ohkawara S, Takagi K, and Yoshinaga M

    23   129 - 142   1994

     More details

    Authorship:Lead author  

    researchmap

  • 2. IL-1 レセプター・アンタゴニスト (<シンポジウム>II 研究室から外来へ : サイトカイン研究の進歩とアレルギー臨床への応用)

    大河原 進, 松川 昭博

    アレルギー   42 ( 3 )   340 - 340   1993

     More details

    Language:Japanese   Publisher:一般社団法人 日本アレルギー学会  

    DOI: 10.15036/arerugi.42.340_2

    CiNii Article

    researchmap

  • Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits. Reviewed

    Matsukawa A, Ohkawara S, Maeda T, Takagi K, and Yoshinaga M

    Clin. Exp. Immunol.   93   206 - 211   1993

     More details

    Authorship:Lead author  

    researchmap

  • Lipoma arborescens with hemarthrosis of the knee. A case report Reviewed

    Edamitsu S, Mizuta H, Kubota K, Matsukawa A, and Takagi K

    Acta Orthop. Scand.   64   601 - 602   1993

     More details

  • A case of pancreatic pseudocyst being complicated with fistulization into the transverse colon and presenting repeated melena.

    HIZAWA Yuuki, SAITO Hiroshi, NAKAJIMA Hitoshi, KAWAGUCHI Hitoshi, MUNAKATA Akihiro, YOSHIDA Yutaka, SASAKI Mutsuo, MATSUKAWA Masakatsu, NAKAZAWA Hideo, KUDO Hajime

    Nippon Shokakibyo Gakkai Zasshi   90 ( 7 )   1611 - 1614   1993

     More details

    Language:Japanese   Publisher:The Japanese Society of Gastroenterology  

    DOI: 10.11405/nisshoshi1964.90.1611

    PubMed

    CiNii Article

    researchmap

  • Production, purification and characterization of a rabbit recombinant IL-1 receptor antagonist Reviewed

    Matsukawa A, Mori S, Ohkawara S, Maeda T, Tanase S, Edamitsu S, Yanagi F, and Yoshinaga M

    Biomed. Res. 13:269-277   13 ( 4 )   269 - 277   1992

     More details

    Authorship:Lead author   Language:English   Publisher:Biomedical Research Press  

    DOI: 10.2220/biomedres.13.269

    CiNii Article

    researchmap

  • インターロイキン-1レセプター

    松川昭博

    最新医学からのアプローチ5サイトカインレセプター   166 - 176   1992

     More details

    Publisher:メジカルビュー社  

    CiNii Article

    researchmap

  • A Randomized Controlled Study of 5-Fluorouracil/Doxorubicin/Mitomycin C/OK-432(FAM-OK) Therapy and 5-Fluorouracil/Epirubicin/Mitomycin C/OK-432(FEN-OK) Therapy for Advanced Gastrointestinal Cancer

    TSUSHIMA Kenichi, SAKATA Yuh, MUNAKATA Akihiro, SATO Toshinobu, CHIBA Yohichi, KIMURA Masahiro, FUKUSHI Gen, MATSUKAWA Masakatsu, HIGUCHI Kenshiro, WADA Kazuo

    The Hirosaki medical journal   43 ( 1 )   1 - 6   1991.3

     More details

    Language:Japanese   Publisher:Hirosaki University  

    CiNii Article

    CiNii Books

    researchmap

  • Follow-up Study of Double-stay Reconstruction Using Iliotibial Tract for ACL Injury.

    Mizuta Hiroshi, Kubota Kenji, Shiraishi Minoru, Kai Koichi, Matsukawa Akihiro, Nakamura Eiichi, Takagi Katsumasa

    Orthopedics & Traumatology   40 ( 1 )   16 - 19   1991

     More details

    Language:Japanese   Publisher:West-Japanese Society of Orthopedics & Traumatology  

    Sixty-seven patients had double-stay reconstruction using iliotibial tract for anterior cruciate ligament (ACL) injury. Thirty patients were evaluated at least 2 years postoperatively to assess the results and ability to return to sports.<br>Follow-up study consisted of an interview, clinical and radiological examinations. In 28 patients the complaint of giving way completely disappeared and in 2 patients they had experienced it several times during sports. N-test was negative in 26 patients and trace or apprehension in 4 patients.<br>To evaluate the instability in flexion, anterior drawer rate (ADR) was measured radiologically by a mid-point measurement method. The difference in ADR between the reconstructed and healthy knee was less than 5% in 20 patients. The range of motion was full or nearly full in all of patients.<br>Fifteen patients showed wasting of the thigh more than 1cm measured at 10cm above the proximal pole of the patella. Sports activity improved significantly and 90% of the patients returned to the sports. In conclusion, the results of double-stay reconstruction using iliotibial tract for ACL injury was satisfactory.

    DOI: 10.5035/nishiseisai.40.16

    CiNii Article

    researchmap

  • Two Rare Cases of a Stress Fracture.

    Nakamura Eiichi, Mizuta Hiroshi, Nagamoto Noriyoshi, Sakuma Katsuhiko, Matsukawa Akihiro, Yonemura Kensuke, Takagi Katsumasa

    Orthopedics & Traumatology   39 ( 4 )   1470 - 1472   1991

     More details

    Language:Japanese   Publisher:West-Japanese Society of Orthopedics & Traumatology  

    We recently had two rare cases of a stress fracture in the lower extremity. The first case was a 14-year-old sprinter who suffered a stress fracture of the medial malleolus. The second case was a 15-year-old baseball player who had an initial stress fracture in the femur and later stress fracture in the ipsilateral tibia. We shortly discussed about these cases.

    DOI: 10.5035/nishiseisai.39.1470

    CiNii Article

    researchmap

  • Cytokines as inflammatory mediators with special reference to IL-1.:with special reference to IL-1

    Goto Fumimasa, Goto Kumiko, Mori Shunsuke, Matsukawa Akihiro, Yoshinaga Masaru

    Ensho Saisei   10 ( 1 )   17 - 23   1990

     More details

    Language:Japanese   Publisher:The Japanese Society of Inflammation and Regeneration  

    DOI: 10.2492/jsir1981.10.17

    CiNii Article

    researchmap

  • A case of anomalous pancreatico-biliary ductal arrangement demonstrated with endoscopic ultrasonography(EUS).

    ENDOH Masaaki, NAKACHI Hiromichi, TAKAHASHI Kenichi, SASAKI Mutsuo, INOUE Shigeaki, RADA Ryukichi, SUZUKI Hidetoshi, SUGIYAMA Yuzuru, ONO Keiichi, MUNAKATA Akihiro, MATSUKAWA Masakatsu

    GASTROENTEROLOGICAL ENDOSCOPY   31 ( 4 )   961 - 965   1989

     More details

    Language:Japanese   Publisher:Japan Gastroenterological Endoscopy Society  

    A case of anomalous union of the pancreatico-biliary ductal system (AUPBDS) with a fusiform dilatation of the common bile duct, in which the arrangement of the two ductal systems was demonstrated with endoscopic ultrasonography (EUS), was reported. A 34-aged male was admitted for a surgical treatment with congenital dilatation of the bile duct. ERCP revealed AUPBDS of biliary joining type with a common channel of 13 mm in length. The constricted part of the common bile duct that seemed to join the main pancreatic duct within the pancreatic parenchyma was demonstarated by conventional ultrasonography. With EUS, the junction of the two ducts was much more clearly depicted and located in the pancreatic parenchyma. In conclusion, EUS seemed to be one of the most useful methods in imaging the extramural junction of pancreatic and biliary ducts in AUPBDS.

    DOI: 10.11280/gee1973b.31.961

    CiNii Article

    researchmap

  • Transoral extirpation of the foramen magnum tumor a case report.

    Sasaki Akira, Nakamura Takafumi, Maeda Yuichi, Hashimoto Noburo, Takagi Katsumasa, Matsukawa Akihiro

    Orthopedics & Traumatology   38 ( 2 )   737 - 739   1989

     More details

    Language:Japanese   Publisher:West-Japanese Society of Orthopedics & Traumatology  

    There are a few reports about surgery of foramen magnum tumors by the anterior approach. We report a case of foramen magnum meningioma who was treated by transoral extirpation and had a good result. A 77-year-old woman was admitted to the Kumamoto University Hospital on June 9th, 1988. 10 year prior to the admission she noticed the numbness in the hands and legs. In 1984 she suffered from pain and dysesthesia in the right chest. In May 1988 she could not walk at all. MRI disclosed an intradural and extramedullary tumor at the level of foramen magnum. The tumor was resected completely by transoral approach and a posterior occipito-C2 fusion by Luque rectangular rod was added. After the operation her pain in the right chest faded away and muscle strength improved gradually. Five months after the operation she is doing standing exercise.

    DOI: 10.5035/nishiseisai.38.737

    CiNii Article

    researchmap

  • Arthroscopical study of chondral lesions associated with anterior cruciate ligament injury.

    Mizuta Hiroshi, Kubota Kenji, Kai Kouichi, Sakata Hiroaki, Matsukawa Akihiro, Sakamoto Kenshi, Otawa Satoshi, Kitagawa Toshio

    Orthopedics & Traumatology   37 ( 1 )   100 - 105   1988

     More details

    Language:Japanese   Publisher:West-Japanese Society of Orthopedics & Traumatology  

    We studied arthroscopically chondral lesions of 56 knees in 55 patients under 40 years of age with anterior cruciate ligament injuries. Chondral lesions were found in 23 knees. With the passage of time after injury, the frequency of chondral lesions increased and extent and grade of chondral lesions developed. In a group examined more than 3 months after injury, chondral lesions were not present in 4 knees with intact menisci. A presence of chondral lesions in femoral coridyle correlated with a presence of meniscal tear or meniscectomy on the same side. The higher activity after injury or reinjury made frequency with chondral lesions higher.

    DOI: 10.5035/nishiseisai.37.100

    CiNii Article

    researchmap

▼display all

Books

  • 明解病理学 第4版

    ( Role: Joint author)

    2021.11 

     More details

  • 明解病理学 第3版

    ( Role: Joint author)

    医歯薬出版  2017.10 

     More details

  • 「ルービン病理学」改訂版(翻訳分担)

    西村出版  2017 

     More details

  • 明解病理学 第2版

    ( Role: Joint author)

    2013.3 

     More details

  • 炎症

    医歯薬出版株式会社  2013 

     More details

  • 免疫学コア講義

    南山堂  2012 

     More details

  • 「自己評価型病理学ノート」骨・軟部組織

    2011 

     More details

  • ダイナミック病理学

    西村出版  2010 

     More details

  • 明解病理学

    医歯薬出版  2009 

     More details

  • 感染とサイトカイン・サイトカイン情報伝達

    医歯薬出版社  2009 

     More details

  • 炎症・再生医学事典

    朝倉出版  2009 

     More details

  • 図説分子病態学4版

    中外医学社  2008 

     More details

  • Master of Medicine:Systemic pathology

    2007 

     More details

  • 炎症とサイトカイン・シグナル伝達

    岡山医学会誌  2006 

     More details

  • 自然免疫/炎症とサイトカイン・シグナル伝達

    岡山医学会誌  2006 

     More details

  • 動物モデルにおける尿酸結晶誘発関節炎−サイトカイン・ケモカインの産生とそのネットワ−ク−

    メディカルレビュ-社  2003 

     More details

  • The biological response to planned and unplanned injuries: Cellular, molecular and genetic aspects

    Elsevier  2003 

     More details

  • Chemokines in the lung

    Marcel Dekker  2003 

     More details

  • 図説分子病態学

    中外医学社  2003 

     More details

  • Monthly Book Derma 75

    全日本病院出版会  2003 

     More details

  • Helicobacter meets inflammatory bowel disease

    Medical Tribune Inc  2002 

     More details

▼display all

MISC

  • SPRED2制御したexosomeは、がん細胞においてmacrophageの極性化を促進し、IL6-STAT3シグナルを活性化する(Exosome regulated by SPRED2, promotes macrophage polarization and activate IL6-STAT3 signaling)

    高 桐, テン・ミャオ, 藤澤 真義, 大原 利章, 王 天一, トウン・ニンテインダ, 李 春寧, 吉村 禎造, 松川 昭博

    日本病理学会会誌   113 ( 1 )   324 - 324   2024.2

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • AIを用いた組織切片厚の推定法の開発

    藤澤 真義, 大原 利章, 樋口 拓浩, 松川 昭博

    日本病理学会会誌   113 ( 1 )   314 - 314   2024.2

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 鉄キレート効果を持つHIF-PH阻害薬は抗腫瘍免疫応答を向上させる(Pseudo-hypoxia by iron chelator arguments the tumor immune response against MSS colorectal cancer)

    陳 悦華, 大原 利章, 王 宇沢, 浜田 祐輔, 藤澤 真義, 松川 昭博

    日本病理学会会誌   113 ( 1 )   311 - 311   2024.2

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • SPRED2の欠損はマウスの腫瘍においてオートファジーとマイトファジーを抑制する(SPRED2 deficiency downregulates autophagy and mitophagy in tumors in cancer-bearing mouse model)

    王 天一, 高 桐, 藤澤 真義, 大原 利章, 吉村 禎造, 松川 昭博

    日本病理学会会誌   113 ( 1 )   298 - 298   2024.2

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • AIを用いた組織切片厚の推定法の開発

    藤澤 真義, 大原 利章, 樋口 拓浩, 松川 昭博

    日本病理学会会誌   113 ( 1 )   314 - 314   2024.2

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 鉄キレート効果を持つHIF-PH阻害薬は抗腫瘍免疫応答を向上させる(Pseudo-hypoxia by iron chelator arguments the tumor immune response against MSS colorectal cancer)

    陳 悦華, 大原 利章, 王 宇沢, 浜田 祐輔, 藤澤 真義, 松川 昭博

    日本病理学会会誌   113 ( 1 )   311 - 311   2024.2

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • SPRED2の欠損はマウスの腫瘍においてオートファジーとマイトファジーを抑制する(SPRED2 deficiency downregulates autophagy and mitophagy in tumors in cancer-bearing mouse model)

    王 天一, 高 桐, 藤澤 真義, 大原 利章, 吉村 禎造, 松川 昭博

    日本病理学会会誌   113 ( 1 )   298 - 298   2024.2

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • 鉄キレート剤による抗腫瘍免疫応答の向上 マウス肺癌モデルを用いて(Iron chelator enhances the tumor immune response in lung cancer in mice)

    浜田 祐輔, 大原 利章, 王 宇沢, 陳 悦華, 藤澤 真義, 松川 昭博

    日本病理学会会誌   113 ( 1 )   370 - 370   2024.2

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • ホストのSpred2欠損は、マウスの乳がんモデルにおけるがんの進行を抑制します(Spred2 deficiency in T cells suppresses the progression of cancer in mouse breast cancer models)

    Tian Miao, 吉村 禎造, 李 春寧, 大原 利章, 藤澤 真義, 松川 昭博

    日本病理学会会誌   113 ( 1 )   335 - 335   2024.2

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • SPRED2制御したexosomeは、がん細胞においてmacrophageの極性化を促進し、IL6-STAT3シグナルを活性化する(Exosome regulated by SPRED2, promotes macrophage polarization and activate IL6-STAT3 signaling)

    高 桐, テン・ミャオ, 藤澤 真義, 大原 利章, 王 天一, トウン・ニンテインダ, 李 春寧, 吉村 禎造, 松川 昭博

    日本病理学会会誌   113 ( 1 )   324 - 324   2024.2

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • ホストのSpred2欠損は、マウスの乳がんモデルにおけるがんの進行を抑制します(Spred2 deficiency in T cells suppresses the progression of cancer in mouse breast cancer models)

    Tian Miao, 吉村 禎造, 李 春寧, 大原 利章, 藤澤 真義, 松川 昭博

    日本病理学会会誌   113 ( 1 )   335 - 335   2024.2

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • 鉄キレート剤による抗腫瘍免疫応答の向上 マウス肺癌モデルを用いて(Iron chelator enhances the tumor immune response in lung cancer in mice)

    浜田 祐輔, 大原 利章, 王 宇沢, 陳 悦華, 藤澤 真義, 松川 昭博

    日本病理学会会誌   113 ( 1 )   370 - 370   2024.2

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • 鉄キレート効果を持つHIF-PH阻害薬は抗腫瘍免疫応答を向上させる(HIF-PH inhibitors with iron chelating ability enhance the tumor immune response)

    大原 利章, 陳 悦華, 王 宇沢, 濱田 祐輔, 菊地 覚次, 野間 和広, 田澤 大, 藤澤 真義, 藤原 俊義, 松川 昭博

    日本癌学会総会記事   82回   248 - 248   2023.9

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • 鉄キレート効果を持つHIF-PH阻害薬は抗腫瘍免疫応答を向上させる(HIF-PH inhibitors with iron chelating ability enhance the tumor immune response)

    大原 利章, 陳 悦華, 王 宇沢, 濱田 祐輔, 菊地 覚次, 野間 和広, 田澤 大, 藤澤 真義, 藤原 俊義, 松川 昭博

    日本癌学会総会記事   82回   248 - 248   2023.9

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • 腕頭動脈から分岐した左総頸動脈より気管孔へ出血した一例

    尾山 貴徳, 野田 卓男, 宮田 将徳, 渡邉 宏和, 鷲尾 洋介, 吉本 順子, 大原 利章, 松川 昭博

    日本小児外科学会雑誌   59 ( 3 )   723 - 723   2023.5

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 生検検体を用いた胆道癌におけるPD-L1発現の検討

    松本 和幸, 高木 章乃夫, 大原 利章, 藤澤 真義, 高原 政宏, 加藤 博也, 吉田 龍一, 楳田 祐三, 八木 孝仁, 松川 昭博

    日本消化器病学会雑誌   119 ( 臨増大会 )   A730 - A730   2022.10

     More details

    Language:Japanese   Publisher:(一財)日本消化器病学会  

    researchmap

  • 生検検体を用いた胆道癌におけるPD-L1発現の検討

    松本 和幸, 高木 章乃夫, 大原 利章, 藤澤 真義, 高原 政宏, 加藤 博也, 吉田 龍一, 楳田 祐三, 八木 孝仁, 松川 昭博

    日本消化器病学会雑誌   119 ( 臨増大会 )   A730 - A730   2022.10

     More details

    Language:Japanese   Publisher:(一財)日本消化器病学会  

    researchmap

  • コロナ禍における医学科1年次行動科学I〜社会におけるコミュニケーション〜の実施とアウトカム

    三好 智子, 小崎 吉訓, 越智 可奈子, 吉田 登志子, 山根 正修, 赤穂 宗一郎, 伊野 英男, 大塚 愛二, 松川 昭博

    医学教育   52 ( Suppl. )   122 - 122   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • コロナ禍における医学科1年次行動科学I〜社会におけるコミュニケーション〜の実施とアウトカム

    三好 智子, 小崎 吉訓, 越智 可奈子, 吉田 登志子, 山根 正修, 赤穂 宗一郎, 伊野 英男, 大塚 愛二, 松川 昭博

    医学教育   52 ( Suppl. )   122 - 122   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 医学科1年生における行動科学授業「コロナ禍での医学生生活を考える」 コロナ禍での入学の現状と課題

    越智 可奈子, 三好 智子, 小崎 吉訓, 赤穂 宗一郎, 吉田 登志子, 山根 正修, 伊野 英男, 大塚 愛二, 松川 昭博

    医学教育   52 ( Suppl. )   147 - 147   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 医学科1年生における行動科学授業「コロナ禍での医学生生活を考える」 コロナ禍での入学の現状と課題

    越智 可奈子, 三好 智子, 小崎 吉訓, 赤穂 宗一郎, 吉田 登志子, 山根 正修, 伊野 英男, 大塚 愛二, 松川 昭博

    医学教育   52 ( Suppl. )   147 - 147   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 肺腺癌におけるSpred2の発現と増殖、浸潤との関連の検討

    太田 陽子, 藤澤 真義, 吉村 禎造, スマルディカ・イワヤン, 枝園 和彦, 阪口 政清, 豊岡 伸一, 松川 昭博

    日本病理学会会誌   110 ( 1 )   291 - 291   2021.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 異なる亜集団の腫瘍細胞から放出されたエクソソームWnt7aによリ4T1細胞の転移は促進される(4T1 cells promote tumor metastasis by exosomal Wnt7a released from distinct subpopulations)

    李 春寧, 大原 利章, 藤澤 真義, 阪口 政清, 山本 健一, 田 ミャオ, 王 宇沢, 吉村 禎造, 松川 昭博

    日本病理学会会誌   110 ( 1 )   231 - 231   2021.3

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • アンメットニーズに応える粘膜下注入材の開発 : 低侵襲医療のさらなる安全化と医療費適正化

    松川 昭博

    医科学応用研究財団研究報告 / 鈴木謙三記念医科学応用研究財団 [編]   40   146 - 153   2021

     More details

    Language:Japanese   Publisher:鈴木謙三記念医科学応用研究財団  

    CiNii Books

    researchmap

  • ラット頭蓋骨欠損モデルに対する間葉系幹細胞と凍結乾燥リン酸化プルランの有用性

    村岡 聡介, 三澤 治夫, 瀧川 朋亨, 山根 健太郎, 池田 吉宏, 辻 寛謙, 高尾 真一郎, 松川 昭博, 尾崎 敏文

    日本整形外科学会雑誌   94 ( 8 )   S1711 - S1711   2020.9

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    J-GLOBAL

    researchmap

  • 岡山大学医療教育学生会の活動 学生の満足・不満調査の結果と合わせて

    荒木 さくら, 橋本 千名津, 高瀬 ミキ, 瀬尾 里奈, 久保 卓也, 片岡 仁美, 松川 昭博

    医学教育   51 ( Suppl. )   218 - 218   2020.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 医学科における国際バカロレア教育修了者の強み 医学科1年次の行動科学における評価より

    三好 智子, 山根 正修, 小崎 吉訓, 佐藤 明香, 万代 康弘, 吉田 登志子, Sabina Mahmood, 伊野 英男, 大塚 愛二, 松川 昭博

    医学教育   51 ( Suppl. )   114 - 114   2020.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 医学科における国際バカロレア教育修了者の強み 医学科1年次の行動科学における評価より

    三好 智子, 山根 正修, 小崎 吉訓, 佐藤 明香, 万代 康弘, 吉田 登志子, Sabina Mahmood, 伊野 英男, 大塚 愛二, 松川 昭博

    医学教育   51 ( Suppl. )   114 - 114   2020.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 膵癌におけるFNA検体と切除検体とのPD-L1発現の検討

    松本 和幸, 高木 章乃夫, 大原 利章, 藤澤 真義, 高原 政宏, 加藤 博也, 吉田 龍一, 楳田 祐三, 八木 孝仁, 松川 昭博, 岡田 裕之

    日本消化器病学会雑誌   116 ( 臨増大会 )   A826 - A826   2019.11

     More details

    Language:Japanese   Publisher:(一財)日本消化器病学会  

    researchmap

  • ラットにおけるチタン結合性BMPの骨形成促進効果についての検討

    内野 崇彦, 塩崎 泰之, 吉田 晶, 宇川 諒, 池田 吉宏, 村岡 聡介, 辻 寛謙, 伊藤 嘉浩, 松川 昭博, 尾崎 敏文

    日本整形外科学会雑誌   93 ( 8 )   S1941 - S1941   2019.9

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    J-GLOBAL

    researchmap

  • 行動科学におけるらせん型カリキュラムの必要性

    三好 智子, 山根 正修, 飯田 淳義, 万代 康弘, 吉田 登志子, 伊野 英男, 那須 保友, 松川 昭博

    医学教育   50 ( Suppl. )   229 - 229   2019.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 簡略化した外科指導者養成講習会の実施

    山根 正修, 松川 昭博

    医学教育   50 ( Suppl. )   194 - 194   2019.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 乳癌における静脈浸潤の新規検索法

    藤澤 真義, モウモウアウン・エイ, 柳井 広之, 大森 昌子, 松川 昭博

    日本病理学会会誌   108 ( 1 )   289 - 289   2019.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 高齢発症で再発を繰り返し、致死的な経過をたどった若年性顆粒膜細胞腫の一例(Juvenile granulosa cell tumor with unusual clinical course: a late-onset and late recurrent case)

    太田 陽子, タテ・サン, 伏見 聡一郎, 藤澤 真義, 柳井 広之, 戸田 博子, 大森 昌子, 國友 忠義, 松川 昭博

    日本病理学会会誌   108 ( 1 )   408 - 408   2019.4

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • ラットにおけるチタン結合性BMPの骨形成促進効果についての検討

    内野 崇彦, 塩崎 泰之, 吉田 晶, 宇川 諒, 池田 吉宏, 村岡 聡介, 辻 寛謙, 伊藤 嘉浩, 松川 昭博, 尾崎 敏文

    移植   53 ( 6 )   382 - 382   2019.3

     More details

    Language:Japanese   Publisher:(一社)日本移植学会  

    researchmap

  • 新規多糖誘導体リン酸化プルランフィルムとBMP-2の併用はラット脊椎固定モデルにおいて骨癒合を促進する

    宇川 諒, 塩崎 泰之, 村岡 聡介, 池田 吉宏, 辻 寛謙, 吉田 晶, 吉原 久美子, 瀧川 朋亨, 三澤 治夫, 尾崎 敏文, 松川 昭博

    Journal of Spine Research   10 ( 3 )   683 - 683   2019.3

     More details

    Language:Japanese   Publisher:(一社)日本脊椎脊髄病学会  

    J-GLOBAL

    researchmap

  • ヒト卵巣癌における線維芽細胞の由来

    藤澤 真義, 柳井 広之, 和仁 洋治, 伏見 聡一郎, 松川 昭博

    日本病理学会会誌   107 ( 1 )   389 - 389   2018.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 肺腺がんにおけるSpred2の役割の解明

    太田 陽子, 藤澤 真義, 吉村 禎造, スマルディカ・イワヤン, 枝園 和彦, 阪口 政清, 豊岡 伸一, 松川 昭博

    日本病理学会会誌   107 ( 1 )   414 - 414   2018.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • ラット脊椎固定モデルにおけるrhBMP2添加リン酸化プルランフィルムの有用性の検討

    宇川 諒, 塩崎 泰之, 村岡 聡介, 池田 吉弘, 内野 崇彦, 小田 孔明, 吉村 将秀, 吉田 晶, 瀧川 朋亨, 三澤 治夫, 尾崎 敏文, 松川 昭博

    移植   52 ( 6 )   582 - 582   2018.2

     More details

    Language:Japanese   Publisher:(一社)日本移植学会  

    researchmap

  • Spred-2 deficiency exacerbates lipopolysaccharide (LPS)/D-galactosamine (D-GalN) induced acute liver injury Reviewed

    Yang Xu, Teizo Yoshimura, Masayoshi Fujisawa, Toshiaki Ohara, Cuiming Sun, Akihiro Matsukawa

    CYTOKINE   100   137 - 137   2017.12

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    Web of Science

    researchmap

  • Spred-2 protects mice from ConA-induced liver injury

    Cuiming Sun, Teizo Yoshimura, Masatoshi Fujisawa, Toshiaki Ohara, Xu Yang, Akihiro Matsukawa

    CYTOKINE   100   120 - 120   2017.12

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    Web of Science

    researchmap

  • Spred-2欠損はGalN/LPS誘導性の急性肝障害を悪化させる(Spred-2 deficiency exacerbated GalN/LPS induced acute liver injury) Reviewed

    楊 旭, 吉村 禎造, 藤澤 真義, 大原 利章, 佐藤 美和, 美野 愛, 松川 昭博

    日本病理学会会誌   106 ( 1 )   446 - 446   2017.3

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • 除鉄はマウスiPS細胞の腫瘍化を未分化マーカーの発現制御を介して抑制する(Tumorigenesis of miPS cells is prevented from suppressing the stemness by iron depletion treatment) Reviewed

    大原 利章, Xing Boyi, 桂 佑貴, 松川 昭博

    日本病理学会会誌   106 ( 1 )   405 - 405   2017.3

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • 可視光硬化型ゼラチンとコラーゲン結合性肝細胞増殖因子を用いた脊髄損傷治療

    山根 健太郎, 吉田 晶, 松川 昭博, 伊藤 嘉浩, 尾崎 敏文

    移植   51 ( 6 )   517 - 517   2016.12

     More details

    Language:Japanese   Publisher:(一社)日本移植学会  

    researchmap

  • 医学部6年次生は二次救命処置のリーダーができるか

    飯田 淳義, 万代 康弘, 芝 直基, 塚原 紘平, 内藤 宏道, 寺戸 通久, 佐藤 圭路, 鵜川 豊世武, 中尾 篤典, 松川 昭博, 那須 保友

    日本救急医学会雑誌   27 ( 9 )   444 - 444   2016.9

     More details

    Language:Japanese   Publisher:(一社)日本救急医学会  

    researchmap

  • 多糖複合体を基材とした感染制御能と生体吸収性を有する抗菌薬含有骨セメントの開発

    渡邉典行, 香川洋平, 張偉, 吉村将秀, 吉田晶, 田中雅人, 吉田靖弘, 松川昭博, 尾崎敏文

    日本整形外科学会雑誌   90 ( 8 )   S1819 - S1819   2016.8

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 新規生体材料リン酸化プルランによるインプラントコーティング技術の開発

    香川 洋平, 渡邉 典行, 張 偉, 吉村 将秀, 吉田 晶, 吉田 靖弘, 尾崎 敏文, 松川 昭博

    日本整形外科学会雑誌   90 ( 8 )   S1813 - S1813   2016.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 5年次SDによるワクチン予防接種 臨床実習プログラムとしての評価

    大塚 勇輝, 山根 正修, 日高 啓介, 飯田 淳義, 万代 康弘, 三好 智子, 松川 昭博

    医学教育   47 ( Suppl. )   112 - 112   2016.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 医学部の前臨床2年次での英語PBLグループへの参加(Joining the English PBL group as a Pre-clinical Second Year Medical Student)

    佐武 秀紀, 佐々並 三紗, 松川 昭博, Mahmood Sabina

    医学教育   47 ( Suppl. )   281 - 281   2016.7

     More details

    Language:English   Publisher:(一社)日本医学教育学会  

    researchmap

  • 学生主体による医学英語学習グループがどのように医学英語教育に関わっているか(How a Medical English learning group managed by students can contribute to medical English education)

    池田 礼奈, Mahmood Sabina, 松川 昭博

    医学教育   47 ( Suppl. )   281 - 281   2016.7

     More details

    Language:English   Publisher:(一社)日本医学教育学会  

    researchmap

  • 臨床実習に臨み学生が修得すべき事 学生の考え、指導医の考え

    川野 香, 難波 満理奈, 山根 正修, 飯田 淳義, 万代 康弘, 三好 智子, 片岡 仁美, 松川 昭博

    医学教育   47 ( Suppl. )   276 - 276   2016.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 患者アンケートからみた臨床実習の評価

    難波 満里奈, 川野 香, 山根 正修, 飯田 淳義, 万代 康弘, 三好 智子, 片岡 仁美, 松川 昭博

    医学教育   47 ( Suppl. )   276 - 276   2016.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 全臨床系教室を対象とした個別の学内FDの取り組み

    山根 正修, 松川 昭博

    医学教育   47 ( Suppl. )   217 - 217   2016.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 医学生による予防接種実践コースのカリキュラム作成

    山根 正修, 松川 昭博, 万代 康弘, 飯田 淳義, 三好 智子

    医学教育   47 ( Suppl. )   216 - 216   2016.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 学生アンケートに基づく漢方教育への提言

    日高 啓介, 松川 昭博, 大塚 勇輝, 飯田 淳義, 万代 康弘, 三好 智子, 山根 正修

    医学教育   47 ( Suppl. )   136 - 136   2016.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 臨床実習前に行う医療シミュレーション教育コースの取り組み

    万代 康弘, 山根 正修, 飯田 淳義, 三好 智子, 松川 昭博, 谷本 光音

    医学教育   47 ( Suppl. )   119 - 119   2016.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • てんかんの原因となった、髄膜腫を併存した髄膜血管腫症の1例

    河原 明奈, 伏見 聡一郎, 板倉 淳哉, 小田 晋輔, 太田 陽子, 堀田 真智子, 藤澤 真義, 柳井 広之, 松川 昭博

    日本病理学会会誌   105 ( 1 )   562 - 562   2016.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 乳癌細胞によるGM-CSF産生を介したマクロファージにおけるMCP-1/CCL2の誘導(Induction of MCP-1/CCL2 in macrophages via GM-CSF production by breast cancer cells)

    吉村 禎造, Imamichi Tomozumi, Weiss Jonathan M., 佐藤 美和, Li Liangzhu, 松川 昭博, Wang Ji Ming

    日本病理学会会誌   105 ( 1 )   326 - 326   2016.4

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • 遺伝子組換えから病態へのアプローチ Spred-2による炎症の制御

    松川 昭博

    日本病理学会会誌   105 ( 1 )   265 - 265   2016.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Spred-2欠損によるシスプラチン腎障害増悪における好中球の関与

    藤井 裕生, 何 佳利, 吉村 禎造, 藤澤 真義, 佐藤 美和, 楊 旭, 松川 昭博

    日本病理学会会誌   105 ( 1 )   592 - 592   2016.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • ミャンマーの乳がんの組織学的側面(Histologic Profile of Breast Cancer in Myanmar) Reviewed

    サン・タ・テ, 藤澤 真義, 伏見 聡一郎, イー・ミント・ミント, Yang Xu, Aye Moh Moh Aung, 渡邉 治之, 荒嶋 康晴, 大原 利章, 松川 昭博

    日本病理学会会誌   105 ( 1 )   566 - 566   2016.4

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • 臨床病態に近い不均一性とがん幹細胞性を備えた新規腫瘍モデルの開発 Reviewed

    大原 利章, 友野 靖子, 吉村 禎造, 藤澤 真義, 松川 昭博

    日本病理学会会誌   105 ( 1 )   365 - 365   2016.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Spred-2欠損はGalN/LPS誘導性の急性腎障害を悪化させる(Spred-2 deficiency exacerbates D-Galactosamine/lipopolysaccharide -induced acute liver injury) Reviewed

    楊 旭, 吉村 禎造, 藤澤 真義, 大原 利章, 山口 隆廣, サン・タ・テ, 小田 晋輔, 佐藤 美和, 美野 愛, 松川 昭博

    日本病理学会会誌   105 ( 1 )   449 - 450   2016.4

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • 膀胱腫瘍におけるRas-Raf-ERK経路とその制御因子Spred-2の解析

    小田 晋輔, 藤澤 真義, 吉村 禎造, 大原 利章, 河原 明奈, 山口 隆廣, 太田 陽子, 松川 昭博

    日本病理学会会誌   105 ( 1 )   464 - 464   2016.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 可視光硬化型ゼラチンとコラーゲン結合性肝細胞増殖因子を用いた脊髄損傷治療

    山根健太郎, 吉田晶, 松川昭博, 伊藤嘉浩, 尾崎敏文

    移植   51 ( 6 )   517 - 517   2016

  • 新規生体吸収性骨セメントの細胞動態の検討

    ZHANG W, 吉田晶, 山根健太郎, 香川洋平, 篠原健介, 吉田靖弘, 松川昭博, 尾崎敏文

    日本整形外科学会雑誌   89 ( 8 )   S1575 - S1575   2015.9

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 新規生体材料によるインプラントコーティング

    香川 洋平, 山根 健太郎, 篠原 健介, 渡邉 典行, 張 偉, 吉田 晶, 吉田 靖弘, 尾崎 敏文, 松川 昭博

    日本整形外科学会雑誌   89 ( 8 )   S1576 - S1576   2015.9

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 脊髄損傷治療におけるコラーゲン結合性ドメイン連結肝細胞増殖因子の有用性

    山根 健太郎, 吉田 晶, 篠原 健介, 張 偉, 香川 洋平, 渡邉 典行, 伊藤 嘉浩, 田中 雅人, 松川 昭博, 尾崎 敏文

    日本整形外科学会雑誌   89 ( 8 )   S1622 - S1622   2015.9

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 多糖複合体リン酸化プルランを用いた抗菌薬含有骨セメントの開発

    渡邉 典行, 山根 健太郎, 香川 洋平, 篠原 健介, 張 偉, 吉田 晶, 松川 昭博, 吉田 靖弘, 田中 雅人, 尾崎 敏文

    日本整形外科学会雑誌   89 ( 8 )   S1577 - S1577   2015.9

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • シミュレーションセンター運用の現状と問題点 将来に向けて シミュレーションセンター運営におけるシミュレーションスペシャリストの重要性

    万代 康弘, 三好 智子, 香西 佳美, 伊野 英男, 片岡 仁美, 松川 昭博, 谷本 光音

    医学教育   46 ( Suppl. )   72 - 72   2015.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • SD(Student Doctor)による予防接種の導入

    原田 洸, 山根 正修, 三好 智子, 松川 昭博

    医学教育   46 ( Suppl. )   190 - 190   2015.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 診療参加型臨床実習における評価の改善

    山根 正修, 松川 昭博

    医学教育   46 ( Suppl. )   183 - 183   2015.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 外科系医師のための指導者養成講習会の開催

    山根 正修, 万代 康弘, 伊野 英男, 松川 昭博

    医学教育   46 ( Suppl. )   138 - 138   2015.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 臨床実習1年後のOSCE手術室清潔操作・患者安全シナリオの実践

    万代 康弘, 山根 正修, 松川 昭博, 芝 直基, 三好 智子, 谷本 光音

    医学教育   46 ( Suppl. )   125 - 125   2015.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 5年次OSCEの導入に当たり 医学部でのOSCEの位置づけ

    三好 智子, 山根 正修, 芝 直基, 万代 康弘, 松川 昭博, 谷本 光音

    医学教育   46 ( Suppl. )   125 - 125   2015.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 脊髄損傷急性期における肝細胞増殖因子の抗炎症効果について コラーゲン結合性改変HGFを用いた検討

    山根 健太郎, 篠原 健介, 伊藤 嘉浩, 杉本 佳久, 田中 雅人, 松川 昭博, 尾崎 敏文

    Journal of Spine Research   6 ( 3 )   585 - 585   2015.3

     More details

    Language:Japanese   Publisher:(一社)日本脊椎脊髄病学会  

    researchmap

  • ミャンマーの乳がんの症例におけるマウス乳腺腫瘍ウイルス(MMTV)のenv様配列の検出(Detection of Mouse Mammary Tumor Virus(MMTV) env-like sequence in breast cancer cases in Myanmar)

    サン・タテ, ミント・イーイー, ミント・アイアイ, モン・ミャット, イーミン・トミント, ソー・ラミン, 板倉 淳哉, 伏見 聡一郎, 伊藤 利洋, 松川 昭博

    日本病理学会会誌   104 ( 1 )   425 - 425   2015.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 創傷治癒はSpred-2欠損で短縮する

    河原 明奈, 板倉 淳哉, 小田 晋輔, 伏見 聡一郎, 伊藤 利博, 松川 昭博

    日本病理学会会誌   104 ( 1 )   392 - 392   2015.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 病理と基礎生命科学との接点(第12回) 免疫応答と疾患

    松川 昭博

    病理と臨床   33 ( 3 )   311 - 316   2015.3

     More details

    Language:Japanese   Publisher:(株)文光堂  

    researchmap

  • 仙骨部にPlemorphic hyalinaizing angiectatic tumor(PHAT)様の腫瘍を認めた一例

    山口 隆廣, 河原 明奈, 太田 陽子, 小田 晋輔, 板倉 淳哉, 伏見 聡一郎, サン・タテ, 松川 昭博, 豊田 博

    日本病理学会会誌   104 ( 1 )   364 - 364   2015.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 非典型的な組織像を示した膵solid-pseudopapillary neoplasm(SPN)の一例

    小田 晋輔, 河原 明奈, 伏見 聡一郎, 太田 陽子, 山口 隆廣, サン・タテ, 板倉 淳哉, 大原 俊章, 平 麻美, 松川 昭博

    日本病理学会会誌   104 ( 1 )   355 - 355   2015.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Spred-2の欠損はリポポリサッカライドに誘発される急性肺炎を増悪させる(Spred-2 Deficiency Exacerbates Lipopolysaccharide-induced Acute Lung Inflammation)

    楊 旭, 伊藤 利洋, 伏見 聡一郎, 高橋 索真, 板倉 淳哉, 佐藤 美和, 美野 愛, 松川 昭博

    日本病理学会会誌   104 ( 1 )   284 - 284   2015.3

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • IgG4関連疾患の診断病理 その進歩と問題点 1型自己免疫性膵炎の病理所見 CD163陽性マクロファージの意義

    内野 かおり, 能登原 憲司, 松川 昭博

    日本病理学会会誌   104 ( 1 )   191 - 191   2015.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 鉄コントロールを用いた新規がん幹細胞治療法の基礎的検討 Reviewed

    大原 利章, 伏見 総一郎, 松川 昭博

    日本病理学会会誌   104 ( 1 )   283 - 283   2015.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 限局性皮質異形成と皮質結節(結節性硬化症)との鑑別が問題になった一例

    太田陽子, 山口隆廣, 小田晋輔, 河原明奈, 板倉淳哉, 伏見聡一郎, 大原俊章, 平麻美, 宮田元, 松川昭博

    日本病理学会会誌   104 ( 1 )   2015

  • 膀胱粘膜下傍神経節腫の2例

    小田 晋輔, 伏見 聡一郎, 山口 隆廣, 伊藤 利洋, 大枝 忠史, 市川 孝治, 柳井 広之, 國友 忠義, 中本 周, 松川 昭博

    鳥取医学雑誌   42 ( 3-4 )   147 - 152   2014.12

     More details

    Language:Japanese   Publisher:(公社)鳥取県医師会  

    われわれは膀胱に発生した傍神経節腫の2例を経験した。症例1は90歳代女性。血尿の精査中、膀胱鏡で右壁に3cm大の粘膜下腫瘍が認められ、経尿道的膀胱腫瘍切除術(transurethral resection of bladder tumor:TURBT)を施行された。症例2は70歳代男性。胸部大動脈瘤術後の経過観察中に、Computed tomography(CT)検査にて膀胱腫瘍を指摘され、膀胱鏡を行ったところ新たに別の粘膜下腫瘍が認められTURBTを施行された。2例とも病理組織学的に傍神経節腫と診断された。膀胱に発生する傍神経節腫はまれであり、文献的考察を加えて報告する。(著者抄録)

    researchmap

  • 新しい可視光硬化ゼラチンを用いた家兎骨軟骨欠損モデルにおける組織修復効果

    馬崎哲朗, 山根健太郎, 吉田晶, 松川昭博, 中村真理子, 吉田靖弘, 北嶋隆, 伊藤嘉浩, 尾崎敏文

    日本整形外科学会雑誌   88 ( 8 )   S1587 - S1587   2014.8

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 新規生体材料によるインプラントコーティング技術

    香川 洋平, 馬崎 哲朗, 山根 健太郎, 篠原 健介, 吉田 晶, 松川 昭博, 中村 真理子, 吉田 靖弘, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文

    日本整形外科学会雑誌   88 ( 8 )   S1501 - S1501   2014.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • QCM-Dによる様々な細胞種の接着と伸展の観察

    竹下 裕治, 張本 乾一, 玉井 美保, 南 隆之, 荻 博次, 長岡 紀幸, 松川 昭博, 吉田 靖弘, 田川 陽一

    日本生物工学会大会講演要旨集   平成26年度   154 - 154   2014.8

     More details

    Language:Japanese   Publisher:(公社)日本生物工学会  

    researchmap

  • 脊髄損傷急性期における肝細胞増殖因子の抗炎症効果の検討

    山根 健太郎, 馬崎 哲朗, 吉田 晶, 香川 洋平, 篠原 健介, 北嶋 隆, 伊藤 嘉浩, 松川 昭博, 田中 雅人, 尾崎 敏文

    日本整形外科学会雑誌   88 ( 8 )   S1510 - S1510   2014.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 臨床実習前の医療教育シミュレーションコース

    山根 正修, 芝 直基, 三好 智子, 内海 方嗣, 万代 康弘, 松川 昭博, 岡山大学医学部医学科教務委員会

    医学教育   45 ( Suppl. )   136 - 136   2014.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • Ras-Raf-ERK経路からみたA型インフルエンザ(H1N1)感染

    松川 昭博, 伊藤 利洋

    NEUROINFECTION   19 ( 1 )   40 - 42   2014.7

     More details

    Language:Japanese   Publisher:日本神経感染症学会  

    researchmap

  • 家兎骨軟骨欠損モデルにおける可視光硬化ゼラチンおよび骨髄間質細胞の組織修復効果

    馬崎 哲朗, 塩崎 泰之, 山根 健太郎, 吉田 晶, 松川 昭博, 中村 真理子, 吉田 靖弘, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文

    移植   49 ( 1 )   178 - 178   2014.5

     More details

    Language:Japanese   Publisher:(一社)日本移植学会  

    researchmap

  • 可視光硬化型ゼラチンとコラーゲン結合性肝細胞増殖因子を用いた脊髄損傷治療

    山根健太郎, 馬崎哲朗, 篠原健介, 吉田晶, 松川昭博, 中村真理子, 吉田靖弘, 北嶋隆, 伊藤嘉浩, 田中雅人, 尾崎敏文

    J Spine Res   5 ( 3 )   473 - 473   2014.3

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 骨髄移植後の皮膚GVHDの経過中にVZV肝炎を発症した1例

    河原 明奈, 伊藤 利洋, 伏見 聡一郎, 板倉 淳哉, 小田 晋輔, 松川 昭博

    日本病理学会会誌   103 ( 1 )   303 - 303   2014.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Exophiala dermatitidis感染による肺出血および多発脳梗塞を認めた急性骨髄性白血病の一剖検例

    伏見 聡一郎, 伊藤 利洋, 片瀬 直樹, 玉村 亮, サン・タテ, 板倉 淳哉, 河原 明奈, 小田 晋輔, 松川 昭博

    日本病理学会会誌   103 ( 1 )   293 - 293   2014.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Spred2欠損マウスにおける敗血症抵抗性のメカニズム

    板倉 淳哉, 小田 晋輔, 河原 明奈, 佐藤 美和, 美野 愛, 伏見 聡一郎, 伊藤 利洋, 松川 昭博

    日本病理学会会誌   103 ( 1 )   248 - 248   2014.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • インフルエンザウィルス(H1N1)感染症ならびに二次性細菌性肺炎のエピジェネティクス解析

    伊藤 利洋, 板倉 淳哉, 河原 明奈, 小田 晋輔, 伏見 聡一郎, 松川 昭博

    日本病理学会会誌   103 ( 1 )   224 - 224   2014.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Ras/ERK系と大腸粘膜治癒 Ras/ERK系の阻害因子Spred-2の解析を通じて

    高橋 索真, 平岡 佐規子, 伏見 聡一郎, 伊藤 利洋, 板倉 淳哉, 木村 亮二朗, 楊 旭, 篠倉 美理, 中川 裕貴, 住居 優一, 竹井 大介, 井口 俊博, 半井 明日香, 森藤 由記, 秋田 光洋, 原田 馨太, 岡田 裕之, 松川 昭博, 山本 和秀

    消化器と免疫   ( 50 )   66 - 68   2014.3

     More details

    Language:Japanese   Publisher:日本消化器免疫学会  

    【目的】Ras/ERK系を抑制するSpred-2のIBDへの関与を検討する。【方法】Spred-2 KOマウスおよびWTマウスにDSS腸炎を誘導し、症状変化・組織像・大腸粘膜の細胞増殖を評価した。【結果】Spred-2 KOマウスではWTマウスより腸炎の症状が軽く、腸管上皮の再生が速やかであった。また、腸管上皮中のBrdU陽性細胞の比率が有意に高かった。【結論】Spred-2はIBDにおける粘膜治癒を抑制している可能性がある。(著者抄録)

    researchmap

  • 家兎骨軟骨欠損モデルにおける可視光硬化ゼラチンおよび結合性改変成長因子CBD-BMP4による組織修復効果

    馬崎 哲朗, 山根 健太郎, 吉田 晶, 松川 昭博, 伊藤 嘉浩, 尾崎 敏文

    中部日本整形外科災害外科学会雑誌   57 ( 春季学会 )   124 - 124   2014.3

     More details

    Language:Japanese   Publisher:(一社)中部日本整形外科災害外科学会  

    researchmap

  • 間質性肺炎モデルにおけるSpred-2の役割

    水田 亮, 伊藤 利洋, 板倉 淳哉, 伏見 聡一郎, 松川 昭博

    日本病理学会会誌   103 ( 1 )   392 - 392   2014.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • モノクロラミンによる酸化ストレスとK562細胞の分化誘導

    荻野 哲也, 松川 昭博

    日本病理学会会誌   103 ( 1 )   357 - 357   2014.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 帝王切開中に発見・切除された子宮perivascular epithelioid cell tumor(PEComa)の一例

    小田 晋輔, 内野 かおり, 和仁 洋治, 松川 昭博

    日本病理学会会誌   103 ( 1 )   342 - 342   2014.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 固形癌に対する除鉄誘導による血管新生阻害薬併用療法の確立

    大原利章, 木村文昭, 浦野真一, 二宮卓之, 勝部亮一, 野間和広, 友野靖子, 藤原俊義, 松川昭博

    日本鉄バイオサイエンス学会学術集会プログラム・抄録集   38th   2014

  • 家兎骨軟骨欠損モデルにおける可視光硬化ゼラチンおよび骨髄間質細胞の組織修復効果

    馬崎哲朗, 塩崎泰之, 山根健太郎, 吉田晶, 松川昭博, 中村真理子, 吉田靖弘, 北嶋隆, 伊藤嘉浩, 尾崎敏文

    移植(Web)   49 ( 1 )   178(J-STAGE)   2014

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 多糖誘導体リン酸化プルランをキーマテリアルとした多目的硬組織接着剤の開発

    吉田靖弘, 松川昭博, 高柴正悟, 沖原巧, 伊東孝

    医科学応用研究財団研究報告   31   23 - 27   2014

     More details

    Language:Japanese   Publisher:(公財)鈴木謙三記念医科学応用研究財団  

    researchmap

  • 多糖誘導体リン酸化プルランをキーマテリアルとした多目的硬組織接着剤の開発

    吉田靖弘, 吉田靖弘, 松川昭博, 高柴正悟, 沖原巧, 伊東孝

    医科学応用研究財団研究報告(CD-ROM)   31   2014

  • 十二指腸乳頭部に発生したgangliocytic paragangliomaの細胞像と組織像の検討

    伏見 聡一郎, 井上 博文, 小田 晋輔, 河原 明奈, 板倉 淳哉, 平 麻美, 伊藤 利洋, 松川 昭博, 加藤 博也, 市村 浩一, 柳井 広之

    日本臨床細胞学会岡山支部会誌   32   36 - 36   2013.12

     More details

    Language:Japanese   Publisher:岡山県臨床細胞学会  

    researchmap

  • Ras-Raf-ERK経路からみたA型インフルエンザ(H1N1)感染

    松川 昭博

    NEUROINFECTION   18 ( 2 )   120 - 120   2013.9

     More details

    Language:Japanese   Publisher:日本神経感染症学会  

    researchmap

  • 可視光硬化型ゼラチンとコラーゲン結合性ドメイン連結成長因子を用いた脊髄損傷治療

    篠原 健介, 馬崎 哲朗, 塩崎 泰之, 吉田 晶, 松川 昭博, 尾崎 敏文

    日本整形外科学会雑誌   87 ( 8 )   S1440 - S1440   2013.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 家兎骨軟骨欠損モデルにおける可視光硬化ゼラチンおよび骨髄間質細胞の組織修復効果

    香川 洋平, 馬崎 哲朗, 塩崎 泰之, 山根 健太郎, 吉田 晶, 松川 昭博, 中村 真理子, 吉田 靖弘, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文

    日本整形外科学会雑誌   87 ( 8 )   S1405 - S1405   2013.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • ケンフェロールが骨粗鬆症モデルマウスの骨吸収と骨組織に与える影響

    吉田 晶, 塩崎 泰之, 馬場 哲朗, 山根 健太郎, 松川 昭博, 北嶋 隆, 伊藤 嘉浩, 美野 愛, 佐藤 美和, 尾崎 敏文

    日本整形外科学会雑誌   87 ( 8 )   S1380 - S1380   2013.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 可視光硬化ゼラチンとcollagen binding domain(CBD)-BMP4の併用による家兎骨軟骨組織修復効果

    馬崎 哲朗, 塩崎 泰之, 山根 健太郎, 香川 洋平, 篠原 健介, 吉田 晶, 松川 昭博, 中村 真理子, 吉田 靖弘, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文

    日本整形外科学会雑誌   87 ( 8 )   S1606 - S1606   2013.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 医学生の臨床実習充実化のために研修医が果たす役割 岡山大学病院初期研修医の学生教育に対する意識調査

    三好 智子, 片岡 仁美, 小比賀 美香子, 渡辺 文恵, 別府 治恵, 森 祐子, 山根 正修, 松川 昭博, 尾崎 敏文, 谷本 光音

    医学教育   44 ( Suppl. )   112 - 112   2013.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 臨床実習における臨床技術認定制度の導入 名札に張って分かる技術認定シールを作成

    山根 正修, 松川 昭博, 岡山大学医学部臨床系教育企画委員会

    医学教育   44 ( Suppl. )   144 - 144   2013.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • MAPK/ERK Pathway Activation Leads to Severe Ischemia-Reperfusion-Induced Lung Injury

    M. Okada, M. Yamane, N. Iga, H. Nishikawa, S. Yamamoto, S. Otani, N. Waki, S. Hirayama, K. Miyoshi, S. Sugimoto, S. Toyooka, T. Oto, A. Matsukawa, S. Miyoshi

    The Journal of Heart and Lung Transplantation   32 ( 4 )   2013.4

     More details

    Language:English   Publisher:Elsevier {BV}  

    DOI: 10.1016/j.healun.2013.01.309

    researchmap

  • 炎症・免疫機構の新基軸と疾病の病理 A型インフルエンザウイルス(H1N1)感染とMAPK経路

    松川 昭博, 伊藤 利洋

    日本病理学会会誌   102 ( 1 )   185 - 185   2013.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • T細胞Suppressor of Cytokine Signaling 5(SOCS5)の過剰発現はLPSトレランス効果を増強する

    伊藤 利洋, 板倉 淳哉, 佐藤 美和, 美野 愛, 伏見 聡一郎, 松川 昭博

    日本病理学会会誌   102 ( 1 )   326 - 326   2013.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 多彩な組織像を示す乳腺腺様嚢胞癌の3例

    大森 昌子, 豊田 博, 柳井 広之, 高田 尚良, 松川 昭博, 吉野 正

    日本病理学会会誌   102 ( 1 )   370 - 370   2013.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 硬組織接着性多糖誘導体リン酸化プルランの骨再生能の検討

    山根 健太郎, 塩崎 泰之, 馬崎 哲朗, 杉本 佳久, 瀧川 朋亨, 田中 雅人, 松川 昭博, 尾崎 敏文

    Journal of Spine Research   4 ( 3 )   575 - 575   2013.3

     More details

    Language:Japanese   Publisher:(一社)日本脊椎脊髄病学会  

    researchmap

  • コラーゲン結合性骨形成蛋白質BMP4の骨芽細胞に対する影響

    吉田 晶, 古松 毅之, 塩崎 泰之, 馬崎 哲朗, 松川 昭博, 中村 真理子, 吉田 靖弘, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文

    移植   47 ( 6 )   498 - 498   2012.12

     More details

    Language:Japanese   Publisher:(一社)日本移植学会  

    researchmap

  • マウスにおける改変型成長因子Collagen binding domain BMP4の効果

    塩崎 泰之, 馬崎 哲朗, 吉田 晶, 山根 健太郎, 田中 雅人, 松川 昭博, 尾崎 敏文

    移植   47 ( 6 )   498 - 498   2012.12

     More details

    Language:Japanese   Publisher:(一社)日本移植学会  

    researchmap

  • 家兎骨軟骨欠損モデルにおける可視光硬化ゼラチンの骨軟骨組織修復の効果

    馬崎 哲朗, 塩崎 泰之, 吉田 晶, 松川 昭博, 中村 真理子, 吉田 靖弘, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文

    日本バイオマテリアル学会大会予稿集   シンポジウム2012   325 - 325   2012.11

     More details

    Language:Japanese   Publisher:日本バイオマテリアル学会  

    researchmap

  • マウスを用いた遺伝子改変成長因子Collagen binding domain BMP4の効果

    塩崎 泰之, 馬崎 哲郎, 山根 健太郎, 吉田 靖弘, 中村 真理子, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文, 松川 昭博

    日本バイオマテリアル学会大会予稿集   シンポジウム2012   269 - 269   2012.11

     More details

    Language:Japanese   Publisher:日本バイオマテリアル学会  

    researchmap

  • ウサギの骨欠損モデルにおいてコラーゲン結合性骨形成蛋白質は骨形成を促進する

    吉田 晶, 塩崎 泰之, 馬崎 哲朗, 古松 毅之, 松川 昭博, 中村 真理子, 吉田 靖弘, 北島 隆, 伊藤 嘉浩, 尾崎 敏文

    日本バイオマテリアル学会大会予稿集   シンポジウム2012   270 - 270   2012.11

     More details

    Language:Japanese   Publisher:日本バイオマテリアル学会  

    researchmap

  • ウサギ尺骨骨欠損モデルを用いたリン酸化プルランの骨再生能の検討

    山根 健太郎, 塩崎 泰之, 馬崎 哲朗, 吉田 晶, 杉本 佳久, 瀧川 朋亨, 田中 雅人, 松川 昭博, 尾崎 敏文

    日本整形外科学会雑誌   86 ( 8 )   S1349 - S1349   2012.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • ウサギの骨欠損モデルにおけるコラーゲン結合性骨形成蛋白質の有効性

    馬崎 哲朗, 塩崎 泰之, 吉田 晶, 松川 昭博, 中村 真理子, 吉田 靖弘, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文

    日本整形外科学会雑誌   86 ( 8 )   S1071 - S1071   2012.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • コラーゲン結合型BMP4の骨芽細胞に対する影響

    吉田 晶, 馬崎 哲朗, 塩崎 泰之, 古松 毅之, 松川 昭博, 中村 真理子, 吉田 靖弘, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文

    日本整形外科学会雑誌   86 ( 8 )   S1343 - S1343   2012.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • Intratarsal keratinous cyst of the Meibomian glandの2例

    内野 かおり, 藤澤 真義, 松川 昭博

    日本病理学会会誌   101 ( 1 )   296 - 296   2012.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 炎症の発現・制御におけるサイトカインシグナル伝達

    松川 昭博

    日本病理学会会誌   101 ( 1 )   175 - 175   2012.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 大腸癌における組織中のCD204陽性M2マクロファージの浸潤様式の検討

    松本 正樹, 左村 和磨, 加藤 恵美, 伏見 聡一郎, 板倉 淳哉, 伊藤 利洋, 荻野 哲也, 松川 昭博

    日本病理学会会誌   101 ( 1 )   441 - 441   2012.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • リンパ節生検でKaposi肉腫と多中心型Castleman病と診断したAIDSの1例

    伏見 聡一郎, 能登原 憲司, 板倉 淳哉, 伊藤 利洋, 荻野 哲也, 松川 昭博, 石川 典由, 中本 周

    日本病理学会会誌   101 ( 1 )   378 - 378   2012.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 酸化ストレスによる白血病細胞の分化とERKのリン酸化の修飾

    荻野 哲也, 平 麻美, 伏見 聡一郎, 松川 昭博

    日本病理学会会誌   101 ( 1 )   374 - 374   2012.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 抗酸菌性肉芽腫形成時の混合型白血病(MLL)の病理学的役割(Pathological role of mixed lineage leukemia (MLL) during mycobacterial granuloma formation)

    伊藤 利洋, 板倉 淳哉, 伏見 聡一郎, 荻野 哲也, Kunkel Steven, 松川 昭博

    日本病理学会会誌   101 ( 1 )   279 - 279   2012.3

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • インフルエンザ感染におけるThioredoxin binding protein 2(TBP-2)の役割

    八代 将登, 山田 睦子, 藤井 洋輔, 斉藤 有希恵, 長岡 義晴, 津下 充, 山下 信子, 塚原 宏一, 松川 昭博, 森島 恒雄

    日本小児科学会雑誌   116 ( 2 )   240 - 240   2012.2

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  • 肝RFA後に広範な肉芽組織を形成した1例

    原田 聡介, 郷原 英夫, 芝本 健太郎, 井石 龍比古, 金澤 右, 内海 方嗣, 松田 浩明, 八木 孝仁, 中村 進一郎, 伏見 聡一郎, 松川 昭博

    Japanese Journal of Radiology   30 ( Suppl.I )   69 - 69   2012.2

     More details

    Language:Japanese   Publisher:(公社)日本医学放射線学会  

    researchmap

  • 虚血再灌流肺障害にはMAPK経路の活性化が関与する

    岡田真典, 山根正修, 伊賀徳周, 原田昌明, 西川仁士, 平山伸, 山本澄治, 脇直久, 三好健太郎, 大谷真二, 杉本誠一郎, 宗淳一, 豊岡伸一, 大藤剛宏, 松川昭博, 三好新一郎

    日本肺および心肺移植研究会プログラム・抄録集   28th   15   2012

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • A Novel Chemokine-Receptor Antagonist Inhibits Activation of LPS-Stimulated Peritoneal Macrophages and Peritoneal Adhesion Reviewed

    Tomoyuki Oshio, Rei Kawashima, Yuki I. Kawamura, Toshihiko Okada, Tatsuya Haga, Akihiro Matsukawa, Shigeru Kakuta, Yoichiro Iwakura, Taeko Dohi

    GASTROENTEROLOGY   140 ( 5 )   S647 - S647   2011.5

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:W B SAUNDERS CO-ELSEVIER INC  

    Web of Science

    researchmap

  • 岡山大学自然生命科学研究支援センター動物資源部門津島北施設—Tsushima-Kita Branch Animal Experimental Facility, Department of Animal Resources, Advanced Science Research Center, Okayama University

    樅木, 勝巳, 高嶋, 留美, 松川, 昭博

    岡山実験動物研究会報   27   52 - 55   2011.5

     More details

    Language:Japanese   Publisher:岡山実験動物研究会  

    CiNii Article

    researchmap

  • 赤白血病細胞株K562における細胞分化のレドックス制御

    荻野 哲也, 平 麻美, 松川 昭博

    日本病理学会会誌   100 ( 1 )   372 - 372   2011.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Concanavalin A肝炎におけるCD4+T細胞SOCS1の役割

    岡 浩介, 高須賀 裕樹, 伏見 聡一郎, 松川 昭博

    日本病理学会会誌   100 ( 1 )   495 - 495   2011.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 管周囲性の増殖パターンを示す前立腺low grade stromal sarcomaの一例

    伏見 聡一郎, 板倉 淳哉, 伊藤 利洋, 平 麻美, 荻野 哲也, 柳井 広之, 松川 昭博

    日本病理学会会誌   100 ( 1 )   438 - 438   2011.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 画像上多発肝腫瘤と認識された大腸癌化学療法中の肝類洞病変

    内野 かおり, 藤澤 真義, 能登原 憲司, 松川 昭博

    日本病理学会会誌   100 ( 1 )   382 - 382   2011.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 【Th17細胞分化の誘導と抑制】Th17細胞のSOCSによる制御

    松川 昭博

    臨床免疫・アレルギー科   54 ( 4 )   418 - 423   2010.10

     More details

    Language:Japanese   Publisher:(有)科学評論社  

    researchmap

  • 肝移植後早期合併症 移植後真菌感染症で特異な臨床症状のみられた劇症肝不全の1例

    岡島 英明, 岩崎 寛智, 須田 博子, 林田 信太郎, 井田 智, 武市 卒之, 上野 美佳子, 阿曽沼 克弘, 松川 昭博, 猪山 賢一, 猪股 裕紀洋

    臨牀と研究   87 ( 9 )   1316 - 1317   2010.9

     More details

    Language:Japanese   Publisher:大道学館出版部  

    38歳男。高度の黄疸を伴った肝機能異常を認め、肝性昏睡が出現したため持続血液濾過透析、血漿交換を行うも改善なく、弟をドナーとした緊急肝移植を行った。術後早期にAST、ALT、T-Bilの上昇を認め、急性拒絶反応と考えてステロイドパルスを行った。術後38日目にCRPが上昇し、胸部X線で両肺野に浸潤影がみられた。腹水からカンジダ陽性、サイトメガロウイルス早期抗原陽性細胞を認め、免疫抑制剤を中止し、抗菌療法、抗真菌療法、抗ウイルス療法を行った。術後70日には感染は改善したが、AST、ALT、T-Bilが再上昇し、免疫抑制剤を再開した。術後121日目に痙攣を伴った意識消失が出現し、ショック状態に陥り、頭部CTで多数の低吸収域を認め、心電図では完全房室ブロックで、緊急ペースメーカーを挿入した。しかし、心不全状態は持続し、多臓器不全に陥り術後126日目に死亡した。剖検所見で脳および心筋に真菌塊による塞栓形成を認めた。

    researchmap

  • T細胞特異的SOCS5過剰発現はマウス抗II型コラーゲン抗体関節炎において関節炎を遷延させる

    高畑 智宏, 松川 昭博, 西田 圭一郎, 尾崎 敏文

    日本整形外科学会雑誌   84 ( 8 )   S1145 - S1145   2010.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • Choroid plexus carcinomaの2例

    安藤 翠, 市村 浩一, 田中 健大, 柳井 広之, 松川 昭博, 吉野 正

    日本病理学会会誌   99 ( 1 )   354 - 354   2010.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • セルブロック法併用で診断しえた膵腫瘍の2症例 転移性膵腫瘍と原発性膵内分泌腫瘍

    井上 博文, 藤田 勝, 松岡 博美, 今井 みどり, 那須 篤子, 市村 浩一, 田中 健大, 柳井 広之, 大原 信哉, 松川 昭博

    日本臨床細胞学会雑誌   49 ( Suppl.1 )   276 - 276   2010.3

     More details

    Language:Japanese   Publisher:(公社)日本臨床細胞学会  

    researchmap

  • 著明な細胞外粘液とsignet ring cell carcinomaからなる結節を形成したinvasive lobular carcinomaの一例

    大森 昌子, 柳井 広之, 豊田 博, 松川 昭博

    日本病理学会会誌   99 ( 1 )   341 - 341   2010.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 酸化ストレスによる白血病細胞の分化誘導修飾

    荻野 哲也, 平 麻美, 松川 昭博

    日本病理学会会誌   99 ( 1 )   274 - 274   2010.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • マクロファージのシグナル伝達 ガレクチン9によるマクロファージのFcgレセプター発現制御とコラーゲン抗体誘導関節炎への効果(Galectin-9 ameliorates immune complex-induced arthritis by regulating FcgR expression on macrophages)

    有川 智博, 渡邊 浩大, 松川 昭博, 大水 総一, 仁木 敏朗, 山内 清明, 平島 光臣

    日本免疫学会総会・学術集会記録   39   105 - 105   2009.11

     More details

    Language:English   Publisher:(NPO)日本免疫学会  

    researchmap

  • 子宮頸癌の最近の知見と細胞診 腺系病変を中心に 子宮頸部の神経内分泌腫瘍 組織分類と細胞像

    柳井 広之, 藤田 勝, 田中 正純, 戸井 紳二, 吉野 正, 松川 昭博

    日本臨床細胞学会雑誌   48 ( Suppl.2 )   433 - 433   2009.9

     More details

    Language:Japanese   Publisher:(公社)日本臨床細胞学会  

    researchmap

  • 妊娠期にみられた乳腺血管肉腫の1例

    松岡 博美, 藤田 勝, 今井 みどり, 井上 博文, 森下 由美子, 那須 篤子, 大森 昌子, 市村 浩一, 柳井 広之, 松川 昭博

    日本臨床細胞学会雑誌   48 ( Suppl.2 )   559 - 559   2009.9

     More details

    Language:Japanese   Publisher:(公社)日本臨床細胞学会  

    researchmap

  • マウス抗II型コラーゲン抗体関節炎におけるTh1/2反応とSOCS3・SOCS5による制御

    高畑 智宏, 松川 昭博, 西田 圭一郎, 尾崎 敏文

    日本整形外科学会雑誌   83 ( 8 )   S1120 - S1120   2009.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 当院における子宮内膜細胞診の疑陽性判定症例の再検討

    井上 博文, 藤田 勝, 松岡 博美, 今井 みどり, 那須 篤子, 森下 由美子, 市村 浩一, 大森 昌子, 大原 信哉, 柳井 広之, 松川 昭博, 則松 良明

    日本臨床細胞学会中国四国連合会会報   ( 24 )   31 - 31   2009.7

     More details

    Language:Japanese   Publisher:日本臨床細胞学会-中国四国連合会  

    researchmap

  • 超音波内視鏡下膵穿刺吸引細胞診における検体の取り扱いとその有用性(第二報)

    井上 博文, 藤田 勝, 松岡 博美, 今井 みどり, 那須 篤子, 森下 由美子, 市村 浩一, 大森 昌子, 大原 信哉, 柳井 広之, 松川 昭博, 越川 卓

    日本臨床細胞学会中国四国連合会会報   ( 24 )   39 - 39   2009.7

     More details

    Language:Japanese   Publisher:日本臨床細胞学会-中国四国連合会  

    researchmap

  • 免疫学 感染とサイトカイン・サイトカイン情報伝達

    松川 昭博

    医学のあゆみ   229 ( 12 )   1157 - 1158   2009.6

  • TTF-1陽性を示したgliosarcomaの一例

    伏見 聡一郎, 宮田 元, 中本 周, 荻野 哲也, 松川 昭博, 大浜 栄作

    日本病理学会会誌   98 ( 1 )   296 - 296   2009.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 動脈瘤破裂で緊急入院し敗血症ショックで死亡した神経線維腫症I型(Neurofibromatosis 1:NF1)の一例

    岡崎 泰昌, 飛田 陽, 板倉 淳哉, 荻野 哲也, 松川 昭博

    日本病理学会会誌   98 ( 1 )   290 - 290   2009.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • モノクロラミン誘発性アポトーシスにおけるinhibitor of apoptosis proteinおよびp53AIP1の変化

    荻野 哲也, 大森 昌子, 松川 昭博

    日本病理学会会誌   98 ( 1 )   279 - 279   2009.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 膀胱内進展により自然尿中に腫瘍細胞を認めた乳房外Paget病の1例

    藤田 勝, 松岡 博美, 井上 博文, 今井 みどり, 森下 由美子, 那須 篤子, 市村 浩一, 柳井 広之, 松川 昭博

    日本臨床細胞学会雑誌   48 ( Suppl.1 )   267 - 267   2009.3

     More details

    Language:Japanese   Publisher:(公社)日本臨床細胞学会  

    researchmap

  • T細胞SOCSとエンドトキシン(LPS)トレランス

    小畠 千晶, 若林 宏, 伏見 聡一郎, 原 淳子, 松川 昭博

    日本病理学会会誌   98 ( 1 )   398 - 398   2009.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 組織球性絨毛間腔炎の3例

    柳井 広之, 江口 香, 吉野 正, 松川 昭博

    日本病理学会会誌   98 ( 1 )   373 - 373   2009.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • T細胞SOCS3過剰発現による敗血症免疫調節

    松川 昭博, 原 淳子, 渡辺 治之, 荒嶋 康晴, 伏見 聡一郎

    日本病理学会会誌   98 ( 1 )   365 - 365   2009.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • マウス抗II型コラーゲン抗体関節炎におけるTh1/2反応とSOCS3・SOCS5による制御

    高畑 智宏, 松川 昭博, 西田 圭一郎, 尾崎 敏文

    日本整形外科学会雑誌   82 ( 8 )   S1244 - S1244   2008.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • バルプロ酸は骨折治癒を促進する マウス骨折モデルを用いた検討

    久慈 怜, 高畑 智宏, 松川 昭博, 古松 毅之, 野田 知之, 尾崎 敏文

    日本整形外科学会雑誌   82 ( 8 )   S1260 - S1260   2008.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • ガレクチン9は敗血症抵抗性に働く

    松川 昭博, 原 淳子, 飛田 陽, 平島 光臣

    Inflammation and Regeneration   28 ( 4 )   361 - 361   2008.7

     More details

    Language:Japanese   Publisher:(一社)日本炎症・再生医学会  

    researchmap

  • ガレクチン-9はC5aの産生阻害により抗コラーゲン抗体誘導関節炎を抑制する

    渡邊 浩大, 有川 智博, 坂田 研明, 坂田 敦子, 仁木 敏郎, 松川 昭博, 平島 光臣

    日本リウマチ学会総会・学術集会・国際リウマチシンポジウムプログラム・抄録集   52回・17回   264 - 264   2008.4

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • マウス抗II型コラーゲン抗体関節炎におけるTh1/2/17反応とSOCS3・SOCS5による制御

    高畑 智宏, 松川 昭博, 西田 圭一郎, 尾崎 敏文

    日本リウマチ学会総会・学術集会・国際リウマチシンポジウムプログラム・抄録集   52回・17回   385 - 385   2008.4

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 病理解剖を行われたリウマチ性疾患患者14症例の検討

    若林 宏, 山中 龍太郎, 三宅 剛平, 高杉 幸司, 杉山 晃一, 山下 美鈴, 矢野 隆介, 相田 哲史, 槇野 博史, 松川 昭博

    日本リウマチ学会総会・学術集会・国際リウマチシンポジウムプログラム・抄録集   52回・17回   286 - 286   2008.4

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • Tリンパ球依存性ConA肝炎におけるT細胞SOCS3の役割解明

    伏見 聡一郎, 高畑 智宏, 若林 宏, 荻野 哲也, 松川 昭博

    日本病理学会会誌   97 ( 1 )   255 - 255   2008.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 炎症研究の新しい展開 炎症制御とSOCS(Suppressors of cytokine signaling)

    松川 昭博

    日本病理学会会誌   97 ( 1 )   141 - 141   2008.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 唾液腺腺房細胞癌の二症例

    今井 みどり, 藤田 勝, 井上 博文, 松岡 博美, 森下 由美子, 岡崎 泰昌, 大森 昌子, 柳井 広之, 松川 昭博, 吉野 正

    日本臨床細胞学会雑誌   47 ( Suppl.1 )   183 - 183   2008.3

     More details

    Language:Japanese   Publisher:(公社)日本臨床細胞学会  

    researchmap

  • 胃癌術後化学療法中、蓚酸カルシウムの著明な沈着を伴うアスペルギルス肺炎で死亡した1例

    板倉 淳哉, 伏見 聡一郎, 荻野 哲也, 大森 昌子, 松川 昭博

    日本病理学会会誌   97 ( 1 )   398 - 398   2008.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 気管支腺上皮性乳頭腫の一例

    大森 昌子, 柳井 広之, 荻野 哲也, 松川 昭博, 吉野 正

    日本病理学会会誌   97 ( 1 )   375 - 375   2008.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • T細胞性白血病細胞株Jurkat細胞におけるモノクロラミン誘発性アポトーシスのメカニズム

    荻野 哲也, 大森 昌子, 松川 昭博

    日本病理学会会誌   97 ( 1 )   310 - 310   2008.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 超音波内視鏡下戦死吸引細胞診が有用であった膵内分泌腫瘍の二例

    井上博文, 藤田勝, 松岡博美, 今井みどり, 森下由美子, 市村浩一, 大森昌子, 大原伸哉, 柳井広之, 松川昭博

    日本臨床細胞学会雑誌   47   512   2008

     More details

  • 酸化ストレス 細胞・臓器機能への影響とその制御 好中球由来のオキシダントによる細胞の機能修飾

    荻野 哲也, Tin Aung Than, 大森 昌子, 寳迫 睦美, 平松 万尚, 尾崎 倫孝, 松川 昭博, 岡田 茂

    Organ Biology   14 ( 3 )   213 - 213   2007.10

     More details

    Language:Japanese   Publisher:(一社)日本臓器保存生物医学会  

    researchmap

  • T細胞SOCS3によるマウス敗血症モデルの自然免疫調節

    松川 昭博, 伏見 聡一郎, 若林 宏, 渡辺 弘之

    Inflammation and Regeneration   27 ( 4 )   420 - 420   2007.7

     More details

    Language:Japanese   Publisher:(一社)日本炎症・再生医学会  

    researchmap

  • T細胞SOCS3過剰発現は薬剤誘発性劇症肝炎を悪化させる

    松川 昭博, 沼田 亨祐, 伊藤 隆明

    日本病理学会会誌   96 ( 1 )   171 - 171   2007.2

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Nuclear palisadingを伴うDFSPから発生したfibrosarcomaの一例

    大森 昌子, 柳井 広之, 荻野 哲也, 松川 昭博, 吉野 正

    日本病理学会会誌   96 ( 1 )   337 - 337   2007.2

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 肺塞栓症にて死亡した上大静脈原発の血管肉腫の一剖検例

    伏見 聡一郎, 荻野 哲也, 平松 万尚, 大森 昌子, 柳井 広之, 松川 昭博

    日本病理学会会誌   96 ( 1 )   316 - 316   2007.2

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • モノクロラミンによるカルシウム輸送の修飾

    荻野 哲也, 大森 昌子, 松川 昭博

    日本病理学会会誌   96 ( 1 )   289 - 289   2007.2

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 関節リウマチ〜臨床解析と新治療 安定性ガレクチン-9は慢性関節リウマチのラット/マウスモデルを抑制する(Stable Galectin-9 suppresses rat/murine models of rheumatoid arthritis)

    Sakata Ken-mei, Seki Masako, Takashita Keisuke, Ito Kanako, Arikawa Tomohiro, Matsukawa Akihiro, Sakata Atsuko, Hirashima Mitsuomi

    日本免疫学会総会・学術集会記録   36   290 - 290   2006.11

     More details

    Language:English   Publisher:(NPO)日本免疫学会  

    researchmap

  • 急性大動脈解離の破裂により死亡した若年女性の1例

    美作 宗太郎, 大津 由紀, 幸松 宏恵, 是枝 亜子, 米満 孝聖, 恒成 茂行, 松川 昭博, 橋谷田 真樹, 舟山 眞人

    日本法医学雑誌   60 ( 2 )   197 - 197   2006.10

     More details

    Language:Japanese   Publisher:(NPO)日本法医学会  

    researchmap

  • 動脈硬化による冠動脈のリモデリングに及ぼす中膜の拡大と脆弱化の影響

    塩見 雅志, 山田 悟士, 板部 洋之, 松川 昭博, 伊藤 隆

    日本動脈硬化学会総会プログラム・抄録集   38回   238 - 238   2006.7

     More details

    Language:Japanese   Publisher:(一社)日本動脈硬化学会  

    researchmap

  • Atypical teratoid rhabdoid tumor(AT/RT)の一例

    大森 昌子, 柳井 広之, 荻野 哲也, 井上 智, 松川 昭博, 吉野 正

    日本病理学会会誌   95 ( 1 )   312 - 312   2006.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 摂食抑制ペプチド,ニューロメジンUの炎症における役割の解明

    森山 麻衣子, 井上 博雅, 松川 昭博, 佐藤 貴弘, 加納 龍彦, 吉村 昭彦, 児島 将康

    日本内分泌学会雑誌   82 ( 1 )   95 - 95   2006.4

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    researchmap

  • ジメチルアセチル-β-シクロデキストリンによるエンドトキシンショック抑制の機構解明

    本山 敬一, 有馬 英俊, 松川 昭博, 平山 文俊, 上釜 兼人

    日本薬学会年会要旨集   126年会 ( 3 )   139 - 139   2006.3

     More details

    Language:Japanese   Publisher:(公社)日本薬学会  

    researchmap

  • 自然免疫/炎症とサイトカインシグナル伝達.

    松川昭博

    岡山医誌   118,109-112   2006

  • 炎症とサイトカインシグナル伝達.

    松川昭博

    岡山医誌   118,185-186   2006

     More details

  • 安定化ガレクチン9はコラーゲン関節炎重症度を軽減させる

    積 正子, 竹下 慶亮, 坂田 研明, 山中 徹, 松川 昭博, 坂田 敦子, 平島 光臣

    日本免疫学会総会・学術集会記録   35   253 - 253   2005.11

     More details

    Language:Japanese   Publisher:(NPO)日本免疫学会  

    researchmap

  • 関節リウマチ滑膜組織におけるガレクチン9発現と滑膜細胞アポトーシス誘導

    坂田 研明, 積 正子, 山中 徹, 松川 昭博, 坂田 敦子, 平島 光臣

    日本免疫学会総会・学術集会記録   35   253 - 253   2005.11

     More details

    Language:Japanese   Publisher:(NPO)日本免疫学会  

    researchmap

  • 安定化ガレクチン9による関節リウマチ滑膜細胞死誘導と関節炎モデル治療の試み

    坂田 研明, 積 正子, 伊藤 佳奈子, 有川 智博, 税田 直樹, 山中 徹, 松川 昭博, 坂田 敦子, 平島 光臣

    アレルギー   54 ( 8-9 )   1087 - 1087   2005.9

  • 薬剤誘発性劇症肝炎におけるSOCS3の分子基盤 治療分子標的としての可能性

    松川 昭博, 沼田 亨祐, 渡辺 弘之, 伊藤 隆明, 久保 允人

    炎症・再生   25 ( 4 )   394 - 394   2005.7

     More details

    Language:Japanese   Publisher:(一社)日本炎症・再生医学会  

    researchmap

  • 肺におけるPML蛋白質,SUMO-1の発現

    伊藤 隆明, 宇高 直子, 松川 昭博

    日本病理学会会誌   94 ( 1 )   295 - 295   2005.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 肺癌細胞株におけるSTATの発現

    宇高 直子, 松川 昭博, 伊藤 隆明

    日本病理学会会誌   94 ( 1 )   202 - 202   2005.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • ガレクチン9による抗腫瘍効果

    松川 昭博, 伊藤 隆明, 平島 光臣

    日本病理学会会誌   94 ( 1 )   234 - 234   2005.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • SOCS3による薬剤誘発性劇症肝炎の調節機構の解明

    沼田 亨祐, 渡辺 弘之, 伊藤 隆明, 松川 昭博

    日本病理学会会誌   94 ( 1 )   229 - 229   2005.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • マウス敗血症モデルを用いたSOCS5による自然免疫調節機構の解析

    渡辺 弘之, 沼田 亨祐, 伊藤 隆明, 松川 昭博

    日本病理学会会誌   94 ( 1 )   227 - 227   2005.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • エンドトキシンショックに対するジメチルアセチル-β-シクロデキストリンの抑制効果

    本山 敬一, 有馬 英俊, 松川 昭博, 三宅 健介, 西本 洋志, 平山 文俊, 上釜 兼人

    薬剤学: 生命とくすり   65 ( Suppl. )   118 - 118   2005.3

     More details

    Language:Japanese   Publisher:(公社)日本薬剤学会  

    researchmap

  • 自然免疫/炎症の発現・制御に関わるサイトカインとシグナル伝達因子の機能解明

    松川 昭博

    日本病理学会会誌   93 ( 2 )   13 - 13   2004.10

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • マクロファージ・好中球特異的Stat3欠損マウスにみる獲得免疫反応

    松川 昭博, 伊藤 隆明

    炎症・再生   24 ( 4 )   515 - 515   2004.7

     More details

    Language:Japanese   Publisher:(一社)日本炎症・再生医学会  

    researchmap

  • 肺転移をきたした悪性腱鞘巨細胞腫の1例

    川添 泰弘, 薬師寺 俊剛, 松川 昭博, 佐藤 広生, 高木 克公

    日本整形外科学会雑誌   78 ( 6 )   S713 - S713   2004.6

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • マクロファージ・好中球に発現するStat3によるTh1・Th2型獲得免疫制御

    松川 昭博, 伊藤 隆明

    日本病理学会会誌   93 ( 1 )   225 - 225   2004.5

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 生体肝移植術後の真菌感染症による感染性完全房室ブロック

    岡島 英明, 吉元 和彦, 小寺 厚志, 武市 卒之, 上野 美佳子, 阿曽沼 克弘, 河野 宏明, 松川 昭博, 猪山 賢一, 猪股 裕紀洋

    日本外科学会雑誌   105 ( 臨増 )   594 - 594   2004.3

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 腹腔常在マクロファージに発現するStat3による急性炎症制御作用

    松川 昭博, 竹田 潔, 審良 静男

    日本免疫学会総会・学術集会記録   33   135 - 135   2003.11

     More details

    Language:Japanese   Publisher:(NPO)日本免疫学会  

    researchmap

  • 敗血性腹膜炎モデルにおけるCCケモカインリセプター8の機能解析

    松川 昭博, 佐野 元市郎, 前田 貴子, Kunkel Steven, Lira Sergio

    炎症・再生   23 ( 6 )   473 - 473   2003.11

     More details

    Language:Japanese   Publisher:(一社)日本炎症・再生医学会  

    researchmap

  • 【痛風・高尿酸血症とサイトカイン】痛風関節炎のメカニズムとサイトカイン 動物モデルにおける尿酸結晶誘発関節炎 サイトカイン・ケモカインの産生とそのネットワーク

    松川 昭博

    高尿酸血症と痛風   11 ( 2 )   147 - 151   2003.9

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    痛風関節炎は,高尿酸血症を背景に関節周囲に沈着した尿酸結晶(MSU結晶)が関節内に遊離して起こる急性関節炎であり,局所に浸潤した白血球,特に好中球がMSU結晶の貪食と消化に働く.この炎症反応は,MSU結晶の刺激によってホストが産生する種々の炎症メディエーターによって起こるが,近年のin vitro及びin vivoの研究から,関節炎発症におけるサイトカインの役割が明らかになってきた.そこで,ウサギ尿酸結晶誘発関節炎を用いた著者等の解析を中心に,関節炎誘発に関わるサイトカイン・ケモカインとそのネットワークについて最近の知見を交えて述べた

    researchmap

  • 椎間板細胞はヘルニア発生早期に炎症性サイトカインを発現する 新たな椎間板ヘルニアモデルを用いて

    吉田 正一, 中村 孝文, 松川 昭博, 瀬井 章, 菊池 太朗, 水溜 正也, 高木 克公

    日本整形外科学会雑誌   77 ( 8 )   S956 - S956   2003.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 【好中球と皮膚疾患】好中球と炎症

    松川 昭博

    Derma.   ( 75 )   1 - 7   2003.6

     More details

    Language:Japanese   Publisher:(株)全日本病院出版会  

    生体に微生物の侵入などの異変がおこると,好中球はただちに内皮細胞間隙を割り込んで血管外へ遊出し,局所に浸潤する.浸潤した好中球は微生物を認識・貪食し,その酸素依存性及び非依存性の殺菌機構により消化する.即ち,好中球浸潤は炎症反応で最も顕著な細胞反応であり,浸潤した好中球は一次生体防御系の上で中心的な役割を担っている.しかし,活性化された好中球から放出される種々の因子は必然的に正常なホストの組織傷害をも伴う.このように,本来は防御系に働く炎症反応が自己組織の傷害を量的・時間的に過剰に引き起こす場合,医学的には病的現象としての「炎症」ととらえられ,治療の対象となる

    researchmap

  • CXCケモカインIL-8とGROの異なるin vivo作用

    藤原 一徳, 松川 昭博, 大河原 進, 吉永 秀

    日本免疫学会総会・学術集会記録   31   306 - 306   2001.12

     More details

    Language:Japanese   Publisher:(NPO)日本免疫学会  

    researchmap

  • 急性肝障害時にみられるmacrophage-derived chemokine(MDC,CCL22)の抗炎症作用

    松川 昭博, Lukacs Nicholas, Kunkel Steven, 吉永 秀

    日本免疫学会総会・学術集会記録   31   312 - 312   2001.12

     More details

    Language:Japanese   Publisher:(NPO)日本免疫学会  

    researchmap

  • A case of juvenile hyaline fibromatosis

    Honda Y, Ohkawara S, Iyama K, Matsukawa A, Yoshinaga M

    Jpn J Diagn Pathol   17 ( 2 )   190 - 192   2000

     More details

    Language:Japanese  

    researchmap

  • 【高尿酸血症と痛風】重要性を増した合併症の治療と対策 痛風関節炎のメカニズム

    松川 昭博

    Medical Practice   16 ( 7 )   1113 - 1116   1999.7

     More details

    Language:Japanese   Publisher:(株)文光堂  

    researchmap

  • Propionibacterium acnesによる実験的肺肉芽腫形成と単球/マクロファージ・リンパ球集簇に関するMCP-1の役割

    一安 秀範, 菅 守隆, 彌永 和宏, 山本 太郎, 高橋 利弘, 松川 昭博, 吉永 秀, 安藤 正幸

    日本サルコイドーシス学会雑誌   18 ( 1 )   33 - 33   1998.11

     More details

    Language:Japanese   Publisher:日本サルコイドーシス  

    researchmap

  • 痛風治療剤コルヒチンの作用機序 モデル動物を用いてのサイトカイン産生及び白血球機能評価

    松川 昭博

    リウマチ   38 ( 2 )   343 - 343   1998.4

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • ウサギ尿酸結晶誘発関節炎におけるTNFα,IL-1β,IL-8の産生とそのネットワーク

    松川 昭博, 吉永 秀

    プリン・ピリミジン代謝   21 ( 2 )   180 - 183   1997.12

     More details

    Language:Japanese   Publisher:(一社)日本痛風・尿酸核酸学会  

    researchmap

  • 痛風・高尿酸血症の病態 尿酸塩による関節炎の病態

    松川 昭博, 吉永 秀

    Mebio   14 ( 9 )   56 - 62   1997.9

     More details

    Language:Japanese   Publisher:(株)メジカルビュー社  

    researchmap

  • ウサギ尿酸結晶誘発関節炎におけるMCP-1の発現動態

    松川 昭博

    リウマチ   37 ( 2 )   261 - 261   1997.4

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 尿酸結晶関節炎におけるIL-8の産生動態とその局在

    松川 昭博

    リウマチ   36 ( 2 )   247 - 247   1996.4

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 抑制基調サーボ機構として機能する正常臓器内のIL-1 receptor antagonist

    松川 昭博

    日本病理学会会誌   85 ( 1 )   181 - 181   1996.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 好中球,マクロファージの活性化と組織障害:Interleukin-8, Monocyte Chemoattractant Protein-1の役割

    吉村 禎造, 松川 昭博, 山城 重雄

    化学療法の領域   12 ( 2 )   222 - 227   1996.1

     More details

    Language:Japanese   Publisher:(株)医薬ジャーナル社  

    researchmap

  • 内因性IL-1 receptor antagonist(IL-1ra)は炎症自己制御因子として機能する

    福本 巧, 松川 昭博, 木村 真

    日本整形外科学会雑誌   69 ( 8 )   s1440 - s1440   1995.8

  • 実験関節炎におけるIL-1raの動態と役割

    吉永 秀, 松川 昭博

    日本整形外科学会雑誌   69 ( 8 )   s1557 - s1557   1995.8

  • in vivoにおけるONO-5046の好中球エラスターゼ活性抑制効果 LPSおよびIL-8誘導関節炎を用いて

    松川 昭博

    リウマチ   35 ( 2 )   356 - 356   1995.4

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 黄色ブドウ球菌加熱死菌関節炎におけるTumor necrosis factor-α(TNF-α),Interleukin-1(IL-1)の役割

    木村 真, 松川 昭博, 枝光 淳

    日本整形外科学会雑誌   68 ( 8 )   s1497 - s1497   1994.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 炎症局所におけるIL-1receptor antagonist(IL-1ra)の意義

    松川 昭博

    リウマチ   34 ( 2 )   453 - 453   1994.4

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • LPS関節炎における軟骨破壊のメカニズム

    松川 昭博

    リウマチ   33 ( 6 )   710 - 710   1993.12

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 抗ウサギIL-1レセプターアンタゴニスト・モノクローナル中和抗体の開発とこれを用いたIL-1活性の再検討

    松川 昭博, 大河原 進, 枝光 淳, 高本 克公, 吉永 秀

    日本免疫学会総会・学術集会記録   23   352 - 352   1993.10

     More details

    Language:Japanese   Publisher:(NPO)日本免疫学会  

    researchmap

  • ウサギLPS胸膜炎に伴う細胞浸潤と血管透過性亢進の誘導におけるIL-1、TNF-αの役割

    枝光 淳, 大河原 進, 松川 昭博, 高木 克公, 吉永 秀

    日本免疫学会総会・学術集会記録   23   353 - 353   1993.10

     More details

    Language:Japanese   Publisher:(NPO)日本免疫学会  

    researchmap

  • インターロイキンと病態 インターロイキン1,TNF

    松川 昭博, 大河原 進

    BIO medica   8 ( 9 )   703 - 707   1993.8

     More details

    Language:Japanese   Publisher:(株)北隆館  

    researchmap

  • 尿酸結晶関節炎におけるIL-1,TNFαの関与

    松川 昭博

    日本整形外科学会雑誌   67 ( 8 )   s1271 - s1271   1993.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • IL-1レセプターアンタゴニスト

    松川 昭博, 吉永 秀

    Annual Review免疫   1993   110 - 117   1993.1

     More details

    Language:Japanese   Publisher:(株)中外医学社  

    researchmap

  • ウサギLPS誘発関節炎におけるInterleukin-1 (IL-1)の役割 ウサギIL-1receptor antagonist (IL-1ra)を用いての炎症の解析

    松川 昭博

    リウマチ   32 ( 6 )   778 - 778   1992.12

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 炎症局所で見出したIL-1抑制因子の構造と機能

    大河原 進, 松川 昭博

    病態生理   11 ( 12 )   962 - 966   1992.12

     More details

    Language:Japanese   Publisher:(株)永井書店  

    researchmap

  • ウサギLipopolysaccharide (LPS)関節炎におけるInterleukin-1,Tumor necrosis factor-α (TNF-α)の役割

    松川 昭博

    日本整形外科学会雑誌   66 ( 8 )   S1356 - S1356   1992.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 最近注目されている各種インヒビター IL-1レセプター・アンタゴニスト

    大河原 進, 松川 昭博, 枝光 淳

    臨床免疫   24 ( 5 )   607 - 618   1992.5

     More details

    Language:Japanese   Publisher:(有)科学評論社  

    researchmap

  • 炎症の場における好中球の蛋白合成能 特にIL-1,IL-1raの産生

    大河原 進, 松川 昭博, 吉永 秀

    月刊細胞   24 ( 6 )   220 - 224   1992.5

     More details

    Language:Japanese   Publisher:(株)ニュー・サイエンス社  

    researchmap

  • LPS関節炎におけるInterleukin-1の役割

    松川 昭博

    日本病理学会会誌   81 ( 1 )   170 - 170   1992.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 侵襲と生体反応

    松川 昭博, 相良 孝昭, 吉永 秀

    外科と代謝・栄養   24 ( 4 )   457 - 464   1990.9

     More details

    Language:Japanese   Publisher:日本外科代謝栄養学会  

    researchmap

  • 炎症とIL1

    大河原 進, 相良 孝昭, 松川 昭博

    自律神経   27 ( 4 )   369 - 374   1990.8

     More details

    Language:Japanese   Publisher:日本自律神経学会  

    researchmap

  • タンパク合成能に依存した多核白血球の新しい機能

    相良 孝昭, 松川 昭博, 後藤 文正

    病態生理   9 ( 7 )   582 - 585   1990.7

     More details

    Language:Japanese   Publisher:(株)永井書店  

    researchmap

  • 反復性膝蓋骨脱臼における大腿骨顆部骨性形態のレ線的検討

    松川 昭博, 水田 博志, 久保田 健治

    整形外科と災害外科   38 ( 4 )   1684 - 1687   1990.3

  • 炎症から免疫応答へのシナップスとしてのサイトカイン

    後藤 久美子, 後藤 文正, 松川 昭博

    臨床免疫   22 ( 3 )   422 - 432   1990.3

     More details

    Language:Japanese   Publisher:(有)科学評論社  

    researchmap

  • スポーツ選手における第2ケーラー病について

    松川 昭博, 水田 博志, 久保田 健治

    日本足の外科研究会雑誌   10   149 - 152   1989.7

     More details

    Language:Japanese   Publisher:(一社)日本足の外科学会  

    researchmap

  • スポーツによる両膝前十字靱帯損傷の3例

    松川 昭博, 水田 博志, 久保田 健治

    臨床スポーツ医学   6 ( 別冊 )   278 - 280   1989.6

     More details

    Language:Japanese   Publisher:(株)文光堂  

    researchmap

▼display all

Presentations

  • 日本における医学生の情報リテラシー能力の検討

    三好智子, 越智可奈子, 小﨑吉訓, 松川昭博

    第56回日本医学教育学会大会 

     More details

    Event date: 2024.8.9 - 2024.8.10

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • SPRED2の欠損はマウスの腫瘍においてオートファジーとマイトファジーを抑制する

    王天一, 高桐, 藤澤真義, 大原利章, 吉村禎造, 松川昭博

    第113回日本病理学会総会 

     More details

    Event date: 2024.3.28 - 2024.3.30

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • ホストのSpred2欠損は、マウスの乳がんモデルにおけるがんの進行を抑制する

    Miao Tian, 吉村禎造, 李春寧, 大原利章, 藤澤真義, 松川昭博

    第113回日本病理学会総会 

     More details

    Event date: 2024.3.28 - 2024.3.30

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • SPRED2制御したexosomeは、がん細胞においてmacrophageの極性化を促進し、IL-6/STAT3シグナルを活性化する

    高桐、テンミャオ, 藤澤真義, 大原利章, 王天一, トウンニンティンダ, 李春寧, 吉村禎造, 松川昭博

    第113回日本病理学会総会 

     More details

    Event date: 2024.3.28 - 2024.3.30

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • AIを用いた組織切片厚の推定法の開発

    藤澤真義, 大原利章, 樋口拓浩, 松川昭博

    第113回日本病理学会総会 

     More details

    Event date: 2024.3.28 - 2024.3.30

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • 鉄キレート効果を持つHIF-PH阻害薬は抗腫瘍免疫応答を向上させる

    陳悦華, 大原利章, 王宇沢, 浜田祐輔, 藤澤真義, 松川昭博

    第113回日本病理学会総会 

     More details

    Event date: 2024.3.28 - 2024.3.30

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • Microvessel shape in cancer tissues is associated with clinicopathological parameters and prognosis

    Wint Wint Swe, Masayoshi Fujisawa, Toshiaki Ohara, Akihiro Matsukawa

     More details

    Event date: 2024.3.28 - 2024.3.30

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Tumor vessels with specific morphology as a prognostic factor in esophageal cancer

    HNIN THIDA TUN, Masayoshi Fujisawa, Toshiaki Ohara, Akihiro Matsukawa

     More details

    Event date: 2024.3.28 - 2024.3.30

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 悪性症候群後に発症した小脳変性症の1剖検例

    千葉陽一, 太田仁士, 吉井りつ, 野中和香子, 松川昭博, 佐藤明, 上野正樹

    第113回日本病理学会総会 

     More details

    Event date: 2024.3.28 - 2024.3.30

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • 鉄キレート剤による抗腫瘍免疫応答の向上:マウス肺癌モデルを用いて

    浜田祐輔, 大原利章, 王宇沢, 陳悦華, 藤澤真義, 松川昭博

    第113回日本病理学会総会 

     More details

    Event date: 2024.3.28 - 2024.3.30

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • Exosome under the control of SPRED2 promotes M1 macrophage polarization and activate IL6-STAT3 signaling in esophageal cancer cell

    Tong Gao, Miao Tian, Masahiro Fujisawa, Toshiaki Ohara, Tianyi Wang, Yuze Wang, Hnin Thida Tun, Chunning Li, Teizo Yoshimura, Akihiro Matsukawa

     More details

    Event date: 2024.1.17 - 2024.1.19

    Language:English   Presentation type:Poster presentation  

    researchmap

  • SPRED2 promotes autophagy via mTORC1 signaling pathway in hepatocellular carcinoma

    Tianyi Wang, Tong Gao, Toshiaki Ohara, Masayoshi Fujisawa, Teizo Yoshimura, Akihiro Matsukawa

     More details

    Event date: 2024.1.17 - 2024.1.19

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 臨床実習前医学生におけるゾーニング実習の実践

    越智可奈子、萩谷英大、小﨑吉訓、三好智子、山下範之、伊野英男、成瀬恵治、大塚文男、松川 昭博

     More details

    Event date: 2023.10.31 - 2023.11.2

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • mTORC1のキナーゼ活性をアロステリックに阻害する非ラパログリガンドのin silicoおよびin cellハイブリッド選択

    Raef Sham, 松川昭博, 越智由香里, 伊藤嘉浩, 宮武秀行

    第96回日本生化学会 

     More details

    Event date: 2023.10.31 - 2023.11.2

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • 臨床実習前医学生におけるゾーニング実習の実践

    越智可奈子, 萩谷英大, 小﨑吉訓, 三好智子, 山下範之, 伊野英男, 成瀬恵治, 大塚文男, 松川 昭博

    第55回日本医学教育学会大会 

     More details

    Event date: 2023.7.28 - 2023.7.29

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • 医学生は、学内演習でもコミュニケーションにおける成長を自覚するのか。コロナ禍での挑戦

    越智可奈子、萩谷英大、小﨑吉訓、三好智子、山下範之、伊野英男、成瀬恵治、大塚文男、松川 昭博

    第55回日本医学教育学会大会 

     More details

    Event date: 2023.7.28 - 2023.7.29

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • 医学生は、学内演習でもコミュニケーションにおける成長を自覚するのか コロナ禍での挑戦

    三好 智子, 川端 崇義, 猪田 宏美, 小崎 吉訓, 越智 可奈子, 赤穂 宗一郎, 座間味 義人, 伊野 英男, 成瀬 恵治, 松川 昭博

    医学教育  2023.7  (一社)日本医学教育学会

     More details

    Event date: 2023.7

    Language:Japanese  

    researchmap

  • 腕頭動脈から分岐した左総頸動脈より気管孔へ出血した一例

    尾山 貴徳, 野田 卓男, 宮田 将徳, 渡邉 宏和, 鷲尾 洋介, 吉本 順子, 大原 利章, 松川 昭博

    日本小児外科学会雑誌  2023.5  (一社)日本小児外科学会

     More details

    Event date: 2023.5

    Language:Japanese  

    researchmap

  • マウス閉塞性細気管支炎モデルにおけるFormyl peptide receptor (FPR)の役割解明

    中村薫, 大原利章, 吉村禎造, 松川昭博

     More details

    Event date: 2023.4.13 - 2023.4.15

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 鉄キレート剤を用いた肺癌に対する抗腫瘍免疫応答の向上

    浜田祐輔, 大原利章, チン ユエファ, 藤澤真義, 松川昭博

    第112回日本病理学会総会 

     More details

    Event date: 2023.4.13 - 2023.4.15

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 鉄キレート効果を持つHIF-PH阻害薬は抗腫瘍免疫応答を向上させる

    陳悦華, 大原利章, 浜田祐輔, 藤澤真義, 松川昭博

    第112回日本病理学会総会 

     More details

    Event date: 2023.4.13 - 2023.4.15

    Language:English   Presentation type:Poster presentation  

    researchmap

  • SPRED2は食道がん細胞のマクロファージをエクソソームのIL-6/STAT3を介して、M2表現形に変化させる

    高桐, 田ミョウ, 藤澤真義, 大原利章, 王天偉, 李春寧, 王宇沢, トウン, ティンダニン, 吉村禎造, 松川昭博

    第112回日本病理学会総会 

     More details

    Event date: 2023.4.13 - 2023.4.15

    Language:English   Presentation type:Poster presentation  

    researchmap

  • HCC細胞のオートファジーにおけるSpred2の機能及びmTORC1活性化との関係

    王天偉, 高桐, 藤澤真義, 大原利章, 吉村禎造, 松川昭博

    第112回日本病理学会総会 

     More details

    Event date: 2023.4.13 - 2023.4.15

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • TNBCにおける転移能の獲得と鉄代謝の変動

    王宇沢, 大原利章, チン ユエファ, 浜田祐輔, 李春寧, 藤澤真義, 松川昭博

    第112回日本病理学会総会 

     More details

    Event date: 2023.4.13 - 2023.4.15

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • 乳癌における複雑分岐血管の臨床病理学的意義

    Wint wint Sue, 藤澤真義, 松川昭博

    第112回日本病理学会総会 

     More details

    Event date: 2023.4.13 - 2023.4.15

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 腫瘍環境のSpred2欠損は乳がんの増殖と転移を抑制する

    Tian Miao, 吉村禎造, 李春寧, 大原利章, 藤澤真義, 松川昭博

     More details

    Event date: 2023.4.13

    Presentation type:Poster presentation  

    researchmap

  • SPRED2は食道がん細胞のマクロファージを、エクソソームのIL6/STAT3を介して、M2表現形に分化させる(SPRED2 polarizes macrophages into M2 phenotype via exosomal IL-6/STAT3 axis in esophageal carcinoma)

    高 桐, 田 ミョウ, 藤澤 真義, 大原 利章, 王 天偉, 李 春寧, 王 宇沢, トウン・ティンダ・ニン, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2023.3  (一社)日本病理学会

     More details

    Event date: 2023.3

    Language:English  

    researchmap

  • 腫瘍環境のSpred2欠損は乳がんの増殖と転移を抑制する(Spred2 deficiency in the tumor microenvironment inhibits the progression of breast cancer in mice.)

    Tian Miao, 吉村 禎造, 李 春寧, 大原 利章, 藤澤 真義, 松川 昭博

    日本病理学会会誌  2023.3  (一社)日本病理学会

     More details

    Event date: 2023.3

    Language:English  

    researchmap

  • TNBCにおける転移能の獲得と鉄代謝の変動(Changes in iron metabolism associated with the acquisition of metastatic potential in TNBC cells)

    王 宇沢, 大原 利章, チン・ユエファ, 浜田 祐輔, 李 春寧, 藤澤 真義, 松川 昭博

    日本病理学会会誌  2023.3  (一社)日本病理学会

     More details

    Event date: 2023.3

    Language:English  

    researchmap

  • HCC細胞のオートファジーにおけるSpred2の機能及びmTORC1活性化との関係(Role of Spred2 in autophagy in HCC cells and its relation to mTORC1 activation)

    王 天偉, 高 桐, 藤澤 真義, 大原 利章, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2023.3  (一社)日本病理学会

     More details

    Event date: 2023.3

    Language:English  

    researchmap

  • マウス閉塞性細気管支炎モデルにおけるFormyl peptide receptor(FPR)の役割解明

    中村 薫, 大原 利章, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2023.3  (一社)日本病理学会

     More details

    Event date: 2023.3

    Language:Japanese  

    researchmap

  • 肺がんに対する鉄キレート剤を用いた抗腫瘍免疫応答の向上

    浜田祐輔, 大原利章, WANG Yuze, CHEN Yuehua, 藤澤真義, 木村文昭, 松川昭博

    日本鉄バイオサイエンス学会学術集会プログラム・抄録集  2023 

     More details

    Event date: 2023

    researchmap

  • Spred2 regulates cancer stemness in HCC cells, targeting on miR-506-3p and its downstream KLF4

    Tong Gao, Sachio Ito, Aye Moh Moh Aung, Masahiro Fujisawa, Toshiaki Ohara, Teizo Yoshimura, Tianyi Wang, Akihiro Matsukawa

    2022.12.7 

     More details

    Event date: 2022.12.7 - 2022.12.9

    Presentation type:Poster presentation  

    researchmap

  • Spred2 regulates cancer stemness in HCC cells, targeting on miR-506-3p and its downstream KLF4.

    Tong Gao, Sachio Ito, Aye Moh Moh Aung, Masahiro Fujisawa, Toshiaki Ohara, Teizo Yoshimura, Tianyi Wang, Akihiro Matsukawa

     More details

    Event date: 2022.12.7 - 2022.12.9

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Spred2:炎症と癌の制御に関わるシグナルコンダクター Invited

    松川昭博

    第68回日本病理学会秋期特別総会  2022.11.8 

     More details

    Event date: 2022.11.7 - 2022.11.8

    Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • 生検検体を用いた胆道癌におけるPD-L1発現の検討

    松本 和幸, 高木 章乃夫, 大原 利章, 藤澤 真義, 高原 政宏, 加藤 博也, 吉田 龍一, 楳田 祐三, 八木 孝仁, 松川 昭博

    日本消化器病学会雑誌  2022.10  (一財)日本消化器病学会

     More details

    Event date: 2022.10

    Language:Japanese  

    researchmap

  • 生検検体を用いた胆道癌におけるPD-L1発現の検討

    松本 和幸, 高木 章乃夫, 大原 利章, 藤澤 真義, 高原 政宏, 加藤 博也, 吉田 龍一, 楳田 祐三, 八木 孝仁, 松川 昭博

    日本消化器病学会雑誌  2022.10  (一財)日本消化器病学会

     More details

    Event date: 2022.10

    Language:Japanese  

    researchmap

  • ウィズコロナ下の学生ワクチン接種実習における岡山大学の工夫と課題について

    小崎 吉訓, 越智 加奈子, 赤穂 宗一郎, 三好 智子, 山口 貴子, 伊野 英男, 松川 昭博, 伊達 勲

    医学教育  2022.7  (一社)日本医学教育学会

     More details

    Event date: 2022.7

    Language:Japanese  

    researchmap

  • 行動科学講義により多文化社会の意識を高める(Raising Awareness about Cultural Communities in Medical Students through Behavioral Science Lectures)

    マハムド・サビナ, 松川 昭博, 三好 智子

    医学教育  2022.7  (一社)日本医学教育学会

     More details

    Event date: 2022.7

    Language:English  

    researchmap

  • 医学科1年生における手指衛生指導の実践と課題

    越智 可奈子, 三好 智子, 小崎 吉訓, 赤穂 宗一郎, 小山 敏広, 山下 範之, 伊野 英男, 松川 昭博, 伊達 勲

    医学教育  2022.7  (一社)日本医学教育学会

     More details

    Event date: 2022.7

    Language:Japanese  

    researchmap

  • コロナ禍が医学生の研修病院やキャリア選択にどのような影響を与えたか

    西村 晏夕眸, 武内 恵太, 小崎 吉訓, 越智 可奈子, 三好 智子, 松川 昭博

    医学教育  2022.7  (一社)日本医学教育学会

     More details

    Event date: 2022.7

    Language:Japanese  

    researchmap

  • 臨床実習前の医学生に対する学生講義の有用性

    武内 恵太, 石井 康道, 吉野 明日香, 松川 昭博, 三好 智子

    医学教育  2022.7  (一社)日本医学教育学会

     More details

    Event date: 2022.7

    Language:Japanese  

    researchmap

  • 腫瘍血管同定のための二重免疫染色と乳癌の予後判定への応用(Double immunostaining for tumor vessel identification and its application in breast cancer prognosis)

    ニン・ウインウイン・・スウエ, 松川 昭博, 藤澤 真義

    日本病理学会会誌  2022.3  (一社)日本病理学会

     More details

    Event date: 2022.3

    Language:English  

    researchmap

  • 4T1細胞放出Wnt7aを含む小胞小体細胞亜群通信に関与し肺への細胞転移を促進(Interclonal Cooperation by Exosomal Wnt7a Promotes Lung Metastasis of the 4T1 Breast Cancer cells)

    李 春寧, 吉村 禎造, 大原 利章, 藤澤 真義, 王 宇沢, 松川 昭博

    日本病理学会会誌  2022.3  (一社)日本病理学会

     More details

    Event date: 2022.3

    Language:English  

    researchmap

  • Spred2は部分的にmiR-506-3p/KLF4/Stat3シグナルをターゲットしてHCCにおいて幹細胞性を制御する(Spred2 regulates stemness in HCC, partly targeting on miR-506-3p/KLF4/Stat3 signaling)

    高 桐, 藤澤 真義, 大原 利章, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2022.3  (一社)日本病理学会

     More details

    Event date: 2022.3

    Language:English  

    researchmap

  • 病態解明に向けた免疫学的アプローチ シグナル伝達からみた炎症・がんの制御

    松川 昭博

    日本病理学会会誌  2022.3  (一社)日本病理学会

     More details

    Event date: 2022.3

    Language:Japanese  

    researchmap

  • 肺腺癌におけるSpred2の発現と増殖・浸潤との関係(The role of Spred2 in lung adenocarcinoma)

    太田 陽子, ガオ・トン, 藤澤 真義, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2022.3  (一社)日本病理学会

     More details

    Event date: 2022.3

    Language:English  

    researchmap

  • 鉄キレート剤による偽低酸素は抗腫瘍効果とCD8+T細胞活性化を両立する(Pseudo-hypoxia by iron chelators consists anti-cancer effect and CD8+ T-cell activation)

    陳 悦華, 大原 利章, 王 宇沢, 濱田 祐輔, 藤澤 真義, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2022.3  (一社)日本病理学会

     More details

    Event date: 2022.3

    Language:English  

    researchmap

  • 転移性トリプルネガティブ乳がんに対する鉄キレート剤の効果(Effects of Iron Chelators on Metastatic Triple-negative Breast Cancer)

    王 宇沢, 李 春寧, 田 ミャオ, 陳 悦華, 吉村 禎造, 藤澤 真義, 大原 利章, 松川 昭博

    日本病理学会会誌  2022.3  (一社)日本病理学会

     More details

    Event date: 2022.3

    Language:English  

    researchmap

  • HCC細胞のオートファジーにおけるSpred2の機能及びm TOR活性化との関係(Role of Spred2 in autophagy in HCC cells and its relation to mTOR activation)

    王 天一, 高 桐, 藤澤 真義, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2022.3  (一社)日本病理学会

     More details

    Event date: 2022.3

    Language:English  

    researchmap

  • 鉄キレート剤は抗腫瘍効果の他に免疫活性効果を持っている(Iron chelator has anti-cancer effect and immune activation effect)

    浜田 祐輔, 大原 利章, 王 宇沢, 陳 悦華, 吉村 禎造, 藤澤 真義, 松川 昭博

    日本病理学会会誌  2022.3  (一社)日本病理学会

     More details

    Event date: 2022.3

    Language:English  

    researchmap

  • Spred2 regulates cancer stemness in HCC cells, targeting on miR-506-3p and its downstream KLF4

    Tong Gao, Aye Moh Moh Aung, Masahiro Fujisawa, Toshiaki Ohara, Teizo Yoshimura, Sachio Ito, Akihiro Matsukawa

    第50回日本免疫学会総会 

     More details

    Event date: 2021.12.8 - 2021.12.10

    Presentation type:Poster presentation  

    researchmap

  • Distinct subpopulations of the murine 4T1 breast cancer cells cooperate with cancer metastasis through Wnt/β-catenin signaling pathway by exosomal Wnt7a

    Chunning Li, Teizo Yoshimura, Akihiro Matsukawa

    第50回日本免疫学会総会 

     More details

    Event date: 2021.12.8 - 2021.12.10

    Presentation type:Poster presentation  

    researchmap

  • コロナ禍における医学科1年次行動科学I~社会におけるコミュニケーション~の実施とアウトカム

    三好智子, 小崎吉訓, 越智可奈子, 吉田登志子, 山根正修, 赤穂宗一郎, 伊野英男, 大塚愛二, 松川昭博

    第53回日本医学教育学会大会 

     More details

    Event date: 2021.7.30 - 2021.7.31

    Presentation type:Oral presentation (general)  

    researchmap

  • 医学科1年生における行動科学授業 「コロナ禍での医学生生活を考える」-コロナ禍での入学の現状と課題

    越智 可奈子, 三好 智子, 小崎 吉訓, 赤穂 宗一郎, 吉田 登志子, 山根 正修, 伊野 英男, 大塚 愛二, 松川 昭博

    第53回日本医学教育学会大会 

     More details

    Event date: 2021.7.30 - 2021.7.31

    Presentation type:Oral presentation (general)  

    researchmap

  • 医学科1年生における行動科学授業「コロナ禍での医学生生活を考える」 コロナ禍での入学の現状と課題

    越智 可奈子, 三好 智子, 小崎 吉訓, 赤穂 宗一郎, 吉田 登志子, 山根 正修, 伊野 英男, 大塚 愛二, 松川 昭博

    医学教育  2021.7  (一社)日本医学教育学会

     More details

    Event date: 2021.7

    Language:Japanese  

    researchmap

  • コロナ禍における医学科1年次行動科学I〜社会におけるコミュニケーション〜の実施とアウトカム

    三好 智子, 小崎 吉訓, 越智 可奈子, 吉田 登志子, 山根 正修, 赤穂 宗一郎, 伊野 英男, 大塚 愛二, 松川 昭博

    医学教育  2021.7  (一社)日本医学教育学会

     More details

    Event date: 2021.7

    Language:Japanese  

    researchmap

  • 4T1乳癌モデルにおいてMCP-1産生を促す癌細胞・線維芽細胞間のクロストーク .

    吉村禎造, 今村真悠, Tiantian Li, 田ミャオ, 李春寧, 藤澤真義, 松川昭博

    第110回日本病理学会総会 

     More details

    Event date: 2021.4.22 - 2021.4.24

    Presentation type:Oral presentation (general)  

    researchmap

  • 4T1乳癌モデルにおいてMCP-1産生を促す癌細胞・線維芽細胞間のクロストーク

    吉村禎造, 今村真悠, Tiantian Li, 田ミャオ, 李春寧, 藤澤真義, 松川昭博

    第110回日本病理学会総会 

     More details

    Event date: 2021.4.22 - 2021.4.24

    Presentation type:Oral presentation (general)  

    researchmap

  • 腫瘍環境のSpred2欠損は4T1乳がん細胞の増殖と転移を抑制する

    Miao Tian, 吉村禎造, 李春寧, 大原利章, 藤澤真義, 松川昭博

    第110回日本病理学会総会 

     More details

    Event date: 2021.4.22 - 2021.4.24

    Presentation type:Poster presentation  

    researchmap

  • 乳癌における傍導管浸潤(periductal invasion)の臨床病理学的意義

    藤澤真義, 大森昌子, 松川昭博

    第110回日本病理学会総会 

     More details

    Event date: 2021.4.22 - 2021.4.24

    Presentation type:Poster presentation  

    researchmap

  • 肺腺癌におけるSpred2の発現の検討と増殖、浸潤との関連

    太田陽子, 藤澤真義, 吉村禎造, IWayan S, ん和彦, 阪口政清, 豊岡伸一, 松川昭博

    第110回日本病理学会総会 

     More details

    Event date: 2021.4.22 - 2021.4.24

    Presentation type:Poster presentation  

    researchmap

  • 癌関連線維芽細胞に対する鉄キレート剤の効果

    王宇沢, 大原利章, 李春寧, 田ミャオ, 小槙志保, 吉村禎造, 藤澤真義, 松川昭博

    第110回日本病理学会総会 

     More details

    Event date: 2021.4.22 - 2021.4.24

    Presentation type:Poster presentation  

    researchmap

  • Spred2はHCCで幹細胞性をmiR-506-3pによって一部負に抑制する

    高桐、藤澤真義、大原利章、吉村禎造、王天一、伊藤佐智夫、松川昭博

    第110回日本病理学会総会 

     More details

    Event date: 2021.4.22 - 2021.4.24

    Presentation type:Oral presentation (general)  

    researchmap

  • 異なる亜集団の腫瘍細胞から放出されたエクソソームWnt7aにより4T1細胞の転移は促進される

    李春寧、大原利章、藤澤真義、阪口政清、山本健一、田ミャオ、王宇沢、吉村禎造、松川昭博

    第110回日本病理学会総会 

     More details

    Event date: 2021.4.22 - 2021.4.24

    Presentation type:Oral presentation (general)  

    researchmap

  • IgG4関連消化器病変の診断における胃生検の有用性

    内野かおり, 能登原憲司, 上原剛, 倉石康弘, 板倉淳哉, 松川昭博

    第110回日本病理学会総会 

     More details

    Event date: 2021.4.22 - 2021.4.24

    Presentation type:Poster presentation  

    researchmap

  • HCC細胞のオートファジーにおけるSpred2の役割とERK活性化との関係

    王天一, 藤澤真義, 大原利章, 吉村禎造, 高桐, 松川昭博

    第110回日本病理学会総会 

     More details

    Event date: 2021.4.22 - 2021.4.24

    Presentation type:Poster presentation  

    researchmap

  • 4T1乳癌モデルにおいてMCP-1産生を促す癌細胞・線維芽細胞間のクロストーク(Crosstalk between cancer cells and fibroblasts for MCP: production of MCP-1 in 4T1 breast cancer)

    吉村 禎造, 今村 真悠, り・てぃあんてぃあん, てぃあん・みあお, 李 春寧, 藤澤 真義, 松川 昭博

    日本病理学会会誌  2021.3  (一社)日本病理学会

     More details

    Event date: 2021.3

    Language:English  

    researchmap

  • 乳癌における傍導管浸潤(periductal invasion)の臨床病理学的意義

    藤澤 真義, 大森 昌子, 松川 昭博

    日本病理学会会誌  2021.3  (一社)日本病理学会

     More details

    Event date: 2021.3

    Language:Japanese  

    researchmap

  • Spred2はHCCで幹細胞性をmiR-506-3pによって一部負に抑制する(Spred2 down-regulates stemness in HCC partly through targeting miR-506-3p)

    高 桐, 藤澤 真義, Aye Moh Moh Aung, 大原 利章, 吉村 禎造, 王 天一, 伊藤 佐智夫, 松川 昭博

    日本病理学会会誌  2021.3  (一社)日本病理学会

     More details

    Event date: 2021.3

    Language:English  

    researchmap

  • 肺腺癌におけるSpred2の発現と増殖、浸潤との関連の検討

    太田 陽子, 藤澤 真義, 吉村 禎造, スマルディカ・イワヤン, 枝園 和彦, 阪口 政清, 豊岡 伸一, 松川 昭博

    日本病理学会会誌  2021.3  (一社)日本病理学会

     More details

    Event date: 2021.3

    Language:Japanese  

    researchmap

  • 癌関連線維芽細胞に対する鉄キレート剤の効果(Effects of Iron Chelators on Cancer-associated Fibroblasts)

    王 宇沢, 大原 利章, 李 春寧, 田 ミャオ, 小槙 志保, 吉村 禎造, 藤澤 真義, 松川 昭博

    日本病理学会会誌  2021.3  (一社)日本病理学会

     More details

    Event date: 2021.3

    Language:English  

    researchmap

  • HCC細胞のオートファジーにおけるSpred2の役割とERK活性化との関係(Role of Spred2 in autophagy in HCC cells and its relation to ERK activation)

    王 天一, 藤澤 真義, 大原 利章, 吉村 禎造, 高 桐, 松川 昭博

    日本病理学会会誌  2021.3  (一社)日本病理学会

     More details

    Event date: 2021.3

    Language:English  

    researchmap

  • 腫瘍環境のSpred2欠損は4T1乳がん細胞の増殖と転移を抑制する(Spred2 deficiency in cancer microenvironment inhibits progression of 4T1 breast cancer cells in mice)

    Tian Miao, 吉村 禎造, 李 春寧, 大原 利章, 藤澤 真義, 松川 昭博

    日本病理学会会誌  2021.3  (一社)日本病理学会

     More details

    Event date: 2021.3

    Language:English  

    researchmap

  • IgG4関連消化器病変の診断における胃生検の有用性(Utility of gastric biopsy in diagnosing IgG4-related gastrointestinal disease)

    内野 かおり, 能登原 憲司, 上原 剛, 倉石 康弘, 板倉 淳哉, 松川 昭博

    日本病理学会会誌  2021.3  (一社)日本病理学会

     More details

    Event date: 2021.3

    Language:English  

    researchmap

  • 異なる亜集団の腫瘍細胞から放出されたエクソソームWnt7aによリ4T1細胞の転移は促進される(4T1 cells promote tumor metastasis by exosomal Wnt7a released from distinct subpopulations)

    李 春寧, 大原 利章, 藤澤 真義, 阪口 政清, 山本 健一, 田 ミャオ, 王 宇沢, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2021.3  (一社)日本病理学会

     More details

    Event date: 2021.3

    Language:English  

    researchmap

  • 先輩から後輩へ〜臨床実習は怖くない〜

    久保卓也, 池内綾介, 窪征宣, 三好智子, 松川昭博

    第52回日本医学教育学会 

     More details

    Event date: 2020.7.17 - 2020.7.18

    researchmap

  • 医学科における国際バカロレア教育修了者の強み〜医学科1年次の行動科学における評価より〜

    三好智子, 山根正修, 小崎吉訓, 佐藤明香, 万代康弘, 吉田登志子, Mahmood Sabina, 伊野英男, 大塚愛二, 松川昭博

    第52回日本医学教育学会 

     More details

    Event date: 2020.7.17 - 2020.7.18

    researchmap

  • 岡山大学医療教育学生会

    久保卓也, 橋本千名津, 松川昭博

    第52回日本医学教育学会 

     More details

    Event date: 2020.7.17 - 2020.7.18

    researchmap

  • 医学科における国際バカロレア教育修了者の強み 医学科1年次の行動科学における評価より

    三好 智子, 山根 正修, 小崎 吉訓, 佐藤 明香, 万代 康弘, 吉田 登志子, Sabina Mahmood, 伊野 英男, 大塚 愛二, 松川 昭博

    医学教育  2020.7  (一社)日本医学教育学会

     More details

    Event date: 2020.7

    Language:Japanese  

    researchmap

  • 岡山大学医療教育学生会 学生会はなぜ続くのか

    久保 卓也, 橋本 千名津, 松川 昭博

    医学教育  2020.7  (一社)日本医学教育学会

     More details

    Event date: 2020.7

    Language:Japanese  

    researchmap

  • 岡山大学医療教育学生会の活動 学生の満足・不満調査の結果と合わせて

    荒木 さくら, 橋本 千名津, 高瀬 ミキ, 瀬尾 里奈, 久保 卓也, 片岡 仁美, 松川 昭博

    医学教育  2020.7  (一社)日本医学教育学会

     More details

    Event date: 2020.7

    Language:Japanese  

    researchmap

  • 留学報告会は学生の留学指向を高める

    前田 雛乃, 久保 卓也, 松川 昭博

    医学教育  2020.7  (一社)日本医学教育学会

     More details

    Event date: 2020.7

    Language:Japanese  

    researchmap

  • 先輩から後輩へ 臨床実習は怖くない

    久保 卓也, 池内 綾介, 窪 征宣, 三好 智子, 松川 昭博

    医学教育  2020.7  (一社)日本医学教育学会

     More details

    Event date: 2020.7

    Language:Japanese  

    researchmap

  • 医学科における国際バカロレア教育修了者の強み 医学科1年次の行動科学における評価より

    三好 智子, 山根 正修, 小崎 吉訓, 佐藤 明香, 万代 康弘, 吉田 登志子, Sabina Mahmood, 伊野 英男, 大塚 愛二, 松川 昭博

    医学教育  2020.7  (一社)日本医学教育学会

     More details

    Event date: 2020.7

    Language:Japanese  

    researchmap

  • 急激な経過をたどりdiffuse alveolar hemorrhageにて死亡したSLEの一例

    河原明奈, 藤澤真義, 松川昭博

    第108回日本病理学会総会 

     More details

    Event date: 2020.4.16 - 2020.4.18

    Presentation type:Poster presentation  

    researchmap

  • 癌転移は,エキソソームの異なる細胞亜群からの放出によって調節される

    李春寧, 吉村禎造, 田ミョウ, 大原利章, 藤澤真義, 松川昭博

    第108回日本病理学会総会 

     More details

    Event date: 2020.4.16 - 2020.4.18

    researchmap

  • Spred2 deficiency exacerbated Concanavalin A-induced liver injury by attracting T cells via CXCL9/10

    孫翠明, 吉村禎造, 藤澤真義, 大原利章, 松川昭博

    第108回日本病理学会総会 

     More details

    Event date: 2020.4.16 - 2020.4.18

    researchmap

  • 食道癌の幹細胞性を制御する鉄キレート療法の開発

    大原利章, 鳴坂徹, Boyi Xing, Yuze Wang, 松川 昭博

    第108回日本病理学会総会 

     More details

    Event date: 2020.4.16 - 2020.4.18

    researchmap

  • Spred2 involved in tumor stemness maintenance down-regulates malignant potential of HepG2 HCC

    高桐, 吉村禎造, 大原利章, 藤澤真義, 松川昭博

    第108回日本病理学会総会 

     More details

    Event date: 2020.4.16 - 2020.4.18

    Presentation type:Poster presentation  

    researchmap

  • 乳癌における血管浸潤の検索法:新規法(Elastin and collagen 4 double staining)と従来法との比較検討

    藤澤真義, 大森昌子, 松川昭博

    第108回日本病理学会総会 

     More details

    Event date: 2020.4.16 - 2020.4.18

    Presentation type:Poster presentation  

    researchmap

  • 乳癌における血管浸潤の検索法 新規法(Elastin and collagen 4 double staining)と従来法との比較検討

    藤澤 真義, 大森 昌子, 松川 昭博

    日本病理学会会誌  2020.3  (一社)日本病理学会

     More details

    Event date: 2020.3

    Language:Japanese  

    researchmap

  • 癌転移は,エキソソームの異なる細胞亜群からの放出によって調節される(Cancer metastasis is regulated via exosomes released from distinct cell subpopulation)

    李 春寧, 吉村 禎造, 田 ミョウ, 大原 利章, 藤澤 真義, 松川 昭博

    日本病理学会会誌  2020.3  (一社)日本病理学会

     More details

    Event date: 2020.3

    Language:English  

    researchmap

  • 食道癌の幹細胞性を制御する鉄キレート療法の開発(Stemness control by iron chelator is a novel therapeutic strategy for esophageal cancer)

    大原 利章, 鳴坂 徹, Xing Boyi, Wang Yuze, 松川 昭博

    日本病理学会会誌  2020.3  (一社)日本病理学会

     More details

    Event date: 2020.3

    Language:English  

    researchmap

  • 急激な経過をたどりdiffuse alveolar hemorrhageにて死亡したSLEの一例

    河原 明奈, 藤澤 真義, 松川 昭博

    日本病理学会会誌  2020.3  (一社)日本病理学会

     More details

    Event date: 2020.3

    Language:Japanese  

    researchmap

  • Spred2は腫瘍幹細胞性の維持に関与しHepG2 HCCの悪性度を低下させる(Spred2 involved in tumor stemness maintenance down-regulates malignant potential of HepG2 HCC)

    高 桐, 吉村 禎造, 大原 利章, 藤澤 真義, 松川 昭博

    日本病理学会会誌  2020.3  (一社)日本病理学会

     More details

    Event date: 2020.3

    Language:English  

    researchmap

  • Spred2欠損はコンカナバリンA誘発性肝傷害をCXCL9/10を介したT細胞の誘引により悪化させる(Spred2 deficiency exacerbated Concanavalin A-induced liver injury by attracting T cells via CXCL9/10)

    孫 翠明, 吉村 禎造, 藤澤 真義, 大原 利章, 松川 昭博

    日本病理学会会誌  2020.3  (一社)日本病理学会

     More details

    Event date: 2020.3

    Language:English  

    researchmap

  • ラット頭蓋骨欠損モデルに対する間葉系幹細胞と凍結乾燥リン酸化プルランの有用性

    村岡聡介, 三澤治夫, 瀧川朋亨, 山根健太郎, 池田吉宏, 辻寛謙, 高尾真一郎, 松川昭博, 尾崎敏文

    日本整形外科学会雑誌  2020 

     More details

    Event date: 2020

    researchmap

  • Granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent and independent production of the chemokine monocyte chemoattractant protein -1 (MCP-1) by macrophages in the 4T1 murine breast cancer.

    Yoshimura T, Mukaida N, Matsukawa A

    第48回日本免疫学会総会 

     More details

    Event date: 2019.12.11

    Presentation type:Poster presentation  

    researchmap

  • 悪性症候群後に発症し、20年以上の経過後死亡した小脳性運動失調症の一剖検例

    千葉陽一, 吉井りつ, 野中和香子, 松川昭博, 佐藤明, 上野正樹

    第10回日本神経病理学会中国四国地方会 

     More details

    Event date: 2019.11.23 - 2019.11.24

    Presentation type:Oral presentation (general)  

    researchmap

  • 膵癌におけるFNA検体と切除検体とのPD-L1発現の検討

    松本 和幸, 高木 章乃夫, 大原 利章, 藤澤 真義, 高原 政宏, 加藤 博也, 吉田 龍一, 楳田 祐三, 八木 孝仁, 松川 昭博, 岡田 裕之

    日本消化器病学会雑誌  2019.11  (一財)日本消化器病学会

     More details

    Event date: 2019.11

    Language:Japanese  

    researchmap

  • Hsa-miR-200b-3p negatively regulates angiogenesis in hepatocellular carcinoma by targeting ERG expression in endothelial cells

    Moh-Moh-Aung A, Fujisawa M, Katayama H, Yoshimura T, Ohara T, Matsukawa A

     More details

    Event date: 2019.10.19 - 2019.10.23

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Extracellular vesicles from cancer cell subpopulation affect metastasis and stemness of distinct cancer cell population

    Li C, Yoshimura T, Tian M, Ohara T, Fujisawa M, Matsukawa A

    17th International Congress of Immunology 

     More details

    Event date: 2019.10.19 - 2019.10.23

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Spred2 deficiency accelerates cancer growth, migration and invasion in HepG2 cells via activating ERK-MAPK pathway

    Gao T, Yang X, Yoshimura T, Fujisawa M, Ohara T, Matsukawa A

     More details

    Event date: 2019.10.19 - 2019.10.23

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Spred2 deficiency exacerbated Concanavalin A-induced liver injury in mice through increased interferon γ production from T cells

    Sun C, Yoshimura T, Fujisawa M, Ohara T, Matsukawa A

     More details

    Event date: 2019.10.19 - 2019.10.23

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • ラットにおけるチタン結合性BMPの骨形成促進効果についての検討

    内野 崇彦, 塩崎 泰之, 吉田 晶, 宇川 諒, 池田 吉宏, 村岡 聡介, 辻 寛謙, 伊藤 嘉浩, 松川 昭博, 尾崎 敏文

    日本整形外科学会雑誌  2019.9  (公社)日本整形外科学会

     More details

    Event date: 2019.9

    Language:Japanese  

    researchmap

  • Education and Research in Okayama University Medical School & Hospital

    Matsukawa A

    2nd International Health Promotion conference 

     More details

    Event date: 2019.8.19 - 2019.8.22

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  • 簡略化した外科指導者養成講習会の実施

    山根正修, 松川昭博

    第51回日本医学教育学会 

     More details

    Event date: 2019.7.26 - 2019.7.27

    Presentation type:Oral presentation (general)  

    researchmap

  • 学生による留学オリエンテーションのいろは

    久保卓也, 今村真悠, 住田まどか, 中村薫, 松川昭博

    第51回日本医学教育学会 

     More details

    Event date: 2019.7.26 - 2019.7.27

    Presentation type:Oral presentation (general)  

    researchmap

  • 行動科学におけるらせん型カリキュラムの必要性

    三好智子, 山根正修, 飯田淳義, 万代康弘, 吉田登志子, 伊野英男, 那須保友, 松川昭博

    第51回日本医学教育学会 

     More details

    Event date: 2019.7.26 - 2019.7.27

    Presentation type:Oral presentation (general)  

    researchmap

  • 学生による留学オリエンテーションのすすめ

    久保 卓也, 今村 真悠, 住田 まどか, 中村 薫, 松川 昭博

    医学教育  2019.7  (一社)日本医学教育学会

     More details

    Event date: 2019.7

    Language:Japanese  

    researchmap

  • The role of tumor cell-derived GM-CSF in the progression of 4T1 murine breast cancer. Invited

    Yoshimura T, Nakamura K, Li C, Fujisawa M, Li T, Mukaida N, Matsukawa A

    The 26th International Symposium on Molecular Cell Biology of Macrophages 

     More details

    Event date: 2019.6.6 - 2019.6.7

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • The relationship between the PD-L1 expression of surgical resected and fine-needle aspiration specimens for patients with pancreatic cancer

    Matsumoto K, Ohara T, Fujisawa M, Takaki A, Takahara M, Kato H, Horiguchi S, Matsukawa A, Okada H

     More details

    Event date: 2019.5.18 - 2019.5.21

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Fpr2-deficiency in Non-tumor Cells Decreases Lung Metastasis of 4T1 Murine Breast Cancer Cells

    吉村 禎造, Weiss Jonathan M, Li Chunning、Li Tiantian, Gong Wanghua, 松川 昭博, Wang Ji Ming

    第108回日本病理学会総会 

     More details

    Event date: 2019.5.9 - 2019.5.11

    Presentation type:Oral presentation (general)  

    researchmap

  • マウス4T1乳癌モデルにおける新たなMCP-1産生機序の同定―腫瘍細胞・線維芽細胞間のクロストーク

    今村 真悠, 藤澤 真, Li Tiantian, 河原 明奈, 松川 昭博, 吉村 禎造

    第108回日本病理学会総会 

     More details

    Event date: 2019.5.9 - 2019.5.11

    Presentation type:Poster presentation  

    researchmap

  • Downregulated miR-200b-3p plays a role in angiogenesis of hepatocellular carcinoma by targeting ERG

    モウモウアウン エイ, 藤澤 真義, 吉村 禎造, 松川 昭博

    第108回日本病理学会総会 

     More details

    Event date: 2019.5.9 - 2019.5.11

    Presentation type:Oral presentation (general)  

    researchmap

  • 癌細胞が産生するGM-CSFは、癌の進展・転移に関わるか? マウス4T1乳癌モデルでの検討

    中村 薫, Li Chunning, Li Tiantian, 藤澤 真義, 松川 昭博, 向田 直史, 吉村 禎造

    第108回日本病理学会総会 

     More details

    Event date: 2019.5.9 - 2019.5.11

    Presentation type:Poster presentation  

    researchmap

  • Spred2 deletion accelerates growth, migration and invasion in HepG2 cells by activating ERK pathway

    高 桐, 楊 旭, 藤澤 真義, 大原 利章, 吉村 禎造, 松川 昭博

    第108回日本病理学会総会 

     More details

    Event date: 2019.5.9 - 2019.5.11

    Presentation type:Poster presentation  

    researchmap

  • Cancer progression can be regulated by exosomes from distinct cell subpopulation

    李 春寧, 田 ミョウ, 大原 利章, 藤澤 真義, 吉村 禎造, 松川 昭博

    第108回日本病理学会総会 

     More details

    Event date: 2019.5.9 - 2019.5.11

    Presentation type:Poster presentation  

    researchmap

  • Spred2 protects mice from ConA-induced liver injury by regulating IFN gamma production

    孫 翠明, 藤澤 真義, 大原 利章, 吉村 禎造, 松川 昭博

    第108回日本病理学会総会 

     More details

    Event date: 2019.5.9 - 2019.5.11

    Presentation type:Poster presentation  

    researchmap

  • 食道癌の幹細胞性を制御する鉄キレート療法の開発

    大原 利章, 鳴坂 徹, Xing Boyi, Chen Yuehua, 松川 昭博

    第108回日本病理学会総会 

     More details

    Event date: 2019.5.9 - 2019.5.11

    Presentation type:Oral presentation (general)  

    researchmap

  • 高齢発症で再発を繰り返し、致死的な経過をたどった若年性顆粒膜細胞腫の一例

    太田 陽子, タテ サン, 伏見 聡一郎, 藤澤 真義, 柳井 広之, 戸田 博子, 大森 昌子, 國友 忠義, 松川 昭博

    第108回日本病理学会総会 

     More details

    Event date: 2019.5.9 - 2019.5.11

    Presentation type:Poster presentation  

    researchmap

  • 乳癌における静脈浸潤の新規検索法

    藤澤真義, モウモウアウン エイ, 柳井 広之, 大森 昌子, 松川 昭博

    第108回日本病理学会総会 

     More details

    Event date: 2019.5.9 - 2019.5.11

    Presentation type:Oral presentation (general)  

    researchmap

  • 肺線維芽細胞の増殖におけるSpred2の役割

    河原 明奈, 水田 亮, 藤澤 真義, 吉村 禎造, 松川 昭博

    第108回日本病理学会総会 

     More details

    Event date: 2019.5.9 - 2019.5.11

    Presentation type:Poster presentation  

    researchmap

  • THE RELATIONSHIP BETWEEN THE PD-L1 EXPRESSION OF SURGICAL RESECTED AND FINE-NEEDLE ASPIRATION SPECIMENS FOR PATIENTS WITH PANCREATIC CANCER

    Matsumoto Kazuyuki, Ohara Toshiaki, Fujisawa Masayoshi, Takaki Akinobu, Takahara Masahiro, Kato Hironari, Horiguchi Shigeru, Matsukawa Akihiro, Okada Hiroyuki

    GASTROENTEROLOGY  2019.5 

     More details

    Event date: 2019.5

    researchmap

  • 乳癌における静脈浸潤の新規検索法

    藤澤 真義, モウモウアウン・エイ, 柳井 広之, 大森 昌子, 松川 昭博

    日本病理学会会誌  2019.4  (一社)日本病理学会

     More details

    Event date: 2019.4

    Language:Japanese  

    researchmap

  • Spred2はINF gamma生産を調節することによりマウスのConA誘発肝障害を予防する(Spred2 protects mice from ConA-induced liver injury by regulating IFN gamma production)

    孫 翠明, 藤澤 真義, 大原 利章, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2019.4  (一社)日本病理学会

     More details

    Event date: 2019.4

    Language:English  

    researchmap

  • 癌細胞が産生するGM-CSFは、癌の進展・転移に関わるか? マウス4T1乳癌モデルでの検討

    中村 薫, Li Chunning, Li Tiantian, 藤澤 真義, 松川 昭博, 向田 直史, 吉村 禎造

    日本病理学会会誌  2019.4  (一社)日本病理学会

     More details

    Event date: 2019.4

    Language:Japanese  

    researchmap

  • マウス4T1乳癌モデルにおける新たなMCP-1産生機序の同定 腫瘍細胞・線維芽細胞間のクロストーク

    今村 真悠, 藤澤 真義, Li Tiantian, 河原 明奈, 松川 昭博, 吉村 禎造

    日本病理学会会誌  2019.4  (一社)日本病理学会

     More details

    Event date: 2019.4

    Language:Japanese  

    researchmap

  • HepG2細胞におけるSpred2遺伝子の不活化はERK経路を活性化して細胞増殖、移動および浸潤を促進する(Spred2 deletion accelerates growth, migration and invasion in HepG2 cells by activating ERK pathway)

    高 桐, 楊 旭, 藤澤 真義, 大原 利章, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2019.4  (一社)日本病理学会

     More details

    Event date: 2019.4

    Language:English  

    researchmap

  • 食道癌の幹細胞性を制御する鉄キレート療法の開発(Stemness control by iron chelator can be a novel therapeutic strategy for esophageal cancer)

    大原 利章, 鳴坂 徹, Xing Boyi, Chen Yuehua, 松川 昭博

    日本病理学会会誌  2019.4  (一社)日本病理学会

     More details

    Event date: 2019.4

    Language:English  

    researchmap

  • 肺線維芽細胞の増殖におけるSpred2の役割

    河原 明奈, 水田 亮, 藤澤 真義, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2019.4  (一社)日本病理学会

     More details

    Event date: 2019.4

    Language:Japanese  

    researchmap

  • miR-200b-3p発現低下は転写因子ERGを標的として肝細胞癌の血管新生に関与する(Downregulated miR-200b-3p plays a role in angiogenesis of hepatocellular carcinoma by targeting ERG)

    エイ・モウモウ・アウン, 藤澤 真義, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2019.4  (一社)日本病理学会

     More details

    Event date: 2019.4

    Language:English  

    researchmap

  • 高齢発症で再発を繰り返し、致死的な経過をたどった若年性顆粒膜細胞腫の一例(Juvenile granulosa cell tumor with unusual clinical course: a late-onset and late recurrent case)

    太田 陽子, タテ・サン, 伏見 聡一郎, 藤澤 真義, 柳井 広之, 戸田 博子, 大森 昌子, 國友 忠義, 松川 昭博

    日本病理学会会誌  2019.4  (一社)日本病理学会

     More details

    Event date: 2019.4

    Language:English  

    researchmap

  • 非腫瘍細胞におけるFpr2欠損は4T1マウス乳癌細胞の肺転移を抑制する(Fpr2-deficiency in Non-tumor Cells Decreases Lung Metastasis of 4T1 Murine Breast Cancer Cells)

    吉村 禎造, Weiss Jonathan M., Li Chunning, Li Tiantian, Gong Wanghua, 松川 昭博, Wang Ji MIng

    日本病理学会会誌  2019.4  (一社)日本病理学会

     More details

    Event date: 2019.4

    Language:English  

    researchmap

  • 異なる細胞亜集団に由来するエキソソームによって癌の進行が制御される可能性(Cancer progression can be regulated by exosomes from distinct cell subpopulation)

    李 春寧, 田 ミョウ, 大原 利章, 藤澤 真義, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2019.4  (一社)日本病理学会

     More details

    Event date: 2019.4

    Language:English  

    researchmap

  • ラットにおけるチタン結合性BMPの骨形成促進効果についての検討

    内野 崇彦, 塩崎 泰之, 吉田 晶, 宇川 諒, 池田 吉宏, 村岡 聡介, 辻 寛謙, 伊藤 嘉浩, 松川 昭博, 尾崎 敏文

    移植  2019.3  (一社)日本移植学会

     More details

    Event date: 2019.3

    Language:Japanese  

    researchmap

  • 新規多糖誘導体リン酸化プルランフィルムとBMP-2の併用はラット脊椎固定モデルにおいて骨癒合を促進する

    宇川 諒, 塩崎 泰之, 村岡 聡介, 池田 吉宏, 辻 寛謙, 吉田 晶, 吉原 久美子, 瀧川 朋亨, 三澤 治夫, 尾崎 敏文, 松川 昭博

    Journal of Spine Research  2019.3  (一社)日本脊椎脊髄病学会

     More details

    Event date: 2019.3

    Language:Japanese  

    researchmap

  • Spred2 deficiency exacerbates adipose tissue inflammation and systemic insulin resistance in mice.

    Ohkura T, Yoshimura T, Matsukawa A

    第47回日本免疫学会学術集会 

     More details

    Event date: 2018.12.10 - 2018.12.12

    Presentation type:Symposium, workshop panel (public)  

    researchmap

  • What did Behavior Sciences bring to first year students in Okayama Medical school, Japan?

    Miyoshi T, Yamane M, Iida A, Mandai Y, Matsukawa A, Nasu Y

    AMEE 2018 

     More details

    Event date: 2018.8.25 - 2018.8.29

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 学生企画によるアクティブ・ラーニング型研究オリエンテーション・報告会の実践報告

    久保卓也, 今村真悠, 住田まどか, 林田慎太郎, 松川昭博

    第50回日本医学教育学会 

     More details

    Event date: 2018.8.3 - 2018.8.4

    researchmap

  • 臨床現場に繋がる継続的なプロフェショナリズム教育を目指して

    片岡仁美, 小比賀美香子, 川畑智子, 勅使河原早苗, 渡邉真由, 三好智子, 小川弘子, 岩瀬敏秀, 佐藤勝, 佐藤明香, 大塚文男, 山根正修, 松川昭博

    第53回日本医学教育学会 

     More details

    Event date: 2018.8.3 - 2018.8.4

    researchmap

  • 学生が研究を通して自らの成長に期待すること

    住田まどか, 久保卓也, 今村真悠, 林田慎太郎, 松川昭博

    第53回日本医学教育学会 

     More details

    Event date: 2018.8.3 - 2018.8.4

    researchmap

  • 学生が医学研究インターンシップにおける研究室(学内・国内・海外)選択で考慮する要因

    今村真悠, 久保卓也, 住田まどか, 林田慎太郎, 松川昭博

    第50回日本医学教育学会 

     More details

    Event date: 2018.8.3 - 2018.8.4

    researchmap

  • 骨形成促進のための整形外科バイオマテリアル ラットにおけるチタン結合性BMPの骨形成促進効果についての検討

    内野 崇彦, 塩崎 泰之, 吉田 晶, 宇川 諒, 池田 吉宏, 村岡 聡介, 辻 寛謙, 野田 知之, 伊藤 嘉浩, 尾崎 敏文, 松川 昭博

    日本整形外科学会雑誌  2018.8  (公社)日本整形外科学会

     More details

    Event date: 2018.8

    Language:Japanese  

    researchmap

  • 骨形成促進のための整形外科バイオマテリアル ラットにおけるチタン結合性BMPの骨形成促進効果についての検討

    内野 崇彦, 塩崎 泰之, 吉田 晶, 宇川 諒, 池田 吉宏, 村岡 聡介, 辻 寛謙, 野田 知之, 伊藤 嘉浩, 尾崎 敏文, 松川 昭博

    日本整形外科学会雑誌  2018.8  (公社)日本整形外科学会

     More details

    Event date: 2018.8

    Language:Japanese  

    researchmap

  • 学生が医学研究インターンシップにおける研究室(学内・国内・海外)選択で考慮する要因

    今村 真悠, 久保 卓也, 住田 まどか, 林田 慎太郎, 松川 昭博

    医学教育  2018.7  (一社)日本医学教育学会

     More details

    Event date: 2018.7

    Language:Japanese  

    researchmap

  • 学生が研究を通して自らの成長に期待すること

    住田 まどか, 久保 卓也, 今村 真悠, 林田 慎太郎, 松川 昭博

    医学教育  2018.7  (一社)日本医学教育学会

     More details

    Event date: 2018.7

    Language:Japanese  

    researchmap

  • 学生企画によるアクティブ・ラーニング型研究オリエンテーション・報告会の実践報告

    久保 卓也, 今村 真悠, 住田 まどか, 林田 慎太郎, 松川 昭博

    医学教育  2018.7  (一社)日本医学教育学会

     More details

    Event date: 2018.7

    Language:Japanese  

    researchmap

  • 胎児期に一過性骨髄異常増殖症を発症し胎盤にfetal thrombotic vasculopathyを伴ったダウン症候群の1例

    濱崎友洋, 藤澤真義, 伏見聡一郎, 堀田真智子, 苗村智, 和仁洋治, 宮原宏幸, 吉村禎造, 松川昭博

    第107回日本病理学会学術集会 

     More details

    Event date: 2018.6.21 - 2018.6.23

    Presentation type:Poster presentation  

    researchmap

  • Spred-2 protects mice from ConA-induced liver injury

    Sun C, Yshimura T, Fujisawa M, Ohara T, Yang Xu, Matsukawa A

     More details

    Event date: 2018.6.21 - 2018.6.23

    Presentation type:Oral presentation (general)  

    researchmap

  • miRNA-200b-3p may play a role in angiogenesis of hepatocellular carcinoma by targeting ERG

    Moh-Moh-Aung A, Fujisawa M, Yoshimura T, Matsukawa A

    第107回日本病理学会学術集会 

     More details

    Event date: 2018.6.21 - 2018.6.23

    Presentation type:Poster presentation  

    researchmap

  • Spred2 deficiency exacerbates visceral adipose tissue inflammation and insulin resistance in mice

    Ohkura T, Marutani R, Yoshimura T, Fujisawa M, Ohara T, Matsukawa A

    第107回日本病理学会学術集会 

     More details

    Event date: 2018.6.21 - 2018.6.23

    Presentation type:Oral presentation (general)  

    researchmap

  • ヒト卵巣癌における線維芽細胞の由来

    藤澤真義, 柳井広之, 和仁洋治, 伏見聡一朗, 松川昭博

    第107回日本病理学会学術集会 

     More details

    Event date: 2018.6.21 - 2018.6.23

    researchmap

  • The role of tumor cell-derived GM-CSF in the progression of 4T1 murine breast cancer.

    Yoshimura T, Nakamura K, Sato M, Li C, Fujisawa M, Mukaida N, Matsukawa A

    第107回日本病理学会学術集会 

     More details

    Event date: 2018.6.21 - 2018.6.23

    Presentation type:Oral presentation (general)  

    researchmap

  • ブレオマイシン肺線維症モデルにおけるSpred-2の役割

    河原明奈, 水田亮, 藤澤真義, 吉村禎造, 松川昭博

    第107回日本病理学会学術集会 

     More details

    Event date: 2018.6.21 - 2018.6.23

    Presentation type:Oral presentation (general)  

    researchmap

  • Ras-Raf-ERK/MAPK経路とその制御因子Spred2による炎症・がんの制御

    松川昭博

    第107回日本病理学会学術集会 

     More details

    Event date: 2018.6.21

    Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • 除鉄による癌幹細胞の幹細胞性マーカーと機能は制御される(Iron depletion suppress the stemness markers and functions of cancer stem cells)

    大原 利章, Sun Yingfu, 友野 靖子, 松川 昭博

    日本病理学会会誌  2018.4  (一社)日本病理学会

     More details

    Event date: 2018.4

    Language:English  

    researchmap

  • microRNA 200b-3pはERGを標的とすることで肝細胞癌の血管新生に関与している可能性がある(MicroRNA 200b-3p May Play a Role in Angiogenesis of Hepatocellular Carcinoma by Targeting ERG)

    エイ・モゥモゥ・アウン, 藤澤 真義, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2018.4  (一社)日本病理学会

     More details

    Event date: 2018.4

    Language:English  

    researchmap

  • 4T1マウス乳癌の進展におけるがん細胞由来GM-CSFの果たす役割(The role of tumor cell-derived GM-CSF in the progression of 4T1 murine breast cancer)

    吉村 禎造, 中村 薫, 佐藤 美和, 李 春寧, 藤澤 真義, 向田 直史, 松川 昭博

    日本病理学会会誌  2018.4  (一社)日本病理学会

     More details

    Event date: 2018.4

    Language:English  

    researchmap

  • ブレオマイシン肺線維症モデルにおけるSpred-2の役割

    河原 明奈, 水田 亮, 藤澤 真義, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2018.4  (一社)日本病理学会

     More details

    Event date: 2018.4

    Language:Japanese  

    researchmap

  • ヒト卵巣癌における線維芽細胞の由来

    藤澤 真義, 柳井 広之, 和仁 洋治, 伏見 聡一郎, 松川 昭博

    日本病理学会会誌  2018.4  (一社)日本病理学会

     More details

    Event date: 2018.4

    Language:Japanese  

    researchmap

  • 免疫病理学の新展開 Ras-Raf-ERK/MAPK経路とその制御因子Spred-2による炎症・がんの制御

    松川 昭博

    日本病理学会会誌  2018.4  (一社)日本病理学会

     More details

    Event date: 2018.4

    Language:Japanese  

    researchmap

  • 肺腺がんにおけるSpred2の役割の解明

    太田 陽子, 藤澤 真義, 吉村 禎造, スマルディカ・イワヤン, 枝園 和彦, 阪口 政清, 豊岡 伸一, 松川 昭博

    日本病理学会会誌  2018.4  (一社)日本病理学会

     More details

    Event date: 2018.4

    Language:Japanese  

    researchmap

  • Spred2欠損は内臓脂肪織炎、インスリン抵抗性を増悪させる

    大倉 隆宏, 丸谷 梨栄, 吉村 禎造, 藤澤 真義, 大原 利章, 松川 昭博

    日本病理学会会誌  2018.4  (一社)日本病理学会

     More details

    Event date: 2018.4

    Language:Japanese  

    researchmap

  • 除鉄による癌幹細胞の幹細胞性マーカーと機能は制御される(Iron depletion suppress the stemness markers and functions of cancer stem cells)

    大原 利章, Sun Yingfu, 友野 靖子, 松川 昭博

    日本病理学会会誌  2018.4  (一社)日本病理学会

     More details

    Event date: 2018.4

    Language:English  

    researchmap

  • 胎児期に一過性骨髄異常増殖症を発症し胎盤にfetal thrombotic vasculopathyを伴ったダウン症の1例

    濱崎 友洋, 藤澤 真義, 伏見 聡一郎, 堀田 真智子, 苗村 智, 和仁 洋治, 吉村 禎造, 松川 昭博

    日本病理学会会誌  2018.4  (一社)日本病理学会

     More details

    Event date: 2018.4

    Language:Japanese  

    researchmap

  • ラット脊椎固定モデルにおけるrhBMP2添加リン酸化プルランフィルムの有用性の検討

    宇川 諒, 塩崎 泰之, 村岡 聡介, 池田 吉弘, 内野 崇彦, 小田 孔明, 吉村 将秀, 吉田 晶, 瀧川 朋亨, 三澤 治夫, 尾崎 敏文, 松川 昭博

    移植  2018.2  (一社)日本移植学会

     More details

    Event date: 2018.2

    Language:Japanese  

    researchmap

  • 鉄キレート剤の幹細胞性制御による新規癌治療法の確立

    大原利章, 大原利章, 桂佑貴, 野間和広, 鳴坂徹, 二宮卓之, 友野靖子, 田澤大, 香川俊輔, 白川靖博, 松川昭博, 藤原俊義

    日本消化器癌発生学会総会プログラム・抄録集  2018 

     More details

    Event date: 2018

    researchmap

  • ラットにおけるチタン結合性BMPの骨形成促進効果についての検討

    内野崇彦, 塩崎泰之, 吉田晶, 宇川諒, 池田吉宏, 村岡聡介, 辻寛謙, 伊藤嘉浩, 松川昭博, 尾崎敏文

    移植(Web)  2018 

     More details

    Event date: 2018

    researchmap

  • ラット脊椎固定モデルにおけるrhBMP2添加リン酸化プルランフィルムの有用性の検討

    宇川諒, 塩崎泰之, 村岡聡介, 吉田晶, 瀧川朋亨, 三澤治夫, 尾崎敏文, 松川昭博

    Journal of Spine Research  2018 

     More details

    Event date: 2018

    researchmap

  • 多糖複合体を担体とした抗菌薬伝達システムの開発

    渡邉 典行, 吉田 晶, 田中 雅人, 松川 昭博, 尾崎 敏文

    日本整形外科学会雑誌  2017.8  (公社)日本整形外科学会

     More details

    Event date: 2017.8

    Language:Japanese  

    researchmap

  • Spred-2欠損はGalN/LPS誘導性の急性肝障害を悪化させる

    楊旭, 吉村禎造, 藤澤真義, 大原利章, 佐藤美和, 美野愛, 松川昭博

    第106回日本病理学会総会  2017 

     More details

    Event date: 2017.4.27 - 2017.4.29

    researchmap

  • polyI:CによるAktリン酸化抑制を介した腫瘍細胞の転移抑制機構(Poly I:C suppress migration of carcinoma cells by inhibiting Akt phosphorylation)

    山口 隆廣, 吉村 禎造, 大原 利章, 藤澤 真義, 松川 昭博

    日本病理学会会誌  2017.3  (一社)日本病理学会

     More details

    Event date: 2017.3

    Language:English  

    researchmap

  • ラブドイド形質を呈した低分化大腸癌の一例

    太田 陽子, 伏見 聡一郎, 堀田 真智子, 河田 卓也, 板倉 淳哉, 藤澤 真義, 和仁 洋治, 松川 昭博

    日本病理学会会誌  2017.3  (一社)日本病理学会

     More details

    Event date: 2017.3

    Language:Japanese  

    researchmap

  • Effects of faculty development for graduate medical education

    Miyoshi T, Obika M, Kataoka H, Noma K, Otsuka F, Mahmood S, Matsukawa A, Makino H

    AMEE 

     More details

    Event date: 2015.9.5 - 2015.9.9

    researchmap

  • Biodegradation of phosphopullulan-cementfor bone regeneration in Vitro And in Vivo

    Yoshida A, Yamane K, Kagawa Y, Sakaguchi E, Nakamura M, Yoshida Y, Matsukawa A, Ozaki T

    ORS 61th annual meeting 

     More details

    Event date: 2015.3.28 - 2015.3.31

    researchmap

  • Anti-inflammatory effect of Hepatocyte Growth factor in Acute Phase of Spinal cord injury

    Yamane K, Kagawa Y, Shinohara K, Watanabe N, Yoshida A, Matsukawa A, Ozaki T

    ORS 61th annual meeting 

     More details

    Event date: 2015.3.28 - 2015.3.31

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • Implant coating technology with new bioadhesive Materials

    Kagawa Y, Yamane K, Shinohara K, Watanabe N, Yoshida A, Matsukawa A, Ozaki T

    ORS 61th annual meeting 

     More details

    Event date: 2015.3.28 - 2015.3.31

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Neural regeneration in spinal cord injury using combination of photoreactive gelatin and fusion protein of hepatocyte growth factor.

    Yamane K, Mazaki T, Yoshida A, Yoshida Y, Nakamura M, Kitajima T, Ito Y, Matsukawa A, Ozaki T

    ORS 60th annual meeting 

     More details

    Event date: 2014.3.15 - 2014.3.18

    researchmap

  • Articular Cartilage Repair Using A Photo-crosslinkable Gelatin With BMP4 Fusion Protein With Collagen Binding Domain (CBD-BMP4) In Rabbits

    Mazaki T, Ito Y, Matsukawa A, Ozaki T

    ORS 60th annual meeting 

     More details

    Event date: 2014.3.15 - 2014.3.18

    researchmap

  • Comparison of macrophage morphology and phenotypes in type 1 autoimmune pancreatitis and other inflammatory diseases of the digestive organs

    Uchino K, Notohara K, Wani Y, Fujisawa M, Matsukawa A

    International symposium. IgG4-RD & associated conditions 

     More details

    Event date: 2014.2.16 - 2014.2.19

    researchmap

  • The impact of Spred-2 on colonic repair in mice with DSS-undued colitis

    Takahashi S, Fushimi S, Ito T, Inokuchi T, Nakarai A, Akita M, Harada K, Hiraoka S, Okada H, Yamamoto K, Matsukawa A

    UEG Week 2013 

     More details

    Event date: 2013.10.12 - 2013.10.16

    researchmap

  • Spred-2 deficiency exacebates Influenza A Virus (H1N1)-induced Pneumonia

    Ito T, Yoshimura A, Matsukawa A

    15th International Congress of Immunology 

     More details

    Event date: 2013.8.22 - 2013.8.27

    researchmap

  • Notch system in the linkage of innate and adaptive immunity in pulmonary infectious diseases

    Ito T, Matsukawa A

    21th International Symposium on Molecular Cell Biology of Macrophages 

     More details

    Event date: 2013.5.21 - 2013.5.22

    researchmap

  • 多彩な組織像を示す乳腺腺様嚢胞癌の3例

    大森 昌子, 豊田 博, 柳井 広之, 高田 尚良, 松川 昭博, 吉野 正

    日本病理学会会誌  2013.4  (一社)日本病理学会

     More details

    Event date: 2013.4

    Language:Japanese  

    researchmap

  • Spred2欠損マウスは敗血症性抵抗性を示す

    板倉 淳哉, 伊藤 利洋, 佐藤 美和, 美野 愛, 伏見 聡一郎, 松川 昭博

    日本病理学会会誌  2013.4  (一社)日本病理学会

     More details

    Event date: 2013.4

    Language:Japanese  

    researchmap

  • Spred-2発現ベクターの作製とその応用

    篠倉 美理, 木村 亮二朗, 伊藤 利洋, 松川 昭博

    日本病理学会会誌  2013.4  (一社)日本病理学会

     More details

    Event date: 2013.4

    Language:Japanese  

    researchmap

  • 1型自己免疫性膵炎におけるマクロファージの分布の検討

    内野 かおり, 能登原 憲司, 藤澤 真義, 和仁 洋治, 松川 昭博

    日本病理学会会誌  2013.4  (一社)日本病理学会

     More details

    Event date: 2013.4

    Language:Japanese  

    researchmap

  • 硬組織接着性多糖誘導体リン酸化プルランの骨再生能の検討

    山根 健太郎, 塩崎 泰之, 馬崎 哲朗, 杉本 佳久, 瀧川 朋亨, 田中 雅人, 松川 昭博, 尾崎 敏文

    Journal of Spine Research  2013.3  (一社)日本脊椎脊髄病学会

     More details

    Event date: 2013.3

    Language:Japanese  

    researchmap

  • rticular cartilage repair using a photo-crosslinkable gelatin with mone marrow derived stromal cells in rabbits

    Mazaki T, Shiozaki Y, Yamane K, Yoshida A, Matsukawa A, Yoshida Y, Nakamura M, Kitajima T, Ito Y, Ozaki T

    2013 ORS annual meeting 

     More details

    Event date: 2013.1.26 - 2013.1.29

    researchmap

  • マウスにおける改変型成長因子Collagen binding domain BMP4の効果

    塩崎 泰之, 馬崎 哲朗, 吉田 晶, 山根 健太郎, 田中 雅人, 松川 昭博, 尾崎 敏文

    移植  2012.12  (一社)日本移植学会

     More details

    Event date: 2012.12

    Language:Japanese  

    researchmap

  • コラーゲン結合性骨形成蛋白質BMP4の骨芽細胞に対する影響

    吉田 晶, 古松 毅之, 塩崎 泰之, 馬崎 哲朗, 松川 昭博, 中村 真理子, 吉田 靖弘, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文

    移植  2012.12  (一社)日本移植学会

     More details

    Event date: 2012.12

    Language:Japanese  

    researchmap

  • ウサギの骨欠損モデルにおいてコラーゲン結合性骨形成蛋白質は骨形成を促進する

    吉田 晶, 塩崎 泰之, 馬崎 哲朗, 古松 毅之, 松川 昭博, 中村 真理子, 吉田 靖弘, 北島 隆, 伊藤 嘉浩, 尾崎 敏文

    日本バイオマテリアル学会大会予稿集  2012.11  日本バイオマテリアル学会

     More details

    Event date: 2012.11

    Language:Japanese  

    researchmap

  • マウスを用いた遺伝子改変成長因子Collagen binding domain BMP4の効果

    塩崎 泰之, 馬崎 哲郎, 山根 健太郎, 吉田 靖弘, 中村 真理子, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文, 松川 昭博

    日本バイオマテリアル学会大会予稿集  2012.11  日本バイオマテリアル学会

     More details

    Event date: 2012.11

    Language:Japanese  

    researchmap

  • 家兎骨軟骨欠損モデルにおける可視光硬化ゼラチンの骨軟骨組織修復の効果

    馬崎 哲朗, 塩崎 泰之, 吉田 晶, 松川 昭博, 中村 真理子, 吉田 靖弘, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文

    日本バイオマテリアル学会大会予稿集  2012.11  日本バイオマテリアル学会

     More details

    Event date: 2012.11

    Language:Japanese  

    researchmap

  • Clinical significance of CD204-positive M2 macrophage in colorectal cancer.

    Fushimi S, Matsumoto M, Takahashi S, Ogino T, Itakura J, Ito T, Matsukawa A

    The 24th European Congress of Pathology 

     More details

    Event date: 2012.9.8 - 2012.9.12

    Language:English  

    researchmap

  • コラーゲン結合型BMP4の骨芽細胞に対する影響

    吉田 晶, 馬崎 哲朗, 塩崎 泰之, 古松 毅之, 松川 昭博, 中村 真理子, 吉田 靖弘, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文

    日本整形外科学会雑誌  2012.8  (公社)日本整形外科学会

     More details

    Event date: 2012.8

    Language:Japanese  

    researchmap

  • ウサギ尺骨骨欠損モデルを用いたリン酸化プルランの骨再生能の検討

    山根 健太郎, 塩崎 泰之, 馬崎 哲朗, 吉田 晶, 杉本 佳久, 瀧川 朋亨, 田中 雅人, 松川 昭博, 尾崎 敏文

    日本整形外科学会雑誌  2012.8  (公社)日本整形外科学会

     More details

    Event date: 2012.8

    Language:Japanese  

    researchmap

  • ウサギの骨欠損モデルにおけるコラーゲン結合性骨形成蛋白質の有効性

    馬崎 哲朗, 塩崎 泰之, 吉田 晶, 松川 昭博, 中村 真理子, 吉田 靖弘, 北嶋 隆, 伊藤 嘉浩, 尾崎 敏文

    日本整形外科学会雑誌  2012.8  (公社)日本整形外科学会

     More details

    Event date: 2012.8

    Language:Japanese  

    researchmap

  • 「患者から学ぶ」臨床実習のための授業 私たち学習者ができること

    光田 栄子, 徳増 一樹, 小林 宏紀, 中村 千華, 松谷 歩, 後藤 良子, 清水 大, 松本 聖, 松川 昭博, 松岡 賢市, 久本 晃子

    医学教育  2012.7  (一社)日本医学教育学会

     More details

    Event date: 2012.7

    Language:Japanese  

    researchmap

  • 岡山大学医学部医学科クリニカルクラークシップハンドブック

    徳増 一樹, 光田 栄子, 小林 宏紀, 中村 千華, 清水 大, 大西 康博, 羽田 佑, 後藤 良子, 和泉 誠人, 碓井 喜明, 波戸本 理絵, 高橋 達也, 多屋 彗, 松谷 歩, 松川 昭博

    医学教育  2012.7  (一社)日本医学教育学会

     More details

    Event date: 2012.7

    Language:Japanese  

    researchmap

  • Spred-2 negatively regulates influenza A virus (H1N1)-induced pneumonia

    Ito T, Yoshimura A, Matsukawa A

    99th Annual Meeting, The American Association of Immunologists 

     More details

    Event date: 2012.5.4 - 2012.5.8

    Language:English  

    researchmap

  • EXPRESSION OF OTHER M2-MACROPHAGE MARKERS IN CD163+ DENDRITIC MACROPHAGES IN LYMPHOPLASMACYTIC SCLEROSING PANCREATITIS

    Uchino K, Notohara K, Fujisawa S, Wani Y, Matsukawa A

    USCAP 2012 Annual meeting 

     More details

    Event date: 2012.3.17 - 2012.3.23

    Language:English  

    researchmap

  • Negative regulation of cytokine signaling in inflammation Invited

    MATSUKAWA A

    The 5th International symposium for future technology creating better human health and society 

     More details

    Event date: 2012.3.15 - 2012.3.16

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  • 抗酸菌性肉芽腫形成時の混合型白血病(MLL)の病理学的役割(Pathological role of mixed lineage leukemia (MLL) during mycobacterial granuloma formation)

    伊藤 利洋, 板倉 淳哉, 伏見 聡一郎, 荻野 哲也, Kunkel Steven, 松川 昭博

    日本病理学会会誌  2012.3  (一社)日本病理学会

     More details

    Event date: 2012.3

    Language:English  

    researchmap

  • Growth FactorGrowth Factor with New Features: Development of Collagen Binding Domain

    Mazaki T, Shiozaki Y, Yoshida A, Matsukawa A, Yoshida Y, Nakamura M, Kitajima T, Ito Y, Ozaki T

    BMP4ORS 

     More details

    Event date: 2012.2.4 - 2012.2.7

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Thioredoxin-1 suppresses lung inflammation and oxidative injury in influenza virus-induced pneumonia in mice

    Yashiro M, Tsukahara H, Matsukawa A, Fujii Y, Nagaoka Y, Tsuge M, Yamashita N, Masutani H, Yodoi J, Hoshino Y, Morishima T

    15th US-Japan Acute Respiratory Infections Panel Meeting 

     More details

    Event date: 2011.11.12 - 2011.11.15

    Language:English   Presentation type:Poster presentation  

    researchmap

  • The role of SOCS3 and SOCS5 in a murine model of arthritis induced by anti-type II collagen antibody.

    Takahata T, Matsukawa A, Nishida K, Ozaki T

    The 17th International Rheumatology Symposium 

     More details

    Event date: 2008.4.20 - 2008.4.23

    Language:English   Presentation type:Poster presentation  

    researchmap

  • The CXC chemokine GRO is a principal mediator for neutrophil infiltration in lipopolysacchride (LPS)-induced uveitis in rabbits.

    Mo JS, Matsukawa A, Ohkawara S, Yoshinaga M

    Association for Research in Vision and Ophthalmology Annual Meeting 

     More details

    Event date: 1999.5.9 - 1999.5.14

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Neutralization of IL-13 increases lethality in a murine model of acute septic peritonitis

    Matsukawa A, Lukacs NW, Strieter RM, Kunkel SL

    Experimental biology 

     More details

    Event date: 1999.4.17 - 1999.4.21

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • Sequential generation of cytokines during initiative phase of inflammation, with reference to neutrophils. Invited

    Matsukawa A, Yoshinaga M

    The 3rd World Congress on Inflammation 

     More details

    Event date: 1997.11.16 - 1997.11.20

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  • Experimental pulmonary granuloma formation induced by Propionibacterium acnes in sensitized rabbit

    Ichiyasu H, Suga M, Kohrogi H, Mizobe T, Yamanaka T, Yamamoto T, Iyonaga K, Takahashi T, Mastukawa A, Yoshinaga M, Ando M

    5th WASOG Meeing 

     More details

    Event date: 1997.9.17 - 1997.9.19

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • Experimental pulmonary granuloma formation induced by Propionibacterium acnes

    Ichiyasu H, Suga M, Mizobe T, Yamanaka T, Yamamoto T, Iyonaga K, Takahashi T, Mastukawa A, Yoshinaga M, Ando M

    American Thoracic Society International Conference 

     More details

    Event date: 1997.5.16 - 1997.5.21

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • Homologous IL-8 induces destruction of cartilage, and production of IL-1 and IL-1 receptor antagonist in rabbits.

    Matsukawa A, Yoshimura T, Maeda T, Ohkawara S, Yoshinaga M

    The 9th International congress of Immunology 

     More details

    Event date: 1995.7.23 - 1995.7.29

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • The tissue distribution of IL-1receptor antagonist (IL-1Ra) in normal rabbits

    Matsukawa A, Maeda T, Ohkawara S, Yoshinaga M

     More details

    Event date: 1995.5.18 - 1995.5.19

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • Role of Tumor necrosis factor-a, Interleukin-1 and Interleukin-1 receptor antagonist during the course of LPS-induced arthritis in rabbits

    Matsukawa A, Ohkawara S, Maeda T, Edamitsu S, Kimura M, Fukumoto T, Takagi K, Yoshinaga M

    Lymphokine and Cytokine Workshop 

     More details

    Event date: 1993.10.17 - 1993.10.21

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • Role of IL-1 and IL-1ra in the pathogenesis of LPS-induced arthritis in rabbits

    Matsukawa A, Ohkawara S, Maeda T, Yoshinaga M

    WACIID 

     More details

    Event date: 1993

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • What did Behavior Sciences bring to first year students in Okayama Medical school, Japan?

    AMEE 2018  2018 

     More details

  • Sarcomatoid changeがみられたclear cell RCC with unusual papillary configurationの一例

    第63回日本病理学会秋期特別総会  2017 

     More details

  • 生体適合性の高いリン酸化プルランを用いて抗菌薬コーティングしたインプラントの感染予防能

    第37回整形外科バイオマテリアル研究会  2017 

     More details

  • ラットにおけるチタン結合性BMPの骨形成促進効果についての検討

    第37回整形外科バイオマテリアル研究会  2017 

     More details

  • ラット脊椎固定モデルにおけるrhBMP2添加リン酸化プルランフィルムの有用性の検討

    第37回整形外科バイオマテリアル研究会  2017 

     More details

  • Spred-2 deficiency exacerbates lipopolysaccharide(LPS)/D-galctosamine (D-GalN) nduced liver injury.

    Cytokine 2017  2017 

     More details

  • The role of tumor cell-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in the progression of 4T1 murine breast cancer.

    Cytokine 2017  2017 

     More details

  • Spred-2 protects mice from ConA-induced liver injury.

    Cytokine 2017  2017 

     More details

  • 肝外胆管腫瘍

    第220回岡山外科病理研究会  2017 

     More details

  • ラブライド形質を呈した低分化大腸癌の一例

    第106回日本病理学会総会  2017 

     More details

  • 除鉄はマウスiPS細胞の腫瘍化を未分化マーカーの発現制御を介して抑制する

    第106回日本病理学会総会  2017 

     More details

  • poly:ICによるAktリン酸化抑制を介した腫瘍細胞の低位抑制機構

    第106回日本病理学会総会  2017 

     More details

  • 間質性肺炎モデルにおけるSpred-2の役割

    第106回日本病理学会総会  2017 

     More details

  • The antimicrobial peptide CRAMP is critical for colon inflammation, cancer and microbial homeostasis

    第106回日本病理学会総会  2017 

     More details

  • 医学教育学生会のこれまでの歩みと今後の展望

    第49回日本医学教育学会  2017 

     More details

  • 学生が作成するハンドブックを用いた臨床実習教育プロジェクトPOCCE

    第49回日本医学教育学会  2017 

     More details

  • 5年次OSCEの意義について

    第49回日本医学教育学会  2017 

     More details

  • 一年次社会コミィニケーション(行動科学科目)を受講して

    第49回日本医学教育学会  2017 

     More details

  • 医学科1年次に導入した行動科学がもたらしたもの

    第49回日本医学教育学会  2017 

     More details

  • 新規接着材料リン酸化プルランを用いた体内埋植医療製品

    イノベーション・ジャパン2017  2017 

     More details

  • 岡山大学医学部医学科における国際バカロレア修了生の受け入れについて

    大学教育再生加速プログラム(AP)採択事業シンポジウム  2017 

     More details

  • 著明な偽血管肉腫様構造を示した乳腺化生癌の1例

    第106回日本病理学会総会  2017 

     More details

  • ヒト卵巣癌における線維芽細胞の由来

    第106回日本病理学会総会  2017 

     More details

  • 膀胱腫瘍におけるRas-ERK経路とその制御因子Spred-2の解析

    第106回日本病理学会総会  2017 

     More details

  • 多糖複合体を機材とした感染制御能を有する抗菌薬含有セメントの開発

    第31回日本整形外科学会基礎学術集会  2016 

     More details

  • 糖複合体を基材とした感染制御能と生体吸収性を有する抗菌薬含有骨セメントの開発

    第36回整形外科バイオマテリアル研究会  2016 

     More details

  • 臨床実習前に行う医療教育シミュレーション教育コースの取り組み

    第48回日本医学教育学会大会  2016 

     More details

  • 多房性嚢胞性変化を呈したsex cord tumor with annular tubules(SCTAT)の一例

    日本病理学会総会  2016 

     More details

  • ミャンマーの乳がんの組織学的側面

    日本病理学会総会  2016 

     More details

  • Spred-2欠損はGalN/LPS誘導性の急性腎障害を悪化させる

    日本病理学会総会  2016 

     More details

  • 膀胱腫瘍におけるRas-Raf-ERK経路とその制御因子Spred-2の解析

    日本病理学会総会  2016 

     More details

  • Spred-2欠損によるシスプラチン腎障害憎悪における好中球の関与

    日本病理学会総会  2016 

     More details

  • Regulation of macrophage anti-microbial functions by the histone methyltransferase MLL1.

    Immunology 2016  2016 

     More details

  • Spred-2欠損はGalN/LPS誘導性の急性腎障害を悪化させる

    第37回日本炎症再生医学会  2016 

     More details

  • 5年次SDによるワクチン予防接種—臨床実習プログラムとしての評価—

    第48回日本医学教育学会大会  2016 

     More details

  • てんかんの原因となった髄膜腫を併存した髄膜血管腫症の1例

    日本病理学会総会  2016 

     More details

  • 全臨床系教室を対象とした個別の学内FDの取り組み

    第48回日本医学教育学会大会  2016 

     More details

  • 患者アンケートからみた臨床実習の評価

    第48回日本医学教育学会大会  2016 

     More details

  • 臨床実習に臨み学生が修得すべき事:学生の考え、指導医の考え

    第48回日本医学教育学会大会  2016 

     More details

  • 学生主体による医学英語学習グループがどのように医学英語教育に関わっているか

    第48回日本医学教育学会大会  2016 

     More details

  • Joining the English PBL group as a Pre-clinical Second Year Medical Student

    第48回日本医学教育学会大会  2016 

     More details

  • 整形外科・歯科領域コンビネーション製品評価指標素案の作成―革新的医薬品・医療機器・再生医療製品実用化促進事業による取組―

    第6回レギュラトリーサイエンス学会  2016 

     More details

  • Contribution of the activating chromatin-modifying enzymes MLL1 and MYST1 towards epigenetic regulation f CD8+ T cell function

    Frontiers of Immunology in Health & Disease  2016 

     More details

  • 新規生体材料リン酸化プルランによるインプラントコーティング技術の開発

    第31回日本整形外科学会基礎学術集会  2016 

     More details

  • 学生アンケートに基づく漢方教育への提言

    第48回日本医学教育学会大会  2016 

     More details

  • 医学生による予防接種実践コースのカリキュラム作成

    第48回日本医学教育学会大会  2016 

     More details

  • 濾胞性リンパ腫の経過中にT細胞性リンパ腫を合併した2症例

    日本病理学会総会  2016 

     More details

  • 臨床病態に近い不均一性とがん幹細胞を備えた新規腫瘍モデルの開発

    日本病理学会総会  2016 

     More details

  • 右卵巣腫瘍(SCTAT)

    第 119 回日本病理学会中国四国支部学術集会  2016 

     More details

  • リン酸化プルランを用いた接着型ドラッグデリバリーシステムの開発

    中央西日本メディカルイノベーション2016  2016 

     More details

  • 感染防御能を有する革新的整形外科インプラントの開発

    中央西日本メディカルイノベーション2016  2016 

     More details

  • 肝外胆管腫瘍

    第220回岡山外科病理研究会  2016 

     More details

  • New Implant Coating Technology with Phosphopullulan Bioadhesive Materials

    Orthopaedic Research Society  2016 

     More details

  • Spred-2による炎症の制御

    日本病理学会総会  2016 

     More details

  • Induction of MCP-1/CCL2 in macrophages via GM-CSF production by breast cancer cells

    日本病理学会総会  2016 

     More details

  • 多糖複合体リン酸化プルランを用いた抗菌薬含有骨セメントの開発

    第30回日本整形外科学会基礎学術集会  2015 

     More details

  • 多糖複合体リン酸化プルランを用いた抗菌薬含有骨セメントの開発

    第35回整形外科バイオマテリアル研究会  2015 

     More details

  • Thioredoxin-1 suppresses lung inflammation and oxidative injury in influenza virus-induced pneumonia in mice.

    15th US-Japan Acute Respiratory Infections Panel Meeting, 2011  2011 

     More details

  • 黒色真菌Exophiala jeanselmeiによる黒色菌糸症の1例

    第30回広島感染症研究会  2011 

     More details

  • インフルエンザウィルス(H1N1)感染におけるNotchシグナル

    第8回病理学会カンファレンス  2011 

     More details

  • Notchリガンドのインフルエンザウィルス(H1N1)肺炎モデルマウスにおける役割

    第8回病理学会カンファレンス  2011 

     More details

  • インフルエンザ肺炎におけるレドックス制御蛋白チオレドキシン(TRX)の治療的効果

    第114回日本小児科学会学術集会  2011 

     More details

  • Thioredoxin-1 suppresses lung inflammation and oxidative injury in influenza virus-induced pneumonia in mice.

    International Union of Microbiological Societies 2011 Congress 2011  2011 

     More details

  • The Critical Role of Spred-2 in Influenza A Virus (H1N1)-induced Pneumonia

    第40回日本免疫学会  2011 

     More details

  • 縦隔腫瘍

    第106回中国四国支部学術集会  2011 

     More details

  • 炎症の発現・制御におけるサイトカインシグナル伝達

    第43回日本小児感染症学会総会・学術集会  2011 

     More details

  • A CASE OF LOW GRADE STROMAL SARCOMA OF THE PROSTATE WITH A NOVEL ARCHITECTURAL PATTERN: PERIDUCTAL SPREADING PATTERN

    The 7th Asia Pacific IAP Congress  2011 

     More details

  • Dynamic epigenetic regulations in Influenza H1N1 infection

    ART/ITP国際シンポジウム  2011 

     More details

  • インフルエンザウイルス(H1N1)感染におけるNotchシグナルの役割

    第30回岡山免疫懇話会  2011 

     More details

  • Monocyte Chemoattractant Protein-1 (MCP-1)/CCL2 Produced by Non-tumor Cells in Tumor Stroma Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells.

    American Association for Cancer Research  2011 

     More details

  • インフルエンザ感染におけるレドックス制御タンパクチオレドキシン(TRX)の治療効果

    第114回日本小児科学会  2011 

     More details

  • The critical role of notch ligand delta-like 1 in Influenza A virus infection

    Keystone symosia 2011  2011 

     More details

  • Spred-2 protects mice from ConA-induced liver injury

    第32回日本炎症・再生学会  2011 

     More details

  • インフルエンザウィルス(H1N1)感染におけるNotchシグナルの役割

    第32回日本炎症・再生学会  2011 

     More details

  • Kupffer cells as a main source of CXCL9 and CXCL10 in ConA-induced hepatitis.

    第8回病理学会カンファレンス  2011 

     More details

  • 画像上多発肝腫瘤と認識された大腸癌化学療法中の肝類洞病変

    第100回日本病理学会総会  2011 

     More details

  • 赤白血病細胞株K562における細胞分化のレドックス制御

    第100回日本病理学会総会  2011 

     More details

  • 管周囲性の増殖パターンを示す前立腺low grade stromal sarcomaの1例

    第100回日本病理学会総会  2011 

     More details

  • Concanavalin A肝炎におけるCD4+T細胞SOCS1の役割

    第100回日本病理学会総会  2011 

     More details

  • A novel chemokine-receptor antagonist inhibits activation of LPS-stimulated peritoneal macrophages and peritoneal adhesion.

    Digestive Diseasse Week 2011  2011 

     More details

  • 酸化ストレスによる白血球細胞の分化誘導修飾

    第99回日本病理学会総会  2010 

     More details

  • Choroid plexus carcinomaの2例

    第99回日本病理学会総会  2010 

     More details

  • Spred-2, a negative regulator of MAP kinase cascade, controls inflammatory responses

    18th International Symposium on Molecular Cell Biology of Macrophages 2010  2010 

     More details

  • セルブロック法併用で診断しえた膵腫瘍の2症例ー転移性膵腫瘍と原発性膵内分泌腫瘍ー

    第51回日本臨床細胞学会総会  2010 

     More details

  • 左副鼻腔病変

    第102回スライドカンファレンス  2010 

     More details

  • 炎症とサイトカインシグナル伝達

    第7回日本病理学会カンファレンス  2010 

     More details

  • Forced expression of SOCS5, but not SOCS3, in T cells prolongs the severity of murine arthritis induced by anti-type II collagen antibody

    ORS 56th Annual Meeting  2010 

     More details

  • 白血病治療中に敗血症とposterior reversible encephalopathy syndrome(PRES)様の画像所見を呈した急性脳症の 一剖検例

    第51回日本神経病理学会総会  2010 

     More details

  • 著明な細胞外粘液とsignet ring cell carcinomaからなる結節を形成したinvasive lobular carcinomaの一例

    第99回日本病理学会総会  2010 

     More details

  • インフルエンザ感染におけるレドックス制御タンパクチオレドキシン(TRX)の役割

    第58回日本ウイルス学会  2010 

     More details

  • Spred-2 protects mice from ConA-induced liver injury

    第7回日本病理学会カンファレンス  2010 

     More details

  • Spred-2, a negative regulator of MAP kinase cascade, controls inflammatory responses

    14th International congress of Immunology  2010 

     More details

  • An autopsy case of 'possible' posterior reversible encephalopathy syndrome (PRES) associated with Bacillus cereus sepsis during the treatment of acute myeloid leukemia.

    XVIIth International Congress of Neuropathology  2010 

     More details

  • Pathological role of mixed lineage leukemia (MLL) during mycobacterial antigen-elicited granuloma formation

    9th Annual Pathology Research Symposium  2010 

     More details

  • 膣壁腫瘍

    第103回日本病理学会中国四国支部学術集会スライドカンファレンス  2010 

     More details

  • TTF-1陽性を示したgliosarcomaの一例

    第98回日本病理学会  2009 

     More details

  • 頸部腫瘍

    第199回岡山外科病理研究会  2009 

     More details

  • 卵巣腫瘍

    岡山外科病理  2009 

     More details

  • 卵巣腫瘍

    第197回岡山外科病理研究会  2009 

     More details

  • 後頭部皮膚病変

    第197回岡山外科病理研究会  2009 

     More details

  • 炎症とサイトカインシグナル伝達

    第20回リンパ系・免疫系懇話会  2009 

     More details

  • モノクロラミン誘発性アポトーシスにおけるinhibitor of apoptosis proteinおよびp53AIP1の変化

    第98回日本病理学会  2009 

     More details

  • 動脈瘤破裂で緊急入院し敗血症ショックで志望した神経線維腫症I型(Neurofibromatosis 1:NF1)の一例

    第98回日本病理学会  2009 

     More details

  • 組織球性絨毛間腔炎の3例

    第98回日本病理学会  2009 

     More details

  • Forced expression of suppressor of cytokine signaling 3 in T cells protects mice from concanavalin A-induced hepatitis.

    AAI 2009  2009 

     More details

  • 白血病細胞の分化誘導と酸化ストレス

    第62回日本酸化ストレス学会  2009 

     More details

  • 炎症とサイトカイン・シグナル伝達

    第4回八代整形外科セミナー  2009 

     More details

  • The anabolitic effect pf plasma-mediated ablation on the intervertebral disc: stimuation of proteoglycan and IL-8 production.

    Global Spine Congress 2009  2009 

     More details

  • Forced expression of SOCS5 in T cells prolongs the severity of murine arthritis induced by anti-type II collagen antibody

    The 9th World Congress on Inflammation  2009 

     More details

  • Absence of Spred-2 enhances innate immunity during septic peritonitis.

    The 9th World Congress on Inflammation  2009 

     More details

  • 肝臓病変の一例

    第198回岡山外科病理研究会  2009 

     More details

  • T細胞SOCSとエンドトキシン(LPS)トレランス

    第98回日本病理学会  2009 

     More details

  • T細胞SOCS3過剰発現による敗血症免疫制御

    第98回日本病理学会  2009 

     More details

  • 粘液瘤様腫瘍・flat epithelial atypia, 平坦型DCISおよびその関連疾患

    第24回日本臨床細胞学会中国四国連合会学術集会  2009 

     More details

  • 子宮頸部の神経内分泌腫瘍ー組織分類と細胞像

    第48回日本臨床細胞学会秋季大会  2009 

     More details

  • 妊娠期にみられた乳腺血管肉腫の一例

    第48回日本臨床細胞学会秋季大会  2009 

     More details

  • スライドカンファレンス過去100回を振り返って

    第100回日本病理学会中国四国支部学術集会  2009 

     More details

  • 前立腺病変

    第100回日本病理学会中国四国支部学術集会  2009 

     More details

  • 気管支喘息治療中に発症した好酸球性胃腸炎の一例

    第103回日本消化器内視鏡学会中国地方会  2009 

     More details

  • Overexpression of SOCS3 in T cells reduces Th17 response in ConA-induced fulminant hepatitis in mice

    第39回日本免疫学会総会  2009 

     More details

  • Galectin-9 ameliotrates immune complex-induced arthritis by regukating FcrR expression on macrophages

    第39回日本免疫学会総会  2009 

     More details

  • 当院における子宮内膜細胞診の疑陽性判定症例の再検討

    第24回日本臨床細胞学会中国四国連合会学術集会  2009 

     More details

  • 超音波内視鏡下膵穿刺吸引細胞診における献体の取り扱いとその有用性(第二報)

    第24回日本臨床細胞学会中国四国連合会学術集会  2009 

     More details

  • Overexpression of SOCS3 in T cells reduces T-cell mediated fulminant hepatitis

    第38回日本免疫学会総会  2008 

     More details

  • 感染とサイトカイン・シグナル伝達ネットワーク

    第56回日本ウイルス学会学術集会 教育セミナー  2008 

     More details

  • マウス抗II型コラーゲン関節炎におけるTh1/Th2/17反応とSOCS3・SOCS5による制御

    第52回日本病理学会総会  2008 

     More details

  • 病理解剖を行われたリウマチ性疾患患者14症例の検討

    第52回日本病理学会総会  2008 

     More details

  • ガレクチン−9はC5aの産生阻害により抗コラーゲン抗体誘導関節炎を抑制する

    第52回日本病理学会総会  2008 

     More details

  • Galectin-9 ameliorates the severity of antibody-induced arthritis by inhibiting C5 cleavage.

    The 17th International Rheumatology Symposium.  2008 

     More details

  • Autopsy in patients with rheumatic diseases:14-case report.

    The 17th International Rheumatology Symposium  2008 

     More details

  • 炎症制御とSOCS

    第97回日本病理学会総会  2008 

     More details

  • Tリンパ球依存性ConA肝炎におけるT細胞SOCS3の役割解明

    第97回日本病理学会総会  2008 

     More details

  • T細胞株白血病細胞株Jurkat細胞におけるモノクロラミン誘発性アポトーシスのメカニズム

    第97回日本病理学会総会  2008 

     More details

  • Spred-2はアセトアミノフェン誘発劇症肝障害において保護的に働く

    岡山免疫懇話会  2008 

     More details

  • The role of SOCS3 and SOCS5 in a murine model of arthritis induced by anti-type II collagen antibody

    第52回 日本リウマチ学会総会学術集会  2008 

     More details

  • モノクロラミン誘発性アポトーシスにおけるinhibitoe of apoptosis proteinの関与

    第61回日本酸化ストレス学会  2008 

     More details

  • 乳腺血管肉腫の1例

    第28回日本臨床細胞学会岡山支部会  2008 

     More details

  • 腹水中に腫瘍細胞を認めた乳腺小葉癌の1例

    第28回日本臨床細胞学会岡山支部会  2008 

     More details

  • ガレクチン9は敗血症抵抗性に働く

    第29回日本炎症・再生医学会  2008 

     More details

  • Valproic acid promotes fracture repair in a murine model.

    The 11th Biennial Conference of the International Society for Fracture Repair.  2008 

     More details

  • マウス抗II型コラーゲン抗体関節炎におけるTh1/2反応とSOCS3・SOCS5による制御

    第23回日本整形外科学会基礎学術集会  2008 

     More details

  • バルプロ酸は骨折治癒を促進するーマウス骨折モデルを用いた検討ー

    第23回日本整形外科学会基礎学術集会  2008 

     More details

  • 気管支腺上皮性乳頭腫の一例

    第97回日本病理学会総会  2008 

     More details

  • 胃癌術後化学療法中、蓚酸カルシウムの著明な沈着を伴うアスペルギルス肺炎で死亡した1例

    第97回日本病理学会総会  2008 

     More details

  • 唾液腺腺房細胞癌の二症例

    第49回日本臨床細胞学会総会  2008 

     More details

  • 肝腫瘍

    第95回日本病理学会中国四国支部学術集会  2008 

     More details

  • T細胞SOCS3によるマウス敗血症モデルの自然免疫調節

    第28回日本炎症再生学会  2007 

     More details

  • 炎症の分子基盤解明

    熊杏会総会  2007 

     More details

  • モノクロラミン誘発性アポトーシスのメカニズムとSAPK/JNKの関与

    第29回日本フリーラジカル学会/第31回日本過酸化脂質・フリーラジカル学会合同学会  2007 

     More details

  • アセトアミノフェン劇症肝炎におけるT細胞SCOS3の関与

    岡山免疫懇話会  2007 

     More details

  • T細胞SOCS3過剰発現は薬剤誘発性劇症肝炎を悪化させる

    第96回日本病理学会  2007 

     More details

  • モノクロラミンによるカルシウム輸送の修飾

    第96回日本病理学会  2007 

     More details

  • 肺塞栓症にて死亡した上大静脈原発の血管肉腫の一剖検例

    第96回日本病理学会  2007 

     More details

  • Nuclear palisaddingを伴うDFSPから発症したfibrosarcomaの1例

    第96回日本病理学会  2007 

     More details

  • Vaginal cytokine production as biomarkers for the safety evaluation of microbicide-induced vaginal irritation

    37th Annual Meeting of the German Society for Immunology  2007 

     More details

  • CCL2/MCP-1 as a novel biomarker for the safety evaluation of microbicide-induced vaginal irritation

    15th Annual Meeting of the International cytokine society  2007 

     More details

  • 唾液腺腫瘍

    第193回岡山外科病理研究会  2007 

     More details

  • 脳腫瘍

    第94回日本病理学会中国四国支部学術集会  2007 

     More details

  • 生前診断が困難であった非細菌性血栓性心内膜炎の1例

    第97回日本内科学会中国地方会  2007 

     More details

  • Galectin-9 ameliorates the severity of antibody-induced arthritis by inhibiting C5 cleavage

    第37回日本免疫学会総会・学術総会  2007 

     More details

  • アセトアミノフェン誘導劇症肝炎においてSpred-2は保護的な働きをする

    第37回日本免疫学会総会・学術総会  2007 

     More details

  • 耳下腺腫瘍

    第9回耳下腺腫瘍病理研究会  2007 

     More details

  • 炎症とサイトカイン・シグナル伝達

    岡山医学会特別講演(教授就任講演)  2006 

     More details

  • Pivotal role of SOCS5 in T cells in innate immunity during sepsis

    Cytokine 2006  2006 

     More details

  • 動脈硬化による冠動脈拡張反応とそのメカニズムの解析

    第2回ウサギフォーラム[医療に貢献する実験用ウサギの新しい展開]  2006 

     More details

  • ジメチルアセチル-β-シクロデキストリンによるエンドトキシンショック抑制の機構解明

    第126年会日本薬学会  2006 

     More details

  • Cell cycle arrest by physiological oxidant through the oxidation of RB protein

    第14回武田科学振興財団生命科学シンポジウム  2006 

     More details

  • Vaginal cytokine production as a putative biomarker to evaluate vaginal irritants

    International Microbicides conference  2006 

     More details

  • 動脈硬化による冠動脈のリモデリングに及ぼす中膜の肥厚と脆弱化の影響

    第38回日本動脈硬化学会総会・学術集会  2006 

     More details

  • 炎症って何?

    岡山健康講座2006「やさしい保健と健康の話  2006 

     More details

  • Cell cycle arrest through the oxidation of RB protein by physiological oxidant.

    13th Biennial Congress of the Society for Free Radical Research International (SFRRI).  2006 

     More details

  • Atypical teratoid rhabdoid tumor (AT/RT)の一例

    第95回日本病理学総会  2006 

     More details

  • SMC proliferation in the tunica media and macrophage infiltration into the tunica media cause coronary outward remodelling

    International symposium on Atherosclerosis, Satellite symposium  2006 

     More details

  • Cell cycle arrest by physiological oxidant through the oxidation of RB protein

    20th IUBMB International congress of Biochemistry and Molecular Biology and 11th FAOBMB Congress  2006 

     More details

  • 炎症とサイトカイン・シグナル伝達

    第一病理同門会(教授就任講演)  2006 

     More details

  • 食細胞サイトカインシグナル伝達を基盤にした免疫監視機構

    バイオロンジル  2006 

     More details

  • Relation Of Macrophages And Smooth Muscle Cells To Coronary Outward Remodeling

    The 5th International Congress of Pathophysiology  2006 

     More details

  • Cytokine signaling in innate immunity

    第4回RAND  2005 

     More details

  • Role of SOCS3 and SOCS5 in innate immunity during sepsis

    第35回日本免疫学会総会  2005 

     More details

  • 腹腔常在マクロファ-ジに発現するStat3は急性炎症制御因子として働く

    九州バイオサイエンスシンポジウム  2005 

     More details

  • シグナル伝達抑制からみた薬剤誘発性肝炎の解析

    九州バイオサイエンスシンポジウム  2005 

     More details

  • 感染性腹膜炎モデルのシグナル伝達抑制因子による制御

    九州バイオサイエンスシンポジウム  2005 

     More details

  • 安定化ガレクチン9による関節リウマチ滑膜細胞死誘導と関節炎モデル治療の試み

    第55回日本アレルギー学会  2005 

     More details

  • 冠動脈病変が自然発症するWHHLCA or WHHLMIウサギを用いた動脈硬化による冠動脈の拡張反応に関するメカニズムの検討

    第88回関西実験動物研究会  2005 

     More details

  • 肺癌細胞株におけるSTATの発現

    第94回日本病理学会  2005 

     More details

  • マウス敗血症モデルを用いたSOCS5による自然免疫調節機構の解析

    第94回日本病理学会  2005 

     More details

  • SOCS3による薬剤誘発性劇症肝炎の調節機構の解明

    第94回日本病理学会  2005 

     More details

  • ガレクチン9による抗腫瘍効果

    第94回日本病理学会  2005 

     More details

  • 肺におけるPML蛋白質、SUMO-1の発現

    第94回日本病理学会  2005 

     More details

  • 薬剤誘発性劇症肝炎におけるSOCS3の分子基盤:治療分子標的としての可能性

    第26回 日本炎症・再生医学会  2005 

     More details

  • エンドトキシンショックに対するジメチルアセチル-β-シクロデキストリンの抑制効果

    第20回日本薬剤学会記念大会  2005 

     More details

  • Interferon-gamma and collagen synergistically induce monocyte chemoattractant protein-1 production in human polymorphonuclear leukocytes (PMN): Role of discoidin domain receptor 1 (DDR1).

    Experimental Biology 2005  2005 

     More details

  • 自然免疫/炎症の発現・制御に関わるサイトカインとシグナル伝達因子の機能解明

    第50回日本病理学会秋期学術集会  2004 

     More details

  • Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis

    Experimental Biology 2004  2004 

     More details

  • マクロファージ・好中球に発現するStat3によるTh1/Th2型獲得免疫制御

    第93回日本病理学会総会  2004 

     More details

  • マクロファージ・好中球特異的Stat3欠損にみる獲得免疫反応

    第25回日本炎症・再生医学会  2004 

     More details

  • 肺転移を来した悪性腱鞘巨細胞腫の一例

    第37回日本整形外科学会、骨・軟部腫瘍学術集会  2004 

     More details

  • シクロデキストリン誘導体によるエンドトキシンショックの抑制作用

    第22回シクロデキストリンシンポジウム  2004 

     More details

  • 腹腔常在マクロファ-ジに発現するStat3は炎症制御因子として働く

    第2回RAND  2003 

     More details

  • 敗血性腹膜炎モデルにおけるCCケモカインリセプタ-8の機能解析

    第24回日本炎症・再生医学会  2003 

     More details

  • 腹腔常在マクロファ-ジに発現するStat3による急性炎症制御作用

    第33回日本免疫学会総会  2003 

     More details

  • The immunoregulatory role of TARC in the innate immune response to sepsis.

    Experimental Biology 2003  2003 

     More details

  • 感染性腹膜炎モデルにおける食細胞特異的Stat3の役割

    第一回RAND(旧ヘテロフィル研究会)  2002 

     More details

  • Mice with targeted disruption of Stat3 in macrophages and neutrophils are susceptible to septic peritonitis

    Joint meeting of the International Society for Interferon and Cytokine Research, The International Cytokine Society, The Society for Leukocyte Biology, and The European Cytokine Society  2002 

     More details

  • Mice with targeted disruption of Stat3 in macrophages and neutrophils are susceptible to septic peritonitis.

    第32回日本免疫学会総会.学術集会  2002 

     More details

  • Regulation of innate immune response during septic peritonitis by Stat proteins

    The 19th Kumamoto Medical bioscience Synposium  2002 

     More details

  • CXCケモカインIL-8とGROの異なる in vivo 作用

    第31回日本免疫学会学術集会  2001 

     More details

  • Resistance to septic peritonitis in mice lacking CC chemokine receptor 8 via augmenting innate immune response

    Joint meeting of the International Cytokine Society and the Society for Leukocyte Biology  2001 

     More details

  • The protective effect of FR167653, a simultaneous inhibitor of tumor necrosis factor-α and interleukin-1β, in rabbit sepsis is due to attenuation of the inflammatory response rather than to prevention of disseminated intravascular coagulation

    43th Annual Meeting of the American Society of Hematology  2001 

     More details

  • ケモカインおよびそのレセプターの敗血症制御における役割

    第6回ヘテロフィル研究会  2001 

     More details

  • 急性肝障害時にみられるmacrophage-derived chemokine (MDC, CCL22)の抗炎症作用

    第31回日本免疫学会学術集会  2001 

     More details

  • Crucial role of CC chemokine macrophage derived chemokine (MDC) in lethal septic peritonitis in mice

    Experimental biology  2000 

     More details

  • Mice genetically lacking endothelial selectins are resistant to the lethality in a murine model of septic peritonitis

    FASEB meeting  2000 

     More details

  • Endogenous MCP-1 protects mice in a model of acute septic peritonitis.

    Matsukawa A, Hogaboam CM, Lukacs NW, Strieter RM, Kunkel SL

    Keystone meeting  1999 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Involvement of Interleukin-1 and Interleukin-8 in HCG-induced ovulatory process in rabbit

    Ujioka T, Matsukawa A, Tanaka N, Matsuura K, Okamura H

    XV FIGO World Congress of Gynaecology and Obstetrics  1997.8.6 

     More details

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • Potential intermediary role of Interleukin-8 and IL-1 in HCG-induced ovulatory process in rabbits

    Ujioka T, Matsukawa A, Tanaka N, Matsuura K, Okamura H

    30th Annual meeting, Society for The Study of Reproduction  1997.8.4 

     More details

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

▼display all

Industrial property rights

  • 新規なmTORC1阻害作用を有する化合物を含む、制癌剤、発がん抑制剤および寿命延長剤

    宮武秀行, 伊藤嘉浩, Shams Raef Soliman Ahme, 松川昭博

     More details

    Applicant:理化学研究所、岡山大学

    Application no:特願PCT/JP2021/035038  Date applied:2021.9.24

    researchmap

  • 注入材

    松川 昭博, 沖原 巧

     More details

    Applicant:日本MDBソリューションズ株式会社

    Application no:特願2021-143629  Date applied:2021.9.3

    Announcement no:特開2023-037097  Date announced:2023.3.15

    J-GLOBAL

    researchmap

  • 注入材

    松川昭博, 沖原巧

     More details

    Applicant:岡山大学、日本MDBソリューションズ

    Application no:特願2021-143629  Date applied:2021.9.3

    researchmap

  • 生体吸収性のシート又はフィルム

    吉田 靖弘, 松川 昭博, 沖原 巧

     More details

    Applicant:吉田 靖弘

    Application no:特願2019-207022  Date applied:2019.11.15

    Announcement no:特開2020-022861  Date announced:2020.2.13

    Publication no:WO2017-154998  Date published:2017914

    Patent/Registration no:特許第6964312号  Date registered:2021.10.21 

    J-GLOBAL

    researchmap

  • 生体吸収性のシート又はフィルム

    吉田 靖弘, 松川 昭博, 沖原 巧

     More details

    Applicant:吉田 靖弘

    Application no:特願2019-207022  Date applied:2019.11.15

    Announcement no:特開2020-022861  Date announced:2020.2.13

    Patent/Registration no:特許第6964312号  Date registered:2021.10.21 

    J-GLOBAL

    researchmap

  • 生体吸収性のシート又はフィルム

    吉田 靖弘, 松川 昭博, 沖原 巧

     More details

    Applicant:吉田 靖弘

    Application no:特願2019-207022  Date applied:2019.11.15

    Announcement no:特開2020-022861  Date announced:2020.2.13

    J-GLOBAL

    researchmap

  • 徐放性デバイス

    松川 昭博, 菅生 健

     More details

    Applicant:国立大学法人 岡山大学

    Application no:特願2018-011901  Date applied:2018.1.26

    Announcement no:特開2019-126667  Date announced:2019.8.1

    Patent/Registration no:特許第6961504号  Date registered:2021.10.15 

    J-GLOBAL

    researchmap

  • 徐放性デバイス

    松川 昭博, 菅生 健

     More details

    Applicant:国立大学法人 岡山大学

    Application no:特願2018-011901  Date applied:2018.1.26

    Announcement no:特開2019-126667  Date announced:2019.8.1

    J-GLOBAL

    researchmap

  • 生体吸収性のシート又はフィルム

    吉田 靖弘, 松川 昭博, 沖原 巧

     More details

    Applicant:吉田 靖弘

    Application no:特願2018-504565  Date applied:2017.3.8

    Patent/Registration no:特許第6619870号  Date registered:2019.11.22 

    J-GLOBAL

    researchmap

  • 生体吸収性のシート又はフィルム

    吉田 靖弘, 松川 昭博, 沖原 巧

     More details

    Applicant:吉田 靖弘

    Application no:JP2017009320  Date applied:2017.3.8

    Publication no:WO2017-154998  Date published:2017914

    J-GLOBAL

    researchmap

  • リン酸化多糖の製造方法

    沖原 巧, 亀ノ上 翔吾, 吉田 靖弘, 難波 尚子, 松川 昭博, 長岡 紀幸

     More details

    Applicant:国立大学法人 岡山大学

    Application no:特願2014-507863  Date applied:2013.3.25

    Patent/Registration no:特許第5706579号  Date registered:2015.3.6 

    J-GLOBAL

    researchmap

  • リン酸化多糖の製造方法

    沖原 巧, 亀ノ上 翔吾, 吉田 靖弘, 難波 尚子, 松川 昭博, 長岡 紀幸

     More details

    Applicant:国立大学法人 岡山大学

    Application no:JP2013058553  Date applied:2013.3.25

    Publication no:WO2013-146669  Date published:2013103

    J-GLOBAL

    researchmap

  • リン酸化多糖の製造方法

    沖原 巧, 亀ノ上 翔吾, 吉田 靖弘, 難波 尚子, 松川 昭博, 長岡 紀幸

     More details

    Applicant:国立大学法人 岡山大学

    Application no:JP2013058553  Date applied:2013.3.25

    Publication no:WO2013-146669  Date published:2013103

    Patent/Registration no:特許第5706579号  Date registered:2015.3.6 

    J-GLOBAL

    researchmap

▼display all

Awards

  • 日本病理学賞

    2023.10   日本病理学会  

     More details

  • 教育功労賞

    2020.12   岡山大学大学院医歯薬学総合研究科  

     More details

  • 医学部長特別表彰

    2020.11   岡山大学医学部  

     More details

  • 学術研究賞(A演題)

    2004   日本病理学会  

     More details

  • 熊本医学会奨励賞

    2003   熊本大学医学部  

     More details

Research Projects

  • Analysis of the mechanisms by which FPRs play a role in the immune regulation against cancer and organ transplantation and its application to treatments

    Grant number:23K08070  2023.04 - 2026.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    吉村 禎造, 松川 昭博

      More details

    Grant amount:\4420000 ( Direct expense: \3400000 、 Indirect expense:\1020000 )

    researchmap

  • AI病理診断に向けた、組織切片の厚さの簡易計測法の開発と標準化技術の確立

    Grant number:23K11895  2023.04 - 2026.03

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    藤澤 真義, 大原 利章, 松川 昭博

      More details

    Grant amount:\4160000 ( Direct expense: \3200000 、 Indirect expense:\960000 )

    researchmap

  • Mechanisms of cancer metastasis by message Capsule Exosomes

    Grant number:22K19562  2022.06 - 2025.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Research (Exploratory)  Grant-in-Aid for Challenging Research (Exploratory)

    松川 昭博

      More details

    Grant amount:\6500000 ( Direct expense: \5000000 、 Indirect expense:\1500000 )

    researchmap

  • Role of Spred2 in the pathogenesis of cancer and its application for cancer thepapy

    Grant number:21H02988  2021.04 - 2024.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    松川 昭博, 伊藤 嘉浩, 吉村 禎造, 宮武 秀行, 阪口 政清

      More details

    Grant amount:\17420000 ( Direct expense: \13400000 、 Indirect expense:\4020000 )

    1)がんの増殖・転移・幹細胞性獲得におけるSpred2の役割解明
    肝がん細胞株(HepG2, HepG3, HLE)のSpred2をノックダウンすると細胞増殖能はいずれも増加した。最もSpred2発現の多いHepG2細胞からCRISPR-Cas9法でSpred2を消去した細胞を作製し、がん細胞特性を確認した。その結果、がん細胞増殖能・浸潤能は増加し、細胞形態は紡錘形に変化、上皮間葉移行と幹細胞性は増強した。これらの変化は、Spred2の過剰発現で逆転した。Spred2発現は非がん部に比較してがん部で低く(データベース上、および自験例の検討)、Spred2高発現肝がん患者では低発現患者に比べ有意に予後は高かった(データベース解析)。以上より、Spred2は、ERK経路を抑制し、がん細胞のEMTや幹細胞性を負に制御することを明らかにした(現在、論文投稿中)。
    2)ヒトがん組織におけるSpred2の発現
    275の尿路上皮腫瘍の検討結果から、Spred2 mRNA発現は高異型度非浸潤性乳頭状尿路上皮癌 (HGPUC)で最も高く、上皮内癌 (CIS)と浸潤性尿路上皮癌 (IUC)で低下し、Spred2タンパク発現はHGPUCで高く、CISとIUCではHGPUCに比べて減少していることを見いだした。HGPUCでSpred2膜発現を示すものはSpred2膜陰性のものと比べ、ERK活性化レベルとKi67 indexが有意に低かった。以上より、Spred2は非浸潤性膀胱癌の進展を調節する鍵であるものと考えられた(PLoS One. 2021 Nov 24;16(11):e0254289)。
    3)Spred2のがん治療への応用
    SPR-domainのみのSpred2に加え、さらなる短鎖Spred2プラスミドを6種類作製した。これらを用いて、全長Spred2との活性比較を行っている。

    researchmap

  • Multimodal cancer therapy by combination of immune therapy and targeting nanostructured carrier containing anti-cancer drug

    Grant number:21H04965  2021.04 - 2024.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (A)  Grant-in-Aid for Scientific Research (A)

    伊藤 嘉浩, 上田 一樹, 鵜澤 尊規, 秋元 淳, 松川 昭博

      More details

    Grant amount:\42380000 ( Direct expense: \32600000 、 Indirect expense:\9780000 )

    researchmap

  • アンメットニーズに応える多糖誘導体を用いた可視化粘膜下注入材の開発

    2021.04 - 2022.03

    岡山県特別電源所在県科学技術振興事業  岡山県特別電源所在県科学技術振興事業 

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\2000000

  • 大腸憩室症に対する新発想の塞栓材開発

    2020.04 - 2021.03

    橋渡し研究戦略的推進プログラム  橋渡し研究戦略的推進プログラム シーズA 

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\2000000

  • リン酸化プルランの大量・精密製造技術の確立と短期骨再生を可能とするペースト状人工骨の開発

    2019.04 - 2022.03

    経済産業省  戦略的基盤技術高度化支援事業補助金 

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive

    Grant amount:\130000000

  • Development of transplanted lung function-preserving method using a mouse model focusing on the anti-inflammatory related molecule Spred2

    Grant number:19K09306  2019.04 - 2022.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Yamane Masaomi

      More details

    Grant amount:\4420000 ( Direct expense: \3400000 、 Indirect expense:\1020000 )

    A lung injury experiment using a thoracotomy and clamp model was also performed using Spred2 knockout mice and transgenic mice that are Spred2 gene overexpressing mice. Histological images by RT-PCR and H-E staining and arterial gas analysis were performed and evaluated as preliminary experiments, but no difference was observed. Furthermore, the expression level was confirmed by Western blotting using an anti-mouse SPRED2 antibody, but no difference was observed in the preliminary experiment.
    Overexpression of Spred2 at protein and mRNA levels could not be confirmed in Spred2 transgenic mice and conditional knockout mice specifically deficient in bone marrow-derived cells, compared with wild-type in experiments using a hilar clamp model. No significant difference was found in ischemia-reperfusion injury.

    researchmap

  • 多糖誘導体を用いた高操作性可視化粘膜下注入材の開発

    2019.04 - 2020.03

    岡山県特別電源所在県科学技術振興事業  岡山県特別電源所在県科学技術振興事業 

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\2000000

  • Inhibition of formylpeptide receptors for treatment of breast cancer

    Grant number:18K08571  2018.04 - 2021.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Yoshimura Teizo

      More details

    Grant amount:\2600000 ( Direct expense: \2000000 、 Indirect expense:\600000 )

    Tumor infiltrating leukocytes play an important role in the progression of cancer. In this study, we examined the role of the classical chemoattractant receptor Fpr expressed by non-tumor cells in the progression of breast cancer using a transplantable 4T1 mouse breast cancer model. Tumors grew at a similar rate in both strains at the injected sites; however, lung metastases were significantly reduced in Fpr2-deficient mice independently of the chemokine MCP-1 because serum MCP-1 levels were similar between tumor-bearing WT and Fpr2-deficient mice. In tumors of Fpr2-deficient mice, the development of blood vessels was weaker and necrosis of tumor tissue was more apparent. Ly6G+ neutrophils were detected mainly in the peripheral area and did not infiltrate inside tumors. Thus, Fpr2+ neutrophils appear to play a role in the progression of 4T1 breast cancer. Studies focusing on Fprs may lead to the identification of new targets and a potential prevention of breast cancer metastasis.

    researchmap

  • Development and evaluation for practical use of phosphorylated-pullulan film with osteogenic capacity

    Grant number:17K10930  2017.04 - 2020.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    TANAKA Masato

      More details

    Grant amount:\4680000 ( Direct expense: \3600000 、 Indirect expense:\1080000 )

    The phosphorylated pullulan developed by the applicants is a functional polysaccharide derivative that firmly adheres to apatite, which is an inorganic component of living hard tissue. We aimed to develop a film-shaped phosphorylated pullulan that can be expected as a bioadhesive and a carrier for drug delivery, and to combine it with BMP to develop a safe and low-cost bone fusion promoter. The bone formation ability of the rat posterior lateral fixation model was examined, and good bone formation was observed in the BMP-2-added phosphorylated pullulan film group. In this study, phosphorylated pullulan was considered to have extremely low cytotoxicity in bone formation, and could be safely applied clinically.

    researchmap

  • Investigation of molecular basis of exacerbation in chronic respiratory disease caused by respiratory infection

    Grant number:16H05310  2016.04 - 2020.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    Ito Toshihiro

      More details

    Grant amount:\16770000 ( Direct expense: \12900000 、 Indirect expense:\3870000 )

    Patients who have a chronic respiratory disease have a very high risk of respiratory infection due to viruses and bacteria, and it is necessary to elucidate the pathological condition and molecular mechanism and identify the factors that affect each other's diseases. In this study, we focused on SET domain, bifurcated 2 (SETDB2), which is one of the histone H3K9 (9th lysine) methylase, and the expression of SETDB2 showed a significant increase in the chronic respiratory disease model. The importance of SETDB2 in respiratory diseases was clarified by increasing the expression in chronic respiratory diseases and respiratory infections and by indicating the role of SETDB2 in pathological conditions.

    researchmap

  • Development of novel spinal cord injury treatment using advanced bonding technology and neural stem cells

    Grant number:16K10822  2016.04 - 2019.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Sugimoto Yoshihisa

      More details

    Grant amount:\4810000 ( Direct expense: \3700000 、 Indirect expense:\1110000 )

    We analyzed the usefulness of novel spinal cord injury (SCI) treatment using engineered hepatocyte growth factor with a collagen biding domain (CBD-HGF) and visible light-induced, rapidly cross-linkable gelatin in spinal cord injury model of mice. In motor recovery and immunohistochemical analyses, therapeutic effects were identified. CBD-HGF combined with the hydrogel scaffold may be promising for the treatment of serious SCI. About neural stem cells (NCS), we established stem cell culture technology using mouse embryos, however we could not reach transplantation into spinal cord injury model. We plan to continue the study by combining these methods.

    researchmap

  • Challenge to novel antiviral strategy by suppressing signal transduction pathway

    Grant number:16K15258  2016.04 - 2019.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Exploratory Research  Grant-in-Aid for Challenging Exploratory Research

    MATSUKAWA AKIHIRO, Yang Xu, Sun Cuiming, Gao Tong, Miyatake Hideyuki, Kondo Masayuki

      More details

    Grant amount:\3640000 ( Direct expense: \2800000 、 Indirect expense:\840000 )

    In this study, we clarified the mechanism of viral infection from the viewpoint of Ras-Raf-ERK / MAPK and its endogenous suppressor Spred2, and we challenged the antiviral strategy via ERK suppression by supplementation of Spred2. Activation of ERK-MAPK and viral infection were suppressed by Spred2 gene transfer. There was no difference in virus infection in Spred2 overexpressing mice, suggesting that the endogenous Spred2 is sufficient to inhibit the infection. Cell-penetrating Spred2 created in this study failed to inhibit ERK activation, however, supplementation of functional Spred2 protein may become a new antiviral drug.

    researchmap

  • Development and analysis of practical application of damaged intervertebral disc treatment using advanced molecular engineering and bounding technology

    Grant number:16K10823  2016.04 - 2019.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Arataki Shinya

      More details

    Grant amount:\4680000 ( Direct expense: \3600000 、 Indirect expense:\1080000 )

    We analyzed the usefulness of new intervertebral disc regeneration treatment using intervertebral disc degeneration model of rats in combination with cultured disc annulus fibrosus cells and novel, visible light-induced, rapidly cross-linkable gelatin scaffold. Transplanted cells were found to engraft on the transplanted site, but regeneration of the annulus fibrosus was not identified. As a growth factor used for regenerative therapy, we studied BMP-7 that has been reported in the past, but this study suggested the possibility of contribution to degeneration in the annulus fibrosus.

    researchmap

  • Development of fragility fracture treatment using molecular evolution engineering

    Grant number:15K10445  2015.04 - 2018.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Watanabe Noriyuki

      More details

    Grant amount:\4810000 ( Direct expense: \3700000 、 Indirect expense:\1110000 )

    We investigated the availability of a titanium binding bone morphologic protein(TB-BMP), which is a new biological material. TB-BMP coating titanium wires and conventional titanium wires were implanted in the femur of rats. TB-BMP coating titanium wires significantly enhanced bone formation on the surface of titanium compared to conventional titanium wires. Pull-out strength was also significantly increased in TB-BMP group. These results suggest that TB-BMP is a useful material for the treatment for the osteoporotic patients.

    researchmap

  • Therapeutic effects of anti-high mobility group box-1 monoclonal antibody for influenza A virus (H1N1)- induced pneumonia

    Grant number:15K21184  2015.04 - 2017.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)  Grant-in-Aid for Young Scientists (B)

    Nosaka Nobuyuki, MORISHIMA Tsuneo, NISHIBORI Masahiro, TSUKAHARA Hirokazu, MATSUKAWA Akihiro, LIU Keyue, YASHIRO Masato, YAMADA Mutsuko, HATAYAMA Kazuki

      More details

    Grant amount:\2600000 ( Direct expense: \2000000 、 Indirect expense:\600000 )

    Provision for an influenza pandemic is an urgent issue. We aimed to evaluate the therapeutic effects of anti-high mobility group box-1 (HMGB1) monoclonal antibody (mAb) treatment on severe pneumonia induced by influenza A virus in mice. Anti-HMGB1 mAb significantly improved the survival rate of mice with severe influenza pneumonia with attenuated histological changes in the lungs. In addition, anti-HMGB1 mAb also improved the survival rate of mice with influenza pneumonia with 50% lethality even with anti-influenza drug administration. There were no adverse effects found by anti-HMGB1 mAb administration.

    researchmap

  • 感染防御機能を有する革新的骨スクリューの開発

    2014.04 - 2017.03

    経済産業省  医工連携事業化推進事業 

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\200000000

  • New Implant Coating Technology with Phosphopullulan Bioadhesive Materials

    Grant number:26462298  2014.04 - 2017.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Kagawa Yohei

      More details

    Grant amount:\4940000 ( Direct expense: \3800000 、 Indirect expense:\1140000 )

    In the orthopaedic surgery, the early fixation due to the new bone formations around the implant is important. Hydroxyapatite (HA) is often coated on the cementless implant surface. A variety of coating methods have been used, but the best coating procedure still remains controversial. A purpose of this study is to get promotion of the new bone formations by coating HA on implants with phosphopullulan (PP) as matrix. In the mechanical examination, in the quantitative elemental analysis, and in the histological examination, there was evidence of bone neoformation on the surface of the implants in PP+HA groups than in any other groups.
    The PP has little harm to the living body, and does not remain in the body as an alien substance to be absorbed in vivo. The PP coating had a beneficial effect on interfacial shear strength and peri-implant new bone formation in rabbit femurs during the early stages of bone healings.

    researchmap

  • Regulatory mechanism of inflammation and inflammation-related cancer by regulating Ras-Raf-ERK/MAPK

    Grant number:25293095  2013.04 - 2016.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    MATSUKAWA AKIHIRO, ITO Toshihiro, TAKAHASHI Sakuma, FUSHIMI Soichiro, TAIRA Asako, ITAKURA Junya, WATANABE Haruyuki, SATO Miwa

      More details

    Grant amount:\17160000 ( Direct expense: \13200000 、 Indirect expense:\3960000 )

    In this project, we have analyzed the role of Ras-Raf-ERK/MAPK and its endogenous inhibitor, Spred-2 in various animal models, using Spred-2 knock-out (KO) mice. We have demonstrated that Spred-2 plays a central role in the regulation of inflammation in various types of inflammation. Our results suggest that Spred-2 can be a new target for controlling inflammation. We also demonstrated that Spred-2 expressed in clinical cancer tissue may be involved carcinogenesis and cancer progression. Furthermore, our results indicate that Spred-2 may be essential regulator of cancer metastasis by modulating epithelial mesenchymal transition (EMT).

    researchmap

  • The effect of the phospho-pullulan cement for the treatment of metastatic bone tumor

    Grant number:25462335  2013.04 - 2016.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Shinohara Kensuke, OZAKI TOSHIFUMI, MATSUKAWA AKIHIRO

      More details

    Grant amount:\4940000 ( Direct expense: \3800000 、 Indirect expense:\1140000 )

    We investigated the availability of phosphorylated pullulan using with the therapeutic agents of bone malignant tumor. Breast cancer cell line (MDA-MB231), which is high frequency as the primary focus of metastatic bone tumor, was injected into the bone hole that was created by using a 24G needle to the central condylar of the nude mouse femur.These are divided into four groups, non-treatment group, the anti-cancer agent alone group, the anti-cancer agent + phosphorylated pullulan group, and phosphorylated pullulan group. We evaluated the antitumor effect using IVIS successively. Anti-cancer agent was using docetaxel. The antitumor effect was observed in the anti-cancer agent alone group and the anti-cancer agent + phosphorylated pullulan group. This result showed that the phosphorylated pullulan was suggested to be useful as a containing cement of anticancer agent.

    researchmap

  • リン酸化プルランを用いた世界初の多目的接着性人工骨の開発

    2012.04 - 2015.03

    研究成果最適展開支援プログラム  A-STEP 起業挑戦タイプ 

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive

    Grant amount:\150000000

  • インフェクションコントロール型チタン骨プレートの開発

    2012.04 - 2014.03

    研究成果最適展開支援プログラム A-STEP  A-STEP 復興促進プログラム シーズ顕在化タイプ 

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\7997000

  • インフェクションコントロール型チタン骨プレートの開発

    2012 - 2013

    産学が連携した研究開発成果の展開 復興促進プログラム A-STEP シーズ顕在化タイプ 

    松川 昭博

      More details

  • 可視光硬化型ゼラチンを用いた新規歯周病治療用接着材の開発

    2011.04 - 2013.03

    研究成果最適展開支援プログラム  A-STEP 起業検証タイプ 

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive

    Grant amount:\8000000

  • 可視光硬化型ゼラチンを用いた新規歯周病治療用接着材の開発

    2011.04 - 2013.03

    研究成果最適展開支援プログラム  A-STEP 探索タイプ 

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive

    Grant amount:\1700000

  • Development of the multipurpose adhesive system using Drug Delivery for Improved Direct pulp capping, Pulpotomy, and Periodontal treatment

    Grant number:23592822  2011 - 2013

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    NAKAMURA Mariko, YOSHIDA Yasuhiro, MATSUKAWA Akihiro, ITO Yoshihiro

      More details

    Grant amount:\5200000 ( Direct expense: \4000000 、 Indirect expense:\1200000 )

    The purpose of this study is to develop a multi-purpose bio-adhesive system by the visible light-induced crosslinkable geratin and phosphorylated pullulan. The following things were confirmed from these findings. Phosphorylated pullulan-based composite is adhesive to dentin and possesses high biocompatibility. The visible light-induced crosslinkable gelatin is adhesive to dentin and low cellular toxicity. It was suggested that the visible light-induced crosslinkable gelatin and phosphorylated pullulan can be used as key materials of biodegradable adhesives for regeneration and reconstruction of bone and tooth.

    researchmap

  • 進化分子工学と先端接着技術の応用による骨粗鬆症の新しい骨折予防法・治療法の開発

    Grant number:23592187  2011

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    塩崎 泰之, 尾崎 敏文, 松川 昭博

      More details

    Grant amount:\5200000 ( Direct expense: \4000000 、 Indirect expense:\1200000 )

    進化分子工学の手法を用いて創製する結合性改変成長因子Collagen Binding Domain (CBD)等の新規生体材料を効果的に用いることにより,骨粗鬆症患者の骨折予防や骨折治療に有効な新しい骨組織再生・再建技術を開発する。
    CBDの遺伝子配列と,骨形成促進蛋白-4(BMP4)の遺伝子配列を連結した融合遺伝子をベクターにいれ,蚕の卵に導入することによりトランスジェニックカイコを作製する。この時,遺伝子は選択的に絹糸腺で働くようにしおく。絹タンパク質と同時に繭に吐き出されたCBD-BMPは,できた繭から精製することにより得られた。
    ウエスタンブロット法を用いて、作製したタンパク質を測定すると55kDaであった。
    続いて、このCBD-BMPと通常のrhBMPとの効果の比較をマウス大腿骨へ投与する事で検討した。まず、蛍光標識を行ったそれぞれの成長因子を投与後1,3,7日でマウスを屠殺後に非脱灰凍結切片を作成し蛍光顕微鏡で評価した。CBD-BMPに関しては7日後であってもマウス大腿骨内への残存が確認できた。
    続いて、投与後4週後に屠殺し、両群をμCTで撮影し骨密度を比較した。これも2群間で有意にCBD-BMP群が優れていた。(P=0.0489)
    また、これらの大腿骨骨髄からRNAを抽出しRT-PCRを用いて両者を比較した。(CBD-BMP,BMP,生理食塩水の3群)HPRTをハウスキーピング遺伝子としALP,Osteocalcin,Osterixを計測し、P=0.035,0.0599,0.0126とCBD群が優れていた。
    これらの結果よりCBD-BMPは、成長因子の効果を発現するために必要な標的組織への定着が確認できた。また、その効果に関しても放射線学的、遺伝子学的にも確認できた。これらを用いる事で効果的な骨形成が得られ,骨粗鬆症患者の骨折予防や骨折治療に有効である。

    researchmap

  • Creation of binding growth factors by molecular evolutionary engineering and their medical applications

    Grant number:22220009  2010.04 - 2015.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (S)  Grant-in-Aid for Scientific Research (S)

    ITO Yoshihiro, TADA Seiichi, UZAWA Takanori, UEDA Motoki, MATSUKAWA Akihiro, YOSHIDA Yasuhiro, SAKURAGI Makoto, KITAJIMA Takashi

      More details

    Grant amount:\217880000 ( Direct expense: \167600000 、 Indirect expense:\50280000 )

    The concept of growth factor immobilization from Japan was confirmed by not only chemical immobilization, but also design of binding growth factor and extended from biological tissue or organic materials to metal or inorganic materials. For the creation of binding growth factors not only conventional recombinant gene method but also bioorthogonal chemistry, molecular evolutionary engineering, or the fused method was developed. The prepared binding growth factors were applied for direct injection or with substrate for implantation into animals and the effects were confirmed for future regenerative medicine. The developed methodology is also universally applicable for creation of novel functional molecules.

    researchmap

  • Role of T cells in the innate immune response during sepsis

    Grant number:20390111  2008 - 2010

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    MATSUKAWA Akihiro, OKAZAKI Yasumasa, HIDA Akira, KUBO Masato

      More details

    Grant amount:\11960000 ( Direct expense: \9200000 、 Indirect expense:\2760000 )

    T cells exist in the peritoneum under healthy conditions. Rag2Ko mice (T and B cell deficient) showed increased mortality rate during sepsis, which was recovered after adoptive transfer of T cells, but not B cells. Mice with overexpression of SOCS5 in T cells (SOCS5-cTg) demonstrated increased Th1 response in the peritoneum whereas SOCS3-cTg mice exhibited decreased systemic inflammatory response during septic peritonitis, leading to the increased survival rate during sepsis. Thus, T cells appear to be important in innate immunity, which can be controlled by SOCS3/5 in T cells. We also elucidated the crucial roles of T cells in different types of inflammation models, such as T cell-dependent hepatitis and arthritis.

    researchmap

  • Study on the pathogenesis of acute encephalitis and encephalopathy for the effective treatment and prevention

    Grant number:20249053  2008 - 2010

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (A)  Grant-in-Aid for Scientific Research (A)

    MORISHIMA Tsuneo, OKABE Nobuhiko, NAKAGOMI Osamu, NUNOI Hiroyuki, KONDOU Kazuhiro, HOSOYA Mitsuaki, MATSUKAWA Akihiro, KIMURA Hioroshi, YOSHIKAWA Tetsushi, ICHIYAMA Takashi, OKUMURA Akihisa

      More details

    Grant amount:\49400000 ( Direct expense: \38000000 、 Indirect expense:\11400000 )

    We have studied on the clinical features and pathogenesis of acute encephalitis/encephalopathy caused by viruses among children. As an causative agent, Influenza virus was a most common virus, followed by HHV-6 and rotavirus, and overall mortality was 7.7%. In terms of the pathogenesis of CNS damage caused by HHV-6 primary infection (E. subitum), virus growth has not been found in the brain tissue, showing encephalopathy not encephalitis. For treatment of this illness, TRX could be an important target in the near future.

    researchmap

  • Role of signal transduction pathway in host defense during sepsis

    Grant number:17590352  2005 - 2006

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    MATSUKAWA Akihiro

      More details

    Grant amount:\3600000 ( Direct expense: \3600000 )

    Cytokine signaling mediated by STAT pathway is negatively regulated by SOCS proteins. In this project, we have investigated the role of SOCS3/5 that inhibit STAT3/4/6 pathway, in innate immunity during sepsis. Mice with a cell-specific overexpression of SOCS5 in T cells (SOCS5Tg) were resistant to the lethality relative to the wild-type (WT) mice. This was due to the enhanced innate immunity in SOCS5Tg mice whereby CD4+T cells with overexpressed SOCS5 augment type-1 immune response of neutrophils and macrophages. Enhanced type-1 response during sepsis was also seen in mice lacking chemokine receptor 8 (CCR8), suggesting an important role of chemokine signaling in innate immunity. In inflammation, resident macrophages, but not other cell types, play a regulatory role through a Stat3 signaling pathway by mediating the anti-inflammatory role of IL-10. Macrophages lacking STAT3 showed decreased expression of Fcy receptor and compliment receptor 1 (CCR1), which was conversely augmented in macrophages lacking SOCS3. This might be responsible for the augmented phagocytic activities of macrophages lacking STAT3/SOCS3. Mice with a cell-specific deletion of STAT3 in phagocytes augmented Thl and Th2 type acquired immune response, possibly due to enhanced APC activities off the cells. On the other hand, mice with a cell-specific overexpression of SOCS3 in T cells (SOCS3Tg mice) were resistant to sepsis due to decreased type-1 response in tissue, resulting in alleviated organ damage. The SOCS3Tg mice were also deleterious in drug-induced hepatotoxicity by increasing STAT1 activation while decreasing STAT3 activation in hepatocytes.

    researchmap

  • Mechanisms of neuroendocrine differentiation of lung carcinoma cells and their cell biological siginifcances : trials from the points of proteomics analyses

    Grant number:16590318  2004 - 2005

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    ITO Takaaki, UDAKA Naoko, MATSUKAWA Akihiro, ARAKI Norie

      More details

    Grant amount:\3600000 ( Direct expense: \3600000 )

    Aims of this research projects include following issues : 1. analyses alterations of mRNAs and proteins expressed in human lung cancer cell lines transfected with a lung neuroendocrine master gene, hASH1, 2. analyses cell biological effects including cell differentiation, proliferation and morphogenesis by gain or loss of the neuroendocrine genes, 3. focuses some key molecules among the molecules found by DNA miroarray and proteomics analyses ad study functions of these molecules.
    We have established hASH1-transfected human lung adenocarcinoma cell lines and Notch1-transfected human small cell carcinoma cell lines. HASH1 transfection induced neuroendocrine phenotypes in adenocarcinoma cells and upregulation of neuroendocrine markers such as chromogranin A, but, the tumors grown in the subcutaneous tissue of nude mice showed usual adenocarcinoma morphology even though they have neuroendocrine differentiation. On the other hand, the Notch1-transfected human small cell carcinoma cell lines lose neuroendocrine phenotypes, showing nuclear translocation of HES1 and loss of nuclear hASH1. Moreover, Notch1 transfection made the cuture cells, which were floating in the medium before transfection, adhere to the plastic dishes, and up-regulated expression of E-cadherin, integrins, and CD44. Moreover, we studied cross-talks between the Notch1-Hes1-hASH1 system and other cell signalling systems. Cell proliferation signals via MAP kinase and ATT/PI3kinase downregulated hASH1 and alter cell differentiation toward non-neuroendocrine. We found that small cell carcinoma cells posesse large amount of STAT3, but STAT3 was underphosphorylated though non-small cell carcinoma cells have phosphorylated STAT3. Thus, neuroednodrine differentiation is affected by various signalling systems. We recently established Flag-, HA-, hASH1-transfected human adenocarcinoma cell lines to study proteins associated with hASH1 and its DNA binding sites. In the near future, we will clarify important molecules involved in neuroendocrine differentiation, and more precise molecular mechanisms of lung epithelial cell and lung carcinoma cell differentiation.

    researchmap

  • Analysis of signal transduction pathway in innate immunity during sepsis

    Grant number:15590349  2003 - 2004

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    MATSUKAWA Akihiro

      More details

    Grant amount:\3600000 ( Direct expense: \3600000 )

    Stat3 is a transcription factor mediating anti-inflammatory properties of IL-10. To understand the role of Stat3 in inflammation, mice with targeted disruption of Stat3 in macrophages and neutrophils were succumbed to septic peritonitis. The mice displayed an excessive local and systemic inflammation relative to the control mice, an event that was accompanied by substantial increases in the level of multiple cytokines. Hepatic and renal injury was significantly exacerbated in mice with Stat3 deficiency. In addition, the mice exhibited an increased lethality after intraperitoneal inoculation of live bacteria recovered. In vitro, productions of inflammatory cytokines were significantly augmented when cells were stimulated with a synthetic lipopeptide, macrophage-activating lipopeptide-2(MALP-2) and LPS. Thus, macrophage/neutrophil-specific Stat3 is crucial in modulating multiple organ failure associated with systemic inflammation. Experiments were further carried out to understand the precise role of Stat3 in inflammation. For this purpose, mice lacking Stat3 in macrophages and neutrophils were intraperitoneally injected with thioglycollate and the subsequent inflammatory responses were investigated. We obtained evidence that Stat3 expressed in resident macrophages, but not other cell types, play a central role in the regulation of inflammatory response. Resident macrophages are important in triggering inflammation, but the cells in the same breath appear to control inflammation through Stat3 signaling pathway.
    C57BL/6 and BALB/c mice are prototypical Th1- and Th2-type mouse strains, respectively. We attempted to characterize the innate immune response of macrophages from these mouse strains. We demonstrated that macrophages from BALB/c mice showed impaired bactericidal activity relative to those from C57BL/6 mice, resulting from a lack of effector molecules for bacterial killing by the cells. Thus, innate immune response of macrophages is different between these mouse strains, which may affect the development of Th1 and Th2 adaptive immunity in these strains. In different experiments, we showed that C10, regarded as Th2-type chemokine in acquired immune response, is a potent monocyte chemoattractant in a sterile peritonitis model.

    researchmap

  • Role of Th1/Th2 cytokines and their regulation in a murine model of septic peritonitis

    Grant number:13670222  2001 - 2002

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    MATSUKAWA Akihiro

      More details

    Grant amount:\3500000 ( Direct expense: \3500000 )

    Signal transducer and activator of transcription (Stat)4 and Stat6 are transcription factors that provide type-1 and type-2 response, respectively. Here, we explored the role of Stat4 and Stat6 in innate immunity during septic peritonitis. Stat4^<-/-> and Stat6^<-/-> mice were resistant to the lethality, as compared to wild-type (WT) mice. At the mechanistic level, bacterial levels in Stat6^<-/-> mice were much lower than WT mice, which was associated with increased peritoneal levels of IL-12, TNFα, macrophage derived chemokine (MDC) and C10, known to enhance bacterial clearance. In Stat4^<-/-> mice, hepatic inflammation and injury during sepsis were significantly ameliorated without affecting local responses. This event was associated with increased hepatic levels of IL-10 and IL-13, while decreasing those of MIP-2 and KC. Sepsis-induced renal injury was also abrogated in Stat4^<-/-> mice, which was accompanied by decreased renal levels of MIP-2 and KC without altering IL-10 and IL-13 levels. Thus, Stat6^<-/-> and Stat4^<-/-> mice appeared to be resistant to septic peritonitis by enhancing local bacterial clearance and modulating systemic organ damage, respectively, via balancing cytokine responses. These results clearly highlight an important role of local type-1 and systemic type-2 cytokine response in protective immunity during sepsis, which can be regulated by Stat proteins. We are currently investigating the involvement of Stat proteins in the production of MDC and C10. In addition, the contribution of Stat4 and Stat6 in thymic apoptosis during sepsis is under investigation.

    researchmap

  • 敗血症時の自然免疫におけるCCケモカインリセプター8とそのリガンドの機能解明

    Grant number:13226103  2001

    日本学術振興会  科学研究費助成事業 特定領域研究(C)  特定領域研究(C)

    松川 昭博

      More details

    マウス腹膜炎誘発敗血モデル(cecal ligation and puncture ; CLP)時の浸潤マクロファージにはCCR8の発現増強がみられた。そこで,本モデルにおけるCCR8の生物学的意義を知るために、CCR8-/-およびCCR8+/+にCLPを行い,敗血症に伴う致死率を比較すると、CCR8-/-マウスではCCR8+/+に較べその生存率は有意に高かった。このとき,腹腔内および血中の菌数はCCR8-/-マウスで有意に低く,in vitroにおける菌消化能はCCR8-/-マクロファージで増強していた。腹腔マクロファージのLPS刺激培養上清中の活性酸素、ライソゾーム酵素、一酸化窒素(NO),TNFαおよびCXCL10の産生量は,CCR8-/-マクロファージで有意に高かった。また、脾細胞をconAで刺激した培養上清では,CCR8-/-脾細胞はIFNγ,IL-12の高値,IL-4,IL-13の低値を示した。以上より、CCR8-/-マウスでの免疫反応は自然免疫に必須なI型免疫反応にシフトし、細菌排除に効率的であることが示唆された。
    次に、本モデルでのCCR8のリガンドを検索した.すると,CLP後の腹腔内でのCCL17の一過性上昇が検出され,CLPマウスに抗CCL17抗体を投与し、腹腔内および抹消血中の細菌数を検討すると、抗体投与群ではコントロールに比べ有意な菌数の増加が観察された.このときの腹腔内TNFαおよびCXCL10の産生量はコントロールに較べ有意に増加していた。したがって、CCL17は敗血症時の自然免疫反応を抑制する作用を持つことが示され、CCR8-CCL17の作用は自然免疫時の生体防御に負に働くことが示唆された。

    researchmap

  • 炎症局所での好中球浸潤支配機構とサイトカインカスケードの解明

    Grant number:09770154  1997 - 1998

    日本学術振興会  科学研究費助成事業 奨励研究(A)  奨励研究(A)

    松川 昭博

      More details

    Grant amount:\1800000 ( Direct expense: \1800000 )

    ウサギ急性炎症モデルでのGROの発現動態およびその役割を調べるためには,その遺伝子組み換え体および抗体の作製が必要となる.そこで,LPS刺激ウサギ脾細胞のcDNAライブラリーからGRO cDNAをクローニングし,これを発現ベクター(pQE-30:QIAGEN社)に組み込み,試大腸菌(E.coli M15[pREP4])に導入,ウサギGROの発現を拭みた.次に,大腸菌抽出液からGROタンパクを単離精製し,これをマウスおよびヤギにアジュバントとともに免疫し,モノクローナル抗体およびポリクローナル抗体を作製した.得られた抗体はウサギGROは認識するものの,他のウサギサイトカイン(TNFα,IL-1β,lL-8,MCP-1,IL-1 receptor antagonist)は認識せず,したがって炎症局所のGROの産生動態を知るうえで有用なツールと考えられた.そこで,ウサギGROをウサギ膝関節内に投与し,その時誘導される炎症反応を観察しようと計画した.しかしながら,上記GROは不溶性(8M Ureaには可溶)であったため,これをin Vivoに投与できなかった.そのためBaculovirus Transfer Vectorを用いる方法(Invitrogen社)で再度遺伝子組み換え体の作製を行い,その培養上清および細胞中から可溶性のGROを得た.現在このタンパクを精製中であり,精製後はin Vivoに投与し,その時の炎症反応を観察するとともに,ウサギ炎症モデルでのGROの産生動態を解明しその炎症反応への関与を明らかにしていく予定である.

    researchmap

  • 炎症局所の好中球による単核球浸潤の支配機構の解明

    Grant number:08770161  1996

    日本学術振興会  科学研究費助成事業 奨励研究(A)  奨励研究(A)

    松川 昭博

      More details

    Grant amount:\900000 ( Direct expense: \900000 )

    炎症反応の局面におけるMCP-1の発現動態、その産生細胞を決定し、好中球浸潤と単核球浸潤との相互関係をしるためにこのプロジェクトを計画し,以下の結果を得た.
    1)Con A刺激ウサギ脾細胞のcDNAライブラリーからMCP-1 cDNAをクローニングし、これを発現ベクターに組み込んだ.2)発現ベクターを動物細胞(COS-7 cell)に組み込み、ウサギMCP-1を発現させ,その培養上清からウサギMCP-1を単離、精製した.3)ウサギMCP-1をウサギ膝関節内に投与し,経時的な炎症反応の推移を観察したが,好中球浸潤を伴わない単核球浸潤は誘導できなかった.4)遺伝子組み替えMCP-1を用いて,ポリクローナル抗体およびモノクローナル抗体を作製し,免疫染色およびELISA測定系を開発した.5)ウサギLPS関節炎におけるMCP-1の産生動態は,LPS投与後2-4時間で最高になり,以後その産生量は急速に減少した.これは,好中球浸潤のピーク(9時間)に先行するものであり,その産生細胞は免疫組織化学的に滑膜表層細胞と判明した.6)抗MCP-1抗体の投与による細胞浸潤の変化を観察すると,LPSによる好中球浸潤に影響はなかったものの,単核球浸潤は有意に抑制された.
    以上の結果から,MCP-1は炎症の極めて早い時期から産生され,単核球浸潤を誘導していることが明らかとなった.しかし我々の結果から,先行して誘導される好中球から産生される単核球遊走因子が,つづいておこる単核球浸潤を誘導するという従来の仮説は否定的であると思われた.今後は,in vivoにおける他の炎症性サイトカインとのカスケード反応について検討する予定である.

    researchmap

▼display all

 

Class subject in charge

  • Basic Cancer Microenvironment (2024academic year) special  - その他

  • Professionalism and Behavior Science 1 (2024academic year) special  - その他

  • Professionalism and Behavior Science 2 (2024academic year) special  - その他

  • Professionalism and Behavior Science 3 (2024academic year) special  - その他

  • Professionalism and Behavior Science 5 (2024academic year) special  - その他

  • Professionalism and Behavior Science 5 (2024academic year) special  - その他

  • Vaccine training (2024academic year) special  - その他

  • Medical Tutorial (2024academic year) 1st semester  - 火2~3

  • Medical Research Internship (2024academic year) special  - その他

  • 早期体験実習 (2024academic year) 特別  - その他

  • Research Presentation in Pathophysiology (2024academic year) special  - その他

  • Pathology (1) (2024academic year) special  - その他

  • Practice in Pathology (1) (2024academic year) special  - その他

  • Practicals: Pathology and Experimental Medicine (2024academic year) special  - その他

  • Research Projects: Pathology and Experimental Medicine (2024academic year) special  - その他

  • Research Projects and Practicals: Pathology and Experimental Medicine I (2024academic year) special  - その他

  • Lecture and Research Projects: Pathology and Experimental Medicine I (2024academic year) special  - その他

  • Research Projects and Practicals: Pathology and Experimental Medicine II (2024academic year) special  - その他

  • Lecture and Research Projects: Pathology and Experimental Medicine II (2024academic year) special  - その他

  • Pathology (2024academic year) Concentration  - その他

  • 選択制臨床実習 (2024academic year) 特別  - その他

  • 0 (2023academic year) special  - その他

  • Professionalism and Behavior Science 2 (2023academic year) special  - その他

  • 0 (2023academic year) special  - その他

  • 0 (2023academic year) special  - その他

  • Professionalism and Behavior Science 5 (2023academic year) special  - その他

  • Vaccine training (2023academic year) special  - その他

  • Medical Tutorial (2023academic year) 1st semester  - 火2~3

  • Medical Tutorial (2023academic year) 1st semester  - 火2~3

  • Metamedica (2023academic year) special  - その他

  • 0 (2023academic year) special  - その他

  • Early Exposure : Introduction to Health Care (2023academic year) special  - その他

  • Research Presentation in Pathophysiology (2023academic year) special  - その他

  • Pathology (1) (2023academic year) special  - その他

  • Practice in Pathology (1) (2023academic year) special  - その他

  • Practicals: Pathology and Experimental Medicine (2023academic year) special  - その他

  • Research Projects: Pathology and Experimental Medicine (2023academic year) special  - その他

  • Research Projects and Practicals: Pathology and Experimental Medicine I (2023academic year) special  - その他

  • Lecture and Research Projects: Pathology and Experimental Medicine I (2023academic year) special  - その他

  • Research Projects and Practicals: Pathology and Experimental Medicine II (2023academic year) special  - その他

  • Lecture and Research Projects: Pathology and Experimental Medicine II (2023academic year) special  - その他

  • Pathology (2023academic year) Concentration  - その他

  • 0 (2023academic year) special  - その他

  • Professionalism and Behavior Science 1 (2022academic year) special  - その他

  • プロフェッショナリズム・行動科学Ⅰ (2022academic year) 特別  - その他

  • Professionalism and Behavior Science 2 (2022academic year) special  - その他

  • プロフェッショナリズム・行動科学Ⅱ (2022academic year) 特別  - その他

  • Professionalism and Behavior Science 3 (2022academic year) special  - その他

  • プロフェッショナリズム・行動科学Ⅲ (2022academic year) 特別  - その他

  • Professionalism and Behavior Science 4 (2022academic year) special  - その他

  • プロフェッショナリズム・行動科学Ⅳ (2022academic year) 特別  - その他

  • Professionalism and Behavior Science 5 (2022academic year) special  - その他

  • Vaccine training (2022academic year) special  - その他

  • Medical Tutorial (2022academic year) 1st semester  - 火2~3

  • Medical Tutorial (2022academic year) 1st semester  - 火2~3

  • Metamedica (2022academic year) special  - その他

  • Medical Research Internship (2022academic year) special  - その他

  • Medical Research Internship (2022academic year) special  - その他

  • Early Exposure : Introduction to Health Care (2022academic year) special  - その他

  • Research Presentation in Pathophysiology (2022academic year) special  - その他

  • Pathology (1) (2022academic year) special  - その他

  • Practice in Pathology (1) (2022academic year) special  - その他

  • Research Projects and Practicals: Pathology and Experimental Medicine I (2022academic year) special  - その他

  • Lecture and Research Projects: Pathology and Experimental Medicine I (2022academic year) special  - その他

  • Research Projects and Practicals: Pathology and Experimental Medicine II (2022academic year) special  - その他

  • Lecture and Research Projects: Pathology and Experimental Medicine II (2022academic year) special  - その他

  • Pathology (2022academic year) Concentration  - その他

  • Professionalism and Behavior Science 1 (2021academic year) special  - その他

  • Professionalism and Behavior Science 2 (2021academic year) special  - その他

  • Professionalism and Behavior Science 3 (2021academic year) special  - その他

  • Professionalism and Behavior Science 4 (2021academic year) special  - その他

  • Professionalism and Behavior Science 5 (2021academic year) special  - その他

  • Vaccine training (2021academic year) special  - その他

  • Medical Tutorial (2021academic year) 1st semester  - 火2~3

  • Medical Tutorial (2021academic year) 1st semester  - 火2~3

  • Metamedica (2021academic year) special  - その他

  • Medical Research Internship (2021academic year) special  - その他

  • Early Exposure : Introduction to Health Care (2021academic year) special  - その他

  • Research Presentation in Pathophysiology (2021academic year) special  - その他

  • Pathology (1) (2021academic year) special  - その他

  • Practice in Pathology (1) (2021academic year) special  - その他

  • Research Projects and Practicals: Pathology and Experimental Medicine I (2021academic year) special  - その他

  • Lecture and Research Projects: Pathology and Experimental Medicine I (2021academic year) special  - その他

  • Research Projects and Practicals: Pathology and Experimental Medicine II (2021academic year) special  - その他

  • Lecture and Research Projects: Pathology and Experimental Medicine II (2021academic year) special  - その他

  • Pathology (2021academic year) Concentration  - その他

  • Professionalism and Behavior Science 1 (2020academic year) special  - その他

  • Professionalism and Behavior Science 2 (2020academic year) special  - その他

  • Professionalism and Behavior Science 3 (2020academic year) special  - その他

  • Professionalism and Behavior Science 4 (2020academic year) special  - その他

  • Professionalism and Behavior Science 5 (2020academic year) special  - その他

  • Medical Tutorial (2020academic year) 1st semester  - 火2,火3

  • Medical Tutorial (2020academic year) 1st semester  - 火2,火3

  • Metamedica (2020academic year) special  - その他

  • Medical Research Internship (2020academic year) special  - その他

  • Early Exposure : Introduction to Health Care (2020academic year) special  - その他

  • Research Presentation in Pathophysiology (2020academic year) Year-round  - その他

  • Pathophysiology (2020academic year) Year-round  - その他

  • Pathology (1) (2020academic year) special  - その他

  • Practice in Pathology (1) (2020academic year) special  - その他

  • Research Projects and Practicals: Pathology and Experimental Medicine I (2020academic year) special  - その他

  • Lecture and Research Projects: Pathology and Experimental Medicine I (2020academic year) special  - その他

  • Research Projects and Practicals: Pathology and Experimental Medicine II (2020academic year) special  - その他

  • Lecture and Research Projects: Pathology and Experimental Medicine II (2020academic year) special  - その他

  • Pathology (2020academic year) Concentration  - その他

▼display all

 

Media Coverage

  • 精密な分子標的型抗がん剤の開発 -より副作用の少ない、より効果的な抗がん剤治療のために- Newspaper, magazine

    産経新聞  2021.8.21

     More details

  • 医を紡ぐ 岡山大学医学部150年 第3部未来を担うインタビュー Newspaper, magazine

    山陽新聞社  山陽新聞  2020.8.30

  • 医を紡ぐ 岡山大学医学部150年 第3部未来を担う(1)即戦力 現場主義で臨床力強化 Newspaper, magazine

    山陽新聞社  山陽新聞  2020.8.24

  • 国立大初のバカロレア入試は岡山大学 狙いは「コミュニケーション力」 Newspaper, magazine

    朝日新聞社  Asahi Globe+  2018.6.30

  • グローバルドクターの時代! Newspaper, magazine

    週刊ダイヤモンド  2016.12.17

  • 医療用ねじに抗菌薬塗布 Internet

    株式会社瀬戸内海経済レポート  VISION 岡山  2014.11.10

  • 岡山県産業振興財団、岡山大などと抗菌薬をコーティングした骨ネジの開発プロ始動 Newspaper, magazine

    日刊工業新聞  日刊工業新聞  2014.10.30

  • 抗菌薬塗布骨スクリュー開発 Newspaper, magazine

    山陽新聞社  山陽新聞  2014.10.28

  • 学生にプロ意識をー医学教育改革 TV or radio program

    KSB瀬戸内海放送  2013.1.10

  • 医療の架け橋 Newspaper, magazine

    山陽新聞社  山陽新聞  2011.11.25

  • いきいき健康 Newspaper, magazine

    山陽新聞社  山陽新聞  2010.9.26

  • 臨床力強化へ「参加型」実習 Newspaper, magazine

    山陽新聞社  山陽新聞  2010.7.28

  • 地域医療シンポジウム TV or radio program

    NHK岡山放送  2010.2.16

  • 見学型から参加型実習へ Newspaper, magazine

    山陽新聞社  山陽新聞  2010.1.23

▼display all